1	nature	NN	O	nature	nn	3	SENT_1	[p1l21t124r112b145],
2	publishing	NN	O	publishing	nn	3	SENT_1	[p1l121t120r269b152],
3	group	NN	O	group	nsubj	4	SENT_1	[p1l278t127r362b152],
4	S	NN	O	s	_	0	SENT_1	[p1l1761t108r1783b145],
5	^	CD	NUMBER	^	num	6	SENT_1	[p1l1790t108r1873b145],
6	Mg	NN	O	mg	dobj	4	SENT_1	[p1l1790t108r1873b145],
7	+	CC	O	+	_	0	SENT_1	[p1l1790t108r1873b145],
8	E	NN	O	e	dobj	4	SENT_1	[p1l1882t108r1902b145],
9	A	DT	O	a	det	10	SENT_1	[p1l2045t108r2073b145],
10	Z3c	NN	O	z3c	dep	8	SENT_1	[p1l2082t108r2139b145],
11	+	CC	O	+	_	0	SENT_1	[p1l2082t108r2139b145],
12	Open	VB	O	open	conj_+	8	SENT_1	[p1l22t178r158b241],

1	A	DT	O	a	det	4	SENT_2	[p1l22t321r80b392],
2	Proposal	NN	O	proposal	nn	4	SENT_2	[p1l108t317r468b413],
3	for	IN	O	for	amod	4	SENT_2	[p1l495t316r612b393],
4	lnteg	NN	O	lnteg	_	0	SENT_2	[p1l639t321r851b414],
5	rated	VBN	O	rate	partmod	4	SENT_2	[p1l865t317r1078b393],
6	Efficacy	NNP	O	Efficacy	dep	12	SENT_2	[p1l1111t316r1586b415],
7	—	CD	NUMBER	—	num	6	SENT_2	[p1l1111t316r1586b415],
8	to	TO	O	to	_	0	SENT_2	[p1l1111t316r1586b415],
9	—	CD	NUMBER	—	prep_to	6	SENT_2	[p1l1111t316r1586b415],
10	Effectiveness	NN	O	effectiveness	dep	12	SENT_2	[p1l27t428r577b505],
11	(	CD	NUMBER	(	num	10	SENT_2	[p1l605t431r807b516],
12	E2E	NN	O	e2e	dep	4	SENT_2	[p1l605t431r807b516],
13	)	CD	NUMBER	)	num	15	SENT_2	[p1l605t431r807b516],
14	Clinical	JJ	O	clinical	amod	15	SENT_2	[p1l835t429r1136b505],
15	Trials	NNS	O	trial	dep	12	SENT_2	[p1l1156t429r1374b505],

1	HP	NNP	O	HP	nn	2	SENT_3	[p1l21t580r86b614],
2	Selkerm	NNP	O	Selkerm	dep	31	SENT_3	[p1l98t572r279b620],
3	,	,	O	,	_	0	SENT_3	[p1l98t572r279b620],
4	KA	NN	O	ka	nn	5	SENT_3	[p1l291t580r358b614],
5	Oye3	NN	O	oye3	appos	2	SENT_3	[p1l369t572r479b626],
6	,	,	O	,	_	0	SENT_3	[p1l369t572r479b626],
7	H-G	NN	O	h-g	nn	8	SENT_3	[p1l491t580r581b614],
8	Eichler4	NN	O	eichler4	appos	2	SENT_3	[p1l592t572r766b620],
9	,	,	O	,	_	0	SENT_3	[p1l592t572r766b620],
10	NL	NNP	ORGANIZATION	NL	nn	11	SENT_3	[p1l777t580r841b614],
11	Stockbridge5	NNP	O	Stockbridge5	appos	2	SENT_3	[p1l851t573r1123b626],
12	,	,	O	,	_	0	SENT_3	[p1l851t573r1123b626],
13	CR	JJ	O	cr	amod	14	SENT_3	[p1l1135t580r1199b614],
14	Mehta6	NN	O	mehta6	appos	2	SENT_3	[p1l1209t572r1367b620],
15	,	,	O	,	_	0	SENT_3	[p1l1209t572r1367b620],
16	KI	NNP	O	KI	nn	18	SENT_3	[p1l1379t580r1429b614],
17	Kaitin1	NNP	O	Kaitin1	nn	18	SENT_3	[p1l1441t572r1624b620],
18	’	NN	O	’	appos	2	SENT_3	[p1l1441t572r1624b620],
19	7	CD	NUMBER	7	num	18	SENT_3	[p1l1441t572r1624b620],
20	,	,	O	,	_	0	SENT_3	[p1l1441t572r1624b620],
21	NE	NN	O	ne	nn	22	SENT_3	[p1l1635t580r1700b614],
22	McElwee8	NN	O	mcelwee8	appos	2	SENT_3	[p1l1710t572r1923b620],
23	,	,	O	,	_	0	SENT_3	[p1l1710t572r1923b620],
24	PK	NN	O	pk	nn	25	SENT_3	[p1l21t643r83b676],
25	Honig9	NN	O	honig9	appos	2	SENT_3	[p1l93t635r250b688],
26	,	,	O	,	_	0	SENT_3	[p1l93t635r250b688],
27	IK	NN	O	ik	appos	2	SENT_3	[p1l261t643r312b684],
28	Erban1	NN	O	erban1	dep	31	SENT_3	[p1l322t635r510b676],
29	’	CD	NUMBER	’	num	28	SENT_3	[p1l322t635r510b676],
30	1	CD	NUMBER	1	num	31	SENT_3	[p1l322t635r510b676],
31	°	NN	O	°	dep	36	SENT_3	[p1l322t635r510b676],
32	and	CC	O	and	_	0	SENT_3	[p1l521t640r597b676],
33	RB	NN	O	rb	nn	34	SENT_3	[p1l607t643r667b676],
34	D’Agostino	NN	O	d’agostino	dep	36	SENT_3	[p1l679t635r987b688],
35	”’	CD	NUMBER	”’	num	36	SENT_3	[p1l679t635r987b688],
36	12	CD	NUMBER	12	_	0	SENT_3	[p1l679t635r987b688],

1	We	PRP	O	we	nsubj	2	SENT_4	[p1l20t762r74b791],
2	propose	VBP	O	propose	_	0	SENT_4	[p1l84t769r228b799],
3	an	DT	O	a	det	12	SENT_4	[p1l237t769r278b791],
4	"	``	O	"	punct	12	SENT_4	[p1l285t760r748b799],
5	efficacy-to-effectiveness	NN	O	efficacy-to-effectiveness	nn	12	SENT_4	[p1l285t760r748b799],
6	”	CD	NUMBER	”	num	12	SENT_4	[p1l285t760r748b799],
7	(	CD	NUMBER	(	num	12	SENT_4	[p1l755t761r840b795],
8	E2E	NN	O	e2e	nn	12	SENT_4	[p1l755t761r840b795],
9	)	CD	NUMBER	)	num	12	SENT_4	[p1l755t761r840b795],
10	clinical	JJ	O	clinical	amod	12	SENT_4	[p1l850t760r970b791],
11	trial	NN	O	trial	nn	12	SENT_4	[p1l979t760r1047b791],
12	design	NN	O	design	dep	2	SENT_4	[p1l1058t760r1185b799],
13	,	,	O	,	_	0	SENT_4	[p1l1058t760r1185b799],
14	in	IN	O	in	_	0	SENT_4	[p1l1195t761r1225b790],
15	which	WDT	O	which	dobj	20	SENT_4	[p1l1234t760r1339b791],
16	an	DT	O	a	det	18	SENT_4	[p1l1349t769r1390b791],
17	effectiveness	NN	O	effectiveness	nn	18	SENT_4	[p1l1400t760r1631b791],
18	trial	NN	O	trial	nsubj	20	SENT_4	[p1l1639t760r1707b791],
19	would	MD	O	would	aux	20	SENT_4	[p1l1717t760r1826b791],
20	commence	VB	O	commence	prepc_in	2	SENT_4	[p1l1836t769r2030b791],
21	seamlessly	RB	O	seamlessly	advmod	20	SENT_4	[p1l21t813r211b853],
22	upon	IN	O	upon	_	0	SENT_4	[p1l220t822r310b852],
23	completion	NN	O	completion	prep_upon	20	SENT_4	[p1l320t813r521b852],
24	of	IN	O	of	_	0	SENT_4	[p1l531t813r568b844],
25	the	DT	O	the	det	27	SENT_4	[p1l573t813r631b844],
26	efficacy	NN	O	efficacy	nn	27	SENT_4	[p1l640t813r776b853],
27	trial	NN	O	trial	prep_of	23	SENT_4	[p1l783t813r862b844],
28	.	.	O	.	_	0	SENT_4	[p1l783t813r862b844],

1	Efﬁcacy	NN	O	efﬁcacy	nn	2	SENT_5	[p1l871t813r1004b853],
2	trials	NNS	O	trial	nsubj	3	SENT_5	[p1l1010t813r1095b844],
3	use	VBP	O	use	_	0	SENT_5	[p1l1105t822r1163b844],
4	inclusion/exclusion	NN	O	inclusion/exclusion	nn	5	SENT_5	[p1l1173t813r1511b846],
5	criteria	NNS	O	criterion	nsubj	7	SENT_5	[p1l1521t814r1643b844],
6	to	TO	O	to	aux	7	SENT_5	[p1l1652t818r1688b844],
7	produce	VB	O	produce	xcomp	3	SENT_5	[p1l1698t813r1844b852],
8	relatively	RB	O	relatively	advmod	9	SENT_5	[p1l1854t813r2016b853],
9	homogeneous	JJ	O	homogeneous	amod	10	SENT_5	[p1l22t868r277b906],
10	samples	NNS	O	sample	dobj	7	SENT_5	[p1l287t868r430b906],
11	of	IN	O	of	_	0	SENT_5	[p1l439t867r476b898],
12	participants	NNS	O	participant	prep_of	10	SENT_5	[p1l483t868r695b906],
13	with	IN	O	with	_	0	SENT_5	[p1l703t868r780b898],
14	the	DT	O	the	det	16	SENT_5	[p1l789t868r847b898],
15	target	NN	O	target	nn	16	SENT_5	[p1l855t872r963b906],
16	condition	NN	O	condition	prep_with	7	SENT_5	[p1l972t868r1150b903],
17	,	,	O	,	_	0	SENT_5	[p1l972t868r1150b903],
18	conducted	VBN	O	conduct	partmod	16	SENT_5	[p1l1159t868r1347b898],
19	in	IN	O	in	_	0	SENT_5	[p1l1358t868r1388b898],
20	settings	NNS	O	setting	prep_in	18	SENT_5	[p1l1398t868r1538b906],
21	that	WDT	O	that	nsubj	22	SENT_5	[p1l1546t868r1618b898],
22	foster	VBP	O	foster	rcmod	20	SENT_5	[p1l1626t867r1728b898],
23	adherence	NN	O	adherence	dobj	22	SENT_5	[p1l1737t868r1923b898],
24	to	TO	O	to	_	0	SENT_5	[p1l1931t872r1967b898],
25	rigorous	JJ	O	rigorous	amod	27	SENT_5	[p1l1977t868r2124b906],
26	clinical	JJ	O	clinical	amod	27	SENT_5	[p1l20t921r140b952],
27	protocols	NNS	O	protocol	prep_to	22	SENT_5	[p1l152t921r326b960],
28	.	.	O	.	_	0	SENT_5	[p1l152t921r326b960],

1	Effectiveness	NN	O	effectiveness	nn	2	SENT_6	[p1l334t921r555b952],
2	trials	NNS	O	trial	nsubj	3	SENT_6	[p1l563t921r648b952],
3	use	VBP	O	use	_	0	SENT_6	[p1l658t930r716b952],
4	inclusion/exclusion	NN	O	inclusion/exclusion	nn	5	SENT_6	[p1l726t921r1064b953],
5	criteria	NNS	O	criterion	dobj	3	SENT_6	[p1l1074t922r1196b952],
6	that	WDT	O	that	nsubj	7	SENT_6	[p1l1205t921r1277b952],
7	generate	VBP	O	generate	rcmod	5	SENT_6	[p1l1286t925r1444b960],
8	heterogeneous	JJ	O	heterogeneous	amod	9	SENT_6	[p1l1454t921r1722b960],
9	samples	NNS	O	sample	dobj	7	SENT_6	[p1l1731t921r1875b959],
10	that	WDT	O	that	nsubj	13	SENT_6	[p1l1884t921r1956b952],
11	are	VBP	O	be	cop	13	SENT_6	[p1l1964t930r2019b952],
12	more	RBR	O	more	advmod	13	SENT_6	[p1l21t983r112b1005],
13	similar	JJ	O	similar	rcmod	9	SENT_6	[p1l121t974r239b1005],
14	to	TO	O	to	_	0	SENT_6	[p1l246t978r282b1005],
15	the	DT	O	the	det	18	SENT_6	[p1l290t974r348b1005],
16	general	JJ	O	general	amod	18	SENT_6	[p1l357t974r489b1013],
17	patient	NN	O	patient	nn	18	SENT_6	[p1l501t975r626b1013],
18	spectrum	NN	O	spectrum	prep_to	13	SENT_6	[p1l635t978r812b1013],
19	,	,	O	,	_	0	SENT_6	[p1l635t978r812b1013],
20	conducted	VBN	O	conduct	partmod	18	SENT_6	[p1l821t974r1008b1005],
21	in	IN	O	in	_	0	SENT_6	[p1l1020t975r1049b1004],
22	more	RBR	O	more	advmod	24	SENT_6	[p1l1060t983r1151b1005],
23	varied	JJ	O	varied	amod	24	SENT_6	[p1l1159t974r1269b1005],
24	settings	NNS	O	setting	prep_in	20	SENT_6	[p1l1279t975r1428b1013],
25	,	,	O	,	_	0	SENT_6	[p1l1279t975r1428b1013],
26	with	IN	O	with	_	0	SENT_6	[p1l1436t974r1513b1005],
27	protocols	NNS	O	protocol	prep_with	24	SENT_6	[p1l1524t974r1689b1013],
28	that	WDT	O	that	nsubj	29	SENT_6	[p1l1697t974r1769b1005],
29	approximate	JJ	O	approximate	rcmod	27	SENT_6	[p1l1778t975r2004b1013],
30	typical	JJ	O	typical	amod	32	SENT_6	[p1l20t1028r137b1067],
31	clinical	JJ	O	clinical	amod	32	SENT_6	[p1l147t1028r267b1058],
32	care	NN	O	care	dobj	29	SENT_6	[p1l277t1037r359b1058],
33	.	.	O	.	_	0	SENT_6	[p1l277t1037r359b1058],

1	In	IN	O	in	_	0	SENT_7	[p1l369t1029r399b1058],
2	E2E	NN	O	e2e	nn	3	SENT_7	[p1l411t1029r472b1058],
3	trials	NNS	O	trial	prep_in	13	SENT_7	[p1l480t1028r576b1063],
4	,	,	O	,	_	0	SENT_7	[p1l480t1028r576b1063],
5	results	VBZ	O	result	csubjpass	13	SENT_7	[p1l586t1028r701b1058],
6	from	IN	O	from	_	0	SENT_7	[p1l709t1027r792b1058],
7	the	DT	O	the	det	10	SENT_7	[p1l801t1028r859b1058],
8	efficacy	NN	O	efficacy	nn	10	SENT_7	[p1l868t1027r1004b1067],
9	trial	NN	O	trial	nn	10	SENT_7	[p1l1011t1028r1079b1058],
10	component	NN	O	component	prep_from	5	SENT_7	[p1l1090t1032r1294b1066],
11	would	MD	O	would	aux	13	SENT_7	[p1l1302t1028r1411b1058],
12	be	VB	O	be	auxpass	13	SENT_7	[p1l1423t1028r1465b1058],
13	used	VBN	O	use	_	0	SENT_7	[p1l1475t1028r1556b1058],
14	to	TO	O	to	aux	15	SENT_7	[p1l1566t1032r1602b1058],
15	design	VB	O	design	xcomp	13	SENT_7	[p1l1611t1028r1727b1067],
16	the	DT	O	the	det	19	SENT_7	[p1l1736t1028r1794b1058],
17	effectiveness	NN	O	effectiveness	nn	19	SENT_7	[p1l1803t1027r2034b1058],
18	trial	NN	O	trial	nn	19	SENT_7	[p1l2042t1028r2111b1058],
19	component	NN	O	component	dobj	15	SENT_7	[p1l20t1085r234b1119],
20	,	,	O	,	_	0	SENT_7	[p1l20t1085r234b1119],
21	to	TO	O	to	aux	22	SENT_7	[p1l242t1085r278b1112],
22	confirm	VB	O	confirm	ccomp	13	SENT_7	[p1l287t1081r422b1112],
23	and/or	JJ	O	and/or	acomp	22	SENT_7	[p1l432t1081r551b1113],
24	discern	VBP	O	discern	ccomp	23	SENT_7	[p1l559t1081r685b1112],
25	associations	NNS	O	association	dobj	24	SENT_7	[p1l695t1082r910b1112],
26	between	IN	O	between	_	0	SENT_7	[p1l920t1081r1073b1112],
27	clinical	JJ	O	clinical	amod	28	SENT_7	[p1l1083t1081r1203b1112],
28	characteristics	NNS	O	characteristic	prep_between	25	SENT_7	[p1l1213t1081r1466b1112],
29	and	CC	O	and	_	0	SENT_7	[p1l1475t1081r1541b1112],
30	treatment	NN	O	treatment	nn	31	SENT_7	[p1l1550t1085r1728b1112],
31	effects	NNS	O	effect	conj_and	28	SENT_7	[p1l1737t1081r1853b1112],
32	in	IN	O	in	_	0	SENT_7	[p1l1864t1082r1893b1111],
33	typical	JJ	O	typical	amod	34	SENT_7	[p1l1902t1081r2020b1120],
34	care	NN	O	care	prep_in	28	SENT_7	[p1l2030t1090r2112b1116],
35	,	,	O	,	_	0	SENT_7	[p1l2030t1090r2112b1116],
36	and	CC	O	and	_	0	SENT_7	[p1l20t1134r86b1165],
37	potentially	RB	O	potentially	advmod	22	SENT_7	[p1l97t1134r288b1174],
38	to	TO	O	to	aux	39	SENT_7	[p1l295t1139r331b1165],
39	test	VB	O	test	conj_and	22	SENT_7	[p1l340t1139r405b1165],
40	new	JJ	O	new	amod	41	SENT_7	[p1l415t1143r488b1165],
41	hypotheses	NNS	O	hypothesis	dobj	39	SENT_7	[p1l498t1134r710b1174],
42	.	.	O	.	_	0	SENT_7	[p1l498t1134r710b1174],

1	An	DT	O	a	det	3	SENT_8	[p1l718t1136r765b1165],
2	E2E	NN	O	e2e	nn	3	SENT_8	[p1l776t1136r837b1165],
3	approach	NN	O	approach	nsubj	5	SENT_8	[p1l846t1134r1013b1173],
4	may	MD	O	may	aux	5	SENT_8	[p1l1024t1143r1098b1174],
5	improve	VB	O	improve	_	0	SENT_8	[p1l1107t1135r1252b1173],
6	the	DT	O	the	det	8	SENT_8	[p1l1260t1134r1318b1165],
7	evidentiary	JJ	O	evidentiary	amod	8	SENT_8	[p1l1327t1134r1529b1174],
8	basis	NN	O	basis	dobj	5	SENT_8	[p1l1538t1134r1625b1165],
9	for	IN	O	for	_	0	SENT_8	[p1l1633t1134r1683b1165],
10	selecting	VBG	O	select	prepc_for	5	SENT_8	[p1l1691t1134r1849b1174],
11	treatments	NNS	O	treatment	dobj	10	SENT_8	[p1l1858t1139r2063b1170],
12	,	,	O	,	_	0	SENT_8	[p1l1858t1139r2063b1170],
13	expand	VB	O	expand	dep	5	SENT_8	[p1l20t1189r151b1227],
14	understanding	NN	O	understanding	dobj	13	SENT_8	[p1l162t1189r423b1227],
15	of	IN	O	of	_	0	SENT_8	[p1l433t1188r469b1219],
16	the	DT	O	the	det	17	SENT_8	[p1l475t1189r533b1219],
17	effectiveness	NN	O	effectiveness	prep_of	14	SENT_8	[p1l542t1188r773b1219],
18	of	IN	O	of	_	0	SENT_8	[p1l782t1188r818b1219],
19	treatments	NNS	O	treatment	prep_of	17	SENT_8	[p1l824t1193r1019b1219],
20	in	IN	O	in	_	0	SENT_8	[p1l1029t1189r1059b1219],
21	subgroups	NNS	O	subgroup	prep_in	19	SENT_8	[p1l1069t1189r1257b1227],
22	with	IN	O	with	_	0	SENT_8	[p1l1266t1189r1342b1219],
23	particular	JJ	O	particular	amod	25	SENT_8	[p1l1354t1189r1525b1227],
24	clinical	JJ	O	clinical	amod	25	SENT_8	[p1l1533t1189r1653b1219],
25	features	NNS	O	feature	prep_with	21	SENT_8	[p1l1662t1188r1815b1224],
26	,	,	O	,	_	0	SENT_8	[p1l1662t1188r1815b1224],
27	and	CC	O	and	_	0	SENT_8	[p1l1824t1189r1889b1219],
28	foster	JJ	O	foster	amod	29	SENT_8	[p1l1899t1188r2001b1219],
29	incorporation	NN	O	incorporation	dobj	13	SENT_8	[p1l21t1243r261b1281],
30	of	IN	O	of	_	0	SENT_8	[p1l271t1242r308b1273],
31	effectiveness	NN	O	effectiveness	nn	32	SENT_8	[p1l314t1242r545b1273],
32	information	NN	O	information	prep_of	29	SENT_8	[p1l556t1242r763b1273],
33	into	IN	O	into	_	0	SENT_8	[p1l774t1243r842b1273],
34	regulatory	JJ	O	regulatory	amod	35	SENT_8	[p1l852t1242r1038b1281],
35	processes	NNS	O	process	prep_into	13	SENT_8	[p1l1047t1251r1227b1281],
36	.	.	O	.	_	0	SENT_8	[p1l1047t1251r1227b1281],

1	This	DT	O	this	det	2	SENT_9	[p1l7t1437r167b1500],
2	article	NN	O	article	nsubj	3	SENT_9	[p1l201t1437r429b1500],
3	proposes	VBZ	O	propose	_	0	SENT_9	[p1l460t1459r789b1520],
4	an	DT	O	a	det	11	SENT_9	[p1l823t1460r906b1500],
5	“	NN	O	“	nn	11	SENT_9	[p1l940t1437r1901b1521],
6	efficacy-to-effectiveness	NN	O	efficacy-to-effectiveness	nn	11	SENT_9	[p1l940t1437r1901b1521],
7	”	CD	NUMBER	”	num	11	SENT_9	[p1l940t1437r1901b1521],
8	(	CD	NUMBER	(	num	11	SENT_9	[p1l1938t1437r2139b1514],
9	E2E	NN	O	e2e	nn	11	SENT_9	[p1l1938t1437r2139b1514],
10	)	CD	NUMBER	)	num	11	SENT_9	[p1l1938t1437r2139b1514],
11	approach	NN	O	approach	dobj	3	SENT_9	[p1l8t1540r334b1623],
12	to	TO	O	to	_	0	SENT_9	[p1l358t1552r426b1603],
13	clinical	JJ	O	clinical	amod	14	SENT_9	[p1l452t1540r706b1603],
14	trials	NNS	O	trial	prep_to	3	SENT_9	[p1l728t1540r905b1603],
15	that	WDT	O	that	nsubj	16	SENT_9	[p1l930t1540r1068b1603],
16	includes	VBZ	O	include	rcmod	14	SENT_9	[p1l1091t1540r1383b1603],
17	a	DT	O	a	det	19	SENT_9	[p1l1409t1563r1444b1603],
18	seamless	JJ	O	seamless	amod	19	SENT_9	[p1l1468t1540r1772b1603],
19	transition	NN	O	transition	dobj	16	SENT_9	[p1l1796t1546r2142b1603],
20	from	IN	O	from	_	0	SENT_9	[p1l7t1643r175b1706],
21	efﬁcacy	NN	O	efﬁcacy	prep_from	19	SENT_9	[p1l199t1643r457b1727],
22	to	TO	O	to	_	0	SENT_9	[p1l475t1655r541b1706],
23	effectiveness	NN	O	effectiveness	nn	24	SENT_9	[p1l565t1643r992b1706],
24	trials	NNS	O	trial	prep_to	16	SENT_9	[p1l1014t1643r1203b1706],
25	.	.	O	.	_	0	SENT_9	[p1l1014t1643r1203b1706],

1	Our	PRP$	O	we	poss	2	SENT_10	[p1l1230t1647r1370b1706],
2	proposal	NN	O	proposal	nsubjpass	4	SENT_10	[p1l1390t1643r1690b1726],
3	is	VBZ	O	be	auxpass	4	SENT_10	[p1l1712t1649r1762b1706],
4	structured	VBN	O	structure	_	0	SENT_10	[p1l1786t1643r2143b1706],
5	to	TO	O	to	aux	6	SENT_10	[p1l7t1758r73b1809],
6	capture	VB	O	capture	xcomp	4	SENT_10	[p1l98t1758r354b1829],
7	the	DT	O	the	det	8	SENT_10	[p1l376t1746r484b1809],
8	beneﬁts	NNS	O	beneﬁts	dobj	6	SENT_10	[p1l506t1746r776b1809],
9	of	IN	O	of	_	0	SENT_10	[p1l800t1746r875b1809],
10	an	DT	O	a	det	13	SENT_10	[p1l889t1769r970b1809],
11	integrated	VBN	O	integrate	amod	13	SENT_10	[p1l993t1746r1345b1830],
12	E2E	NN	O	e2e	nn	13	SENT_10	[p1l1367t1751r1505b1808],
13	approach	NN	O	approach	prep_of	8	SENT_10	[p1l1529t1746r1850b1829],
14	without	IN	O	without	_	0	SENT_10	[p1l1871t1746r2143b1809],
15	delaying	VBG	O	delay	prepc_without	6	SENT_10	[p1l8t1849r300b1933],
16	regulatory	JJ	O	regulatory	amod	17	SENT_10	[p1l321t1849r682b1933],
17	review	NN	O	review	dobj	15	SENT_10	[p1l701t1855r931b1912],
18	and	CC	O	and	_	0	SENT_10	[p1l953t1849r1080b1912],
19	approval	NN	O	approval	conj_and	17	SENT_10	[p1l1103t1849r1417b1932],
20	.	.	O	.	_	0	SENT_10	[p1l1103t1849r1417b1932],

1	This	DT	O	this	det	2	SENT_11	[p1l1443t1849r1587b1912],
2	approach	NN	O	approach	nsubj	3	SENT_11	[p1l1612t1849r1932b1932],
3	offers	VBZ	O	offer	_	0	SENT_11	[p1l1956t1849r2144b1912],
4	logistical	JJ	O	logistical	amod	5	SENT_11	[p1l6t1952r312b2036],
5	advantages	NNS	O	advantage	dobj	3	SENT_11	[p1l334t1952r708b2036],
6	by	IN	O	by	_	0	SENT_11	[p1l727t1952r812b2036],
7	minimizing	VBG	O	minimize	prepc_by	3	SENT_11	[p1l829t1958r1232b2036],
8	start-up	JJ	O	start-up	amod	9	SENT_11	[p1l1254t1964r1523b2035],
9	costs	NNS	O	cost	dobj	7	SENT_11	[p1l1546t1964r1711b2015],
10	by	IN	O	by	_	0	SENT_11	[p1l1731t1952r1816b2036],
11	using	VBG	O	use	prepc_by	7	SENT_11	[p1l1833t1958r2019b2036],
12	the	DT	O	the	det	16	SENT_11	[p1l2038t1952r2144b2015],
13	existing	VBG	O	exist	amod	16	SENT_11	[p1l8t2061r280b2139],
14	efficacy	NN	O	efficacy	nn	16	SENT_11	[p1l302t2055r564b2139],
15	trial	NN	O	trial	nn	16	SENT_11	[p1l583t2055r727b2118],
16	infrastructure	NN	O	infrastructure	dobj	11	SENT_11	[p1l749t2055r1252b2118],
17	.	.	O	.	_	0	SENT_11	[p1l749t2055r1252b2118],

1	More	RBR	O	more	advmod	2	SENT_12	[p1l1278t2060r1463b2118],
2	important	JJ	O	important	advmod	5	SENT_12	[p1l1487t2061r1859b2138],
3	,	,	O	,	_	0	SENT_12	[p1l1487t2061r1859b2138],
4	it	PRP	O	it	nsubj	5	SENT_12	[p1l1884t2061r1931b2118],
5	offers	VBZ	O	offer	_	0	SENT_12	[p1l1954t2055r2143b2118],
6	the	DT	O	the	det	7	SENT_12	[p1l7t2158r116b2221],
7	opportunity	NN	O	opportunity	dobj	5	SENT_12	[p1l142t2164r573b2242],
8	for	IN	O	for	_	0	SENT_12	[p1l594t2158r694b2221],
9	improved	VBN	O	improve	amod	10	SENT_12	[p1l718t2158r1059b2241],
10	understanding	NN	O	understanding	prep_for	7	SENT_12	[p1l1082t2158r1603b2242],
11	of	IN	O	of	_	0	SENT_12	[p1l1627t2158r1703b2221],
12	how	WRB	O	how	advmod	16	SENT_12	[p1l1717t2158r1869b2221],
13	a	DT	O	a	det	14	SENT_12	[p1l1891t2181r1927b2221],
14	treatment	NN	O	treatment	nsubj	16	SENT_12	[p1l1949t2170r2139b2221, p1l7t2273r189b2324],
15	will	MD	O	will	aux	16	SENT_12	[p1l210t2261r341b2324],
16	work	VB	O	work	prepc_of	10	SENT_12	[p1l363t2261r545b2324],
17	in	IN	O	in	_	0	SENT_12	[p1l567t2267r635b2323],
18	practice	NN	O	practice	prep_in	16	SENT_12	[p1l658t2267r939b2344],
19	in	IN	O	in	_	0	SENT_12	[p1l964t2267r1032b2323],
20	patients	NNS	O	patient	prep_in	18	SENT_12	[p1l1056t2267r1334b2344],
21	with	IN	O	with	_	0	SENT_12	[p1l1357t2261r1515b2324],
22	a	DT	O	a	det	24	SENT_12	[p1l1540t2284r1575b2324],
23	typical	JJ	O	typical	amod	24	SENT_12	[p1l1597t2261r1834b2345],
24	range	NN	O	range	prep_with	16	SENT_12	[p1l1858t2284r2052b2345],
25	of	IN	O	of	_	0	SENT_12	[p1l2077t2261r2153b2324],
26	characteristics	NNS	O	characteristic	prep_of	24	SENT_12	[p1l8t2363r524b2435],
27	,	,	O	,	_	0	SENT_12	[p1l8t2363r524b2435],
28	comorbidities	NNS	O	comorbidity	conj_and	26	SENT_12	[p1l550t2363r1048b2435],
29	,	,	O	,	_	0	SENT_12	[p1l550t2363r1048b2435],
30	and	CC	O	and	_	0	SENT_12	[p1l1074t2363r1202b2427],
31	treatment	NN	O	treatment	nn	32	SENT_12	[p1l1223t2375r1564b2427],
32	adherence	NN	O	adherence	conj_and	26	SENT_12	[p1l1587t2363r1960b2435],
33	,	,	O	,	_	0	SENT_12	[p1l1587t2363r1960b2435],
34	such	JJ	O	such	_	0	SENT_12	[p1l1986t2363r2142b2427],
35	as	IN	O	as	_	0	SENT_12	[p1l8t2490r72b2530],
36	those	DT	O	those	prep_such_as	24	SENT_12	[p1l94t2467r276b2530],
37	seen	VBN	O	see	partmod	36	SENT_12	[p1l299t2490r448b2530],
38	in	IN	O	in	_	0	SENT_12	[p1l470t2473r536b2529],
39	more	JJR	O	more	dep	40	SENT_12	[p1l558t2490r735b2530],
40	usual	JJ	O	usual	amod	42	SENT_12	[p1l757t2467r937b2530],
41	clinical	JJ	O	clinical	amod	42	SENT_12	[p1l959t2467r1203b2530],
42	settings	NNS	O	setting	prep_in	37	SENT_12	[p1l1226t2473r1501b2551],
43	.	.	O	.	_	0	SENT_12	[p1l1226t2473r1501b2551],

1	In	IN	O	in	_	0	SENT_13	[p1l82t2575r156b2632],
2	addition	NN	O	addition	_	0	SENT_13	[p1l183t2570r487b2633],
3	to	TO	O	to	_	0	SENT_13	[p1l512t2582r581b2633],
4	these	DT	O	these	det	6	SENT_13	[p1l607t2570r793b2633],
5	medical	JJ	O	medical	amod	6	SENT_13	[p1l819t2570r1105b2633],
6	beneﬁts	NNS	O	beneﬁts	prep_in_addition_to	14	SENT_13	[p1l1128t2570r1430b2642],
7	,	,	O	,	_	0	SENT_13	[p1l1128t2570r1430b2642],
8	facilitation	NN	O	facilitation	nsubj	14	SENT_13	[p1l1458t2570r1850b2633],
9	of	IN	O	of	_	0	SENT_13	[p1l1877t2570r1954b2633],
10	early	JJ	O	early	amod	12	SENT_13	[p1l1971t2570r2147b2654],
11	effectiveness	NN	O	effectiveness	nn	12	SENT_13	[p1l8t2673r455b2736],
12	results	NNS	O	result	prep_of	8	SENT_13	[p1l481t2673r712b2736],
13	could	MD	O	could	aux	14	SENT_13	[p1l739t2673r937b2736],
14	have	VB	O	have	_	0	SENT_13	[p1l961t2673r1122b2736],
15	a	DT	O	a	det	16	SENT_13	[p1l1149t2696r1183b2736],
16	role	NN	O	role	dobj	14	SENT_13	[p1l1208t2673r1342b2736],
17	in	IN	O	in	_	0	SENT_13	[p1l1369t2679r1437b2735],
18	the	DT	O	the	det	19	SENT_13	[p1l1462t2673r1572b2736],
19	availability	NN	O	availability	prep_in	16	SENT_13	[p1l1599t2673r1991b2757],
20	and	CC	O	and	_	0	SENT_13	[p1l2015t2673r2145b2736],
21	use	NN	O	use	conj_and	19	SENT_13	[p1l7t2799r119b2839],
22	of	IN	O	of	_	0	SENT_13	[p1l143t2776r218b2839],
23	treatments	NNS	O	treatment	prep_of	19	SENT_13	[p1l230t2788r621b2839],
24	.	.	O	.	_	0	SENT_13	[p1l230t2788r621b2839],

1	Payers	NNS	O	payer	nsubj	2	SENT_14	[p1l647t2781r868b2860],
2	point	VBP	O	point	_	0	SENT_14	[p1l890t2782r1076b2859],
3	out	RP	O	out	prt	2	SENT_14	[p1l1099t2788r1211b2839],
4	that	IN	O	that	complm	8	SENT_14	[p1l1232t2776r1368b2839],
5	eﬂicacy	NN	O	eﬂicacy	nn	6	SENT_14	[p1l1390t2776r1651b2860],
6	trials	NNS	O	trial	nsubj	11	SENT_14	[p1l1669t2776r1844b2839],
7	are	VBP	O	be	cop	8	SENT_14	[p1l1868t2799r1970b2839],
8	necessary	JJ	O	necessary	ccomp	2	SENT_14	[p1l1993t2799r2140b2839, p1l8t2902r228b2963],
9	but	CC	O	but	_	0	SENT_14	[p1l249t2879r366b2942],
10	not	RB	O	not	_	0	SENT_14	[p1l391t2891r509b2942],
11	sufﬁcient	JJ	O	sufﬁcient	conj_negcc	8	SENT_14	[p1l534t2879r859b2942],
12	to	TO	O	to	aux	13	SENT_14	[p1l883t2891r951b2942],
13	inform	VB	O	inform	xcomp	11	SENT_14	[p1l978t2879r1226b2942],
14	decisions	NNS	O	decision	dobj	13	SENT_14	[p1l1252t2879r1581b2942],
15	about	IN	O	about	_	0	SENT_14	[p1l1608t2879r1809b2942],
16	payment	NN	O	payment	nn	17	SENT_14	[p1l1832t2891r2144b2963],
17	coverage	NN	O	coverage	prep_about	13	SENT_14	[p1l8t3005r313b3066],
18	and	CC	O	and	_	0	SENT_14	[p1l337t2982r465b3045],
19	reimbursement	NN	O	reimbursement	prep_about	13	SENT_14	[p1l487t2982r1044b3045],
20	.	.	O	.	_	0	SENT_14	[p1l487t2982r1044b3045],

1	Lack	NN	O	lack	nsubj	17	SENT_15	[p1l1071t2982r1238b3045],
2	of	IN	O	of	_	0	SENT_15	[p1l1258t2982r1333b3045],
3	clear	JJ	O	clear	amod	4	SENT_15	[p1l1347t2982r1512b3045],
4	demonstration	NN	O	demonstration	prep_of	1	SENT_15	[p1l1535t2982r2053b3045],
5	of	IN	O	of	_	0	SENT_15	[p1l2077t2982r2151b3045],
6	comparative	JJ	O	comparative	amod	7	SENT_15	[p1l8t3091r432b3168],
7	clinical	JJ	O	clinical	prep_of	4	SENT_15	[p1l454t3085r702b3148],
8	and	CC	O	and	_	0	SENT_15	[p1l724t3085r850b3148],
9	economic	JJ	O	economic	amod	10	SENT_15	[p1l872t3091r1206b3148],
10	value	NN	O	value	conj_and	4	SENT_15	[p1l1226t3085r1407b3148],
11	in	IN	O	in	_	0	SENT_15	[p1l1429t3091r1496b3147],
12	usual	JJ	O	usual	amod	14	SENT_15	[p1l1518t3085r1699b3148],
13	care	NN	O	care	nn	14	SENT_15	[p1l1721t3108r1858b3148],
14	settings	NNS	O	setting	prep_in	10	SENT_15	[p1l1882t3091r2143b3169],
15	has	VBZ	O	have	aux	17	SENT_15	[p1l7t3188r121b3251],
16	increasingly	RB	O	increasingly	advmod	17	SENT_15	[p1l147t3188r580b3272],
17	resulted	VBN	O	result	_	0	SENT_15	[p1l602t3188r885b3251],
18	in	IN	O	in	_	0	SENT_15	[p1l909t3194r977b3250],
19	outright	JJ	O	outright	amod	20	SENT_15	[p1l1003t3188r1293b3272],
20	denial	NN	O	denial	prep_in	17	SENT_15	[p1l1318t3188r1535b3251],
21	of	IN	O	of	_	0	SENT_15	[p1l1560t3188r1636b3251],
22	coverage	NN	O	coverage	prep_of	20	SENT_15	[p1l1652t3211r1979b3272],
23	,	,	O	,	_	0	SENT_15	[p1l1652t3211r1979b3272],
24	cost	NN	O	cost	prep_in	17	SENT_15	[p1l2007t3200r2146b3251],
25	pass-through	JJ	O	pass-through	amod	24	SENT_15	[p1l6t3291r476b3375],
26	to	TO	O	to	_	0	SENT_15	[p1l499t3303r566b3354],
27	patients	NNS	O	patient	prep_to	24	SENT_15	[p1l590t3297r869b3374],
28	through	IN	O	through	_	0	SENT_15	[p1l893t3291r1178b3375],
29	copayments	NNS	O	copayment	prep_through	27	SENT_15	[p1l1203t3303r1623b3375],
30	(	RB	O	(	advmod	29	SENT_15	[p1l1651t3292r1746b3367],
31	in	IN	O	in	_	0	SENT_15	[p1l1651t3292r1746b3367],
32	the	DT	O	the	det	35	SENT_15	[p1l1770t3291r1879b3354],
33	United	NNP	LOCATION	United	nn	35	SENT_15	[p1l1904t3291r2145b3354],
34	States	NNPS	LOCATION	States	nn	35	SENT_15	[p1l9t3395r264b3471],
35	)	NN	O	)	prep_in	29	SENT_15	[p1l9t3395r264b3471],
36	,	,	O	,	_	0	SENT_15	[p1l9t3395r264b3471],
37	and	CC	O	and	_	0	SENT_15	[p1l292t3394r424b3457],
38	formulary	NN	O	formulary	nn	39	SENT_15	[p1l449t3394r816b3478],
39	restrictions	NNS	O	restriction	conj_and	20	SENT_15	[p1l839t3400r1248b3457],
40	of	IN	O	of	_	0	SENT_15	[p1l1276t3394r1352b3457],
41	use	NN	O	use	prep_of	39	SENT_15	[p1l1368t3417r1502b3457],
42	.	.	O	.	_	0	SENT_15	[p1l1368t3417r1502b3457],

1	These	DT	O	these	det	2	SENT_16	[p1l1531t3394r1734b3457],
2	conditions	NNS	O	condition	nsubj	3	SENT_16	[p1l1760t3394r2141b3457],
3	provide	VBP	O	provide	_	0	SENT_16	[p1l6t3498r291b3581],
4	strong	JJ	O	strong	amod	5	SENT_16	[p1l324t3510r560b3582],
5	incentives	NNS	O	incentive	dobj	3	SENT_16	[p1l590t3504r965b3561],
6	for	IN	O	for	_	0	SENT_16	[p1l998t3498r1104b3561],
7	pharmaceutical	JJ	O	pharmaceutical	amod	8	SENT_16	[p1l1133t3498r1715b3581],
8	companies	NNS	O	company	prep_for	3	SENT_16	[p1l1748t3504r2144b3581],
9	with	IN	O	with	_	0	SENT_16	[p1l7t3601r167b3664],
10	novel	JJ	O	novel	amod	13	SENT_16	[p1l193t3601r388b3664],
11	and	CC	O	and	_	0	SENT_16	[p1l414t3601r546b3664],
12	effective	JJ	O	effective	conj_and	10	SENT_16	[p1l572t3601r869b3664],
13	treatments	NNS	O	treatment	prep_with	8	SENT_16	[p1l894t3613r1283b3664],
14	to	TO	O	to	aux	15	SENT_16	[p1l1309t3613r1377b3664],
15	provide	VB	O	provide	xcomp	3	SENT_16	[p1l1404t3601r1680b3684],
16	comparative	JJ	O	comparative	amod	18	SENT_16	[p1l1707t3607r2153b3684],
17	effectiveness	NN	O	effectiveness	nn	18	SENT_16	[p1l9t3704r466b3767],
18	data	NNS	O	datum	dobj	15	SENT_16	[p1l494t3704r647b3767],
19	as	IN	O	as	_	0	SENT_16	[p1l674t3727r741b3767],
20	close	JJ	O	close	prep_as	15	SENT_16	[p1l769t3704r947b3767],
21	in	IN	O	in	_	0	SENT_16	[p1l975t3710r1045b3766],
22	time	NN	O	time	prep_in	15	SENT_16	[p1l1071t3710r1234b3767],
23	as	IN	O	as	_	0	SENT_16	[p1l1262t3727r1330b3767],
24	possible	JJ	O	possible	amod	27	SENT_16	[p1l1357t3704r1651b3787],
25	to	TO	O	to	_	0	SENT_16	[p1l1678t3716r1747b3767],
26	marketing	VBG	O	market	prep_to	24	SENT_16	[p1l1775t3704r2152b3788],
27	approval	NN	O	approval	prep_as	22	SENT_16	[p2l9t16r331b99],
28	.	.	O	.	_	0	SENT_16	[p2l9t16r331b99],

1	An	DT	O	a	det	3	SENT_17	[p2l81t123r187b181],
2	E2E	NN	O	e2e	nn	3	SENT_17	[p2l210t124r349b181],
3	approach	NN	O	approach	nsubj	5	SENT_17	[p2l373t119r697b202],
4	does	VBZ	O	do	aux	5	SENT_17	[p2l720t119r877b182],
5	face	VB	O	face	_	0	SENT_17	[p2l901t119r1037b182],
6	hurdles	NNS	O	hurdle	dobj	5	SENT_17	[p2l1060t119r1338b182],
7	.	.	O	.	_	0	SENT_17	[p2l1060t119r1338b182],

1	In	IN	O	in	_	0	SENT_18	[p2l1365t124r1437b181],
2	generating	VBG	O	generate	amod	3	SENT_18	[p2l1461t125r1833b203],
3	data	NNS	O	datum	prep_in	12	SENT_18	[p2l1855t119r2019b191],
4	,	,	O	,	_	0	SENT_18	[p2l1855t119r2019b191],
5	the	DT	O	the	det	7	SENT_18	[p2l2043t119r2152b182],
6	potential	JJ	O	potential	amod	7	SENT_18	[p2l7t222r323b305],
7	beneﬁts	NNS	O	beneﬁts	nsubj	12	SENT_18	[p2l344t222r619b285],
8	to	TO	O	to	_	0	SENT_18	[p2l642t234r710b285],
9	all	DT	O	all	det	10	SENT_18	[p2l736t222r817b285],
10	stakeholders	NNS	O	stakeholder	prep_to	7	SENT_18	[p2l841t222r1281b285],
11	will	MD	O	will	aux	12	SENT_18	[p2l1304t222r1434b285],
12	have	VB	O	have	_	0	SENT_18	[p2l1456t222r1616b285],
13	to	TO	O	to	aux	15	SENT_18	[p2l1639t234r1707b285],
14	be	VB	O	be	auxpass	15	SENT_18	[p2l1730t222r1812b285],
15	balanced	VBN	O	balance	xcomp	12	SENT_18	[p2l1834t222r2151b285],
16	along	IN	O	along	_	0	SENT_18	[p2l9t325r196b409],
17	with	IN	O	with	_	0	SENT_18	[p2l213t325r366b388],
18	the	DT	O	the	det	20	SENT_18	[p2l385t325r491b388],
19	incremental	JJ	O	incremental	amod	20	SENT_18	[p2l512t325r922b388],
20	cost	NN	O	cost	prep_along_with	15	SENT_18	[p2l942t337r1077b388],
21	of	IN	O	of	_	0	SENT_18	[p2l1097t325r1171b388],
22	such	PDT	O	such	predet	24	SENT_18	[p2l1183t325r1337b388],
23	a	DT	O	a	det	24	SENT_18	[p2l1358t348r1393b388],
24	design	NN	O	design	prep_of	20	SENT_18	[p2l1413t325r1633b409],
25	and	CC	O	and	_	0	SENT_18	[p2l1654t325r1780b388],
26	the	DT	O	the	det	29	SENT_18	[p2l1799t325r1905b388],
27	potential	JJ	O	potential	amod	29	SENT_18	[p2l1925t337r2148b408, p2l7t428r117b491],
28	perceived	VBN	O	perceive	amod	29	SENT_18	[p2l138t428r474b511],
29	dilution	NN	O	dilution	conj_and	20	SENT_18	[p2l496t428r771b491],
30	of	IN	O	of	_	0	SENT_18	[p2l795t428r870b491],
31	treatment	NN	O	treatment	nn	32	SENT_18	[p2l882t440r1223b491],
32	effect	NN	O	effect	prep_of	29	SENT_18	[p2l1245t428r1429b491],
33	due	JJ	O	due	dep	12	SENT_18	[p2l1452t428r1576b491],
34	to	TO	O	to	aux	35	SENT_18	[p2l1599t440r1665b491],
35	use	VB	O	use	xcomp	33	SENT_18	[p2l1689t451r1802b491],
36	in	IN	O	in	_	0	SENT_18	[p2l1826t434r1893b490],
37	a	DT	O	a	det	40	SENT_18	[p2l1917t451r1951b491],
38	more	RBR	O	more	advmod	40	SENT_18	[p2l1973t451r2153b491],
39	heterogeneous	JJ	O	heterogeneous	amod	40	SENT_18	[p2l7t531r503b615],
40	population	NN	O	population	prep_in	35	SENT_18	[p2l523t531r914b614],
41	.	.	O	.	_	0	SENT_18	[p2l523t531r914b614],

1	Acceptance	NNP	O	Acceptance	nsubj	5	SENT_19	[p2l936t535r1327b614],
2	by	IN	O	by	_	0	SENT_19	[p2l1346t531r1429b615],
3	sponsors	NNS	O	sponsor	prep_by	1	SENT_19	[p2l1447t553r1746b614],
4	will	MD	O	will	aux	5	SENT_19	[p2l1765t531r1891b594],
5	require	VB	O	require	_	0	SENT_19	[p2l1910t537r2153b614],
6	addressing	VBG	O	address	xcomp	5	SENT_19	[p2l9t634r378b718],
7	the	DT	O	the	det	9	SENT_19	[p2l395t634r502b697],
8	technical	JJ	O	technical	amod	9	SENT_19	[p2l522t634r834b697],
9	challenge	NN	O	challenge	dobj	6	SENT_19	[p2l855t634r1175b718],
10	of	IN	O	of	_	0	SENT_19	[p2l1197t634r1271b697],
11	broadening	VBG	O	broaden	prepc_of	9	SENT_19	[p2l1280t634r1678b718],
12	inclusion	NN	O	inclusion	nn	13	SENT_19	[p2l1697t634r2012b697],
13	criteria	NNS	O	criterion	dobj	11	SENT_19	[p2l2033t640r2149b697, p2l7t743r163b800],
14	to	TO	O	to	aux	15	SENT_19	[p2l184t749r250b800],
15	increase	VB	O	increase	xcomp	11	SENT_19	[p2l275t743r555b800],
16	heterogeneity	NN	O	heterogeneity	dobj	15	SENT_19	[p2l577t737r1050b821],
17	while	IN	O	while	_	0	SENT_19	[p2l1068t737r1255b800],
18	retaining	VBG	O	retain	prepc_while	15	SENT_19	[p2l1279t743r1592b821],
19	sufﬁcient	JJ	O	sufﬁcient	amod	21	SENT_19	[p2l1613t737r1927b800],
20	statistical	JJ	O	statistical	amod	21	SENT_19	[p2l1950t743r2150b800, p2l7t840r158b903],
21	power	NN	O	power	dobj	18	SENT_19	[p2l182t862r404b923],
22	in	IN	O	in	_	0	SENT_19	[p2l429t846r497b902],
23	the	DT	O	the	det	24	SENT_19	[p2l521t840r631b903],
24	face	NN	O	face	prep_in	18	SENT_19	[p2l657t840r795b903],
25	of	IN	O	of	_	0	SENT_19	[p2l821t840r897b903],
26	greater	JJR	O	greater	amod	27	SENT_19	[p2l912t852r1160b924],
27	variability	NN	O	variability	prep_of	24	SENT_19	[p2l1181t840r1554b924],
28	.	.	O	.	_	0	SENT_19	[p2l1181t840r1554b924],

1	Acceptance	NNP	O	Acceptance	nsubj	4	SENT_20	[p2l1582t844r1990b923],
2	also	RB	O	also	advmod	4	SENT_20	[p2l2016t840r2152b903],
3	will	MD	O	will	aux	4	SENT_20	[p2l7t943r137b1006],
4	require	VB	O	require	_	0	SENT_20	[p2l163t949r417b1026],
5	demonstrating	VBG	O	demonstrate	xcomp	4	SENT_20	[p2l444t943r969b1027],
6	the	DT	O	the	det	8	SENT_20	[p2l991t943r1102b1006],
7	net	JJ	O	net	amod	8	SENT_20	[p2l1128t955r1240b1006],
8	beneﬁts	NNS	O	beneﬁts	dobj	5	SENT_20	[p2l1262t943r1539b1006],
9	of	IN	O	of	_	0	SENT_20	[p2l1566t943r1642b1006],
10	the	DT	O	the	det	13	SENT_20	[p2l1657t943r1768b1006],
11	EZE	NNP	O	EZE	nn	13	SENT_20	[p2l1793t948r1934b1005],
12	effectiveness	NN	O	effectiveness	nn	13	SENT_20	[p2l1960t943r2149b1006, p2l7t1052r281b1109],
13	components	NNS	O	component	prep_of	8	SENT_20	[p2l306t1058r734b1129],
14	to	TO	O	to	_	0	SENT_20	[p2l757t1058r824b1109],
15	sponsors	NNS	O	sponsor	prep_to	5	SENT_20	[p2l849t1068r1174b1129],
16	,	,	O	,	_	0	SENT_20	[p2l849t1068r1174b1129],
17	regulators	NNS	O	regulator	conj_and	15	SENT_20	[p2l1200t1046r1566b1130],
18	,	,	O	,	_	0	SENT_20	[p2l1200t1046r1566b1130],
19	payers	NNS	O	payer	conj_and	15	SENT_20	[p2l1590t1068r1830b1130],
20	,	,	O	,	_	0	SENT_20	[p2l1590t1068r1830b1130],
21	patients	NNS	O	patient	conj_and	15	SENT_20	[p2l1855t1052r2148b1129],
22	,	,	O	,	_	0	SENT_20	[p2l1855t1052r2148b1129],
23	and	CC	O	and	_	0	SENT_20	[p2l9t1149r139b1212],
24	providers	NNS	O	provider	prep_to	5	SENT_20	[p2l161t1149r516b1232],
25	.	.	O	.	_	0	SENT_20	[p2l161t1149r516b1232],

1	Indeed	RB	O	indeed	advmod	4	SENT_21	[p2l544t1149r807b1221],
2	,	,	O	,	_	0	SENT_21	[p2l544t1149r807b1221],
3	we	PRP	O	we	nsubj	4	SENT_21	[p2l831t1172r927b1212],
4	believe	VBP	O	believe	_	0	SENT_21	[p2l950t1149r1196b1212],
5	that	IN	O	that	complm	12	SENT_21	[p2l1219t1149r1358b1212],
6	the	DT	O	the	det	7	SENT_21	[p2l1380t1149r1490b1212],
7	beneﬁts	NNS	O	beneﬁts	nsubj	12	SENT_21	[p2l1513t1149r1789b1212],
8	of	IN	O	of	_	0	SENT_21	[p2l1814t1149r1890b1212],
9	an	DT	O	a	det	11	SENT_21	[p2l1906t1172r1988b1212],
10	E2E	NN	O	e2e	nn	11	SENT_21	[p2l2012t1154r2152b1211],
11	approach	NN	O	approach	prep_of	7	SENT_21	[p2l9t1252r332b1335],
12	will	MD	O	will	ccomp	4	SENT_21	[p2l354t1252r482b1315],
13	in	IN	O	in	mark	16	SENT_21	[p2l505t1258r573b1314],
14	many	JJ	O	many	amod	15	SENT_21	[p2l596t1275r793b1336],
15	instances	NNS	O	instance	nsubj	16	SENT_21	[p2l812t1258r1132b1315],
16	outweigh	VBP	O	outweigh	advcl	12	SENT_21	[p2l1157t1252r1480b1336],
17	the	DT	O	the	det	18	SENT_21	[p2l1502t1252r1611b1315],
18	risks	NNS	O	risk	dobj	16	SENT_21	[p2l1634t1252r1795b1315],
19	and	CC	O	and	_	0	SENT_21	[p2l1820t1252r1948b1315],
20	value	NN	O	value	conj_and	18	SENT_21	[p2l1968t1252r2153b1315],
21	for	IN	O	for	_	0	SENT_21	[p2l8t1355r106b1419],
22	all	DT	O	all	det	23	SENT_21	[p2l127t1355r206b1419],
23	stakeholders	NNS	O	stakeholder	prep_for	18	SENT_21	[p2l228t1355r673b1419],
24	.	.	O	.	_	0	SENT_21	[p2l228t1355r673b1419],

1	CURRENT	JJ	DATE	current	amod	2	SENT_22	[p2l9t1572r350b1627],
2	TRIALS	NNS	O	trial	_	0	SENT_22	[p2l363t1572r615b1627],
3	SEPARATE	JJ	O	separate	amod	4	SENT_22	[p2l635t1572r996b1627],
4	EFFICACY	NN	O	efficacy	dep	2	SENT_22	[p2l1018t1572r1364b1627],
5	AND	CC	O	and	_	0	SENT_22	[p2l1381t1572r1542b1626],
6	EFFECTIVENESS	NNS	O	effectiveness	nsubj	12	SENT_22	[p2l1563t1572r2130b1627],
7	Both	CC	O	both	dep	6	SENT_22	[p2l9t1667r178b1730],
8	eﬂicacy	NN	O	eﬂicacy	nn	11	SENT_22	[p2l203t1667r468b1751],
9	and	CC	O	and	_	0	SENT_22	[p2l489t1667r619b1730],
10	effectiveness	NN	O	effectiveness	nn	11	SENT_22	[p2l642t1667r1082b1730],
11	trials	NNS	O	trial	nsubj	12	SENT_22	[p2l1105t1667r1282b1730],
12	provide	VBP	O	provide	rcmod	2	SENT_22	[p2l1305t1667r1574b1750],
13	useful	JJ	O	useful	amod	14	SENT_22	[p2l1599t1667r1811b1730],
14	information	NN	O	information	dobj	12	SENT_22	[p2l1834t1667r2147b1730, p2l7t1776r144b1833],
15	for	IN	O	for	_	0	SENT_22	[p2l164t1770r261b1833],
16	health-care	NN	O	health-care	nn	18	SENT_22	[p2l280t1770r663b1833],
17	decision	NN	O	decision	nn	18	SENT_22	[p2l684t1770r966b1833],
18	makers	NNS	O	maker	prep_for	12	SENT_22	[p2l986t1770r1251b1842],
19	,	,	O	,	_	0	SENT_22	[p2l986t1770r1251b1842],
20	patients	NNS	O	patient	conj_and	18	SENT_22	[p2l1272t1776r1559b1853],
21	,	,	O	,	_	0	SENT_22	[p2l1272t1776r1559b1853],
22	clinicians	NNS	O	clinician	prep_for	12	SENT_22	[p2l1581t1770r1921b1842],
23	,	,	O	,	_	0	SENT_22	[p2l1581t1770r1921b1842],
24	health	NN	O	health	nn	25	SENT_22	[p2l1942t1770r2153b1833],
25	plans	NNS	O	plan	prep_for	12	SENT_22	[p2l7t1873r205b1956],
26	,	,	O	,	_	0	SENT_22	[p2l7t1873r205b1956],
27	other	JJ	O	other	amod	28	SENT_22	[p2l230t1873r411b1936],
28	payers	NNS	O	payer	conj_and	18	SENT_22	[p2l431t1895r668b1957],
29	,	,	O	,	_	0	SENT_22	[p2l431t1895r668b1957],
30	and	CC	O	and	_	0	SENT_22	[p2l692t1873r819b1936],
31	regulators	NNS	O	regulator	prep_for	12	SENT_22	[p2l840t1873r1199b1957],
32	.	.	O	.	_	0	SENT_22	[p2l840t1873r1199b1957],

1	‘	NN	O	‘	dep	168	SENT_23	[p2l21t2041r94b2068],
2	Tufts	NNP	ORGANIZATION	Tufts	dep	168	SENT_23	[p2l21t2041r94b2068],
3	Clinical	JJ	ORGANIZATION	clinical	dep	168	SENT_23	[p2l101t2044r192b2068],
4	and	CC	ORGANIZATION	and	dep	168	SENT_23	[p2l200t2045r247b2068],
5	Translational	JJ	ORGANIZATION	translational	dep	168	SENT_23	[p2l253t2045r417b2068],
6	Science	NNP	ORGANIZATION	Science	dep	168	SENT_23	[p2l426t2045r523b2068],
7	Institute	NNP	ORGANIZATION	Institute	dep	168	SENT_23	[p2l531t2046r643b2071],
8	,	,	O	,	_	0	SENT_23	[p2l531t2046r643b2071],
9	Tufts	NNP	ORGANIZATION	Tufts	dep	168	SENT_23	[p2l648t2044r710b2068],
10	University	NNP	ORGANIZATION	University	dep	168	SENT_23	[p2l719t2046r851b2074],
11	,	,	O	,	_	0	SENT_23	[p2l719t2046r851b2074],
12	Boston	NNP	LOCATION	Boston	dep	168	SENT_23	[p2l860t2046r954b2071],
13	,	,	O	,	_	0	SENT_23	[p2l860t2046r954b2071],
14	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l962t2044r1156b2071],
15	,	,	O	,	_	0	SENT_23	[p2l962t2044r1156b2071],
16	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l1164t2045r1222b2071],
17	;	:	O	;	_	0	SENT_23	[p2l1164t2045r1222b2071],
18	zlnstitute	NN	O	zlnstitute	dep	168	SENT_23	[p2l1229t2041r1348b2068],
19	for	IN	O	for	dep	168	SENT_23	[p2l1355t2044r1390b2068],
20	Clinical	JJ	ORGANIZATION	clinical	dep	168	SENT_23	[p2l1397t2045r1487b2068],
21	Research	NN	ORGANIZATION	research	dep	168	SENT_23	[p2l1497t2044r1610b2068],
22	and	CC	ORGANIZATION	and	dep	168	SENT_23	[p2l1618t2045r1665b2068],
23	Health	NNP	ORGANIZATION	Health	dep	168	SENT_23	[p2l1675t2044r1757b2068],
24	Policy	NNP	ORGANIZATION	Policy	dep	168	SENT_23	[p2l1766t2044r1841b2074],
25	Studies	NNPS	ORGANIZATION	Studies	dep	168	SENT_23	[p2l1847t2045r1947b2071],
26	,	,	O	,	_	0	SENT_23	[p2l1847t2045r1947b2071],
27	Tufts	NNP	ORGANIZATION	Tufts	dep	168	SENT_23	[p2l1952t2044r2015b2068],
28	Medical	NNP	ORGANIZATION	Medical	dep	168	SENT_23	[p2l2023t2044r2121b2068],
29	Center	NNP	ORGANIZATION	Center	dep	168	SENT_23	[p2l20t2083r110b2109],
30	,	,	O	,	_	0	SENT_23	[p2l20t2083r110b2109],
31	Boston	NNP	LOCATION	Boston	dep	168	SENT_23	[p2l118t2083r213b2109],
32	,	,	O	,	_	0	SENT_23	[p2l118t2083r213b2109],
33	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l221t2082r414b2109],
34	,	,	O	,	_	0	SENT_23	[p2l221t2082r414b2109],
35	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l422t2083r481b2109],
36	;	:	O	;	_	0	SENT_23	[p2l422t2083r481b2109],
37	3Massachusetts	NNP	O	3Massachusetts	dep	168	SENT_23	[p2l488t2079r688b2106],
38	Institute	NNP	O	Institute	dep	168	SENT_23	[p2l696t2084r802b2106],
39	ofTechno	NNP	O	ofTechno	dep	168	SENT_23	[p2l809t2082r989b2112],
40	|	VBD	O	|	dep	168	SENT_23	[p2l809t2082r989b2112],
41	ogy	NN	O	ogy	dep	168	SENT_23	[p2l809t2082r989b2112],
42	Political	JJ	O	political	dep	168	SENT_23	[p2l997t2082r1095b2106],
43	Science	NN	O	science	dep	168	SENT_23	[p2l1103t2083r1200b2106],
44	and	CC	O	and	dep	168	SENT_23	[p2l1208t2082r1255b2106],
45	Engineering	NNP	O	Engineering	dep	168	SENT_23	[p2l1264t2084r1419b2112],
46	Systems	NNPS	O	Systems	dep	168	SENT_23	[p2l1427t2083r1537b2112],
47	,	,	O	,	_	0	SENT_23	[p2l1427t2083r1537b2112],
48	Cambridge	NNP	LOCATION	Cambridge	dep	168	SENT_23	[p2l1544t2082r1694b2112],
49	,	,	O	,	_	0	SENT_23	[p2l1544t2082r1694b2112],
50	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l1702t2082r1895b2109],
51	,	,	O	,	_	0	SENT_23	[p2l1702t2082r1895b2109],
52	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l1903t2083r1962b2109],
53	;	:	O	;	_	0	SENT_23	[p2l1903t2083r1962b2109],
54	4European	NN	O	4european	dep	168	SENT_23	[p2l1968t2079r2103b2112],
55	Medicines	NNP	ORGANIZATION	Medicines	dep	168	SENT_23	[p2l21t2119r151b2143],
56	Agency	NNP	ORGANIZATION	Agency	dep	168	SENT_23	[p2l158t2121r260b2149],
57	,	,	O	,	_	0	SENT_23	[p2l158t2121r260b2149],
58	London	NNP	LOCATION	London	dep	168	SENT_23	[p2l268t2119r372b2146],
59	,	,	O	,	_	0	SENT_23	[p2l268t2119r372b2146],
60	UK	NNP	LOCATION	UK	dep	168	SENT_23	[p2l381t2121r422b2146],
61	;	:	O	;	_	0	SENT_23	[p2l381t2121r422b2146],
62	5US	NNP	ORGANIZATION	5US	dep	168	SENT_23	[p2l429t2116r475b2143],
63	Food	NNP	ORGANIZATION	Food	dep	168	SENT_23	[p2l483t2119r546b2143],
64	and	CC	ORGANIZATION	and	dep	168	SENT_23	[p2l554t2119r601b2143],
65	Drug	NNP	ORGANIZATION	Drug	dep	168	SENT_23	[p2l610t2120r672b2149],
66	Administration	NNP	ORGANIZATION	Administration	dep	168	SENT_23	[p2l680t2119r871b2143],
67	Centerfor	NNP	ORGANIZATION	Centerfor	dep	168	SENT_23	[p2l880t2119r1007b2143],
68	Drug	NNP	ORGANIZATION	Drug	dep	168	SENT_23	[p2l1014t2120r1076b2149],
69	Evaluation	NN	ORGANIZATION	evaluation	dep	168	SENT_23	[p2l1085t2119r1218b2143],
70	and	CC	ORGANIZATION	and	dep	168	SENT_23	[p2l1226t2119r1273b2143],
71	Research	NN	ORGANIZATION	research	dep	168	SENT_23	[p2l1283t2119r1403b2146],
72	,	,	O	,	_	0	SENT_23	[p2l1283t2119r1403b2146],
73	Silver	NNP	O	Silver	dep	168	SENT_23	[p2l1411t2119r1480b2143],
74	Spring	NNP	DATE	Spring	dep	168	SENT_23	[p2l1487t2120r1576b2149],
75	,	,	O	,	_	0	SENT_23	[p2l1487t2120r1576b2149],
76	Maryland	NNP	LOCATION	Maryland	dep	168	SENT_23	[p2l1584t2119r1711b2149],
77	,	,	O	,	_	0	SENT_23	[p2l1584t2119r1711b2149],
78	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l1719t2116r1898b2146],
79	;	:	O	;	_	0	SENT_23	[p2l1719t2116r1898b2146],
80	6Harvard	NNP	ORGANIZATION	6Harvard	dep	168	SENT_23	[p2l1719t2116r1898b2146],
81	School	NNP	ORGANIZATION	School	dep	168	SENT_23	[p2l1906t2119r1991b2143],
82	of	IN	ORGANIZATION	of	dep	168	SENT_23	[p2l2000t2119r2027b2143],
83	Public	NNP	ORGANIZATION	Public	dep	168	SENT_23	[p2l2033t2119r2110b2143],
84	Health	NNP	ORGANIZATION	Health	dep	168	SENT_23	[p2l21t2156r111b2183],
85	,	,	O	,	_	0	SENT_23	[p2l21t2156r111b2183],
86	Boston	NNP	LOCATION	Boston	dep	168	SENT_23	[p2l119t2157r214b2183],
87	,	,	O	,	_	0	SENT_23	[p2l119t2157r214b2183],
88	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l222t2156r415b2183],
89	,	,	O	,	_	0	SENT_23	[p2l222t2156r415b2183],
90	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l423t2157r482b2183],
91	;	:	O	;	_	0	SENT_23	[p2l423t2157r482b2183],
92	7Tufts	NNP	O	7Tufts	dep	168	SENT_23	[p2l489t2153r562b2180],
93	Center	NNP	O	Center	dep	168	SENT_23	[p2l570t2157r655b2180],
94	forthe	NN	O	forthe	dep	168	SENT_23	[p2l661t2156r745b2180],
95	Study	NN	ORGANIZATION	study	dep	168	SENT_23	[p2l752t2156r826b2186],
96	of	IN	ORGANIZATION	of	dep	168	SENT_23	[p2l832t2156r859b2180],
97	Drug	NNP	ORGANIZATION	Drug	dep	168	SENT_23	[p2l865t2157r927b2186],
98	Development	NNP	ORGANIZATION	Development	dep	168	SENT_23	[p2l936t2156r1118b2186],
99	,	,	O	,	_	0	SENT_23	[p2l936t2156r1118b2186],
100	Boston	NNP	LOCATION	Boston	dep	168	SENT_23	[p2l1126t2157r1221b2183],
101	,	,	O	,	_	0	SENT_23	[p2l1126t2157r1221b2183],
102	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l1229t2156r1422b2183],
103	,	,	O	,	_	0	SENT_23	[p2l1229t2156r1422b2183],
104	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l1431t2157r1489b2183],
105	;	:	O	;	_	0	SENT_23	[p2l1431t2157r1489b2183],
106	3Merck	NNP	ORGANIZATION	3Merck	dep	168	SENT_23	[p2l1496t2153r1586b2180],
107	&	CC	ORGANIZATION	&	dep	168	SENT_23	[p2l1592t2157r1610b2180],
108	Co.	NNP	ORGANIZATION	Co.	dep	168	SENT_23	[p2l1617t2157r1662b2183],
109	,	,	O	,	_	0	SENT_23	[p2l1617t2157r1662b2183],
110	Whitehouse	NNP	ORGANIZATION	Whitehouse	dep	168	SENT_23	[p2l1668t2156r1823b2180],
111	Station	NNP	ORGANIZATION	Station	dep	168	SENT_23	[p2l1830t2157r1927b2183],
112	,	,	O	,	_	0	SENT_23	[p2l1830t2157r1927b2183],
113	New	NNP	LOCATION	New	dep	168	SENT_23	[p2l1936t2158r1992b2180],
114	Jersey	NNP	LOCATION	Jersey	dep	168	SENT_23	[p2l1998t2158r2083b2186],
115	,	,	O	,	_	0	SENT_23	[p2l1998t2158r2083b2186],
116	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l21t2194r80b2220],
117	;	:	O	;	_	0	SENT_23	[p2l21t2194r80b2220],
118	9Col	NN	O	9col	dep	168	SENT_23	[p2l86t2190r254b2223],
119	|	NN	O	|	dep	168	SENT_23	[p2l86t2190r254b2223],
120	egevi	FW	O	egevi	dep	168	SENT_23	[p2l86t2190r254b2223],
121	|	FW	O	|	dep	168	SENT_23	[p2l86t2190r254b2223],
122	|	FW	O	|	dep	168	SENT_23	[p2l86t2190r254b2223],
123	e	LS	O	e	dep	168	SENT_23	[p2l86t2190r254b2223],
124	,	,	O	,	_	0	SENT_23	[p2l86t2190r254b2223],
125	Pennsylvania	NNP	LOCATION	Pennsylvania	dep	168	SENT_23	[p2l262t2193r436b2223],
126	,	,	O	,	_	0	SENT_23	[p2l262t2193r436b2223],
127	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l444t2194r503b2220],
128	;	:	O	;	_	0	SENT_23	[p2l444t2194r503b2220],
129	‘	CD	NUMBER	‘	dep	168	SENT_23	[p2l511t2190r595b2217],
130	°	CD	NUMBER	°	dep	168	SENT_23	[p2l511t2190r595b2217],
131	Tufts	NNP	ORGANIZATION	Tufts	dep	168	SENT_23	[p2l511t2190r595b2217],
132	Cancer	NNP	ORGANIZATION	Cancer	dep	168	SENT_23	[p2l603t2194r692b2217],
133	Center	NNP	ORGANIZATION	Center	dep	168	SENT_23	[p2l698t2194r788b2220],
134	,	,	O	,	_	0	SENT_23	[p2l698t2194r788b2220],
135	Boston	NNP	LOCATION	Boston	dep	168	SENT_23	[p2l796t2194r891b2220],
136	,	,	O	,	_	0	SENT_23	[p2l796t2194r891b2220],
137	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l899t2193r1092b2220],
138	,	,	O	,	_	0	SENT_23	[p2l899t2193r1092b2220],
139	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l1100t2194r1159b2220],
140	;	:	O	;	_	0	SENT_23	[p2l1100t2194r1159b2220],
141	1	CD	NUMBER	1	dep	168	SENT_23	[p2l1167t2190r1172b2206],
142	1	CD	NUMBER	1	dep	168	SENT_23	[p2l1179t2190r1184b2206],
143	Department	NNP	ORGANIZATION	Department	dep	168	SENT_23	[p2l1191t2194r1348b2223],
144	of	IN	ORGANIZATION	of	dep	168	SENT_23	[p2l1355t2193r1382b2217],
145	Mathematics	NNPS	ORGANIZATION	Mathematics	dep	168	SENT_23	[p2l1387t2193r1553b2217],
146	and	CC	ORGANIZATION	and	dep	168	SENT_23	[p2l1561t2193r1608b2217],
147	Statistics	NNPS	ORGANIZATION	Statistics	dep	168	SENT_23	[p2l1616t2194r1735b2220],
148	,	,	O	,	_	0	SENT_23	[p2l1616t2194r1735b2220],
149	Boston	NNP	ORGANIZATION	Boston	dep	168	SENT_23	[p2l1743t2194r1830b2217],
150	University	NNP	ORGANIZATION	University	dep	168	SENT_23	[p2l1840t2195r1972b2223],
151	,	,	O	,	_	0	SENT_23	[p2l1840t2195r1972b2223],
152	Boston	NNP	LOCATION	Boston	dep	168	SENT_23	[p2l1981t2194r2075b2220],
153	,	,	O	,	_	0	SENT_23	[p2l1981t2194r2075b2220],
154	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l21t2230r214b2257],
155	,	,	O	,	_	0	SENT_23	[p2l21t2230r214b2257],
156	USA	NNP	LOCATION	USA	dep	168	SENT_23	[p2l223t2231r281b2257],
157	;	:	O	;	_	0	SENT_23	[p2l223t2231r281b2257],
158	"	``	O	"	dep	168	SENT_23	[p2l289t2227r413b2254],
159	Harvard	NNP	ORGANIZATION	Harvard	dep	168	SENT_23	[p2l289t2227r413b2254],
160	Clinical	JJ	ORGANIZATION	clinical	dep	168	SENT_23	[p2l421t2230r512b2254],
161	Research	NNP	ORGANIZATION	Research	dep	168	SENT_23	[p2l522t2230r634b2254],
162	Institute	NNP	ORGANIZATION	Institute	dep	168	SENT_23	[p2l644t2232r755b2257],
163	,	,	O	,	_	0	SENT_23	[p2l644t2232r755b2257],
164	Boston	NNP	LOCATION	Boston	dep	168	SENT_23	[p2l764t2231r858b2257],
165	,	,	O	,	_	0	SENT_23	[p2l764t2231r858b2257],
166	Massachusetts	NNP	LOCATION	Massachusetts	dep	168	SENT_23	[p2l866t2230r1060b2257],
167	,	,	O	,	_	0	SENT_23	[p2l866t2230r1060b2257],
168	USA	NNP	LOCATION	USA	_	0	SENT_23	[p2l1068t2231r1126b2254],
169	.	.	O	.	_	0	SENT_23	[p2l1068t2231r1126b2254],

1	Correspondence	NN	O	correspondence	_	0	SENT_24	[p2l1133t2230r1354b2260],
2	:	:	O	:	_	0	SENT_24	[p2l1133t2230r1354b2260],
3	HP	NNP	O	HP	nn	4	SENT_24	[p2l1362t2231r1396b2253],
4	Selker	NNP	PERSON	Selker	dep	1	SENT_24	[p2l1403t2230r1481b2254],
5	(	CD	NUMBER	(	num	6	SENT_24	[p2l1488t2230r1914b2260],
6	hselker@tuftsmedicalcenter.org	NN	O	hselker@tuftsmedicalcenter.org	dep	4	SENT_24	[p2l1488t2230r1914b2260],
7	)	CD	NUMBER	)	dep	4	SENT_24	[p2l1488t2230r1914b2260],
8	Received	VBN	O	receive	partmod	4	SENT_24	[p2l21t2284r130b2307],
9	20June	NN	O	20june	nsubj	13	SENT_24	[p2l139t2285r232b2307],
10	201	CD	NUMBER	201	number	11	SENT_24	[p2l239t2286r278b2307],
11	3	CD	NUMBER	3	dep	9	SENT_24	[p2l285t2286r304b2311],
12	;	:	O	;	_	0	SENT_24	[p2l285t2286r304b2311],
13	accepted	VBN	O	accept	dep	8	SENT_24	[p2l311t2284r424b2313],
14	29	CD	DATE	29	num	15	SENT_24	[p2l433t2286r461b2307],
15	August	NNP	DATE	August	tmod	13	SENT_24	[p2l469t2285r556b2313],
16	201	CD	NUMBER	201	num	15	SENT_24	[p2l564t2286r602b2307],
17	3	CD	NUMBER	3	dep	15	SENT_24	[p2l610t2286r628b2310],
18	;	:	O	;	_	0	SENT_24	[p2l610t2286r628b2310],
19	advance	NN	O	advance	dep	1	SENT_24	[p2l635t2284r739b2307],
20	online	NN	O	online	prep	19	SENT_24	[p2l746t2284r823b2307],
21	publication	NN	O	publication	dep	20	SENT_24	[p2l831t2284r969b2313],
22	4	CD	DATE	4	num	21	SENT_24	[p2l977t2286r991b2307],
23	December	NNP	DATE	December	tmod	19	SENT_24	[p2l999t2284r1129b2307],
24	201	CD	NUMBER	201	num	23	SENT_24	[p2l1136t2286r1174b2307],
25	3	CD	NUMBER	3	dep	19	SENT_24	[p2l1182t2286r1200b2307],
26	.	.	O	.	_	0	SENT_24	[p2l1182t2286r1200b2307],

1	doizl	NN	O	doizl	nn	3	SENT_25	[p2l1208t2284r1261b2307],
2	O.l	NN	O	o.l	nn	3	SENT_25	[p2l1268t2286r1297b2307],
3	O38/c	NN	O	o38/c	_	0	SENT_25	[p2l1304t2284r1452b2313],
4	|	CD	NUMBER	|	num	5	SENT_25	[p2l1304t2284r1452b2313],
5	pt	NN	O	pt	dep	3	SENT_25	[p2l1304t2284r1452b2313],
6	.20	CD	NUMBER	.20	num	7	SENT_25	[p2l1304t2284r1452b2313],
7	l	NN	O	l	dep	3	SENT_25	[p2l1304t2284r1452b2313],
8	3	CD	NUMBER	3	dep	7	SENT_25	[p2l1460t2286r1488b2307],
9	.	.	O	.	_	0	SENT_25	[p2l1460t2286r1488b2307],

1	l	NN	O	l	_	0	SENT_26	[p2l1460t2286r1488b2307],
2	77	CD	NUMBER	77	num	1	SENT_26	[p2l1496t2286r1524b2307],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_27	[p2l20t2370r140b2391],
2	PHARMACOLOGY&THERAPEUT	NN	O	pharmacology&therapeut	_	0	SENT_27	[p2l149t2370r600b2391],
3	|	CD	NUMBER	|	dep	2	SENT_27	[p2l149t2370r600b2391],
4	CS	NNP	O	CS	dep	2	SENT_27	[p2l149t2370r600b2391],
5	1	CD	NUMBER	1	num	4	SENT_27	[p2l2126t2371r2135b2391],

1	STATE	NN	O	state	nn	2	SENT_28	[p2l21t2506r163b2543],
2	ART	NN	O	art	_	0	SENT_28	[p2l306t2506r399b2543],

1	o	NN	O	o	nn	3	SENT_29	[p2l9t2761r41b2792],
2	Eﬁlcacy	NN	O	eﬁlcacy	nn	3	SENT_29	[p2l128t2739r394b2823],
3	trials	NNS	O	trial	nsubjpass	5	SENT_29	[p2l417t2739r587b2802],
4	are	VBP	O	be	auxpass	5	SENT_29	[p2l610t2762r710b2802],
5	designed	VBN	O	design	_	0	SENT_29	[p2l734t2739r1042b2823],
6	to	TO	O	to	aux	7	SENT_29	[p2l1063t2751r1129b2802],
7	establish	VB	O	establish	xcomp	5	SENT_29	[p2l1153t2739r1451b2802],
8	the	DT	O	the	det	9	SENT_29	[p2l1473t2739r1580b2802],
9	existence	NN	O	existence	dobj	7	SENT_29	[p2l1603t2745r1917b2802],
10	of	IN	O	of	_	0	SENT_29	[p2l1941t2739r2015b2802],
11	a	DT	O	a	det	13	SENT_29	[p2l2029t2762r2063b2802],
12	treatment	NN	O	treatment	nn	13	SENT_29	[p2l129t2854r463b2905],
13	effect	NN	O	effect	prep_of	9	SENT_29	[p2l483t2842r663b2905],
14	under	IN	O	under	_	0	SENT_29	[p2l683t2842r886b2905],
15	optimal	JJ	O	optimal	amod	16	SENT_29	[p2l906t2842r1169b2925],
16	conditions	NNS	O	condition	prep_under	7	SENT_29	[p2l1189t2842r1564b2905],
17	.	.	O	.	_	0	SENT_29	[p2l1189t2842r1564b2905],

1	To	TO	O	to	_	0	SENT_30	[p2l1588t2845r1671b2905],
2	this	DT	O	this	det	3	SENT_30	[p2l1692t2842r1815b2905],
3	end	NN	O	end	prep_to	7	SENT_30	[p2l1838t2842r1979b2914],
4	,	,	O	,	_	0	SENT_30	[p2l1838t2842r1979b2914],
5	eﬂicacy	NN	O	eﬂicacy	nn	6	SENT_30	[p2l2002t2842r2130b2905, p2l131t2968r283b3029],
6	trials	NNS	O	trial	nsubj	7	SENT_30	[p2l300t2945r471b3008],
7	use	VBP	O	use	_	0	SENT_30	[p2l493t2968r604b3008],
8	exclusion	NN	O	exclusion	nn	9	SENT_30	[p2l627t2945r948b3008],
9	criteria	NNS	O	criterion	dobj	7	SENT_30	[p2l970t2951r1215b3008],
10	that	WDT	O	that	nsubjpass	20	SENT_30	[p2l1235t2945r1369b3008],
11	yield	VBP	O	yield	rcmod	9	SENT_30	[p2l1387t2945r1554b3029],
12	relatively	RB	O	relatively	advmod	13	SENT_30	[p2l1575t2945r1887b3029],
13	homogeneous	JJ	O	homogeneous	amod	14	SENT_30	[p2l1904t2945r2132b3008, p2l131t3072r413b3133],
14	samples	NNS	O	sample	dobj	11	SENT_30	[p2l438t3049r712b3132],
15	of	IN	O	of	_	0	SENT_30	[p2l736t3049r811b3112],
16	participants	NNS	O	participant	prep_of	14	SENT_30	[p2l824t3055r1262b3132],
17	,	,	O	,	_	0	SENT_30	[p2l824t3055r1262b3132],
18	and	CC	O	and	_	0	SENT_30	[p2l1287t3049r1416b3112],
19	are	VBP	O	be	auxpass	20	SENT_30	[p2l1439t3072r1541b3112],
20	conducted	VBN	O	conduct	conj_and	11	SENT_30	[p2l1565t3049r1932b3112],
21	in	IN	O	in	_	0	SENT_30	[p2l1955t3055r2022b3111],
22	settings	NNS	O	setting	prep_in	20	SENT_30	[p2l132t3158r390b3236],
23	that	WDT	O	that	nsubj	24	SENT_30	[p2l411t3152r545b3215],
24	foster	VBP	O	foster	rcmod	22	SENT_30	[p2l565t3152r758b3215],
25	adherence	NN	O	adherence	nsubj	28	SENT_30	[p2l780t3152r1130b3215],
26	to	TO	O	to	aux	28	SENT_30	[p2l1151t3164r1217b3215],
27	carefully	RB	O	carefully	advmod	28	SENT_30	[p2l1240t3152r1537b3236],
28	speciﬁed	VBN	O	speciﬁed	xcomp	24	SENT_30	[p2l1557t3152r1857b3235],
29	clinical	JJ	O	clinical	amod	30	SENT_30	[p2l1878t3152r2123b3215],
30	protocols	NNS	O	protocol	dobj	28	SENT_30	[p2l129t3255r471b3338],
31	,	,	O	,	_	0	SENT_30	[p2l129t3255r471b3338],
32	often	RB	O	often	advmod	28	SENT_30	[p2l497t3255r671b3318],
33	for	IN	O	for	_	0	SENT_30	[p2l693t3255r791b3318],
34	shorter	JJR	O	shorter	amod	35	SENT_30	[p2l814t3255r1061b3318],
35	periods	NNS	O	period	prep_for	24	SENT_30	[p2l1081t3255r1342b3338],
36	than	IN	O	than	_	0	SENT_30	[p2l1364t3255r1520b3318],
37	those	DT	O	those	prep_than	35	SENT_30	[p2l1541t3255r1726b3318],
38	ultimately	RB	O	ultimately	advmod	39	SENT_30	[p2l1749t3255r2101b3339],
39	used	VBN	O	use	partmod	37	SENT_30	[p2l130t3358r290b3421],
40	in	IN	O	in	_	0	SENT_30	[p2l312t3364r379b3420],
41	general	JJ	O	general	amod	43	SENT_30	[p2l401t3358r653b3442],
42	patient	NN	O	patient	nn	43	SENT_30	[p2l674t3364r917b3441],
43	care	NN	O	care	prep_in	39	SENT_30	[p2l939t3381r1094b3421],
44	.	.	O	.	_	0	SENT_30	[p2l939t3381r1094b3421],

1	Efﬁcacy	NN	O	efﬁcacy	nn	2	SENT_31	[p2l1120t3358r1393b3442],
2	trials	NNS	O	trial	nsubjpass	4	SENT_31	[p2l1410t3358r1584b3421],
3	are	VBP	O	be	auxpass	4	SENT_31	[p2l1608t3381r1709b3421],
4	used	VBN	O	use	_	0	SENT_31	[p2l1732t3358r1892b3421],
5	to	TO	O	to	aux	6	SENT_31	[p2l1912t3370r1978b3421],
6	secure	VB	O	secure	xcomp	4	SENT_31	[p2l132t3485r347b3525],
7	regulatory	JJ	O	regulatory	amod	8	SENT_31	[p2l369t3462r726b3546],
8	approval	NN	O	approval	dobj	6	SENT_31	[p2l744t3462r1040b3545],
9	with	IN	O	with	_	0	SENT_31	[p2l1059t3462r1212b3525],
10	labeling	NN	O	labeling	prep_with	6	SENT_31	[p2l1232t3462r1505b3546],
11	of	IN	O	of	_	0	SENT_31	[p2l1525t3462r1599b3525],
12	appropriate	JJ	O	appropriate	amod	13	SENT_31	[p2l1612t3468r2006b3545],
13	conditions	NNS	O	condition	prep_of	10	SENT_31	[p2l131t3564r488b3627],
14	of	IN	O	of	_	0	SENT_31	[p2l510t3564r584b3627],
15	use	NN	O	use	prep_of	13	SENT_31	[p2l595t3587r721b3627],
16	.	.	O	.	_	0	SENT_31	[p2l595t3587r721b3627],

1	o	NN	O	o	nn	3	SENT_32	[p3l9t49r41b80],
2	Eﬁectiveness	NN	MISC	eﬁectiveness	nn	3	SENT_32	[p3l128t27r545b111],
3	trials	NNS	O	trial	nsubjpass	5	SENT_32	[p3l569t27r738b90],
4	are	VBP	O	be	auxpass	5	SENT_32	[p3l759t50r859b90],
5	designed	VBN	O	design	_	0	SENT_32	[p3l882t27r1187b111],
6	to	TO	O	to	aux	7	SENT_32	[p3l1207t39r1273b90],
7	establish	VB	O	establish	xcomp	5	SENT_32	[p3l1296t27r1590b90],
8	whether	IN	O	whether	complm	15	SENT_32	[p3l1610t27r1894b90],
9	treatment	NN	O	treatment	nn	10	SENT_32	[p3l1913t39r2096b90, p3l130t142r307b193],
10	effects	NNS	O	effect	nsubj	15	SENT_32	[p3l328t130r541b193],
11	identiﬁed	VBN	O	identiﬁed	partmod	10	SENT_32	[p3l563t130r891b193],
12	in	IN	O	in	_	0	SENT_32	[p3l912t136r979b192],
13	efficacy	NN	O	efficacy	nn	14	SENT_32	[p3l1001t130r1259b214],
14	trials	NNS	O	trial	prep_in	11	SENT_32	[p3l1276t130r1447b193],
15	carry	VBP	O	carry	ccomp	7	SENT_32	[p3l1470t153r1650b214],
16	over	RP	O	over	prt	15	SENT_32	[p3l1669t153r1817b193],
17	to	TO	O	to	_	0	SENT_32	[p3l1836t142r1902b193],
18	more	JJR	O	more	amod	20	SENT_32	[p3l1925t153r2102b193],
19	typical	JJ	O	typical	amod	20	SENT_32	[p3l130t233r359b317],
20	use	NN	O	use	prep_to	15	SENT_32	[p3l379t256r490b296],
21	of	IN	O	of	_	0	SENT_32	[p3l513t233r587b296],
22	drugs	NNS	O	drug	prep_of	20	SENT_32	[p3l600t233r791b317],
23	in	IN	O	in	_	0	SENT_32	[p3l814t239r880b295],
24	practice	NN	O	practice	prep_in	22	SENT_32	[p3l901t239r1190b316],
25	.	.	O	.	_	0	SENT_32	[p3l901t239r1190b316],

1	To	TO	O	to	_	0	SENT_33	[p3l1214t236r1298b296],
2	this	DT	O	this	det	3	SENT_33	[p3l1320t233r1445b296],
3	end	NN	O	end	prep_to	7	SENT_33	[p3l1468t233r1610b305],
4	,	,	O	,	_	0	SENT_33	[p3l1468t233r1610b305],
5	effectiveness	NN	O	effectiveness	nn	6	SENT_33	[p3l1634t233r2061b296],
6	trials	NNS	O	trial	nsubj	7	SENT_33	[p3l130t335r301b398],
7	use	VBP	O	use	_	0	SENT_33	[p3l323t358r434b398],
8	broader	JJR	O	broader	amod	9	SENT_33	[p3l454t335r725b398],
9	inclusion	NN	O	inclusion	dobj	7	SENT_33	[p3l745t335r1060b398],
10	and	CC	O	and	_	0	SENT_33	[p3l1082t335r1209b398],
11	narrower	JJR	O	narrower	amod	13	SENT_33	[p3l1229t358r1545b398],
12	exclusion	NN	O	exclusion	nn	13	SENT_33	[p3l1566t335r1887b398],
13	criteria	NNS	O	criterion	dobj	7	SENT_33	[p3l1909t341r2087b398, p3l131t444r238b510],
14	,	,	O	,	_	0	SENT_33	[p3l1909t341r2087b398, p3l131t444r238b510],

1	which	WDT	O	which	nsubj	2	SENT_34	[p3l260t438r470b501],
2	produces	VBZ	O	produce	dep	14	SENT_34	[p3l491t438r804b521],
3	heterogeneous	JJ	O	heterogeneous	amod	4	SENT_34	[p3l825t438r1324b522],
4	samples	NNS	O	sample	dobj	2	SENT_34	[p3l1347t438r1616b521],
5	that	WDT	O	that	nsubj	6	SENT_34	[p3l1637t438r1771b501],
6	represent	VBP	O	represent	rcmod	4	SENT_34	[p3l1792t450r2111b521],
7	a	DT	O	a	det	10	SENT_34	[p3l131t564r166b604],
8	usual	JJ	O	usual	amod	10	SENT_34	[p3l186t541r367b604],
9	patient	NN	O	patient	nn	10	SENT_34	[p3l387t547r626b624],
10	spectrum	NN	O	spectrum	dobj	6	SENT_34	[p3l648t553r990b624],
11	;	:	O	;	_	0	SENT_34	[p3l648t553r990b624],
12	they	PRP	O	they	nsubjpass	14	SENT_34	[p3l1012t541r1163b625],
13	are	VBP	O	be	auxpass	14	SENT_34	[p3l1182t564r1282b604],
14	conducted	VBN	O	conduct	_	0	SENT_34	[p3l1305t541r1665b604],
15	in	IN	O	in	prt	14	SENT_34	[p3l1686t547r1752b603],
16	more	RBR	O	more	advmod	17	SENT_34	[p3l1774t564r1951b604],
17	varied	JJ	O	varied	amod	19	SENT_34	[p3l128t644r344b707],
18	clinical	JJ	O	clinical	amod	19	SENT_34	[p3l365t644r610b707],
19	settings	NNS	O	setting	dobj	14	SENT_34	[p3l632t650r891b728],
20	that	WDT	O	that	nsubj	21	SENT_34	[p3l912t644r1046b707],
21	approximate	JJ	O	approximate	rcmod	19	SENT_34	[p3l1067t650r1496b727],
22	usual	JJ	O	usual	amod	24	SENT_34	[p3l1517t644r1698b707],
23	practice	NN	O	practice	nn	24	SENT_34	[p3l1718t650r1990b727],
24	conditions	NNS	O	condition	dobj	21	SENT_34	[p3l131t747r511b819],
25	,	,	O	,	_	0	SENT_34	[p3l131t747r511b819],
26	and	CC	O	and	_	0	SENT_34	[p3l535t747r662b810],
27	they	PRP	O	they	nsubj	28	SENT_34	[p3l681t747r832b831],
28	use	VBP	O	use	conj_and	14	SENT_34	[p3l850t770r961b810],
29	treatment	NN	O	treatment	nn	30	SENT_34	[p3l982t759r1319b810],
30	protocols	NNS	O	protocol	dobj	28	SENT_34	[p3l1338t747r1658b830],
31	that	WDT	O	that	nsubj	32	SENT_34	[p3l1679t747r1813b810],
32	approximate	JJ	O	approximate	rcmod	30	SENT_34	[p3l1834t753r2120b830, p3l130t862r296b913],
33	typical	JJ	O	typical	amod	35	SENT_34	[p3l317t850r546b934],
34	clinical	JJ	O	clinical	amod	35	SENT_34	[p3l568t850r813b913],
35	standards	NNS	O	standard	dobj	32	SENT_34	[p3l835t850r1164b913],
36	of	IN	O	of	_	0	SENT_34	[p3l1187t850r1261b913],
37	care	NN	O	care	prep_of	35	SENT_34	[p3l1273t873r1410b913],
38	and	CC	O	and	_	0	SENT_34	[p3l1433t850r1559b913],
39	durations	NNS	O	duration	prep_of	35	SENT_34	[p3l1581t850r1907b913],
40	of	IN	O	of	_	0	SENT_34	[p3l1929t850r2003b913],
41	treatment	NN	O	treatment	prep_of	35	SENT_34	[p3l130t964r481b1016],
42	.	.	O	.	_	0	SENT_34	[p3l130t964r481b1016],

1	In	IN	O	in	_	0	SENT_35	[p3l82t1165r154b1222],
2	current	JJ	DATE	current	amod	3	SENT_35	[p3l178t1172r435b1223],
3	practice	NN	O	practice	prep_in	10	SENT_35	[p3l455t1166r750b1243],
4	,	,	O	,	_	0	SENT_35	[p3l455t1166r750b1243],
5	efficacy	NN	O	efficacy	nn	8	SENT_35	[p3l776t1160r1037b1244],
6	and	CC	O	and	_	0	SENT_35	[p3l1058t1160r1186b1223],
7	effectiveness	NN	O	effectiveness	nn	8	SENT_35	[p3l1209t1160r1642b1223],
8	trials	NNS	O	trial	nsubjpass	10	SENT_35	[p3l1665t1160r1840b1223],
9	are	VBP	O	be	auxpass	10	SENT_35	[p3l1865t1183r1966b1223],
10	conducted	VBN	O	conduct	_	0	SENT_35	[p3l1990t1183r2145b1223, p3l8t1263r243b1326],
11	separately	RB	O	separately	advmod	10	SENT_35	[p3l266t1263r619b1347],
12	,	,	O	,	_	0	SENT_35	[p3l266t1263r619b1347],
13	with	IN	O	with	_	0	SENT_35	[p3l642t1263r796b1326],
14	effectiveness	NN	O	effectiveness	nn	15	SENT_35	[p3l819t1263r1249b1326],
15	trials	NNS	O	trial	prep_with	10	SENT_35	[p3l1272t1263r1444b1326],
16	typically	RB	O	typically	advmod	17	SENT_35	[p3l1466t1263r1762b1347],
17	done	VBN	O	do	partmod	15	SENT_35	[p3l1782t1263r1951b1326],
18	years	NNS	DATE	year	tmod	17	SENT_35	[p3l1972t1286r2148b1347],
19	later	RB	DATE	later	advmod	17	SENT_35	[p3l6t1366r175b1439],
20	,	,	O	,	_	0	SENT_35	[p3l6t1366r175b1439],
21	if	IN	O	if	mark	37	SENT_35	[p3l200t1366r256b1429],
22	at	IN	O	at	_	0	SENT_35	[p3l271t1378r332b1430],
23	all	DT	O	all	det	24	SENT_35	[p3l355t1358r555b1430],
24	.1	CD	NUMBER	.1	prep_at	37	SENT_35	[p3l355t1358r555b1430],
25	"	``	O	"	punct	24	SENT_35	[p3l355t1358r555b1430],
26	4	CD	NUMBER	4	dep	24	SENT_35	[p3l355t1358r555b1430],
27	Therefore	RB	O	therefore	advmod	24	SENT_35	[p3l578t1366r935b1439],
28	,	,	O	,	_	0	SENT_35	[p3l578t1366r935b1439],
29	approval	NN	O	approval	nsubjpass	37	SENT_35	[p3l961t1366r1265b1450],
30	and	CC	O	and	_	0	SENT_35	[p3l1289t1366r1418b1430],
31	introduction	NN	O	introduction	conj_and	29	SENT_35	[p3l1441t1366r1890b1430],
32	of	IN	O	of	_	0	SENT_35	[p3l1914t1366r1990b1430],
33	new	JJ	O	new	amod	34	SENT_35	[p3l2004t1389r2150b1430],
34	drugs	NNS	O	drug	prep_of	29	SENT_35	[p3l8t1470r207b1554],
35	are	VBP	O	be	auxpass	37	SENT_35	[p3l235t1493r338b1533],
36	currently	RB	DATE	currently	advmod	37	SENT_35	[p3l365t1470r695b1554],
37	based	VBN	O	base	advcl	17	SENT_35	[p3l714t1470r918b1533],
38	on	IN	O	on	_	0	SENT_35	[p3l944t1493r1032b1533],
39	results	NNS	O	result	prep_on	37	SENT_35	[p3l1058t1470r1288b1533],
40	from	IN	O	from	_	0	SENT_35	[p3l1314t1470r1487b1533],
41	optimized	VBN	O	optimize	dep	46	SENT_35	[p3l1514t1470r1875b1553],
42	patient	NN	O	patient	nn	43	SENT_35	[p3l1899t1476r2148b1553],
43	samples	NNS	O	sample	dobj	41	SENT_35	[p3l8t1573r281b1656],
44	and	CC	O	and	_	0	SENT_35	[p3l305t1573r433b1636],
45	ideal	JJ	O	ideal	conj_and	41	SENT_35	[p3l455t1573r621b1636],
46	conditions	NNS	O	condition	prep_from	37	SENT_35	[p3l644t1573r1029b1645],
47	,	,	O	,	_	0	SENT_35	[p3l644t1573r1029b1645],
48	without	IN	O	without	_	0	SENT_35	[p3l1051t1573r1323b1636],
49	data	NNS	O	datum	prep_without	37	SENT_35	[p3l1346t1573r1492b1636],
50	on	IN	O	on	_	0	SENT_35	[p3l1514t1596r1601b1636],
51	effectiveness	NN	O	effectiveness	prep_on	49	SENT_35	[p3l1625t1573r2057b1636],
52	in	IN	O	in	_	0	SENT_35	[p3l2081t1579r2148b1635],
53	usual	JJ	O	usual	amod	55	SENT_35	[p3l7t1676r194b1739],
54	clinical	JJ	O	clinical	amod	55	SENT_35	[p3l219t1676r474b1739],
55	care	NN	O	care	prep_in	51	SENT_35	[p3l499t1699r641b1739],
56	that	WDT	O	that	nsubj	59	SENT_35	[p3l665t1676r804b1739],
57	could	MD	O	could	aux	59	SENT_35	[p3l828t1676r1025b1739],
58	be	VB	O	be	cop	59	SENT_35	[p3l1046t1676r1128b1739],
59	generalizable	JJ	O	generalizable	rcmod	55	SENT_35	[p3l1153t1676r1618b1760],
60	to	TO	O	to	_	0	SENT_35	[p3l1642t1688r1710b1739],
61	the	DT	O	the	det	63	SENT_35	[p3l1735t1676r1845b1739],
62	broader	JJR	O	broader	amod	63	SENT_35	[p3l1869t1676r2148b1739],
63	population	NN	O	population	prep_to	59	SENT_35	[p3l6t1779r391b1862],
64	and	CC	O	and	_	0	SENT_35	[p3l415t1779r543b1842],
65	conditions	NNS	O	condition	conj_and	63	SENT_35	[p3l567t1779r935b1842],
66	in	IN	O	in	_	0	SENT_35	[p3l959t1785r1027b1841],
67	which	WDT	O	which	rel	74	SENT_35	[p3l1048t1779r1263b1842],
68	the	DT	O	the	det	70	SENT_35	[p3l1285t1779r1393b1842],
69	new	JJ	O	new	amod	70	SENT_35	[p3l1417t1802r1562b1842],
70	medication	NN	O	medication	nsubjpass	74	SENT_35	[p3l1582t1779r1977b1842],
71	ultimately	RB	O	ultimately	advmod	74	SENT_35	[p3l2000t1779r2145b1842, p3l7t1882r238b1966],
72	will	MD	O	will	aux	74	SENT_35	[p3l254t1882r380b1945],
73	be	VB	O	be	auxpass	74	SENT_35	[p3l399t1882r479b1945],
74	used	VBN	O	use	rcmod	65	SENT_35	[p3l500t1882r674b1945],
75	.	.	O	.	_	0	SENT_35	[p3l500t1882r674b1945],

1	The	DT	O	the	det	2	SENT_36	[p3l81t1985r204b2048],
2	path	NN	O	path	nsubj	9	SENT_36	[p3l223t1985r372b2068],
3	to	TO	O	to	_	0	SENT_36	[p3l391t1997r455b2048],
4	postapproval	JJ	O	postapproval	amod	6	SENT_36	[p3l475t1985r910b2068],
5	effectiveness	NN	O	effectiveness	nn	6	SENT_36	[p3l930t1985r1346b2048],
6	trials	NNS	O	trial	prep_to	2	SENT_36	[p3l1365t1985r1532b2048],
7	is	VBZ	O	be	cop	9	SENT_36	[p3l1553t1991r1602b2048],
8	a	DT	O	a	det	9	SENT_36	[p3l1623t2008r1657b2048],
9	road	NN	O	road	_	0	SENT_36	[p3l1676t1985r1829b2048],
10	not	RB	O	not	neg	12	SENT_36	[p3l1847t1997r1959b2048],
11	often	RB	O	often	advmod	12	SENT_36	[p3l1978t1985r2147b2048],
12	taken	VBN	O	take	partmod	9	SENT_36	[p3l7t2088r207b2151],
13	.	.	O	.	_	0	SENT_36	[p3l7t2088r207b2151],

1	In	IN	O	in	_	0	SENT_37	[p3l231t2093r300b2150],
2	a	DT	O	a	det	6	SENT_37	[p3l320t2111r354b2151],
3	typical	JJ	O	typical	amod	6	SENT_37	[p3l372t2088r595b2172],
4	drug	NN	O	drug	nn	6	SENT_37	[p3l615t2088r774b2172],
5	development	NN	O	development	nn	6	SENT_37	[p3l792t2088r1226b2171],
6	program	NN	O	program	prep_in	13	SENT_37	[p3l1244t2110r1553b2172],
7	,	,	O	,	_	0	SENT_37	[p3l1244t2110r1553b2172],
8	a	DT	O	a	det	11	SENT_37	[p3l1575t2111r1609b2151],
9	promising	JJ	O	promising	amod	11	SENT_37	[p3l1626t2094r1971b2172],
10	drug	NN	O	drug	nn	11	SENT_37	[p3l1990t2088r2149b2172],
11	candidate	NN	O	candidate	nsubjpass	13	SENT_37	[p3l8t2191r334b2254],
12	is	VBZ	O	be	auxpass	13	SENT_37	[p3l355t2197r404b2254],
13	identiﬁed	VBN	O	identiﬁed	_	0	SENT_37	[p3l425t2191r765b2263],
14	,	,	O	,	_	0	SENT_37	[p3l425t2191r765b2263],
15	early-phase	JJ	O	early-phase	amod	16	SENT_37	[p3l787t2191r1173b2275],
16	safety	NN	O	safety	nsubjpass	21	SENT_37	[p3l1195t2191r1389b2275],
17	and	CC	O	and	_	0	SENT_37	[p3l1406t2191r1531b2254],
18	dosing	NN	O	dosing	nn	19	SENT_37	[p3l1551t2191r1777b2275],
19	studies	NNS	O	study	nsubjpass	21	SENT_37	[p3l1796t2191r2028b2254],
20	are	VBP	O	be	auxpass	21	SENT_37	[p3l2050t2214r2149b2254],
21	conducted	VBN	O	conduct	parataxis	13	SENT_37	[p3l8t2294r376b2366],
22	,	,	O	,	_	0	SENT_37	[p3l8t2294r376b2366],
23	and	CC	O	and	_	0	SENT_37	[p3l398t2294r522b2357],
24	targeted	VBN	O	target	conj_and	13	SENT_37	[p3l539t2294r812b2378],
25	efficacy	NN	O	efficacy	nn	26	SENT_37	[p3l831t2294r1083b2378],
26	trials	NNS	O	trial	nsubjpass	28	SENT_37	[p3l1098t2294r1266b2357],
27	are	VBP	O	be	auxpass	28	SENT_37	[p3l1286t2317r1384b2357],
28	done	VBN	O	do	ccomp	24	SENT_37	[p3l1405t2294r1585b2357],
29	.	.	O	.	_	0	SENT_37	[p3l1405t2294r1585b2357],

1	If	IN	O	if	mark	3	SENT_38	[p3l1609t2294r1666b2356],
2	these	DT	O	these	nsubj	3	SENT_38	[p3l1675t2294r1847b2357],
3	succeed	VB	O	succeed	advcl	10	SENT_38	[p3l1868t2294r2145b2366],
4	,	,	O	,	_	0	SENT_38	[p3l1868t2294r2145b2366],
5	marketing	VBG	O	market	amod	6	SENT_38	[p3l7t2397r361b2481],
6	approval	NN	O	approval	nsubj	10	SENT_38	[p3l381t2397r676b2480],
7	and	CC	O	and	_	0	SENT_38	[p3l697t2397r823b2460],
8	publication	NN	O	publication	nsubj	10	SENT_38	[p3l841t2397r1231b2480],
9	may	MD	O	may	aux	10	SENT_38	[p3l1251t2420r1398b2481],
10	follow	VB	O	follow	_	0	SENT_38	[p3l1415t2397r1636b2460],
11	.	.	O	.	_	0	SENT_38	[p3l1415t2397r1636b2460],

1	Once	RB	DATE	once	advmod	5	SENT_39	[p3l1661t2401r1841b2460],
2	a	DT	O	a	det	3	SENT_39	[p3l1863t2420r1897b2460],
3	drug	NN	O	drug	nsubjpass	5	SENT_39	[p3l1918t2397r2080b2481],
4	is	VBZ	O	be	auxpass	5	SENT_39	[p3l2099t2403r2149b2460],
5	approved	VBN	O	approve	dep	9	SENT_39	[p3l8t2501r352b2584],
6	,	,	O	,	_	0	SENT_39	[p3l8t2501r352b2584],
7	developers	NNS	O	developer	nsubj	9	SENT_39	[p3l378t2501r754b2584],
8	are	VBP	O	be	cop	9	SENT_39	[p3l779t2524r882b2564],
9	unlikely	JJ	O	unlikely	_	0	SENT_39	[p3l906t2501r1193b2585],
10	to	TO	O	to	aux	11	SENT_39	[p3l1212t2513r1279b2564],
11	support	VB	O	support	xcomp	9	SENT_39	[p3l1305t2513r1578b2584],
12	an	DT	O	a	det	14	SENT_39	[p3l1602t2524r1683b2564],
13	effectiveness	NN	O	effectiveness	nn	14	SENT_39	[p3l1708t2501r2147b2564],
14	trial	NN	O	trial	dobj	11	SENT_39	[p3l7t2604r168b2667],
15	.	.	O	.	_	0	SENT_39	[p3l7t2604r168b2667],

1	The	DT	O	the	det	2	SENT_40	[p3l195t2604r323b2667],
2	reasons	NNS	O	reason	nsubj	6	SENT_40	[p3l347t2627r610b2667],
3	for	IN	O	for	_	0	SENT_40	[p3l634t2604r734b2667],
4	this	DT	DATE	this	prep_for	2	SENT_40	[p3l756t2604r884b2667],
5	may	MD	DATE	may	aux	6	SENT_40	[p3l908t2627r1059b2688],
6	be	VB	O	be	_	0	SENT_40	[p3l1077t2604r1158b2667],
7	that	IN	O	that	complm	22	SENT_40	[p3l1181t2604r1319b2667],
8	with	IN	O	with	_	0	SENT_40	[p3l1340t2604r1497b2667],
9	more	JJR	O	more	amod	11	SENT_40	[p3l1520t2627r1703b2667],
10	heterogeneous	JJ	O	heterogeneous	amod	11	SENT_40	[p3l1726t2604r2143b2688, p3l8t2731r123b2771],
11	populations	NNS	O	population	prep_with	22	SENT_40	[p3l143t2708r547b2791],
12	and	CC	O	and	_	0	SENT_40	[p3l569t2708r695b2771],
13	poorer	JJR	O	poorer	amod	17	SENT_40	[p3l713t2730r944b2791],
14	signal-to	JJ	O	signal-to	amod	17	SENT_40	[p3l965t2708r1474b2792],
15	—	NN	O	—	nn	17	SENT_40	[p3l965t2708r1474b2792],
16	noise	NN	O	noise	nn	17	SENT_40	[p3l965t2708r1474b2792],
17	ratios	NNS	O	ratio	prep_with	22	SENT_40	[p3l1494t2714r1702b2780],
18	,	,	O	,	_	0	SENT_40	[p3l1494t2714r1702b2780],
19	effectiveness	NN	O	effectiveness	nn	20	SENT_40	[p3l1724t2708r2148b2771],
20	trials	NNS	O	trial	nsubj	22	SENT_40	[p3l7t2811r179b2874],
21	often	RB	O	often	advmod	22	SENT_40	[p3l203t2811r377b2874],
22	show	VBP	O	show	ccomp	6	SENT_40	[p3l401t2811r579b2874],
23	lesser	JJR	O	lesser	amod	24	SENT_40	[p3l598t2811r789b2874],
24	effects	NNS	O	effect	dobj	22	SENT_40	[p3l812t2811r1025b2874],
25	than	IN	O	than	_	0	SENT_40	[p3l1047t2811r1203b2874],
26	the	DT	O	the	det	28	SENT_40	[p3l1225t2811r1332b2874],
27	efficacy	NN	O	efficacy	nn	28	SENT_40	[p3l1356t2811r1615b2895],
28	trials	NNS	O	trial	prep_than	22	SENT_40	[p3l1633t2811r1806b2874],
29	on	IN	O	on	_	0	SENT_40	[p3l1830t2834r1916b2874],
30	which	WDT	O	which	rel	34	SENT_40	[p3l1937t2811r2148b2874],
31	licensing	NN	O	licensing	nn	32	SENT_40	[p3l6t2914r309b2998],
32	decisions	NNS	O	decision	nsubjpass	34	SENT_40	[p3l328t2914r637b2977],
33	were	VBD	O	be	auxpass	34	SENT_40	[p3l656t2937r815b2977],
34	based	VBN	O	base	rcmod	28	SENT_40	[p3l834t2914r1042b2977],
35	.	.	O	.	_	0	SENT_40	[p3l834t2914r1042b2977],

1	Furthermore	RB	O	furthermore	advmod	47	SENT_41	[p3l1067t2914r1520b2986],
2	,	,	O	,	_	0	SENT_41	[p3l1067t2914r1520b2986],
3	more	JJR	O	more	amod	4	SENT_41	[p3l1542t2937r1717b2977],
4	toxicity	NN	O	toxicity	nsubjpass	7	SENT_41	[p3l1737t2920r1992b2998],
5	may	MD	O	may	aux	7	SENT_41	[p3l2008t2937r2153b2998],
6	be	VB	O	be	auxpass	7	SENT_41	[p3l6t3017r85b3080],
7	found	VBN	O	find	parataxis	47	SENT_41	[p3l106t3017r310b3080],
8	when	WRB	O	when	advmod	9	SENT_41	[p3l327t3017r516b3080],
9	used	VBN	O	use	conj_and	9	SENT_41	[p3l536t3017r695b3080],
10	with	IN	O	with	_	0	SENT_41	[p3l712t3017r865b3080],
11	more	JJR	O	more	amod	13	SENT_41	[p3l885t3040r1063b3080],
12	typical	JJ	O	typical	amod	13	SENT_41	[p3l1083t3017r1312b3101],
13	regimens	NNS	O	regimen	prep_with	9	SENT_41	[p3l1332t3023r1645b3101],
14	and	CC	O	and	_	0	SENT_41	[p3l1667t3017r1793b3080],
15	in	IN	O	in	_	0	SENT_41	[p3l1813t3023r1880b3079],
16	general	JJ	O	general	amod	17	SENT_41	[p3l1900t3017r2150b3101],
17	populations	NNS	O	population	prep_in	9	SENT_41	[p3l6t3113r451b3204],
18	.5	CD	NUMBER	.5	dep	9	SENT_41	[p3l6t3113r451b3204],
19	If	IN	O	if	mark	23	SENT_41	[p3l472t3120r529b3183],
20	independent	JJ	O	independent	amod	21	SENT_41	[p3l539t3120r962b3204],
21	funding	NN	O	funding	nsubjpass	23	SENT_41	[p3l980t3120r1246b3205],
22	is	VBZ	O	be	auxpass	23	SENT_41	[p3l1264t3127r1312b3184],
23	found	VBN	O	find	advcl	47	SENT_41	[p3l1332t3120r1531b3184],
24	for	IN	O	for	_	0	SENT_41	[p3l1549t3120r1644b3184],
25	a	DT	O	a	det	28	SENT_41	[p3l1663t3143r1697b3184],
26	postapproval	JJ	O	postapproval	amod	28	SENT_41	[p3l1714t3120r2148b3204],
27	effectiveness	NN	O	effectiveness	nn	28	SENT_41	[p3l8t3224r435b3287],
28	trial	NN	O	trial	prep_for	23	SENT_41	[p3l455t3224r614b3296],
29	,	,	O	,	_	0	SENT_41	[p3l455t3224r614b3296],
30	those	DT	O	those	nsubj	47	SENT_41	[p3l635t3224r818b3287],
31	conducting	VBG	O	conduct	xcomp	47	SENT_41	[p3l840t3224r1229b3308],
32	it	PRP	O	it	nsubj	37	SENT_41	[p3l1248t3230r1294b3287],
33	may	MD	O	may	aux	37	SENT_41	[p3l1313t3247r1460b3308],
34	or	CC	O	or	cc	37	SENT_41	[p3l1478t3247r1550b3287],
35	may	MD	O	may	aux	37	SENT_41	[p3l1569t3247r1716b3308],
36	not	RB	O	not	neg	37	SENT_41	[p3l1733t3236r1847b3287],
37	have	VB	O	have	ccomp	31	SENT_41	[p3l1866t3224r2021b3287],
38	the	DT	O	the	det	39	SENT_41	[p3l2041t3224r2148b3287],
39	involvement	NN	O	involvement	dobj	37	SENT_41	[p3l8t3327r439b3390],
40	of	IN	O	of	_	0	SENT_41	[p3l461t3327r536b3390],
41	the	DT	O	the	det	43	SENT_41	[p3l549t3327r656b3390],
42	original	JJ	O	original	amod	43	SENT_41	[p3l680t3327r951b3411],
43	investigators	NNS	O	investigator	prep_of	39	SENT_41	[p3l973t3333r1429b3411],
44	,	,	O	,	_	0	SENT_41	[p3l973t3333r1429b3411],
45	may	MD	O	may	aux	47	SENT_41	[p3l1454t3350r1602b3411],
46	not	RB	O	not	neg	47	SENT_41	[p3l1621t3339r1737b3390],
47	have	VB	O	have	_	0	SENT_41	[p3l1758t3327r1915b3390],
48	access	NN	O	access	dobj	47	SENT_41	[p3l1939t3350r2148b3390],
49	to	TO	O	to	_	0	SENT_41	[p3l7t3442r72b3493],
50	information	NN	O	information	prep_to	47	SENT_41	[p3l94t3430r507b3493],
51	that	WDT	O	that	nsubj	53	SENT_41	[p3l527t3430r660b3493],
52	would	MD	O	would	aux	53	SENT_41	[p3l678t3430r891b3493],
53	inform	VB	O	inform	rcmod	50	SENT_41	[p3l911t3430r1148b3493],
54	understanding	NN	O	understanding	dobj	53	SENT_41	[p3l1169t3430r1670b3514],
55	of	IN	O	of	_	0	SENT_41	[p3l1690t3430r1763b3493],
56	the	DT	O	the	det	57	SENT_41	[p3l1773t3430r1879b3493],
57	heterogeneity	NN	O	heterogeneity	prep_of	54	SENT_41	[p3l1899t3430r2143b3493, p3l7t3540r254b3618],
58	of	IN	O	of	_	0	SENT_41	[p3l271t3534r344b3597],
59	effects	NNS	O	effect	prep_of	57	SENT_41	[p3l355t3534r565b3597],
60	in	IN	O	in	_	0	SENT_41	[p3l586t3540r652b3596],
61	various	JJ	O	various	amod	62	SENT_41	[p3l669t3540r918b3597],
62	subgroups	NNS	O	subgroup	prep_in	59	SENT_41	[p3l940t3534r1308b3618],
63	,	,	O	,	_	0	SENT_41	[p3l940t3534r1308b3618],
64	and	CC	O	and	_	0	SENT_41	[p3l1331t3534r1455b3597],
65	may	MD	O	may	aux	67	SENT_41	[p3l1475t3557r1620b3618],
66	not	RB	O	not	neg	67	SENT_41	[p3l1637t3546r1750b3597],
67	have	VB	O	have	conj_and	47	SENT_41	[p3l1767t3534r1921b3597],
68	access	NN	O	access	dobj	67	SENT_41	[p3l1943t3557r2146b3597],
69	to	TO	O	to	_	0	SENT_41	[p3l7t3649r74b3700],
70	efficacy	NN	O	efficacy	nn	72	SENT_41	[p3l100t3637r365b3721],
71	trial	NN	O	trial	nn	72	SENT_41	[p3l385t3637r530b3700],
72	data	NNS	O	datum	prep_to	67	SENT_41	[p3l555t3637r703b3700],
73	that	WDT	O	that	nsubj	75	SENT_41	[p3l725t3637r862b3700],
74	could	MD	O	could	aux	75	SENT_41	[p3l886t3637r1082b3700],
75	generate	VB	O	generate	rcmod	72	SENT_41	[p3l1105t3649r1402b3721],
76	predictive	JJ	O	predictive	amod	77	SENT_41	[p3l1425t3637r1777b3720],
77	models	NNS	O	model	dobj	75	SENT_41	[p3l1801t3637r2055b3700],
78	to	TO	O	to	aux	79	SENT_41	[p3l2079t3649r2147b3700],
79	facilitate	VB	O	facilitate	xcomp	75	SENT_41	[p3l7t3740r305b3803],
80	translation	NN	O	translation	dobj	79	SENT_41	[p3l327t3740r706b3803],
81	into	IN	O	into	_	0	SENT_41	[p3l730t3746r866b3803],
82	widespread	JJ	O	widespread	amod	83	SENT_41	[p3l890t3740r1290b3823],
83	use	NN	O	use	prep_into	79	SENT_41	[p3l1312t3763r1443b3803],
84	.	.	O	.	_	0	SENT_41	[p3l1312t3763r1443b3803],

1	As	IN	O	as	_	0	SENT_42	[p3l1469t3744r1557b3803],
2	an	DT	O	a	det	3	SENT_42	[p3l1582t3763r1663b3803],
3	alternative	NN	O	alternative	prep_as	12	SENT_42	[p3l1688t3740r2055b3803],
4	to	TO	O	to	_	0	SENT_42	[p3l2078t3752r2145b3803],
5	this	DT	O	this	det	9	SENT_42	[p4l7t21r130b84],
6	uncertain	JJ	O	uncertain	amod	9	SENT_42	[p4l151t27r480b84],
7	and	CC	O	and	_	0	SENT_42	[p4l501t21r627b84],
8	disjointed	JJ	O	disjointed	amod	9	SENT_42	[p4l647t21r986b105],
9	process	NN	O	process	prep_to	3	SENT_42	[p4l1004t43r1275b104],
10	,	,	O	,	_	0	SENT_42	[p4l1004t43r1275b104],
11	we	PRP	O	we	nsubj	12	SENT_42	[p4l1295t44r1388b84],
12	suggest	VBP	O	suggest	_	0	SENT_42	[p4l1409t33r1658b105],
13	the	DT	O	the	det	18	SENT_42	[p4l1676t21r1782b84],
14	integrated	VBN	O	integrate	amod	18	SENT_42	[p4l1802t21r2148b105],
15	continuous	JJ	O	continuous	amod	18	SENT_42	[p4l8t130r391b187],
16	translational	JJ	O	translational	amod	18	SENT_42	[p4l413t124r844b187],
17	research	NN	O	research	nn	18	SENT_42	[p4l865t124r1150b187],
18	process	NN	O	process	nsubj	19	SENT_42	[p4l1170t146r1424b207],
19	described	VBN	O	describe	ccomp	12	SENT_42	[p4l1447t124r1778b187],
20	below	IN	O	below	prep	19	SENT_42	[p4l1797t124r2011b187],
21	.	.	O	.	_	0	SENT_42	[p4l1797t124r2011b187],

1	PROPOSED	VBN	O	propose	_	0	SENT_43	[p4l11t339r406b395],
2	APPROACH	NN	O	approach	dobj	1	SENT_43	[p4l424t339r825b395],

1	Elements	NNS	O	element	nsubjpass	35	SENT_44	[p4l10t440r327b498],
2	of	IN	O	of	_	0	SENT_44	[p4l345t440r416b498],
3	integrated	VBN	O	integrate	amod	5	SENT_44	[p4l431t441r794b514],
4	E2E	NN	O	e2e	nn	5	SENT_44	[p4l816t443r936b497],
5	trials	NNS	O	trial	prep_of	1	SENT_44	[p4l953t441r1128b498],
6	With	IN	O	with	_	0	SENT_44	[p4l6t538r179b601],
7	the	DT	O	the	det	9	SENT_44	[p4l199t538r305b601],
8	E2E	NN	O	e2e	nn	9	SENT_44	[p4l327t543r463b600],
9	approach	NN	O	approach	prep_with	5	SENT_44	[p4l485t538r817b621],
10	,	,	O	,	_	0	SENT_44	[p4l485t538r817b621],
11	as	IN	O	as	mark	27	SENT_44	[p4l841t561r905b601],
12	planned	VBN	O	plan	partmod	27	SENT_44	[p4l926t538r1204b621],
13	from	IN	O	from	_	0	SENT_44	[p4l1224t538r1391b601],
14	the	DT	O	the	det	15	SENT_44	[p4l1412t538r1518b601],
15	outset	NN	O	outset	prep_from	12	SENT_44	[p4l1540t550r1762b610],
16	,	,	O	,	_	0	SENT_44	[p4l1540t550r1762b610],
17	potentially	RB	O	potentially	advmod	15	SENT_44	[p4l1784t538r2151b622],
18	including	VBG	O	include	_	0	SENT_44	[p4l8t641r333b725],
19	patients	NNS	O	patient	prep_including	15	SENT_44	[p4l352t647r620b724],
20	and	CC	O	and	_	0	SENT_44	[p4l644t641r770b704],
21	other	JJ	O	other	amod	22	SENT_44	[p4l791t641r972b704],
22	stakeholders	NNS	O	stakeholder	prep_including	15	SENT_44	[p4l994t641r1437b713],
23	,	,	O	,	_	0	SENT_44	[p4l994t641r1437b713],
24	an	DT	O	a	det	26	SENT_44	[p4l1462t664r1542b704],
25	effectiveness	NN	O	effectiveness	nn	26	SENT_44	[p4l1564t641r1989b704],
26	trial	NN	O	trial	nsubj	27	SENT_44	[p4l2010t641r2150b704],
27	starts	VBZ	O	start	dep	9	SENT_44	[p4l9t756r196b807],
28	immediately	RB	O	immediately	advmod	27	SENT_44	[p4l222t744r666b828],
29	after	IN	O	after	_	0	SENT_44	[p4l688t744r845b807],
30	the	DT	O	the	det	33	SENT_44	[p4l868t744r978b807],
31	efﬁcacy	NN	O	efﬁcacy	nn	33	SENT_44	[p4l1004t744r1269b828],
32	trial	NN	O	trial	nn	33	SENT_44	[p4l1289t744r1435b807],
33	component	NN	O	component	prep_after	27	SENT_44	[p4l1460t756r1863b827],
34	is	VBZ	O	be	auxpass	35	SENT_44	[p4l1887t750r1939b807],
35	completed	VBN	O	complete	_	0	SENT_44	[p4l1966t767r2144b807, p4l6t847r233b930],
36	.	.	O	.	_	0	SENT_44	[p4l1966t767r2144b807, p4l6t847r233b930],

1	(	NN	O	(	_	0	SENT_45	[p4l262t848r471b923],
2	Here	RB	O	here	advmod	5	SENT_45	[p4l262t848r471b923],
3	,	,	O	,	_	0	SENT_45	[p4l262t848r471b923],
4	we	PRP	O	we	nsubj	5	SENT_45	[p4l493t870r587b910],
5	use	VBP	O	use	rcmod	1	SENT_45	[p4l609t870r721b910],
6	as	IN	O	as	_	0	SENT_45	[p4l744t870r808b910],
7	context	NN	O	context	nn	8	SENT_45	[p4l833t859r1085b910],
8	trials	NNS	O	trial	prep_as	5	SENT_45	[p4l1105t847r1277b910],
9	in	IN	O	in	_	0	SENT_45	[p4l1300t853r1367b909],
10	which	WDT	O	which	rel	15	SENT_45	[p4l1387t847r1598b910],
11	the	DT	O	the	det	12	SENT_45	[p4l1619t847r1726b910],
12	comparator	NN	O	comparator	nsubj	15	SENT_45	[p4l1749t859r2149b930],
13	is	VBZ	O	be	cop	15	SENT_45	[p4l8t956r57b1013],
14	a	DT	O	a	det	15	SENT_45	[p4l81t973r115b1013],
15	placebo	NN	O	placebo	rcmod	8	SENT_45	[p4l135t950r397b1033],
16	rather	RB	O	rather	_	0	SENT_45	[p4l421t950r627b1013],
17	than	IN	O	than	_	0	SENT_45	[p4l647t950r802b1013],
18	an	DT	O	a	det	21	SENT_45	[p4l824t973r904b1013],
19	alternative	JJ	O	alternative	amod	21	SENT_45	[p4l927t950r1284b1013],
20	active	JJ	O	active	amod	21	SENT_45	[p4l1307t956r1502b1013],
21	agent	NN	O	agent	rcmod	8	SENT_45	[p4l1525t962r1724b1034],
22	,	,	O	,	_	0	SENT_45	[p4l1525t962r1724b1034],
23	as	RB	O	as	advmod	24	SENT_45	[p4l1748t973r1813b1013],
24	is	VBZ	O	be	dep	15	SENT_45	[p4l1836t956r1885b1013],
25	usually	RB	O	usually	advmod	24	SENT_45	[p4l1908t950r2152b1034],

1	2	CD	NUMBER	2	nsubj	15	SENT_46	[p4l7t1170r36b1211],
2	the	DT	O	the	det	3	SENT_46	[p4l8t1252r117b1315],
3	case	NN	O	case	dep	1	SENT_46	[p4l143t1275r285b1315],
4	in	IN	O	in	_	0	SENT_46	[p4l311t1258r378b1314],
5	efficacy	NN	O	efficacy	nn	6	SENT_46	[p4l404t1252r668b1336],
6	trials	NNS	O	trial	prep_in	1	SENT_46	[p4l688t1252r883b1324],
7	,	,	O	,	_	0	SENT_46	[p4l688t1252r883b1324],
8	but	CC	O	but	prep	1	SENT_46	[p4l907t1252r1024b1315],
9	the	DT	O	the	det	11	SENT_46	[p4l1046t1252r1155b1315],
10	E2E	NN	O	e2e	nn	11	SENT_46	[p4l1180t1257r1319b1314],
11	method	NN	O	method	dep	8	SENT_46	[p4l1343t1252r1618b1315],
12	also	RB	O	also	advmod	15	SENT_46	[p4l1643t1252r1777b1315],
13	should	MD	O	should	aux	15	SENT_46	[p4l1804t1252r2040b1315],
14	be	VB	O	be	cop	15	SENT_46	[p4l2062t1252r2143b1315],
15	applicable	JJ	O	applicable	_	0	SENT_46	[p4l10t1355r344b1438],
16	to	TO	O	to	prep	15	SENT_46	[p4l363t1367r428b1418],
17	comparative	JJ	O	comparative	amod	18	SENT_46	[p4l450t1361r862b1438],
18	efﬁcacy	NN	O	efﬁcacy	dobj	15	SENT_46	[p4l883t1355r1136b1439],
19	and	CC	O	and	_	0	SENT_46	[p4l1152t1355r1276b1418],
20	effectiveness	NN	O	effectiveness	conj_and	18	SENT_46	[p4l1295t1355r1758b1431],
21	.	.	O	.	_	0	SENT_46	[p4l1295t1355r1758b1431],
22	)	SYM	O	)	dep	18	SENT_46	[p4l1295t1355r1758b1431],

1	The	DT	O	the	det	2	SENT_47	[p4l1781t1355r1905b1418],
2	transition	NN	O	transition	nsubjpass	5	SENT_47	[p4l1923t1361r2141b1418, p4l8t1464r145b1521],
3	could	MD	O	could	aux	5	SENT_47	[p4l167t1458r356b1521],
4	be	VB	O	be	auxpass	5	SENT_47	[p4l374t1458r453b1521],
5	handled	VBN	O	handle	_	0	SENT_47	[p4l474t1458r751b1521],
6	in	IN	O	in	_	0	SENT_47	[p4l772t1464r838b1520],
7	a	DT	O	a	det	8	SENT_47	[p4l860t1481r895b1521],
8	variety	NN	O	variety	prep_in	5	SENT_47	[p4l912t1464r1149b1542],
9	of	IN	O	of	_	0	SENT_47	[p4l1167t1458r1241b1521],
10	ways	NNS	O	way	prep_of	8	SENT_47	[p4l1251t1481r1432b1542],
11	;	:	O	;	_	0	SENT_47	[p4l1251t1481r1432b1542],
12	one	CD	NUMBER	one	nsubj	14	SENT_47	[p4l1456t1481r1578b1521],
13	could	MD	O	could	aux	14	SENT_47	[p4l1600t1458r1789b1521],
14	be	VB	O	be	parataxis	5	SENT_47	[p4l1808t1458r1887b1521],
15	that	IN	O	that	complm	26	SENT_47	[p4l1907t1458r2040b1521],
16	an	DT	O	a	det	24	SENT_47	[p4l2061t1481r2141b1521],
17	external	JJ	O	external	amod	24	SENT_47	[p4l10t1561r279b1624],
18	data	NNS	O	datum	nn	24	SENT_47	[p4l298t1561r438b1624],
19	safety	NN	O	safety	nn	24	SENT_47	[p4l457t1561r648b1645],
20	monitoring	NN	O	monitoring	nn	24	SENT_47	[p4l662t1567r1046b1645],
21	board	NN	O	board	nn	24	SENT_47	[p4l1061t1561r1258b1624],
22	(	CD	NUMBER	(	num	24	SENT_47	[p4l1280t1561r1553b1638],
23	DSMB	NN	O	dsmb	nn	24	SENT_47	[p4l1280t1561r1553b1638],
24	)	NN	O	)	nsubj	26	SENT_47	[p4l1280t1561r1553b1638],
25	would	MD	O	would	aux	26	SENT_47	[p4l1574t1561r1784b1624],
26	review	VB	O	review	ccomp	14	SENT_47	[p4l1803t1567r2024b1624],
27	the	DT	O	the	det	28	SENT_47	[p4l2040t1561r2143b1624],
28	data	NNS	O	datum	dobj	26	SENT_47	[p4l10t1664r150b1727],
29	and	CC	O	and	_	0	SENT_47	[p4l169t1664r293b1727],
30	analytic	JJ	O	analytic	amod	31	SENT_47	[p4l312t1664r571b1748],
31	methods	NNS	O	method	dobj	26	SENT_47	[p4l590t1664r882b1727],
32	of	IN	O	of	_	0	SENT_47	[p4l902t1664r974b1727],
33	the	DT	O	the	det	35	SENT_47	[p4l983t1664r1088b1727],
34	efficacy	NN	O	efficacy	nn	35	SENT_47	[p4l1108t1664r1360b1748],
35	trial	NN	O	trial	prep_of	31	SENT_47	[p4l1374t1664r1512b1727],
36	and	CC	O	and	_	0	SENT_47	[p4l1531t1664r1655b1727],
37	then	RB	O	then	advmod	26	SENT_47	[p4l1672t1664r1823b1727],
38	ratify	VB	O	ratify	ccomp	14	SENT_47	[p4l1842t1664r2022b1748],
39	the	DT	O	the	det	40	SENT_47	[p4l2037t1664r2141b1727],
40	results	NNS	O	result	dobj	38	SENT_47	[p4l10t1767r243b1839],
41	,	,	O	,	_	0	SENT_47	[p4l10t1767r243b1839],
42	using	VBG	O	use	partmod	40	SENT_47	[p4l264t1773r447b1851],
43	go	VB	O	go	ccomp	42	SENT_47	[p4l465t1771r571b1851],
44	/	:	O	/	punct	47	SENT_47	[p4l465t1771r571b1851],
45	no	DT	O	no	det	46	SENT_47	[p4l575t1790r689b1830],
46	—	NN	O	—	nsubj	47	SENT_47	[p4l575t1790r689b1830],
47	go	VB	O	go	parataxis	38	SENT_47	[p4l695t1790r773b1851],
48	criteria	NNS	O	criterion	dobj	47	SENT_47	[p4l795t1773r1035b1830],
49	prespeciﬁed	VBN	O	prespeciﬁed	partmod	48	SENT_47	[p4l1052t1767r1459b1850],
50	by	IN	O	by	_	0	SENT_47	[p4l1476t1767r1559b1851],
51	investigators	NNS	O	investigator	agent	49	SENT_47	[p4l1575t1773r2015b1851],
52	,	,	O	,	_	0	SENT_47	[p4l1575t1773r2015b1851],
53	the	DT	O	the	det	54	SENT_47	[p4l2035t1767r2140b1830],
54	sponsor	NN	O	sponsor	conj_and	51	SENT_47	[p4l10t1893r289b1954],
55	,	,	O	,	_	0	SENT_47	[p4l10t1893r289b1954],
56	and	CC	O	and	_	0	SENT_47	[p4l311t1871r436b1934],
57	the	DT	O	the	det	60	SENT_47	[p4l454t1871r559b1934],
58	responsible	JJ	O	responsible	amod	60	SENT_47	[p4l579t1871r960b1954],
59	regulatory	JJ	O	regulatory	amod	60	SENT_47	[p4l980t1871r1331b1955],
60	agency	NN	O	agency	conj_and	51	SENT_47	[p4l1348t1894r1589b1955],
61	.	.	O	.	_	0	SENT_47	[p4l1348t1894r1589b1955],

1	Approval	NN	O	approval	nsubj	6	SENT_48	[p4l1611t1871r1924b1954],
2	by	IN	O	by	_	0	SENT_48	[p4l1940t1871r2024b1955],
3	the	DT	O	the	det	4	SENT_48	[p4l2039t1871r2144b1934],
4	DSMB	NN	ORGANIZATION	dsmb	prep_by	1	SENT_48	[p4l10t1978r232b2037],
5	would	MD	O	would	aux	6	SENT_48	[p4l251t1974r462b2037],
6	trigger	VB	O	trigger	_	0	SENT_48	[p4l480t1980r706b2058],
7	the	DT	O	the	det	8	SENT_48	[p4l723t1974r828b2037],
8	start	NN	O	start	dobj	6	SENT_48	[p4l849t1986r997b2037],
9	of	IN	O	of	_	0	SENT_48	[p4l1016t1974r1088b2037],
10	the	DT	O	the	det	13	SENT_48	[p4l1097t1974r1202b2037],
11	regulatory	JJ	O	regulatory	amod	13	SENT_48	[p4l1222t1974r1571b2058],
12	approval	NN	O	approval	nn	13	SENT_48	[p4l1587t1974r1877b2057],
13	process	NN	O	process	prep_of	8	SENT_48	[p4l1895t1996r2143b2057],
14	and	CC	O	and	_	0	SENT_48	[p4l10t2077r135b2140],
15	the	DT	O	the	det	16	SENT_48	[p4l153t2077r258b2140],
16	transition	NN	O	transition	conj_and	13	SENT_48	[p4l276t2083r606b2140],
17	from	IN	O	from	_	0	SENT_48	[p4l626t2077r791b2140],
18	the	DT	O	the	det	20	SENT_48	[p4l810t2077r915b2140],
19	efﬁcacy	NN	O	efﬁcacy	nn	20	SENT_48	[p4l936t2077r1190b2161],
20	trial	NN	O	trial	prep_from	6	SENT_48	[p4l1205t2077r1344b2140],
21	to	TO	O	to	_	0	SENT_48	[p4l1362t2089r1427b2140],
22	an	DT	O	a	det	24	SENT_48	[p4l1449t2100r1528b2140],
23	effectiveness	NN	O	effectiveness	nn	24	SENT_48	[p4l1548t2077r1968b2140],
24	trial	NN	O	trial	prep_to	6	SENT_48	[p4l1988t2077r2141b2140],
25	.	.	O	.	_	0	SENT_48	[p4l1988t2077r2141b2140],

1	At	IN	O	at	_	0	SENT_49	[p4l8t2184r88b2243],
2	this	DT	O	this	det	3	SENT_49	[p4l106t2180r228b2243],
3	point	NN	O	point	prep_at	16	SENT_49	[p4l247t2186r443b2263],
4	,	,	O	,	_	0	SENT_49	[p4l247t2186r443b2263],
5	the	DT	O	the	det	6	SENT_49	[p4l463t2180r568b2243],
6	composition	NN	O	composition	nsubjpass	16	SENT_49	[p4l589t2186r1011b2263],
7	of	IN	O	of	_	0	SENT_49	[p4l1031t2180r1104b2243],
8	the	DT	O	the	det	9	SENT_49	[p4l1113t2180r1218b2243],
9	DSMB	NN	ORGANIZATION	dsmb	prep_of	6	SENT_49	[p4l1238t2184r1461b2243],
10	for	IN	O	for	_	0	SENT_49	[p4l1482t2180r1578b2243],
11	the	DT	O	the	det	13	SENT_49	[p4l1595t2180r1700b2243],
12	effectiveness	NN	O	effectiveness	nn	13	SENT_49	[p4l1721t2180r2140b2243],
13	component	NN	O	component	prep_for	9	SENT_49	[p4l10t2295r408b2366],
14	would	MD	O	would	aux	16	SENT_49	[p4l429t2283r648b2346],
15	be	VB	O	be	auxpass	16	SENT_49	[p4l668t2283r749b2346],
16	determined	VBN	O	determine	_	0	SENT_49	[p4l774t2283r1197b2355],
17	,	,	O	,	_	0	SENT_49	[p4l774t2283r1197b2355],
18	potentially	RB	O	potentially	advmod	19	SENT_49	[p4l1221t2283r1600b2367],
19	retaining	VBG	O	retain	ccomp	16	SENT_49	[p4l1620t2289r1936b2367],
20	some	DT	O	some	det	21	SENT_49	[p4l1959t2306r2141b2346],
21	members	NNS	O	member	dobj	19	SENT_49	[p4l9t2386r322b2449],
22	and	CC	O	and	_	0	SENT_49	[p4l343t2386r468b2449],
23	adding	VBG	O	add	ccomp	16	SENT_49	[p4l487t2386r720b2470],
24	others	NNS	O	other	dobj	23	SENT_49	[p4l738t2386r962b2449],
25	.	.	O	.	_	0	SENT_49	[p4l738t2386r962b2449],

1	Although	IN	O	although	mark	11	SENT_50	[p4l984t2386r1306b2470],
2	a	DT	O	a	det	3	SENT_50	[p4l1326t2409r1360b2449],
3	pause	NN	O	pause	nsubj	11	SENT_50	[p4l1377t2408r1568b2469],
4	between	IN	O	between	_	0	SENT_50	[p4l1586t2386r1868b2449],
5	the	DT	O	the	det	9	SENT_50	[p4l1886t2386r1991b2449],
6	efficacy	NN	O	efficacy	nn	9	SENT_50	[p4l2011t2386r2139b2449, p4l10t2512r156b2573],
7	and	CC	O	and	_	0	SENT_50	[p4l172t2489r294b2552],
8	effectiveness	NN	O	effectiveness	nn	9	SENT_50	[p4l313t2489r722b2552],
9	components	NNS	O	component	prep_between	3	SENT_50	[p4l742t2501r1148b2572],
10	might	MD	O	might	aux	11	SENT_50	[p4l1167t2489r1364b2573],
11	occur	VB	O	occur	advcl	40	SENT_50	[p4l1382t2512r1568b2552],
12	as	IN	O	as	mark	15	SENT_50	[p4l1587t2512r1649b2552],
13	sites	NNS	O	site	nsubjpass	15	SENT_50	[p4l1669t2495r1806b2552],
14	are	VBP	O	be	auxpass	15	SENT_50	[p4l1826t2512r1923b2552],
15	added	VBN	O	add	advcl	11	SENT_50	[p4l1943t2489r2144b2552],
16	and	CC	O	and	_	0	SENT_50	[p4l10t2592r136b2655],
17	entry	NN	O	entry	nn	18	SENT_50	[p4l157t2604r339b2676],
18	criteria	NNS	O	criterion	nsubj	32	SENT_50	[p4l357t2598r600b2655],
19	and	CC	O	and	_	0	SENT_50	[p4l622t2592r747b2655],
20	data	NNS	O	datum	conj_and	18	SENT_50	[p4l769t2592r912b2655],
21	collection	NN	O	collection	nsubjpass	23	SENT_50	[p4l934t2592r1266b2655],
22	are	VBP	O	be	auxpass	23	SENT_50	[p4l1288t2615r1388b2655],
23	adjusted	VBN	O	adjust	rcmod	18	SENT_50	[p4l1411t2592r1711b2676],
24	,	,	O	,	_	0	SENT_50	[p4l1411t2592r1711b2676],
25	because	IN	O	because	mark	29	SENT_50	[p4l1732t2592r1999b2655],
26	this	DT	O	this	det	27	SENT_50	[p4l2020t2592r2143b2655],
27	transition	NN	O	transition	nsubjpass	29	SENT_50	[p4l8t2701r332b2758],
28	was	VBD	O	be	auxpass	29	SENT_50	[p4l349t2718r472b2758],
29	planned	VBN	O	plan	advcl	23	SENT_50	[p4l490t2695r762b2778],
30	with	IN	O	with	_	0	SENT_50	[p4l778t2695r927b2758],
31	criteria	NNS	O	criterion	prep_with	29	SENT_50	[p4l946t2701r1183b2758],
32	prespeciﬁed	VBD	O	prespeciﬁed	advcl	40	SENT_50	[p4l1199t2695r1601b2778],
33	from	IN	O	from	_	0	SENT_50	[p4l1619t2695r1782b2758],
34	the	DT	O	the	det	35	SENT_50	[p4l1800t2695r1904b2758],
35	outset	NN	O	outset	prep_from	32	SENT_50	[p4l1924t2707r2140b2767],
36	,	,	O	,	_	0	SENT_50	[p4l1924t2707r2140b2767],
37	it	PRP	O	it	nsubj	42	SENT_50	[p4l10t2804r56b2861],
38	should	MD	O	should	aux	40	SENT_50	[p4l79t2798r315b2861],
39	be	VB	O	be	cop	40	SENT_50	[p4l335t2798r416b2861],
40	short	JJ	O	short	_	0	SENT_50	[p4l440t2798r620b2861],
41	and	CC	O	and	_	0	SENT_50	[p4l643t2798r772b2861],
42	efficient	JJ	O	efficient	conj_and	40	SENT_50	[p4l795t2798r1087b2861],
43	.	.	O	.	_	0	SENT_50	[p4l795t2798r1087b2861],

1	Then	RB	O	then	advmod	26	SENT_51	[p4l1114t2798r1308b2870],
2	,	,	O	,	_	0	SENT_51	[p4l1114t2798r1308b2870],
3	as	IN	O	as	mark	15	SENT_51	[p4l1334t2821r1400b2861],
4	screening	NN	O	screening	nsubj	15	SENT_51	[p4l1425t2804r1760b2882],
5	of	IN	O	of	_	0	SENT_51	[p4l1782t2798r1858b2861],
6	populations	NNS	O	population	prep_of	4	SENT_51	[p4l1870t2798r2141b2881, p4l8t2906r171b2964],
7	for	IN	O	for	_	0	SENT_51	[p4l190t2900r284b2964],
8	the	DT	O	the	det	10	SENT_51	[p4l301t2900r404b2964],
9	effectiveness	NN	O	effectiveness	nn	10	SENT_51	[p4l424t2900r835b2964],
10	trial	NN	O	trial	prep_for	6	SENT_51	[p4l854t2900r990b2964],
11	with	IN	O	with	_	0	SENT_51	[p4l1006t2900r1154b2964],
12	less	JJR	O	less	amod	14	SENT_51	[p4l1172t2900r1286b2964],
13	restrictive	JJ	O	restrictive	amod	14	SENT_51	[p4l1306t2906r1633b2964],
14	criteria	NNS	O	criterion	prep_with	10	SENT_51	[p4l1653t2906r1889b2964],
15	ensues	VBZ	O	ensue	advcl	26	SENT_51	[p4l1907t2923r2141b2972],
16	,	,	O	,	_	0	SENT_51	[p4l1907t2923r2141b2972],
17	some	DT	O	some	det	18	SENT_51	[p4l10t3027r184b3067],
18	patients	NNS	O	patient	nsubj	26	SENT_51	[p4l203t3010r465b3087],
19	who	WP	O	who	nsubj	25	SENT_51	[p4l484t3004r627b3067],
20	would	MD	O	would	aux	25	SENT_51	[p4l646t3004r856b3067],
21	have	VB	O	have	aux	25	SENT_51	[p4l874t3004r1025b3067],
22	been	VBN	O	be	cop	25	SENT_51	[p4l1043t3004r1204b3067],
23	“	RB	O	“	advmod	25	SENT_51	[p4l1224t3004r1464b3067],
24	screen	NN	O	screen	nn	25	SENT_51	[p4l1224t3004r1464b3067],
25	failures	NNS	O	failure	rcmod	18	SENT_51	[p4l1483t3004r1754b3067],
26	”	VBP	O	”	_	0	SENT_51	[p4l1483t3004r1754b3067],
27	for	IN	O	for	mark	35	SENT_51	[p4l1775t3004r1870b3067],
28	the	DT	O	the	det	31	SENT_51	[p4l1887t3004r1992b3067],
29	efficacy	NN	O	efficacy	nn	31	SENT_51	[p4l2012t3004r2138b3067, p4l10t3130r159b3191],
30	trial	NN	O	trial	nn	31	SENT_51	[p4l174t3107r312b3170],
31	component	NN	O	component	nsubj	35	SENT_51	[p4l331t3119r715b3190],
32	might	MD	O	might	aux	35	SENT_51	[p4l734t3107r934b3191],
33	become	VB	O	become	cop	35	SENT_51	[p4l950t3107r1213b3170],
34	appropriate	JJ	O	appropriate	amod	35	SENT_51	[p4l1233t3113r1619b3190],
35	subjects	NNS	O	subject	advcl	26	SENT_51	[p4l1640t3107r1904b3191],
36	for	IN	O	for	_	0	SENT_51	[p4l1925t3107r2020b3170],
37	the	DT	O	the	det	40	SENT_51	[p4l2038t3107r2143b3170],
38	effectiveness	NN	O	effectiveness	nn	40	SENT_51	[p4l10t3210r423b3273],
39	trial	NN	O	trial	nn	40	SENT_51	[p4l441t3210r578b3273],
40	component	NN	O	component	prep_for	35	SENT_51	[p4l597t3222r991b3293],
41	.	.	O	.	_	0	SENT_51	[p4l597t3222r991b3293],

1	Thereby	RB	O	thereby	advmod	8	SENT_52	[p4l1013t3210r1292b3294],
2	,	,	O	,	_	0	SENT_52	[p4l1013t3210r1292b3294],
3	these	DT	O	these	det	4	SENT_52	[p4l1312t3210r1482b3273],
4	results	NNS	O	result	nsubj	8	SENT_52	[p4l1502t3210r1715b3273],
5	will	MD	O	will	aux	8	SENT_52	[p4l1733t3210r1855b3273],
6	be	VB	O	be	cop	8	SENT_52	[p4l1871t3210r1949b3273],
7	more	RBR	O	more	advmod	8	SENT_52	[p4l1967t3233r2141b3273],
8	applicable	JJ	O	applicable	_	0	SENT_52	[p4l10t3313r345b3396],
9	to	TO	O	to	_	0	SENT_52	[p4l364t3325r429b3376],
10	a	DT	O	a	det	12	SENT_52	[p4l451t3336r485b3376],
11	general	JJ	O	general	amod	12	SENT_52	[p4l503t3313r748b3397],
12	population	NN	O	population	prep_to	8	SENT_52	[p4l766t3313r1135b3396],
13	than	IN	O	than	advcl	8	SENT_52	[p4l1154t3313r1306b3376],
14	the	DT	O	the	det	15	SENT_52	[p4l1324t3313r1429b3376],
15	results	NNS	O	result	dep	23	SENT_52	[p4l1449t3313r1665b3376],
16	of	IN	O	of	_	0	SENT_52	[p4l1685t3313r1758b3376],
17	the	DT	O	the	det	19	SENT_52	[p4l1767t3313r1872b3376],
18	efficacy	NN	O	efficacy	nn	19	SENT_52	[p4l1892t3313r2146b3397],
19	trial	NN	O	trial	prep_of	15	SENT_52	[p4l8t3416r147b3479],
20	component	NN	O	component	dep	23	SENT_52	[p4l168t3428r554b3499],
21	(	CD	NUMBER	(	num	20	SENT_52	[p4l577t3417r1149b3499],
22	Supplementary	NNP	O	Supplementary	nn	23	SENT_52	[p4l577t3417r1149b3499],
23	Appendix	NNP	O	Appendix	dep	13	SENT_52	[p4l1164t3417r1515b3498],
24	online	NN	O	online	prep	23	SENT_52	[p4l1534t3416r1792b3493],
25	)	NN	O	)	dep	24	SENT_52	[p4l1534t3416r1792b3493],
26	.	.	O	.	_	0	SENT_52	[p4l1534t3416r1792b3493],

1	The	DT	O	the	det	2	SENT_53	[p4l83t3519r211b3582],
2	use	NN	O	use	nsubjpass	26	SENT_53	[p4l236t3542r350b3582],
3	of	IN	O	of	_	0	SENT_53	[p4l376t3519r451b3582],
4	protocols	NNS	O	protocol	prep_of	2	SENT_53	[p4l465t3519r795b3602],
5	more	RBR	O	more	advmod	6	SENT_53	[p4l821t3542r1003b3582],
6	typical	JJ	O	typical	amod	4	SENT_53	[p4l1028t3519r1264b3603],
7	of	IN	O	of	_	0	SENT_53	[p4l1289t3519r1365b3582],
8	usual	JJ	O	usual	amod	9	SENT_53	[p4l1380t3519r1566b3582],
9	care	NN	O	care	prep_of	6	SENT_53	[p4l1591t3542r1751b3591],
10	,	,	O	,	_	0	SENT_53	[p4l1591t3542r1751b3591],
11	with	IN	O	with	_	0	SENT_53	[p4l1776t3519r1933b3582],
12	more	JJR	O	more	amod	14	SENT_53	[p4l1958t3542r2141b3582],
13	diverse	JJ	O	diverse	amod	14	SENT_53	[p4l10t3622r258b3685],
14	participants	NNS	O	participant	prep_with	6	SENT_53	[p4l283t3628r725b3705],
15	,	,	O	,	_	0	SENT_53	[p4l283t3628r725b3705],
16	and	CC	O	and	_	0	SENT_53	[p4l752t3622r882b3685],
17	in	IN	O	in	amod	4	SENT_53	[p4l906t3628r974b3684],
18	a	DT	O	a	det	20	SENT_53	[p4l1000t3645r1035b3685],
19	wider	JJR	O	wider	amod	20	SENT_53	[p4l1056t3622r1259b3685],
20	range	NN	O	range	pobj	17	SENT_53	[p4l1283t3645r1477b3706],
21	of	IN	O	of	_	0	SENT_53	[p4l1503t3622r1579b3685],
22	clinical	JJ	O	clinical	amod	23	SENT_53	[p4l1594t3622r1848b3685],
23	settings	NNS	O	setting	prep_of	20	SENT_53	[p4l1873t3628r2140b3706],
24	may	MD	O	may	aux	26	SENT_53	[p4l9t3748r161b3809],
25	be	VB	O	be	auxpass	26	SENT_53	[p4l183t3725r265b3788],
26	expected	VBN	O	expect	_	0	SENT_53	[p4l293t3725r611b3808],
27	to	TO	O	to	aux	28	SENT_53	[p4l636t3737r704b3788],
28	alter	VB	O	alter	xcomp	26	SENT_53	[p4l734t3725r905b3797],
29	,	,	O	,	_	0	SENT_53	[p4l734t3725r905b3797],
30	perhaps	RB	O	perhaps	advmod	33	SENT_53	[p4l933t3725r1216b3808],
31	more	RBR	O	more	advmod	32	SENT_53	[p4l1244t3748r1428b3788],
32	often	RB	O	often	advmod	33	SENT_53	[p4l1456t3725r1636b3788],
33	diminish	VB	O	diminish	dep	28	SENT_53	[p4l1664t3725r2004b3797],
34	,	,	O	,	_	0	SENT_53	[p4l1664t3725r2004b3797],
35	the	DT	O	the	det	37	SENT_53	[p4l2032t3725r2143b3788],
36	net	JJ	O	net	amod	37	SENT_53	[p5l9t28r118b79],
37	(	NN	O	(	dobj	28	SENT_53	[p5l144t17r455b100],
38	average	JJ	O	average	amod	41	SENT_53	[p5l144t17r455b100],
39	)	NN	O	)	nn	41	SENT_53	[p5l144t17r455b100],
40	treatment	NN	O	treatment	nn	41	SENT_53	[p5l481t28r822b79],
41	effect	NN	O	effect	dep	37	SENT_53	[p5l844t16r1044b79],
42	.	.	O	.	_	0	SENT_53	[p5l844t16r1044b79],

1	Heterogeneity	NN	O	heterogeneity	nsubj	11	SENT_54	[p5l1071t21r1564b100],
2	of	IN	O	of	_	0	SENT_54	[p5l1585t16r1659b79],
3	the	DT	O	the	det	5	SENT_54	[p5l1672t16r1779b79],
4	treatment	NN	O	treatment	nn	5	SENT_54	[p5l1801t28r2142b79],
5	effect	NN	O	effect	prep_of	1	SENT_54	[p5l10t119r206b182],
6	across	IN	O	across	_	0	SENT_54	[p5l235t142r454b182],
7	the	DT	O	the	det	9	SENT_54	[p5l482t119r593b182],
8	study	NN	O	study	nn	9	SENT_54	[p5l624t119r819b203],
9	sample	NN	O	sample	prep_across	5	SENT_54	[p5l845t119r1094b202],
10	may	MD	O	may	aux	11	SENT_54	[p5l1123t142r1275b203],
11	mute	VB	O	mute	_	0	SENT_54	[p5l1300t131r1481b182],
12	average	JJ	O	average	amod	13	SENT_54	[p5l1511t142r1778b203],
13	effectiveness	NN	O	effectiveness	dobj	11	SENT_54	[p5l1808t119r2138b182, p5l9t245r171b285],
14	.	.	O	.	_	0	SENT_54	[p5l1808t119r2138b182, p5l9t245r171b285],

1	However	RB	O	however	advmod	7	SENT_55	[p5l198t227r520b294],
2	,	,	O	,	_	0	SENT_55	[p5l198t227r520b294],
3	this	DT	O	this	det	4	SENT_55	[p5l544t222r669b285],
4	heterogeneity	NN	O	heterogeneity	nsubj	7	SENT_55	[p5l692t222r1167b306],
5	will	MD	O	will	aux	7	SENT_55	[p5l1185t222r1312b285],
6	also	RB	O	also	advmod	7	SENT_55	[p5l1335t222r1467b285],
7	offer	VB	O	offer	_	0	SENT_55	[p5l1492t222r1650b285],
8	opportunities	NNS	O	opportunity	nsubj	10	SENT_55	[p5l1673t228r2142b305],
9	to	TO	O	to	aux	10	SENT_55	[p5l8t337r76b388],
10	detect	VB	O	detect	xcomp	7	SENT_55	[p5l103t325r316b388],
11	how	WRB	O	how	advmod	14	SENT_55	[p5l339t325r491b388],
12	patient	NN	O	patient	nn	13	SENT_55	[p5l512t331r760b408],
13	characteristics	NNS	O	characteristic	nsubj	14	SENT_55	[p5l784t325r1293b388],
14	affect	VBP	O	affect	ccomp	10	SENT_55	[p5l1319t325r1508b388],
15	treatment	NN	O	treatment	nn	16	SENT_55	[p5l1531t337r1878b388],
16	effects	NNS	O	effect	dobj	14	SENT_55	[p5l1903t325r2141b388],
17	.	.	O	.	_	0	SENT_55	[p5l1903t325r2141b388],

1	Divergence	NN	O	divergence	nsubj	14	SENT_56	[p5l10t433r398b512],
2	of	IN	O	of	_	0	SENT_56	[p5l422t428r496b491],
3	individual	JJ	O	individual	amod	7	SENT_56	[p5l509t428r860b491],
4	and	CC	O	and	_	0	SENT_56	[p5l883t428r1010b491],
5	subgroup	NN	O	subgroup	amod	7	SENT_56	[p5l1033t428r1355b512],
6	treatment	NN	O	treatment	nn	7	SENT_56	[p5l1378t440r1716b491],
7	effects	NNS	O	effect	prep_of	1	SENT_56	[p5l1738t428r1951b491],
8	from	IN	O	from	_	0	SENT_56	[p5l1974t428r2143b491],
9	the	DT	O	the	det	12	SENT_56	[p5l8t531r118b594],
10	overall	JJ	O	overall	amod	12	SENT_56	[p5l143t531r380b594],
11	average	JJ	O	average	amod	12	SENT_56	[p5l405t554r666b615],
12	result	NN	O	result	prep_from	7	SENT_56	[p5l691t531r887b594],
13	will	MD	O	will	aux	14	SENT_56	[p5l909t531r1039b594],
14	occur	VB	O	occur	_	0	SENT_56	[p5l1063t554r1262b594],
15	in	IN	O	in	_	0	SENT_56	[p5l1285t537r1353b593],
16	both	DT	O	both	det	17	SENT_56	[p5l1376t531r1540b594],
17	directions	NNS	O	direction	prep_in	14	SENT_56	[p5l1565t531r1934b594],
18	.	.	O	.	_	0	SENT_56	[p5l1565t531r1934b594],

1	In	IN	O	in	_	0	SENT_57	[p5l1962t536r2035b593],
2	an	DT	O	a	det	5	SENT_57	[p5l2061t554r2142b594],
3	overall	JJ	O	overall	amod	5	SENT_57	[p5l10t634r248b697],
4	negative	JJ	O	negative	amod	5	SENT_57	[p5l273t640r565b718],
5	trial	NN	O	trial	prep_in	12	SENT_57	[p5l589t634r754b706],
6	,	,	O	,	_	0	SENT_57	[p5l589t634r754b706],
7	individuals	NNS	O	individual	nsubjpass	12	SENT_57	[p5l781t634r1175b697],
8	or	CC	O	or	_	0	SENT_57	[p5l1201t657r1275b697],
9	groups	NNS	O	group	nsubjpass	12	SENT_57	[p5l1300t656r1540b718],
10	may	MD	O	may	aux	12	SENT_57	[p5l1565t657r1716b718],
11	be	VB	O	be	auxpass	12	SENT_57	[p5l1736t634r1817b697],
12	detected	VBN	O	detect	_	0	SENT_57	[p5l1844t634r2142b697],
13	who	WP	O	who	nsubj	14	SENT_57	[p5l8t737r157b800],
14	beneﬁted	VBD	O	beneﬁted	ccomp	12	SENT_57	[p5l180t737r506b800],
15	from	IN	O	from	_	0	SENT_57	[p5l528t737r699b800],
16	treatment	NN	O	treatment	prep_from	14	SENT_57	[p5l722t749r1083b809],
17	,	,	O	,	_	0	SENT_57	[p5l722t749r1083b809],
18	whereas	IN	O	whereas	mark	30	SENT_57	[p5l1107t737r1390b800],
19	in	IN	O	in	_	0	SENT_57	[p5l1415t743r1482b799],
20	an	DT	O	a	det	23	SENT_57	[p5l1507t760r1588b800],
21	overall	JJ	O	overall	amod	23	SENT_57	[p5l1613t737r1848b800],
22	positive	JJ	O	positive	amod	23	SENT_57	[p5l1870t743r2143b820],
23	trial	NN	O	trial	prep_in	30	SENT_57	[p5l8t840r166b912],
24	,	,	O	,	_	0	SENT_57	[p5l8t840r166b912],
25	individuals	NNS	O	individual	nsubjpass	30	SENT_57	[p5l190t840r570b903],
26	or	CC	O	or	_	0	SENT_57	[p5l594t863r666b903],
27	groups	NNS	O	group	nsubjpass	30	SENT_57	[p5l687t862r920b924],
28	may	MD	O	may	aux	30	SENT_57	[p5l943t863r1090b924],
29	be	VB	O	be	auxpass	30	SENT_57	[p5l1107t840r1186b903],
30	detected	VBN	O	detect	advcl	14	SENT_57	[p5l1210t840r1498b903],
31	for	IN	O	for	_	0	SENT_57	[p5l1519t840r1616b903],
32	whom	WP	O	whom	dobj	36	SENT_57	[p5l1636t840r1854b903],
33	beneﬁts	NNS	O	beneﬁts	nsubj	36	SENT_57	[p5l1874t840r2140b903],
34	did	VBD	O	do	aux	36	SENT_57	[p5l10t942r122b1005],
35	not	RB	O	not	neg	36	SENT_57	[p5l145t954r260b1005],
36	outweigh	VB	O	outweigh	prepc_for	30	SENT_57	[p5l283t942r602b1026],
37	risks	NNS	O	risk	dobj	36	SENT_57	[p5l626t934r885b1005],
38	.6	CD	NUMBER	.6	num	37	SENT_57	[p5l626t934r885b1005],
39	=	JJ	O	=	amod	37	SENT_57	[p5l626t934r885b1005],
40	7	CD	NUMBER	7	tmod	39	SENT_57	[p5l626t934r885b1005],
41	These	DT	O	these	det	42	SENT_57	[p5l908t942r1104b1005],
42	differences	NNS	O	difference	nsubj	46	SENT_57	[p5l1129t942r1502b1005],
43	also	RB	O	also	advmod	46	SENT_57	[p5l1526t942r1659b1005],
44	could	MD	O	could	aux	46	SENT_57	[p5l1684t942r1876b1005],
45	signiﬁcantly	RB	O	signiﬁcantly	advmod	46	SENT_57	[p5l1900t942r2140b1026, p5l10t1044r218b1128],
46	change	VB	O	change	rcmod	37	SENT_57	[p5l237t1044r476b1128],
47	the	DT	O	the	det	51	SENT_57	[p5l498t1044r605b1107],
48	cost	NN	O	cost	nn	51	SENT_57	[p5l628t1044r1047b1107],
49	—	NN	O	—	nn	51	SENT_57	[p5l628t1044r1047b1107],
50	beneﬁt	NN	O	beneﬁt	nn	51	SENT_57	[p5l628t1044r1047b1107],
51	analysis	NN	O	analysis	dobj	46	SENT_57	[p5l1069t1044r1335b1128],
52	for	IN	O	for	_	0	SENT_57	[p5l1359t1044r1456b1107],
53	use	NN	O	use	prep_for	51	SENT_57	[p5l1478t1067r1589b1107],
54	of	IN	O	of	_	0	SENT_57	[p5l1613t1044r1687b1107],
55	a	DT	O	a	det	56	SENT_57	[p5l1701t1067r1735b1107],
56	treatment	NN	O	treatment	prep_of	53	SENT_57	[p5l1756t1036r2142b1107],
57	.8	CD	NUMBER	.8	num	56	SENT_57	[p5l1756t1036r2142b1107],
58	It	PRP	O	it	nsubjpass	62	SENT_57	[p5l10t1152r59b1210],
59	would	MD	O	would	aux	62	SENT_57	[p5l76t1147r289b1210],
60	not	RB	O	not	neg	62	SENT_57	[p5l309t1159r422b1210],
61	be	VB	O	be	auxpass	62	SENT_57	[p5l439t1147r518b1210],
62	warranted	VBN	O	warrant	rcmod	51	SENT_57	[p5l537t1147r886b1210],
63	to	TO	O	to	aux	64	SENT_57	[p5l904t1159r970b1210],
64	use	VB	O	use	xcomp	62	SENT_57	[p5l991t1170r1101b1210],
65	such	JJ	O	such	amod	66	SENT_57	[p5l1123t1147r1277b1210],
66	results	NNS	O	result	dobj	64	SENT_57	[p5l1297t1147r1515b1210],
67	to	TO	O	to	aux	68	SENT_57	[p5l1535t1159r1601b1210],
68	alter	VB	O	alter	xcomp	64	SENT_57	[p5l1623t1147r1772b1210],
69	regulatory	JJ	O	regulatory	amod	70	SENT_57	[p5l1792t1147r2145b1231],
70	approval	NN	O	approval	dobj	68	SENT_57	[p5l10t1250r303b1333],
71	that	WDT	O	that	nsubjpass	73	SENT_57	[p5l321t1250r454b1313],
72	was	VBD	O	be	auxpass	73	SENT_57	[p5l471t1273r596b1313],
73	based	VBN	O	base	rcmod	70	SENT_57	[p5l615t1250r810b1313],
74	on	IN	O	on	_	0	SENT_57	[p5l830t1273r915b1313],
75	efﬁcacy	NN	O	efﬁcacy	nn	76	SENT_57	[p5l936t1250r1191b1334],
76	data	NNS	O	datum	prep_on	73	SENT_57	[p5l1209t1250r1368b1322],
77	,	,	O	,	_	0	SENT_57	[p5l1209t1250r1368b1322],
78	but	CC	O	but	_	0	SENT_57	[p5l1388t1250r1501b1313],
79	such	JJ	O	such	amod	80	SENT_57	[p5l1521t1250r1674b1313],
80	insights	NNS	O	insight	nsubj	86	SENT_57	[p5l1695t1250r1956b1334],
81	from	IN	O	from	_	0	SENT_57	[p5l1977t1250r2144b1313],
82	the	DT	O	the	det	84	SENT_57	[p5l8t1353r114b1416],
83	effectiveness	NN	O	effectiveness	nn	84	SENT_57	[p5l136t1353r561b1416],
84	component	NN	O	component	prep_from	80	SENT_57	[p5l583t1365r973b1436],
85	could	MD	O	could	aux	86	SENT_57	[p5l993t1353r1183b1416],
86	inform	VB	O	inform	advcl	14	SENT_57	[p5l1203t1353r1441b1416],
87	care	NN	O	care	nn	90	SENT_57	[p5l1461t1376r1598b1416],
88	and	CC	O	and	_	0	SENT_57	[p5l1620t1353r1746b1416],
89	reimbursement	NN	O	reimbursement	conj_and	87	SENT_57	[p5l1766t1353r2140b1416, p5l9t1468r190b1519],
90	decisions	NNS	O	decision	dobj	86	SENT_57	[p5l213t1456r553b1519],
91	.	.	O	.	_	0	SENT_57	[p5l213t1456r553b1519],

1	Such	JJ	O	such	amod	2	SENT_58	[p5l581t1456r748b1519],
2	information	NN	O	information	nsubjpass	16	SENT_58	[p5l772t1456r1197b1519],
3	about	IN	O	about	_	0	SENT_58	[p5l1222t1456r1419b1519],
4	the	DT	O	the	det	5	SENT_58	[p5l1441t1456r1550b1519],
5	heterogeneity	NN	O	heterogeneity	prep_about	2	SENT_58	[p5l1573t1456r2055b1540],
6	of	IN	O	of	_	0	SENT_58	[p5l2076t1456r2151b1519],
7	treatment	NN	O	treatment	nn	8	SENT_58	[p5l8t1571r345b1622],
8	effects	NNS	O	effect	prep_of	5	SENT_58	[p5l368t1559r581b1622],
9	from	IN	O	from	_	0	SENT_58	[p5l604t1559r772b1622],
10	the	DT	O	the	det	13	SENT_58	[p5l794t1559r901b1622],
11	effectiveness	NN	O	effectiveness	nn	13	SENT_58	[p5l924t1559r1352b1622],
12	trial	NN	O	trial	nn	13	SENT_58	[p5l1374t1559r1516b1622],
13	component	NN	O	component	prep_from	8	SENT_58	[p5l1539t1571r1931b1642],
14	could	MD	O	could	aux	16	SENT_58	[p5l1953t1559r2144b1622],
15	be	VB	O	be	auxpass	16	SENT_58	[p5l7t1662r88b1725],
16	represented	VBN	O	represent	_	0	SENT_58	[p5l113t1662r524b1745],
17	in	IN	O	in	_	0	SENT_58	[p5l547t1668r616b1724],
18	multivariable	JJ	O	multivariable	amod	20	SENT_58	[p5l639t1662r1107b1725],
19	predictive	JJ	O	predictive	amod	20	SENT_58	[p5l1130t1662r1481b1745],
20	models	NNS	O	model	prep_in	16	SENT_58	[p5l1504t1662r1777b1734],
21	,	,	O	,	_	0	SENT_58	[p5l1504t1662r1777b1734],
22	described	VBN	O	describe	partmod	20	SENT_58	[p5l1803t1662r2144b1725],
23	further	RB	O	further	advmod	22	SENT_58	[p5l9t1764r249b1828],
24	below	IN	O	below	prep	22	SENT_58	[p5l265t1764r476b1836],
25	,	,	O	,	_	0	SENT_58	[p5l265t1764r476b1836],
26	to	TO	O	to	aux	27	SENT_58	[p5l497t1776r562b1828],
27	aid	VB	O	aid	xcomp	22	SENT_58	[p5l583t1764r684b1828],
28	treatment	NN	O	treatment	nn	29	SENT_58	[p5l702t1776r1031b1828],
29	decisions	NNS	O	decision	dobj	27	SENT_58	[p5l1051t1764r1358b1828],
30	in	IN	O	in	_	0	SENT_58	[p5l1379t1770r1444b1827],
31	the	DT	O	the	det	32	SENT_58	[p5l1463t1764r1568b1828],
32	care	NN	O	care	prep_in	27	SENT_58	[p5l1589t1787r1723b1828],
33	of	IN	O	of	_	0	SENT_58	[p5l1744t1764r1816b1828],
34	individuals	NNS	O	individual	prep_of	32	SENT_58	[p5l1827t1764r2140b1828, p5l10t1868r114b1931],
35	.	.	O	.	_	0	SENT_58	[p5l1827t1764r2140b1828, p5l10t1868r114b1931],

1	In	IN	O	in	_	0	SENT_59	[p5l139t1873r210b1930],
2	addition	NN	O	addition	_	0	SENT_59	[p5l233t1868r519b1931],
3	to	TO	O	to	_	0	SENT_59	[p5l540t1880r606b1931],
4	these	DT	O	these	det	5	SENT_59	[p5l628t1868r803b1931],
5	dimensions	NNS	O	dimension	prep_in_addition_to	30	SENT_59	[p5l826t1868r1238b1940],
6	,	,	O	,	_	0	SENT_59	[p5l826t1868r1238b1940],
7	in	IN	O	in	_	0	SENT_59	[p5l1261t1874r1328b1930],
8	some	DT	O	some	det	9	SENT_59	[p5l1351t1891r1528b1931],
9	cases	NNS	O	case	prep_in	30	SENT_59	[p5l1551t1891r1740b1940],
10	,	,	O	,	_	0	SENT_59	[p5l1551t1891r1740b1940],
11	hypotheses	NNS	O	hypothesis	nsubjpass	33	SENT_59	[p5l1762t1868r2142b1952],
12	generated	VBN	O	generate	partmod	11	SENT_59	[p5l9t1971r337b2055],
13	by	IN	O	by	_	0	SENT_59	[p5l354t1971r437b2055],
14	ﬁndings	NNS	O	ﬁndings	agent	12	SENT_59	[p5l453t1971r724b2055],
15	in	IN	O	in	_	0	SENT_59	[p5l745t1977r810b2033],
16	the	DT	O	the	det	19	SENT_59	[p5l829t1971r933b2034],
17	efﬁcacy	NN	O	efﬁcacy	nn	19	SENT_59	[p5l954t1971r1207b2055],
18	trial	NN	O	trial	nn	19	SENT_59	[p5l1222t1971r1360b2034],
19	component	NN	O	component	prep_in	14	SENT_59	[p5l1380t1983r1763b2054],
20	about	IN	O	about	_	0	SENT_59	[p5l1783t1971r1972b2034],
21	relationships	NNS	O	relationship	prep_about	12	SENT_59	[p5l1991t1971r2139b2034, p5l8t2074r320b2157],
22	between	IN	O	between	_	0	SENT_59	[p5l341t2074r627b2137],
23	clinical	JJ	O	clinical	amod	24	SENT_59	[p5l650t2074r894b2137],
24	characteristics	NNS	O	characteristic	prep_between	21	SENT_59	[p5l916t2074r1405b2137],
25	and	CC	O	and	_	0	SENT_59	[p5l1428t2074r1554b2137],
26	treatment	NN	O	treatment	nn	27	SENT_59	[p5l1573t2086r1909b2137],
27	effects	NNS	O	effect	prep_between	21	SENT_59	[p5l1930t2074r2142b2137],
28	could	MD	O	could	aux	30	SENT_59	[p5l10t2177r205b2240],
29	be	VB	O	be	auxpass	30	SENT_59	[p5l226t2177r307b2240],
30	prespeciﬁed	JJ	O	prespeciﬁed	_	0	SENT_59	[p5l329t2177r755b2260],
31	and	CC	O	and	_	0	SENT_59	[p5l778t2177r907b2240],
32	formally	RB	O	formally	advmod	33	SENT_59	[p5l930t2177r1230b2261],
33	tested	VBN	O	test	conj_and	30	SENT_59	[p5l1249t2177r1456b2240],
34	in	IN	O	in	_	0	SENT_59	[p5l1478t2183r1547b2239],
35	the	DT	O	the	det	37	SENT_59	[p5l1569t2177r1678b2240],
36	effectiveness	NN	O	effectiveness	nn	37	SENT_59	[p5l1703t2177r2140b2240],
37	portion	NN	O	portion	prep_in	33	SENT_59	[p5l8t2286r300b2363],
38	.	.	O	.	_	0	SENT_59	[p5l8t2286r300b2363],

1	In	IN	O	in	_	0	SENT_60	[p5l333t2285r406b2342],
2	such	JJ	O	such	amod	3	SENT_60	[p5l436t2280r598b2343],
3	cases	NNS	O	case	prep_in	9	SENT_60	[p5l628t2303r827b2352],
4	,	,	O	,	_	0	SENT_60	[p5l628t2303r827b2352],
5	the	DT	O	the	det	7	SENT_60	[p5l857t2280r968b2343],
6	effectiveness	NN	O	effectiveness	nn	7	SENT_60	[p5l998t2280r1453b2343],
7	component	NN	O	component	nsubj	9	SENT_60	[p5l1483t2292r1894b2363],
8	would	MD	O	would	aux	9	SENT_60	[p5l1919t2280r2144b2343],
9	include	VB	O	include	_	0	SENT_60	[p5l9t2383r260b2446],
10	targeted	VBN	O	target	dep	9	SENT_60	[p5l281t2383r560b2467],
11	data	NNS	O	datum	nn	12	SENT_60	[p5l581t2383r724b2446],
12	collection	NN	O	collection	dobj	10	SENT_60	[p5l745t2383r1079b2446],
13	to	TO	O	to	aux	14	SENT_60	[p5l1100t2395r1165b2446],
14	test	VB	O	test	xcomp	10	SENT_60	[p5l1188t2395r1306b2446],
15	such	JJ	O	such	amod	16	SENT_60	[p5l1327t2383r1482b2446],
16	hypotheses	NNS	O	hypothesis	dobj	14	SENT_60	[p5l1502t2383r1899b2467],
17	.	.	O	.	_	0	SENT_60	[p5l1502t2383r1899b2467],

1	The	DT	O	the	det	3	SENT_61	[p5l83t2486r210b2549],
2	effectiveness	NN	O	effectiveness	nn	3	SENT_61	[p5l236t2486r681b2549],
3	portion	NN	O	portion	nsubj	5	SENT_61	[p5l706t2492r976b2569],
4	will	MD	O	will	aux	5	SENT_61	[p5l1000t2486r1131b2549],
5	differ	VB	O	differ	_	0	SENT_61	[p5l1157t2486r1346b2549],
6	from	IN	O	from	_	0	SENT_61	[p5l1370t2486r1544b2549],
7	the	DT	O	the	det	9	SENT_61	[p5l1568t2486r1678b2549],
8	efﬁcacy	NN	O	efﬁcacy	nn	9	SENT_61	[p5l1704t2486r1971b2570],
9	portion	NN	O	portion	prep_from	5	SENT_61	[p5l1991t2508r2140b2569, p5l8t2615r146b2672],
10	in	IN	O	in	_	0	SENT_61	[p5l169t2615r235b2671],
11	its	PRP$	O	its	poss	12	SENT_61	[p5l257t2615r333b2672],
12	speciﬁcation	NN	O	speciﬁcation	prep_in	9	SENT_61	[p5l357t2609r790b2692],
13	of	IN	O	of	_	0	SENT_61	[p5l812t2609r886b2672],
14	participants	NNS	O	participant	prep_of	12	SENT_61	[p5l897t2615r1328b2692],
15	,	,	O	,	_	0	SENT_61	[p5l897t2615r1328b2692],
16	treatment	NN	O	treatment	nn	17	SENT_61	[p5l1351t2621r1689b2672],
17	settings	NNS	O	setting	conj_and	14	SENT_61	[p5l1711t2615r1990b2693],
18	,	,	O	,	_	0	SENT_61	[p5l1711t2615r1990b2693],
19	and	CC	O	and	_	0	SENT_61	[p5l2015t2609r2141b2672],
20	the	DT	O	the	det	21	SENT_61	[p5l8t2712r117b2775],
21	protocol	NN	O	protocol	conj_and	14	SENT_61	[p5l141t2712r457b2795],
22	,	,	O	,	_	0	SENT_61	[p5l141t2712r457b2795],
23	but	CC	O	but	_	0	SENT_61	[p5l482t2712r598b2775],
24	such	JJ	O	such	amod	25	SENT_61	[p5l623t2712r782b2775],
25	differences	NNS	O	difference	nsubj	27	SENT_61	[p5l807t2712r1186b2775],
26	will	MD	O	will	aux	27	SENT_61	[p5l1210t2712r1340b2775],
27	need	VB	O	need	conj_but	5	SENT_61	[p5l1364t2712r1532b2775],
28	to	TO	O	to	aux	30	SENT_61	[p5l1556t2724r1622b2775],
29	be	VB	O	be	cop	30	SENT_61	[p5l1647t2712r1728b2775],
30	compatible	JJ	O	compatible	xcomp	27	SENT_61	[p5l1754t2712r2143b2795],
31	with	IN	O	with	_	0	SENT_61	[p5l8t2815r169b2878],
32	the	DT	O	the	det	33	SENT_61	[p5l194t2815r307b2878],
33	request	NN	O	request	prep_with	30	SENT_61	[p5l334t2827r599b2898],
34	for	IN	O	for	_	0	SENT_61	[p5l625t2815r727b2878],
35	approval	NN	O	approval	prep_for	33	SENT_61	[p5l754t2815r1067b2898],
36	by	IN	O	by	_	0	SENT_61	[p5l1091t2815r1179b2899],
37	the	DT	O	the	det	39	SENT_61	[p5l1201t2815r1313b2878],
38	licensing	NN	O	licensing	nn	39	SENT_61	[p5l1339t2815r1666b2899],
39	authority	NN	O	authority	prep_by	30	SENT_61	[p5l1692t2815r2030b2899],
40	on	IN	O	on	_	0	SENT_61	[p5l2054t2838r2143b2878],
41	the	DT	O	the	det	42	SENT_61	[p5l8t2918r117b2981],
42	basis	NN	O	basis	prep_on	39	SENT_61	[p5l141t2918r312b2981],
43	of	IN	O	of	_	0	SENT_61	[p5l338t2918r414b2981],
44	the	DT	O	the	det	47	SENT_61	[p5l428t2918r537b2981],
45	efﬁcacy	NN	O	efﬁcacy	nn	47	SENT_61	[p5l563t2918r827b3002],
46	trial	NN	O	trial	nn	47	SENT_61	[p5l847t2918r993b2981],
47	component	NN	O	component	prep_of	42	SENT_61	[p5l1019t2930r1436b3001],
48	.	.	O	.	_	0	SENT_61	[p5l1019t2930r1436b3001],

1	Enrollment	NN	O	enrollment	nsubj	3	SENT_62	[p5l1465t2918r1868b2981],
2	may	MD	O	may	aux	3	SENT_62	[p5l1892t2941r2041b3002],
3	be	VB	O	be	_	0	SENT_62	[p5l2061t2918r2141b2981],
4	by	IN	O	by	_	0	SENT_62	[p5l7t3022r93b3106],
5	primary	JJ	O	primary	amod	8	SENT_62	[p5l114t3028r585b3106],
6	—	NN	O	—	nn	8	SENT_62	[p5l114t3028r585b3106],
7	care	NN	O	care	nn	8	SENT_62	[p5l114t3028r585b3106],
8	physicians	NNS	O	physician	prep_by	3	SENT_62	[p5l610t3022r981b3106],
9	or	CC	O	or	_	0	SENT_62	[p5l1008t3045r1082b3085],
10	community	NN	O	community	nn	11	SENT_62	[p5l1107t3022r1758b3106],
11	—	NN	O	—	conj_or	8	SENT_62	[p5l1107t3022r1758b3106],
12	based	VBN	O	base	prep	3	SENT_62	[p5l1107t3022r1758b3106],
13	specialists	NNS	O	specialist	dep	12	SENT_62	[p5l1784t3022r2143b3105],
14	rather	RB	O	rather	_	0	SENT_62	[p5l10t3125r223b3188],
15	than	IN	O	than	_	0	SENT_62	[p5l244t3125r402b3188],
16	by	IN	O	by	prep	3	SENT_62	[p5l424t3125r509b3209],
17	special	JJ	O	special	amod	19	SENT_62	[p5l529t3125r768b3208],
18	study	NN	O	study	nn	19	SENT_62	[p5l792t3125r983b3209],
19	sites	NNS	O	site	pobj	16	SENT_62	[p5l1003t3131r1171b3197],
20	,	,	O	,	_	0	SENT_62	[p5l1003t3131r1171b3197],
21	care	NN	O	care	appos	19	SENT_62	[p5l1197t3148r1337b3188],
22	will	MD	O	will	aux	25	SENT_62	[p5l1360t3125r1489b3188],
23	be	VB	O	be	cop	25	SENT_62	[p5l1510t3125r1590b3188],
24	more	RBR	O	more	advmod	25	SENT_62	[p5l1614t3148r1795b3188],
25	typical	JJ	O	typical	rcmod	21	SENT_62	[p5l1818t3125r2054b3209],
26	of	IN	O	of	_	0	SENT_62	[p5l2077t3125r2152b3188],
27	www.nature.com/cpt	JJ	O	www.nature.com/cpt	prep_of	25	SENT_62	[p5l1593t3343r2143b3396],

1	STATE	NN	O	state	nn	2	SENT_63	[p5l1761t3511r1902b3548],
2	ART	NN	O	art	_	0	SENT_63	[p5l2045t3511r2139b3548],

1	community	NN	O	community	nn	2	SENT_64	[p6l9t91r426b169],
2	settings	NNS	O	setting	nsubj	8	SENT_64	[p6l449t91r741b169],
3	,	,	O	,	_	0	SENT_64	[p6l449t91r741b169],
4	and	CC	O	and	_	0	SENT_64	[p6l769t85r900b148],
5	protocol	NN	O	protocol	nn	6	SENT_64	[p6l924t85r1227b168],
6	adjustments	NNS	O	adjustment	conj_and	2	SENT_64	[p6l1253t85r1685b169],
7	may	MD	O	may	aux	8	SENT_64	[p6l1712t108r1863b169],
8	include	VB	O	include	_	0	SENT_64	[p6l1886t85r2149b148],
9	reductions	NNS	O	reduction	dobj	8	SENT_64	[p6l9t188r383b251],
10	in	IN	O	in	_	0	SENT_64	[p6l407t194r475b250],
11	detailed	JJ	O	detailed	amod	12	SENT_64	[p6l499t188r780b251],
12	data	NNS	O	datum	prep_in	9	SENT_64	[p6l803t188r950b251],
13	collection	NN	O	collection	nn	14	SENT_64	[p6l973t188r1319b251],
14	(	NN	O	(	dep	12	SENT_64	[p6l1346t188r1503b264],
15	and	CC	O	and	_	0	SENT_64	[p6l1346t188r1503b264],
16	possibly	RB	O	possibly	advmod	18	SENT_64	[p6l1525t188r1815b272],
17	the	DT	O	the	det	18	SENT_64	[p6l1834t188r1943b251],
18	addition	NN	O	addition	prep_in	9	SENT_64	[p6l1967t188r2148b251, p6l8t297r151b354],
19	of	IN	O	of	_	0	SENT_64	[p6l178t291r254b354],
20	assessments	NNS	O	assessment	prep_of	18	SENT_64	[p6l271t303r699b354],
21	to	TO	O	to	aux	22	SENT_64	[p6l725t303r793b354],
22	test	VB	O	test	xcomp	8	SENT_64	[p6l819t303r944b354],
23	new	JJ	O	new	amod	24	SENT_64	[p6l968t314r1116b354],
24	hypotheses	NNS	O	hypothesis	dobj	22	SENT_64	[p6l1138t291r1537b375],
25	and	CC	O	and	_	0	SENT_64	[p6l1564t291r1695b354],
26	heterogeneity	NN	O	heterogeneity	nsubj	30	SENT_64	[p6l1719t291r2146b375, p6l9t400r103b478],
27	of	IN	O	of	_	0	SENT_64	[p6l127t394r205b457],
28	treatment	NN	O	treatment	nn	29	SENT_64	[p6l221t406r580b457],
29	effects	NNS	O	effect	prep_of	26	SENT_64	[p6l607t394r887b470],
30	)	VBP	O	)	conj_and	8	SENT_64	[p6l607t394r887b470],
31	,	,	O	,	_	0	SENT_64	[p6l607t394r887b470],
32	but	CC	O	but	_	0	SENT_64	[p6l914t394r1034b457],
33	the	DT	O	the	det	34	SENT_64	[p6l1059t394r1172b457],
34	use	NN	O	use	nsubj	40	SENT_64	[p6l1199t417r1317b457],
35	of	IN	O	of	_	0	SENT_64	[p6l1345t394r1422b457],
36	the	DT	O	the	det	37	SENT_64	[p6l1439t394r1552b457],
37	drug	NN	O	drug	prep_of	34	SENT_64	[p6l1580t394r1752b478],
38	would	MD	O	would	aux	40	SENT_64	[p6l1775t394r2002b457],
39	not	RB	O	not	neg	40	SENT_64	[p6l2029t406r2149b457],
40	be	VB	O	be	conj_but	8	SENT_64	[p6l7t497r88b560],
41	beyond	IN	O	beyond	_	0	SENT_64	[p6l113t497r380b581],
42	the	DT	O	the	det	44	SENT_64	[p6l404t497r515b560],
43	label	NN	O	label	nn	44	SENT_64	[p6l540t497r709b560],
44	indications	NNS	O	indication	prep_beyond	40	SENT_64	[p6l735t497r1135b560],
45	being	VBG	O	be	auxpass	46	SENT_64	[p6l1159t497r1360b581],
46	sought	VBN	O	seek	partmod	44	SENT_64	[p6l1385t497r1643b581],
47	.	.	O	.	_	0	SENT_64	[p6l1385t497r1643b581],

1	Before	IN	O	before	_	0	SENT_65	[p6l1673t497r1904b560],
2	initiation	NN	O	initiation	prep_before	26	SENT_65	[p6l1930t503r2147b560, p6l8t606r148b663],
3	of	IN	O	of	_	0	SENT_65	[p6l171t600r245b663],
4	effectiveness	NN	O	effectiveness	nn	5	SENT_65	[p6l259t600r696b663],
5	trials	NNS	O	trial	prep_of	2	SENT_65	[p6l718t600r914b672],
6	,	,	O	,	_	0	SENT_65	[p6l718t600r914b672],
7	regulatory	JJ	O	regulatory	amod	8	SENT_65	[p6l939t600r1302b684],
8	agencies	NNS	O	agency	nsubj	26	SENT_65	[p6l1323t606r1613b684],
9	and	CC	O	and	_	0	SENT_65	[p6l1637t600r1765b663],
10	the	DT	O	the	det	12	SENT_65	[p6l1786t600r1894b663],
11	DSMB	NN	ORGANIZATION	dsmb	nn	12	SENT_65	[p6l1918t604r2145b663],
12	review	NN	O	review	nsubj	26	SENT_65	[p6l9t709r239b766],
13	the	DT	O	the	det	15	SENT_65	[p6l257t703r364b766],
14	prespeciﬁed	JJ	O	prespeciﬁed	amod	15	SENT_65	[p6l386t703r805b786],
15	transition	NN	O	transition	dep	12	SENT_65	[p6l826t709r1165b766],
16	and	CC	O	and	_	0	SENT_65	[p6l1189t703r1316b766],
17	the	DT	O	the	det	18	SENT_65	[p6l1336t703r1443b766],
18	differences	NNS	O	difference	conj_and	12	SENT_65	[p6l1466t703r1839b766],
19	between	IN	O	between	_	0	SENT_65	[p6l1860t703r2150b766],
20	effectiveness	NN	O	effectiveness	nn	23	SENT_65	[p6l9t806r457b869],
21	and	CC	O	and	_	0	SENT_65	[p6l484t806r615b869],
22	efficacy	NN	O	efficacy	nn	23	SENT_65	[p6l640t806r908b890],
23	trials	NNS	O	trial	prep_between	18	SENT_65	[p6l929t806r1131b878],
24	,	,	O	,	_	0	SENT_65	[p6l929t806r1131b878],
25	including	VBG	O	include	partmod	18	SENT_65	[p6l1158t806r1501b890],
26	relaxed	VBN	O	relax	_	0	SENT_65	[p6l1525t806r1784b869],
27	entry	NN	O	entry	nn	28	SENT_65	[p6l1810t818r2001b890],
28	criteria	NNS	O	criterion	dobj	26	SENT_65	[p6l2024t812r2145b869, p6l8t915r176b972],
29	and	CC	O	and	_	0	SENT_65	[p6l205t909r339b972],
30	longer	JJR	O	longer	amod	31	SENT_65	[p6l367t909r603b993],
31	duration	NN	O	duration	dobj	26	SENT_65	[p6l633t909r972b981],
32	,	,	O	,	_	0	SENT_65	[p6l633t909r972b981],
33	to	TO	O	to	aux	34	SENT_65	[p6l1003t921r1072b972],
34	conﬁrm	VB	O	conﬁrm	xcomp	26	SENT_65	[p6l1104t909r1395b972],
35	that	IN	O	that	complm	40	SENT_65	[p6l1424t909r1568b972],
36	the	DT	O	the	det	37	SENT_65	[p6l1596t909r1710b972],
37	plan	NN	O	plan	nsubj	40	SENT_65	[p6l1739t909r1898b992],
38	is	VBZ	O	be	cop	40	SENT_65	[p6l1928t915r1982b972],
39	still	RB	O	still	advmod	40	SENT_65	[p6l2013t909r2148b972],
40	appropriate	JJ	O	appropriate	ccomp	34	SENT_65	[p6l9t1018r435b1095],
41	.	.	O	.	_	0	SENT_65	[p6l9t1018r435b1095],

1	Statistical	JJ	O	statistical	amod	2	SENT_66	[p6l9t1226r348b1283],
2	framework	NN	O	framework	_	0	SENT_66	[p6l367t1225r750b1283],

1	Both	DT	O	both	preconj	5	SENT_67	[p6l9t1323r174b1386],
2	efficacy	NN	O	efficacy	nn	5	SENT_67	[p6l197t1323r455b1407],
3	and	CC	O	and	_	0	SENT_67	[p6l475t1323r601b1386],
4	effectiveness	NN	O	effectiveness	conj_and	2	SENT_67	[p6l624t1323r1051b1386],
5	components	NNS	O	component	nsubjpass	11	SENT_67	[p6l1075t1335r1496b1406],
6	of	IN	O	of	_	0	SENT_67	[p6l1520t1323r1594b1386],
7	E2E	NN	O	e2e	nn	8	SENT_67	[p6l1607t1328r1743b1385],
8	studies	NNS	O	study	prep_of	5	SENT_67	[p6l1767t1323r2002b1386],
9	will	MD	O	will	aux	11	SENT_67	[p6l2024t1323r2150b1386],
10	be	VB	O	be	auxpass	11	SENT_67	[p6l7t1426r85b1489],
11	randomized	VBN	O	randomize	_	0	SENT_67	[p6l107t1426r520b1489],
12	controlled	JJ	O	controlled	amod	14	SENT_67	[p6l540t1426r889b1489],
13	clinical	JJ	O	clinical	amod	14	SENT_67	[p6l909t1426r1153b1489],
14	trials	NNS	O	trial	dobj	11	SENT_67	[p6l1172t1426r1361b1498],
15	,	,	O	,	_	0	SENT_67	[p6l1172t1426r1361b1498],
16	with	IN	O	with	_	0	SENT_67	[p6l1381t1426r1533b1489],
17	sample	NN	O	sample	nn	18	SENT_67	[p6l1555t1426r1791b1509],
18	size	NN	O	size	prep_with	11	SENT_67	[p6l1812t1432r1935b1489],
19	based	VBN	O	base	partmod	18	SENT_67	[p6l1953t1426r2149b1489],
20	on	IN	O	on	_	0	SENT_67	[p6l9t1552r95b1592],
21	prespeciﬁed	JJ	O	prespeciﬁed	prep_on	19	SENT_67	[p6l114t1529r526b1612],
22	or	CC	O	or	_	0	SENT_67	[p6l546t1552r588b1592],
23	and	CC	O	and	prep_with	11	SENT_67	[p6l607t1529r733b1592],
24	statistical	JJ	O	statistical	amod	25	SENT_67	[p6l754t1529r1070b1592],
25	power	NN	O	power	prep_with	11	SENT_67	[p6l1089t1551r1313b1612],
26	.	.	O	.	_	0	SENT_67	[p6l1089t1551r1313b1612],

1	Changes	NNS	O	change	nsubjpass	9	SENT_68	[p6l1337t1529r1645b1613],
2	,	,	O	,	_	0	SENT_68	[p6l1337t1529r1645b1613],
3	including	VBG	O	include	_	0	SENT_68	[p6l1667t1529r1992b1613],
4	new	JJ	O	new	amod	5	SENT_68	[p6l2010t1552r2153b1592],
5	hypotheses	NNS	O	hypothesis	prep_including	1	SENT_68	[p6l7t1632r399b1716],
6	,	,	O	,	_	0	SENT_68	[p6l7t1632r399b1716],
7	could	MD	O	could	aux	9	SENT_68	[p6l421t1632r608b1695],
8	be	VB	O	be	auxpass	9	SENT_68	[p6l625t1632r703b1695],
9	incorporated	VBN	O	incorporate	_	0	SENT_68	[p6l723t1632r1162b1715],
10	into	IN	O	into	_	0	SENT_68	[p6l1180t1638r1312b1695],
11	the	DT	O	the	det	13	SENT_68	[p6l1332t1632r1436b1695],
12	effectiveness	NN	O	effectiveness	nn	13	SENT_68	[p6l1457t1632r1875b1695],
13	portion	NN	O	portion	prep_into	9	SENT_68	[p6l1895t1638r2150b1715],
14	before	IN	O	before	_	0	SENT_68	[p6l7t1735r219b1798],
15	its	PRP$	O	its	poss	16	SENT_68	[p6l240t1741r315b1798],
16	start	NN	O	start	prep_before	9	SENT_68	[p6l336t1747r502b1807],
17	,	,	O	,	_	0	SENT_68	[p6l336t1747r502b1807],
18	in	IN	O	in	_	0	SENT_68	[p6l524t1741r590b1797],
19	a	DT	O	a	det	20	SENT_68	[p6l611t1758r645b1798],
20	manner	NN	O	manner	prep_in	9	SENT_68	[p6l664t1758r930b1798],
21	consistent	JJ	O	consistent	amod	20	SENT_68	[p6l949t1741r1290b1798],
22	with	IN	O	with	_	0	SENT_68	[p6l1307t1735r1458b1798],
23	the	DT	O	the	det	27	SENT_68	[p6l1477t1735r1582b1798],
24	adaptive	JJ	O	adaptive	amod	27	SENT_68	[p6l1604t1735r1886b1818],
25	clinical	JJ	O	clinical	amod	27	SENT_68	[p6l1907t1735r2149b1798],
26	trial	NN	O	trial	nn	27	SENT_68	[p6l7t1838r145b1901],
27	criteria	NNS	O	criterion	prep_with	21	SENT_68	[p6l164t1844r403b1901],
28	of	IN	O	of	_	0	SENT_68	[p6l422t1838r494b1901],
29	the	DT	O	the	det	31	SENT_68	[p6l503t1838r607b1901],
30	US	NNP	ORGANIZATION	US	nn	31	SENT_68	[p6l627t1842r725b1901],
31	Food	NNP	ORGANIZATION	Food	prep_of	27	SENT_68	[p6l746t1838r918b1901],
32	and	CC	ORGANIZATION	and	_	0	SENT_68	[p6l938t1838r1061b1901],
33	Drug	NNP	ORGANIZATION	Drug	nn	34	SENT_68	[p6l1080t1843r1257b1922],
34	Administration	NNP	ORGANIZATION	Administration	prep_of	27	SENT_68	[p6l1274t1838r1809b1901],
35	.	.	O	.	_	0	SENT_68	[p6l1274t1838r1809b1901],

1	Although	IN	O	although	mark	7	SENT_69	[p6l1830t1838r2150b1922],
2	the	DT	O	the	det	4	SENT_69	[p6l8t1941r114b2004],
3	E2E	NN	O	e2e	nn	4	SENT_69	[p6l136t1946r272b2003],
4	transition	NN	O	transition	nsubjpass	7	SENT_69	[p6l293t1947r627b2004],
5	is	VBZ	O	be	auxpass	7	SENT_69	[p6l649t1947r699b2004],
6	not	RB	O	not	neg	7	SENT_69	[p6l721t1953r835b2004],
7	framed	VBN	O	frame	advcl	16	SENT_69	[p6l856t1941r1103b2004],
8	as	IN	O	as	_	0	SENT_69	[p6l1124t1964r1189b2004],
9	an	DT	O	a	det	11	SENT_69	[p6l1211t1964r1292b2004],
10	adaptive	JJ	O	adaptive	amod	11	SENT_69	[p6l1314t1941r1600b2024],
11	sequence	NN	O	sequence	prep_as	7	SENT_69	[p6l1622t1964r1952b2024],
12	,	,	O	,	_	0	SENT_69	[p6l1622t1964r1952b2024],
13	there	EX	O	there	expl	16	SENT_69	[p6l1974t1941r2148b2004],
14	may	MD	O	may	aux	16	SENT_69	[p6l8t2067r160b2128],
15	be	VB	O	be	cop	16	SENT_69	[p6l181t2044r264b2107],
16	circumstances	NNS	O	circumstance	_	0	SENT_69	[p6l292t2050r801b2107],
17	in	IN	O	in	_	0	SENT_69	[p6l829t2050r898b2106],
18	which	WDT	O	which	rel	25	SENT_69	[p6l923t2044r1141b2107],
19	adaptive	JJ	O	adaptive	amod	22	SENT_69	[p6l1169t2044r1468b2127],
20	and	CC	O	and	_	0	SENT_69	[p6l1496t2044r1627b2107],
21	other	JJ	O	other	amod	22	SENT_69	[p6l1653t2044r1843b2107],
22	features	NNS	O	feature	nsubjpass	25	SENT_69	[p6l1869t2044r2147b2107],
23	might	MD	O	might	aux	25	SENT_69	[p6l8t2147r220b2231],
24	be	VB	O	be	auxpass	25	SENT_69	[p6l243t2147r325b2210],
25	incorporated	VBN	O	incorporate	rcmod	16	SENT_69	[p6l351t2147r817b2230],
26	into	IN	O	into	_	0	SENT_69	[p6l842t2153r982b2210],
27	the	DT	O	the	det	28	SENT_69	[p6l1008t2147r1118b2210],
28	efficacy	NN	O	efficacy	prep_into	25	SENT_69	[p6l1146t2147r1413b2231],
29	and	CC	O	and	_	0	SENT_69	[p6l1436t2147r1595b2213],
30	/	:	O	/	punct	32	SENT_69	[p6l1436t2147r1595b2213],
31	or	CC	O	or	dep	32	SENT_69	[p6l1602t2170r1676b2210],
32	effectiveness	NN	O	effectiveness	dep	28	SENT_69	[p6l1701t2147r2147b2210],
33	portions	NNS	O	portion	conj_and	28	SENT_69	[p6l7t2256r326b2333],
34	.	.	O	.	_	0	SENT_69	[p6l7t2256r326b2333],

1	Although	IN	O	although	mark	10	SENT_70	[p6l354t2250r693b2334],
2	the	DT	O	the	det	3	SENT_70	[p6l716t2250r826b2313],
3	data	NNS	O	datum	nsubjpass	10	SENT_70	[p6l852t2250r1001b2313],
4	from	IN	O	from	_	0	SENT_70	[p6l1024t2250r1198b2313],
5	the	DT	O	the	det	7	SENT_70	[p6l1222t2250r1331b2313],
6	efficacy	NN	O	efficacy	nn	7	SENT_70	[p6l1357t2250r1624b2334],
7	portion	NN	O	portion	prep_from	3	SENT_70	[p6l1644t2256r1913b2333],
8	might	MD	O	might	aux	10	SENT_70	[p6l1938t2250r2148b2334],
9	be	VB	O	be	auxpass	10	SENT_70	[p6l7t2353r87b2416],
10	used	VBN	O	use	advcl	37	SENT_70	[p6l110t2353r270b2416],
11	to	TO	O	to	aux	12	SENT_70	[p6l292t2365r359b2416],
12	formulate	VB	O	formulate	xcomp	10	SENT_70	[p6l382t2353r721b2416],
13	appropriate	JJ	O	appropriate	amod	14	SENT_70	[p6l745t2359r1145b2436],
14	hypotheses	NNS	O	hypothesis	dobj	12	SENT_70	[p6l1167t2353r1553b2437],
15	for	IN	O	for	_	0	SENT_70	[p6l1577t2353r1676b2416],
16	testing	NN	O	testing	prep_for	14	SENT_70	[p6l1696t2359r1930b2437],
17	in	IN	O	in	_	0	SENT_70	[p6l1951t2359r2019b2415],
18	the	DT	O	the	det	20	SENT_70	[p6l2041t2353r2149b2416],
19	effectiveness	NN	O	effectiveness	nn	20	SENT_70	[p6l9t2456r442b2519],
20	portion	NN	O	portion	prep_in	12	SENT_70	[p6l465t2462r748b2539],
21	,	,	O	,	_	0	SENT_70	[p6l465t2462r748b2539],
22	in	IN	O	in	_	0	SENT_70	[p6l773t2462r840b2518],
23	the	DT	O	the	det	24	SENT_70	[p6l862t2456r970b2519],
24	analysis	NN	O	analysis	prep_in	12	SENT_70	[p6l995t2456r1264b2540],
25	of	IN	O	of	_	0	SENT_70	[p6l1288t2456r1363b2519],
26	trial	NN	O	trial	nn	27	SENT_70	[p6l1376t2456r1519b2519],
27	results	NNS	O	result	prep_of	24	SENT_70	[p6l1542t2456r1784b2528],
28	,	,	O	,	_	0	SENT_70	[p6l1542t2456r1784b2528],
29	data	NNS	O	datum	nsubjpass	37	SENT_70	[p6l1810t2456r1956b2519],
30	from	IN	O	from	_	0	SENT_70	[p6l1978t2456r2148b2519],
31	the	DT	O	the	det	33	SENT_70	[p6l8t2559r115b2622],
32	two	CD	NUMBER	two	num	33	SENT_70	[p6l138t2571r265b2622],
33	stages	NNS	O	stage	prep_from	29	SENT_70	[p6l290t2571r492b2643],
34	will	MD	O	will	aux	37	SENT_70	[p6l514t2559r642b2622],
35	not	RB	O	not	neg	37	SENT_70	[p6l664t2571r780b2622],
36	be	VB	O	be	auxpass	37	SENT_70	[p6l800t2559r881b2622],
37	combined	VBN	O	combine	_	0	SENT_70	[p6l905t2559r1268b2622],
38	.	.	O	.	_	0	SENT_70	[p6l905t2559r1268b2622],

1	This	DT	O	this	nsubj	8	SENT_71	[p6l1294t2559r1439b2622],
2	facilitates	VBZ	O	facilitate	_	0	SENT_71	[p6l1462t2559r1789b2622],
3	interpretability	NN	O	interpretability	dobj	2	SENT_71	[p6l1813t2565r2145b2642, p6l9t2662r228b2746],
4	of	IN	O	of	_	0	SENT_71	[p6l248t2662r323b2725],
5	the	DT	O	the	det	6	SENT_71	[p6l336t2662r445b2725],
6	inference	NN	O	inference	prep_of	3	SENT_71	[p6l469t2662r792b2725],
7	and	CC	O	and	_	0	SENT_71	[p6l816t2662r945b2725],
8	ensures	VBZ	O	ensure	conj_and	2	SENT_71	[p6l968t2685r1229b2725],
9	control	NN	O	control	dobj	8	SENT_71	[p6l1254t2662r1504b2725],
10	of	IN	O	of	_	0	SENT_71	[p6l1528t2662r1603b2725],
11	type	NN	O	type	nn	13	SENT_71	[p6l1616t2674r1765b2746],
12	1	CD	NUMBER	1	num	13	SENT_71	[p6l1796t2669r1821b2724],
13	error	NN	O	error	prep_of	9	SENT_71	[p6l1851t2685r2027b2725],
14	for	IN	O	for	_	0	SENT_71	[p6l2050t2662r2149b2725],
15	each	DT	O	each	det	16	SENT_71	[p6l9t2765r162b2828],
16	stage	NN	O	stage	prep_for	13	SENT_71	[p6l185t2777r353b2849],
17	separately	RB	O	separately	advmod	8	SENT_71	[p6l375t2765r725b2849],
18	.	.	O	.	_	0	SENT_71	[p6l375t2765r725b2849],

1	When	WRB	O	when	advmod	8	SENT_72	[p6l81t2868r291b2931],
2	data	NNS	O	datum	nsubjpass	8	SENT_72	[p6l313t2868r457b2931],
3	from	IN	O	from	_	0	SENT_72	[p6l476t2868r644b2931],
4	the	DT	O	the	det	6	SENT_72	[p6l663t2868r770b2931],
5	efﬁcacy	NN	O	efﬁcacy	nn	6	SENT_72	[p6l791t2868r1048b2952],
6	trial	NN	O	trial	prep_from	2	SENT_72	[p6l1065t2868r1206b2931],
7	are	VBP	O	be	auxpass	8	SENT_72	[p6l1226t2891r1326b2931],
8	used	VBN	O	use	advcl	22	SENT_72	[p6l1347t2868r1505b2931],
9	to	TO	O	to	aux	10	SENT_72	[p6l1524t2880r1590b2931],
10	formulate	VB	O	formulate	xcomp	8	SENT_72	[p6l1612t2868r1945b2931],
11	questions	NNS	O	question	nsubj	13	SENT_72	[p6l1967t2891r2148b2951, p6l8t2977r176b3034],
12	to	TO	O	to	aux	13	SENT_72	[p6l197t2983r264b3034],
13	investigate	VB	O	investigate	xcomp	10	SENT_72	[p6l288t2977r649b3055],
14	in	IN	O	in	_	0	SENT_72	[p6l672t2977r738b3033],
15	the	DT	O	the	det	17	SENT_72	[p6l760t2971r866b3034],
16	effectiveness	NN	O	effectiveness	nn	17	SENT_72	[p6l890t2971r1316b3034],
17	portion	NN	O	portion	prep_in	13	SENT_72	[p6l1338t2977r1616b3054],
18	,	,	O	,	_	0	SENT_72	[p6l1338t2977r1616b3054],
19	the	DT	O	the	det	20	SENT_72	[p6l1640t2971r1746b3034],
20	hypotheses	NNS	O	hypothesis	nsubj	22	SENT_72	[p6l1768t2971r2149b3055],
21	will	MD	O	will	aux	22	SENT_72	[p6l7t3074r132b3137],
22	fall	VB	O	fall	_	0	SENT_72	[p6l151t3074r257b3137],
23	into	IN	O	into	_	0	SENT_72	[p6l276t3080r409b3137],
24	two	CD	NUMBER	two	num	25	SENT_72	[p6l430t3086r555b3137],
25	categories	NNS	O	category	prep_into	22	SENT_72	[p6l577t3080r931b3158],
26	.	.	O	.	_	0	SENT_72	[p6l577t3080r931b3158],

1	The	DT	O	the	det	2	SENT_73	[p6l954t3074r1079b3137],
2	ﬁrst	NN	O	ﬁrst	nsubj	3	SENT_73	[p6l1099t3074r1232b3137],
3	consists	VBZ	O	consist	_	0	SENT_73	[p6l1252t3080r1516b3137],
4	of	IN	O	of	_	0	SENT_73	[p6l1538t3074r1611b3137],
5	a	DT	O	a	det	7	SENT_73	[p6l1623t3097r1657b3137],
6	small	JJ	O	small	amod	7	SENT_73	[p6l1678t3074r1858b3137],
7	number	NN	O	number	prep_of	3	SENT_73	[p6l1877t3074r2149b3137],
8	of	IN	O	of	_	0	SENT_73	[p6l9t3177r84b3240],
9	primary	JJ	O	primary	amod	12	SENT_73	[p6l96t3183r384b3261],
10	or	CC	O	or	_	0	SENT_73	[p6l403t3200r476b3240],
11	coprimary	JJ	O	coprimary	amod	12	SENT_73	[p6l499t3183r865b3261],
12	hypotheses	NNS	O	hypothesis	prep_of	7	SENT_73	[p6l884t3177r1270b3261],
13	intended	VBN	O	intend	partmod	12	SENT_73	[p6l1294t3177r1603b3240],
14	for	IN	O	for	_	0	SENT_73	[p6l1624t3177r1723b3240],
15	formal	JJ	O	formal	amod	16	SENT_73	[p6l1745t3177r1977b3240],
16	testing	NN	O	testing	prep_for	13	SENT_73	[p6l1999t3189r2146b3240, p6l9t3286r137b3364],
17	,	,	O	,	_	0	SENT_73	[p6l1999t3189r2146b3240, p6l9t3286r137b3364],
18	controlling	VBG	O	control	xcomp	13	SENT_73	[p6l164t3280r556b3364],
19	for	IN	O	for	_	0	SENT_73	[p6l579t3280r679b3343],
20	type	NN	O	type	nn	22	SENT_73	[p6l702t3292r853b3364],
21	1	CD	NUMBER	1	num	22	SENT_73	[p6l884t3287r909b3342],
22	error	NN	O	error	prep_for	18	SENT_73	[p6l941t3303r1119b3343],
23	with	IN	O	with	_	0	SENT_73	[p6l1140t3280r1298b3343],
24	appropriate	JJ	O	appropriate	amod	25	SENT_73	[p6l1323t3286r1731b3363],
25	adaptive	JJ	O	adaptive	prep_with	18	SENT_73	[p6l1756t3280r2051b3363],
26	or	CC	O	or	_	0	SENT_73	[p6l2077t3303r2151b3343],
27	multiplicity	NN	O	multiplicity	nn	28	SENT_73	[p6l8t3383r409b3467],
28	adjustments	NNS	O	adjustment	prep_with	18	SENT_73	[p6l429t3383r861b3467],
29	.	.	O	.	_	0	SENT_73	[p6l429t3383r861b3467],

1	The	DT	O	the	det	2	SENT_74	[p6l886t3383r1012b3446],
2	second	JJ	ORDINAL	second	nsubj	3	SENT_74	[p6l1036t3383r1274b3446],
3	includes	VBZ	O	include	_	0	SENT_74	[p6l1296t3383r1579b3446],
4	a	DT	O	a	det	6	SENT_74	[p6l1603t3406r1637b3446],
5	larger	JJR	O	larger	amod	6	SENT_74	[p6l1658t3383r1856b3467],
6	number	NN	O	number	dobj	3	SENT_74	[p6l1877t3383r2151b3446],
7	of	IN	O	of	_	0	SENT_74	[p6l9t3486r82b3549],
8	secondary	JJ	O	secondary	amod	9	SENT_74	[p6l93t3486r442b3570],
9	hypotheses	NNS	O	hypothesis	prep_of	6	SENT_74	[p6l457t3486r851b3570],
10	,	,	O	,	_	0	SENT_74	[p6l457t3486r851b3570],
11	intended	VBN	O	intend	partmod	9	SENT_74	[p6l873t3486r1173b3549],
12	for	IN	O	for	_	0	SENT_74	[p6l1192t3486r1288b3549],
13	exploratory	JJ	O	exploratory	amod	14	SENT_74	[p6l1308t3486r1701b3570],
14	investigation	NN	O	investigation	prep_for	11	SENT_74	[p6l1717t3492r2151b3570],
15	only	RB	O	only	advmod	11	SENT_74	[p6l9t3589r168b3673],
16	,	,	O	,	_	0	SENT_74	[p6l9t3589r168b3673],
17	without	IN	O	without	_	0	SENT_74	[p6l190t3589r459b3652],
18	control	NN	O	control	prep_without	11	SENT_74	[p6l480t3589r725b3652],
19	of	IN	O	of	_	0	SENT_74	[p6l747t3589r821b3652],
20	type	NN	O	type	nn	22	SENT_74	[p6l832t3601r979b3673],
21	1	CD	NUMBER	1	num	22	SENT_74	[p6l1007t3596r1032b3651],
22	error	NN	O	error	prep_of	18	SENT_74	[p6l1061t3612r1243b3652],
23	.	.	O	.	_	0	SENT_74	[p6l1061t3612r1243b3652],

1	Many	JJ	O	many	amod	2	SENT_75	[p6l1268t3594r1466b3673],
2	hypotheses	NNS	O	hypothesis	nsubj	4	SENT_75	[p6l1484t3589r1864b3673],
3	will	MD	O	will	aux	4	SENT_75	[p6l1885t3589r2011b3652],
4	test	VB	O	test	_	0	SENT_75	[p6l2031t3601r2150b3652],
5	for	IN	O	for	_	0	SENT_75	[p6l8t3692r105b3755],
6	interactions	NNS	O	interaction	prep_for	4	SENT_75	[p6l124t3698r527b3755],
7	between	IN	O	between	_	0	SENT_75	[p6l546t3692r830b3755],
8	treatments	NNS	O	treatment	prep_between	6	SENT_75	[p6l849t3704r1213b3755],
9	and	CC	O	and	_	0	SENT_75	[p6l1234t3692r1360b3755],
10	preselected	JJ	O	preselected	amod	11	SENT_75	[p6l1378t3692r1760b3775],
11	subgroups	NNS	O	subgroup	conj_and	8	SENT_75	[p6l1780t3692r2147b3776],
12	.	.	O	.	_	0	SENT_75	[p6l1780t3692r2147b3776],

1	To	TO	O	to	aux	2	SENT_76	[p7l8t19r92b79],
2	test	VB	O	test	purpcl	13	SENT_76	[p7l112t28r230b79],
3	these	DT	O	these	det	4	SENT_76	[p7l247t16r421b79],
4	hypotheses	NNS	O	hypothesis	dobj	2	SENT_76	[p7l441t16r835b100],
5	,	,	O	,	_	0	SENT_76	[p7l441t16r835b100],
6	participant	NN	O	participant	nn	7	SENT_76	[p7l856t22r1230b99],
7	characteristics	NNS	O	characteristic	nsubj	13	SENT_76	[p7l1250t16r1733b79],
8	in	IN	O	in	_	0	SENT_76	[p7l1754t22r1820b78],
9	the	DT	O	the	det	11	SENT_76	[p7l1839t16r1945b79],
10	effectiveness	NN	O	effectiveness	nn	11	SENT_76	[p7l1966t16r2145b79, p7l8t125r289b182],
11	portion	NN	O	portion	prep_in	7	SENT_76	[p7l316t125r588b202],
12	must	MD	O	must	aux	13	SENT_76	[p7l614t131r791b182],
13	include	VB	O	include	_	0	SENT_76	[p7l817t119r1080b182],
14	subject	JJ	O	subject	amod	15	SENT_76	[p7l1108t119r1359b203],
15	attributes	NNS	O	attribute	dobj	13	SENT_76	[p7l1385t119r1723b182],
16	with	IN	O	with	_	0	SENT_76	[p7l1748t119r1908b182],
17	which	WDT	O	which	dobj	21	SENT_76	[p7l1932t119r2151b182],
18	treatment	NN	O	treatment	nn	19	SENT_76	[p7l8t234r348b285],
19	effects	NNS	O	effect	nsubj	21	SENT_76	[p7l371t222r586b285],
20	may	MD	O	may	aux	21	SENT_76	[p7l609t245r757b306],
21	interact	VB	O	interact	prepc_with	13	SENT_76	[p7l777t228r1059b285],
22	.	.	O	.	_	0	SENT_76	[p7l777t228r1059b285],

1	In	IN	O	in	_	0	SENT_77	[p7l1086t227r1158b284],
2	some	DT	O	some	det	3	SENT_77	[p7l1182t245r1362b285],
3	settings	NNS	O	setting	prep_in	12	SENT_77	[p7l1386t228r1667b306],
4	,	,	O	,	_	0	SENT_77	[p7l1386t228r1667b306],
5	the	DT	O	the	det	6	SENT_77	[p7l1691t222r1799b285],
6	efﬁciency	NN	O	efﬁciency	nsubjpass	12	SENT_77	[p7l1823t222r2153b306],
7	of	IN	O	of	_	0	SENT_77	[p7l9t325r83b388],
8	effectiveness	NN	O	effectiveness	nn	9	SENT_77	[p7l97t325r528b388],
9	trials	NNS	O	trial	prep_of	6	SENT_77	[p7l551t325r724b388],
10	could	MD	O	could	aux	12	SENT_77	[p7l748t325r940b388],
11	be	VB	O	be	auxpass	12	SENT_77	[p7l960t325r1040b388],
12	improved	VBN	O	improve	_	0	SENT_77	[p7l1064t325r1397b408],
13	by	IN	O	by	_	0	SENT_77	[p7l1416t325r1501b409],
14	introducing	VBG	O	introduce	agent	12	SENT_77	[p7l1520t325r1932b409],
15	adaptive	JJ	O	adaptive	amod	17	SENT_77	[p7l1953t325r2144b408, p7l8t434r128b491],
16	interim	NN	O	interim	nn	17	SENT_77	[p7l148t434r397b491],
17	analyses	NNS	O	analysis	dobj	14	SENT_77	[p7l418t428r692b512],
18	with	IN	O	with	_	0	SENT_77	[p7l710t428r860b491],
19	decision	NN	O	decision	nn	20	SENT_77	[p7l881t428r1158b491],
20	rules	NNS	O	rule	prep_with	14	SENT_77	[p7l1178t428r1340b491],
21	for	IN	O	for	_	0	SENT_77	[p7l1360t428r1456b491],
22	dropping	VBG	O	drop	prepc_for	14	SENT_77	[p7l1475t428r1785b512],
23	subgroups	NNS	O	subgroup	dobj	22	SENT_77	[p7l1804t428r2150b512],
24	that	WDT	O	that	nsubj	37	SENT_77	[p7l8t531r145b595],
25	do	VBP	O	do	aux	37	SENT_77	[p7l169t531r255b595],
26	not	RB	O	not	neg	37	SENT_77	[p7l279t543r397b595],
27	appear	VB	O	appear	cop	37	SENT_77	[p7l420t554r656b615],
28	to	TO	O	to	_	0	SENT_77	[p7l678t543r746b595],
29	beneﬁt	JJ	O	beneﬁt	amod	35	SENT_77	[p7l769t531r1012b595],
30	from	IN	O	from	_	0	SENT_77	[p7l1034t531r1207b595],
31	the	DT	O	the	det	33	SENT_77	[p7l1229t531r1339b595],
32	new	JJ	O	new	amod	33	SENT_77	[p7l1362t554r1509b595],
33	treatment	NN	O	treatment	prep_from	29	SENT_77	[p7l1529t523r2006b595],
34	.9	CD	NUMBER	.9	tmod	29	SENT_77	[p7l1529t523r2006b595],
35	’	NN	O	’	prep_to	37	SENT_77	[p7l1529t523r2006b595],
36	1	CD	NUMBER	1	num	37	SENT_77	[p7l1529t523r2006b595],
37	°	NN	O	°	rcmod	23	SENT_77	[p7l1529t523r2006b595],
38	For	IN	O	for	_	0	SENT_77	[p7l2031t537r2150b595],
39	primary	JJ	O	primary	amod	40	SENT_77	[p7l7t641r295b719],
40	hypotheses	NNS	O	hypothesis	prep_for	54	SENT_77	[p7l314t635r719b719],
41	,	,	O	,	_	0	SENT_77	[p7l314t635r719b719],
42	subgroups	NNS	O	subgroup	nsubj	54	SENT_77	[p7l745t635r1122b719],
43	,	,	O	,	_	0	SENT_77	[p7l745t635r1122b719],
44	decision	NN	O	decision	nn	45	SENT_77	[p7l1148t635r1436b698],
45	rules	NNS	O	rule	nsubj	54	SENT_77	[p7l1460t635r1647b707],
46	,	,	O	,	_	0	SENT_77	[p7l1460t635r1647b707],
47	and	CC	O	and	_	0	SENT_77	[p7l1672t635r1801b698],
48	statistical	JJ	O	statistical	amod	49	SENT_77	[p7l1824t635r2148b698],
49	methods	NNS	O	method	nsubj	54	SENT_77	[p7l8t738r304b801],
50	for	IN	O	for	_	0	SENT_77	[p7l324t738r421b801],
51	hypothesis	NN	O	hypothesis	nn	52	SENT_77	[p7l439t738r801b822],
52	testing	NN	O	testing	prep_for	49	SENT_77	[p7l821t744r1048b822],
53	would	MD	O	would	aux	54	SENT_77	[p7l1065t738r1278b801],
54	have	VB	O	have	rcmod	37	SENT_77	[p7l1296t738r1450b801],
55	to	TO	O	to	aux	57	SENT_77	[p7l1469t750r1535b801],
56	be	VB	O	be	auxpass	57	SENT_77	[p7l1554t738r1633b801],
57	prespeciﬁed	VBN	O	prespeciﬁed	xcomp	54	SENT_77	[p7l1652t738r2063b821],
58	to	TO	O	to	aux	59	SENT_77	[p7l2081t750r2146b801],
59	maintain	VB	O	maintain	xcomp	57	SENT_77	[p7l8t847r313b904],
60	the	DT	O	the	det	61	SENT_77	[p7l332t841r437b904],
61	validity	NN	O	validity	dobj	59	SENT_77	[p7l455t841r713b925],
62	of	IN	O	of	_	0	SENT_77	[p7l730t841r803b904],
63	conclusions	NNS	O	conclusion	prep_of	61	SENT_77	[p7l814t841r1228b904],
64	.	.	O	.	_	0	SENT_77	[p7l814t841r1228b904],

1	For	IN	O	for	_	0	SENT_78	[p7l1252t846r1367b904],
2	secondary	JJ	O	secondary	amod	3	SENT_78	[p7l1386t841r1736b925],
3	hypotheses	NNS	O	hypothesis	prep_for	8	SENT_78	[p7l1751t841r2146b925],
4	,	,	O	,	_	0	SENT_78	[p7l1751t841r2146b925],
5	the	DT	O	the	det	6	SENT_78	[p7l8t944r111b1007],
6	objective	NN	O	objective	nsubj	8	SENT_78	[p7l131t944r427b1028],
7	would	MD	O	would	aux	8	SENT_78	[p7l445t944r654b1007],
8	be	VB	O	be	_	0	SENT_78	[p7l670t944r748b1007],
9	to	TO	O	to	aux	10	SENT_78	[p7l766t956r831b1007],
10	identify	VB	O	identify	xcomp	8	SENT_78	[p7l851t944r1111b1028],
11	potential	JJ	O	potential	amod	13	SENT_78	[p7l1126t944r1423b1027],
12	treatment-modifying	JJ	O	treatment-modifying	amod	13	SENT_78	[p7l1441t944r2149b1028],
13	inﬂuences	NNS	O	inﬂuences	dobj	10	SENT_78	[p7l9t1047r355b1110],
14	to	TO	O	to	aux	15	SENT_78	[p7l376t1059r442b1110],
15	inform	VB	O	inform	xcomp	10	SENT_78	[p7l465t1047r703b1110],
16	future	JJ	DATE	future	amod	18	SENT_78	[p7l725t1047r932b1110],
17	hypothesis	NN	O	hypothesis	nn	18	SENT_78	[p7l952t1047r1319b1131],
18	testing	NN	O	testing	dobj	15	SENT_78	[p7l1340t1053r1585b1131],
19	.	.	O	.	_	0	SENT_78	[p7l1340t1053r1585b1131],

1	For	IN	O	for	_	0	SENT_79	[p7l83t1155r203b1213],
2	primary	JJ	O	primary	amod	3	SENT_79	[p7l225t1156r518b1234],
3	hypotheses	NNS	O	hypothesis	prep_for	23	SENT_79	[p7l538t1150r952b1234],
4	,	,	O	,	_	0	SENT_79	[p7l538t1150r952b1234],
5	because	IN	O	because	mark	10	SENT_79	[p7l976t1150r1254b1213],
6	the	DT	O	the	det	8	SENT_79	[p7l1278t1150r1388b1213],
7	effectiveness	NN	O	effectiveness	nn	8	SENT_79	[p7l1413t1150r1856b1213],
8	portion	NN	O	portion	nsubj	10	SENT_79	[p7l1880t1156r2149b1233],
9	will	MD	O	will	aux	10	SENT_79	[p7l7t1253r134b1316],
10	have	VB	O	have	advcl	23	SENT_79	[p7l156t1253r314b1316],
11	more	RBR	O	more	advmod	10	SENT_79	[p7l337t1276r517b1316],
12	diversity	NN	O	diversity	dobj	10	SENT_79	[p7l541t1253r841b1337],
13	in	IN	O	in	_	0	SENT_79	[p7l861t1259r928b1315],
14	participants	NNS	O	participant	prep_in	12	SENT_79	[p7l950t1259r1364b1336],
15	and	CC	O	and	_	0	SENT_79	[p7l1389t1253r1517b1316],
16	settings	NNS	O	setting	conj_and	14	SENT_79	[p7l1540t1259r1821b1337],
17	,	,	O	,	_	0	SENT_79	[p7l1540t1259r1821b1337],
18	standard	JJ	O	standard	amod	19	SENT_79	[p7l1847t1253r2150b1316],
19	deviations	NNS	O	deviation	nsubj	27	SENT_79	[p7l9t1356r350b1419],
20	will	MD	O	will	aux	23	SENT_79	[p7l369t1356r492b1419],
21	generally	RB	O	generally	advmod	23	SENT_79	[p7l510t1356r817b1440],
22	be	VB	O	be	cop	23	SENT_79	[p7l831t1356r908b1419],
23	larger	JJR	O	larger	_	0	SENT_79	[p7l927t1356r1120b1440],
24	and	CC	O	and	_	0	SENT_79	[p7l1140t1356r1263b1419],
25	overall	JJ	O	overall	amod	26	SENT_79	[p7l1282t1356r1506b1419],
26	differences	NNS	O	difference	npadvmod	27	SENT_79	[p7l1526t1356r1885b1419],
27	smaller	JJR	O	smaller	conj_and	23	SENT_79	[p7l1906t1356r2151b1419],
28	than	IN	O	than	prep	23	SENT_79	[p7l8t1459r161b1522],
29	in	IN	O	in	pcomp	28	SENT_79	[p7l182t1465r248b1521],
30	the	DT	O	the	det	32	SENT_79	[p7l267t1459r373b1522],
31	efﬁcacy	NN	O	efﬁcacy	nn	32	SENT_79	[p7l394t1459r650b1543],
32	portion	NN	O	portion	pobj	29	SENT_79	[p7l666t1465r941b1542],
33	.	.	O	.	_	0	SENT_79	[p7l666t1465r941b1542],

1	Thus	RB	O	thus	advmod	14	SENT_80	[p7l964t1459r1146b1531],
2	,	,	O	,	_	0	SENT_80	[p7l964t1459r1146b1531],
3	to	TO	O	to	aux	4	SENT_80	[p7l1167t1471r1233b1522],
4	detect	VB	O	detect	purpcl	14	SENT_80	[p7l1255t1459r1460b1522],
5	a	DT	O	a	det	7	SENT_80	[p7l1480t1482r1514b1522],
6	given	JJ	O	given	amod	7	SENT_80	[p7l1533t1465r1715b1543],
7	effect	NN	O	effect	dobj	4	SENT_80	[p7l1736t1459r1934b1531],
8	,	,	O	,	_	0	SENT_80	[p7l1736t1459r1934b1531],
9	larger	JJR	O	larger	amod	11	SENT_80	[p7l1955t1459r2151b1543],
10	sample	NN	O	sample	nn	11	SENT_80	[p7l9t1562r246b1645],
11	sizes	NNS	O	size	nsubjpass	14	SENT_80	[p7l269t1568r423b1625],
12	will	MD	O	will	aux	14	SENT_80	[p7l443t1562r569b1625],
13	be	VB	O	be	auxpass	14	SENT_80	[p7l586t1562r666b1625],
14	needed	VBN	O	need	_	0	SENT_80	[p7l687t1562r949b1625],
15	.	.	O	.	_	0	SENT_80	[p7l687t1562r949b1625],

1	In	IN	O	in	_	0	SENT_81	[p7l974t1567r1045b1624],
2	cases	NNS	O	case	prep_in	25	SENT_81	[p7l1066t1585r1237b1625],
3	in	IN	O	in	_	0	SENT_81	[p7l1258t1568r1324b1624],
4	which	WDT	O	which	rel	17	SENT_81	[p7l1343t1562r1553b1625],
5	the	DT	O	the	det	6	SENT_81	[p7l1573t1562r1679b1625],
6	conﬁrmation	NN	O	conﬁrmation	nsubj	17	SENT_81	[p7l1701t1562r2150b1625],
7	of	IN	O	of	_	0	SENT_81	[p7l9t1665r85b1728],
8	effects	NNS	O	effect	prep_of	6	SENT_81	[p7l102t1665r322b1728],
9	seen	VBN	O	see	partmod	8	SENT_81	[p7l350t1688r504b1728],
10	in	IN	O	in	_	0	SENT_81	[p7l530t1671r599b1727],
11	the	DT	O	the	det	13	SENT_81	[p7l623t1665r733b1728],
12	eﬂicacy	NN	O	eﬂicacy	nn	13	SENT_81	[p7l760t1665r1027b1749],
13	trial	NN	O	trial	prep_in	9	SENT_81	[p7l1048t1665r1195b1728],
14	is	VBZ	O	be	cop	17	SENT_81	[p7l1221t1671r1272b1728],
15	the	DT	O	the	det	17	SENT_81	[p7l1298t1665r1408b1728],
16	primary	JJ	O	primary	amod	17	SENT_81	[p7l1433t1671r1727b1749],
17	objective	NN	O	objective	rcmod	2	SENT_81	[p7l1749t1665r2086b1749],
18	,	,	O	,	_	0	SENT_81	[p7l1749t1665r2086b1749],
19	a	DT	O	a	det	22	SENT_81	[p7l2114t1688r2149b1728],
20	larger	JJR	O	larger	amod	22	SENT_81	[p7l7t1768r204b1852],
21	sample	NN	O	sample	nn	22	SENT_81	[p7l224t1768r460b1851],
22	size	NN	O	size	nsubjpass	25	SENT_81	[p7l481t1774r603b1831],
23	will	MD	O	will	aux	25	SENT_81	[p7l622t1768r747b1831],
24	be	VB	O	be	auxpass	25	SENT_81	[p7l764t1768r843b1831],
25	warranted	VBN	O	warrant	_	0	SENT_81	[p7l862t1768r1226b1831],
26	.	.	O	.	_	0	SENT_81	[p7l862t1768r1226b1831],

1	In	IN	O	in	_	0	SENT_82	[p7l1251t1773r1321b1830],
2	other	JJ	O	other	amod	3	SENT_82	[p7l1342t1768r1522b1831],
3	cases	NNS	O	case	prep_in	24	SENT_82	[p7l1542t1791r1711b1831],
4	in	IN	O	in	_	0	SENT_82	[p7l1733t1774r1798b1830],
5	which	WDT	O	which	rel	10	SENT_82	[p7l1817t1768r2025b1831],
6	the	DT	O	the	det	7	SENT_82	[p7l2045t1768r2150b1831],
7	objective	NN	O	objective	nsubj	10	SENT_82	[p7l9t1871r308b1955],
8	is	VBZ	O	be	cop	10	SENT_82	[p7l328t1877r377b1934],
9	hypothesis	NN	O	hypothesis	nn	10	SENT_82	[p7l397t1871r756b1955],
10	generation	NN	O	generation	rcmod	3	SENT_82	[p7l777t1877r1136b1955],
11	or	CC	O	or	_	0	SENT_82	[p7l1156t1894r1226b1934],
12	the	DT	O	the	det	13	SENT_82	[p7l1245t1871r1349b1934],
13	development	NN	O	development	conj_or	10	SENT_82	[p7l1370t1871r1807b1954],
14	of	IN	O	of	_	0	SENT_82	[p7l1826t1871r1898b1934],
15	predictive	JJ	O	predictive	amod	16	SENT_82	[p7l1908t1871r2146b1954, p7l8t1980r130b2037],
16	models	NNS	O	model	prep_of	13	SENT_82	[p7l152t1974r417b2046],
17	,	,	O	,	_	0	SENT_82	[p7l152t1974r417b2046],
18	larger	JJR	O	larger	amod	20	SENT_82	[p7l440t1974r638b2058],
19	sample	NN	O	sample	nn	20	SENT_82	[p7l659t1974r897b2057],
20	sizes	NNS	O	size	nsubjpass	24	SENT_82	[p7l919t1980r1074b2037],
21	may	MD	O	may	aux	24	SENT_82	[p7l1096t1997r1243b2058],
22	not	RB	O	not	neg	24	SENT_82	[p7l1261t1986r1375b2037],
23	be	VB	O	be	auxpass	24	SENT_82	[p7l1393t1974r1473b2037],
24	needed	VBN	O	need	_	0	SENT_82	[p7l1495t1974r1758b2037],
25	.	.	O	.	_	0	SENT_82	[p7l1495t1974r1758b2037],

1	CLINICAL	JJ	O	clinical	_	0	SENT_83	[p7l9t2193r257b2236],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	1	SENT_83	[p7l276t2193r742b2236],
3	&	CC	O	&	_	0	SENT_83	[p7l758t2193r795b2235],
4	THERAPEUTICS	NNP	O	THERAPEUTICS	dep	1	SENT_83	[p7l807t2193r1215b2236],

1	E2E-derived	JJ	O	e2e-derived	amod	4	SENT_84	[p7l12t2282r426b2339],
2	clinical	JJ	O	clinical	amod	4	SENT_84	[p7l445t2282r683b2339],
3	predictive	JJ	O	predictive	amod	4	SENT_84	[p7l705t2282r1053b2354],
4	instruments	NNS	O	instrument	nsubj	15	SENT_84	[p7l1073t2282r1490b2339],
5	as	IN	O	as	_	0	SENT_84	[p7l1507t2298r1578b2339],
6	decision	NN	O	decision	nn	7	SENT_84	[p7l1595t2282r1881b2339],
7	aids	NNS	O	aid	prep_as	4	SENT_84	[p7l1900t2282r2040b2339],
8	Separate	JJ	O	separate	amod	7	SENT_84	[p7l10t2383r298b2462],
9	from	IN	O	from	_	0	SENT_84	[p7l318t2379r486b2442],
10	these	DT	O	these	det	11	SENT_84	[p7l505t2379r680b2442],
11	analyses	NNS	O	analysis	prep_from	8	SENT_84	[p7l702t2379r981b2463],
12	of	IN	O	of	_	0	SENT_84	[p7l1003t2379r1076b2442],
13	E2E	NN	O	e2e	nn	14	SENT_84	[p7l1087t2384r1223b2441],
14	trial	NN	O	trial	prep_of	11	SENT_84	[p7l1243t2379r1383b2442],
15	results	VBZ	O	result	_	0	SENT_84	[p7l1403t2379r1641b2451],
16	,	,	O	,	_	0	SENT_84	[p7l1403t2379r1641b2451],
17	but	CC	O	but	_	0	SENT_84	[p7l1662t2379r1775b2442],
18	still	RB	O	still	advmod	19	SENT_84	[p7l1795t2379r1917b2442],
19	representing	VBG	O	represent	dep	30	SENT_84	[p7l1937t2401r2140b2462, p7l10t2488r252b2566],
20	treatment	NN	O	treatment	nn	21	SENT_84	[p7l269t2494r596b2545],
21	effects	NNS	O	effect	dobj	19	SENT_84	[p7l614t2482r839b2554],
22	,	,	O	,	_	0	SENT_84	[p7l614t2482r839b2554],
23	data	NNS	O	datum	nsubjpass	30	SENT_84	[p7l860t2482r1000b2545],
24	from	IN	O	from	_	0	SENT_84	[p7l1019t2482r1182b2545],
25	both	DT	O	both	det	27	SENT_84	[p7l1199t2482r1355b2545],
26	trial	NN	O	trial	nn	27	SENT_84	[p7l1373t2482r1510b2545],
27	components	NNS	O	component	prep_from	23	SENT_84	[p7l1530t2494r1939b2565],
28	could	MD	O	could	aux	30	SENT_84	[p7l1959t2482r2145b2545],
29	be	VB	O	be	auxpass	30	SENT_84	[p7l7t2585r88b2648],
30	used	VBN	O	use	conj_but	15	SENT_84	[p7l111t2585r273b2648],
31	in	IN	O	in	_	0	SENT_84	[p7l295t2591r363b2647],
32	multivariable	JJ	O	multivariable	amod	35	SENT_84	[p7l385t2585r849b2648],
33	patient-speciﬁc	JJ	O	patient-speciﬁc	amod	35	SENT_84	[p7l871t2585r1408b2668],
34	predictive	JJ	O	predictive	amod	35	SENT_84	[p7l1430t2585r1778b2668],
35	models	NNS	O	model	prep_in	30	SENT_84	[p7l1801t2585r2053b2648],
36	of	IN	O	of	_	0	SENT_84	[p7l2077t2585r2152b2648],
37	treatment	NN	O	treatment	nn	38	SENT_84	[p7l8t2700r339b2751],
38	beneﬁts	NNS	O	beneﬁts	prep_of	35	SENT_84	[p7l356t2688r635b2751],
39	.	.	O	.	_	0	SENT_84	[p7l356t2688r635b2751],

1	Examples	NNS	O	example	nsubj	2	SENT_85	[p7l658t2688r981b2771],
2	include	VBP	O	include	_	0	SENT_85	[p7l1002t2688r1249b2751],
3	“	NN	O	“	dobj	2	SENT_85	[p7l1271t2688r1538b2751],
4	clinical	JJ	O	clinical	amod	6	SENT_85	[p7l1271t2688r1538b2751],
5	predictive	JJ	O	predictive	amod	6	SENT_85	[p7l1557t2688r1893b2771],
6	instruments	NNS	O	instrument	dep	3	SENT_85	[p7l1913t2694r2140b2751, p7l9t2791r262b2863],
7	,	,	O	,	_	0	SENT_85	[p7l1913t2694r2140b2751, p7l9t2791r262b2863],
8	”	CD	NUMBER	”	num	10	SENT_85	[p7l1913t2694r2140b2751, p7l9t2791r262b2863],
9	logistic	JJ	O	logistic	amod	10	SENT_85	[p7l286t2791r537b2875],
10	regressions	NNS	O	regression	appos	3	SENT_85	[p7l560t2797r947b2875],
11	that	WDT	O	that	nsubj	12	SENT_85	[p7l970t2791r1107b2854],
12	generate	VBP	O	generate	rcmod	10	SENT_85	[p7l1129t2803r1422b2875],
13	0	CD	PERCENT	0	num	17	SENT_85	[p7l1446t2796r1721b2856],
14	—	CD	PERCENT	—	number	15	SENT_85	[p7l1446t2796r1721b2856],
15	100	CD	PERCENT	100	dep	16	SENT_85	[p7l1446t2796r1721b2856],
16	%	NN	PERCENT	%	dep	17	SENT_85	[p7l1446t2796r1721b2856],
17	predictions	NNS	O	prediction	dobj	12	SENT_85	[p7l1746t2791r2140b2874],
18	of	IN	O	of	_	0	SENT_85	[p7l10t2894r84b2957],
19	diagnoses	NNS	O	diagnosis	prep_of	17	SENT_85	[p7l97t2894r431b2978],
20	and	CC	O	and	_	0	SENT_85	[p7l456t2894r608b2960],
21	/	:	O	/	punct	23	SENT_85	[p7l456t2894r608b2960],
22	or	CC	O	or	dep	23	SENT_85	[p7l614t2917r685b2957],
23	outcomes	NNS	O	outcome	dep	19	SENT_85	[p7l708t2906r1035b2957],
24	as	IN	O	as	amod	23	SENT_85	[p7l1059t2917r1123b2957],
25	decision	NN	O	decision	nn	26	SENT_85	[p7l1147t2894r1430b2957],
26	support	NN	O	support	conj_and	19	SENT_85	[p7l1453t2906r1719b2977],
27	in	IN	O	in	_	0	SENT_85	[p7l1740t2900r1807b2956],
28	real-time	JJ	O	real-time	amod	29	SENT_85	[p7l1829t2894r2142b2957],
29	care	NN	O	care	prep_in	26	SENT_85	[p7l10t3020r161b3060],
30	.	.	O	.	_	0	SENT_85	[p7l10t3020r161b3060],

1	The	DT	O	the	det	3	SENT_86	[p7l184t2997r308b3060],
2	independent	JJ	O	independent	amod	3	SENT_86	[p7l328t2997r756b3080],
3	variables	NNS	O	variable	nsubj	7	SENT_86	[p7l772t2997r1070b3060],
4	in	IN	O	in	_	0	SENT_86	[p7l1091t3003r1157b3059],
5	these	DT	O	these	det	6	SENT_86	[p7l1176t2997r1349b3060],
6	models	NNS	O	model	prep_in	3	SENT_86	[p7l1369t2997r1612b3060],
7	include	VBP	O	include	_	0	SENT_86	[p7l1633t2997r1881b3060],
8	clinical	JJ	O	clinical	amod	11	SENT_86	[p7l1902t2997r2143b3060],
9	and	CC	O	and	_	0	SENT_86	[p7l10t3100r133b3163],
10	biological	JJ	O	biological	amod	11	SENT_86	[p7l150t3100r476b3184],
11	features	NNS	O	feature	dobj	7	SENT_86	[p7l495t3100r752b3163],
12	and	CC	O	and	_	0	SENT_86	[p7l773t3100r896b3163],
13	how	WRB	O	how	advmod	18	SENT_86	[p7l914t3100r1058b3163],
14	patient	JJ	O	patient	amod	15	SENT_86	[p7l1074t3106r1307b3183],
15	characteristics	NNS	O	characteristic	nsubj	18	SENT_86	[p7l1326t3100r1801b3163],
16	and	CC	O	and	_	0	SENT_86	[p7l1822t3100r1945b3163],
17	treatments	NNS	O	treatment	nsubj	18	SENT_86	[p7l1962t3112r2140b3163, p7l9t3215r217b3266],
18	interact	VBP	O	interact	dobj	7	SENT_86	[p7l240t3209r520b3275],
19	,	,	O	,	_	0	SENT_86	[p7l240t3209r520b3275],
20	with	IN	O	with	_	0	SENT_86	[p7l543t3203r696b3266],
21	the	DT	O	the	det	23	SENT_86	[p7l718t3203r824b3266],
22	dependent	JJ	O	dependent	amod	23	SENT_86	[p7l848t3203r1213b3286],
23	variables	NNS	O	variable	nsubj	27	SENT_86	[p7l1231t3203r1535b3266],
24	being	VBG	O	be	cop	27	SENT_86	[p7l1556t3203r1749b3287],
25	the	DT	O	the	det	27	SENT_86	[p7l1769t3203r1875b3266],
26	clinical	JJ	O	clinical	amod	27	SENT_86	[p7l1899t3203r2145b3266],
27	outcomes	NNS	O	outcome	prepc_with	7	SENT_86	[p7l10t3318r337b3369],
28	of	IN	O	of	_	0	SENT_86	[p7l361t3306r435b3369],
29	interest	NN	O	interest	prep_of	27	SENT_86	[p7l448t3312r719b3378],
30	,	,	O	,	_	0	SENT_86	[p7l448t3312r719b3378],
31	and	CC	O	and	_	0	SENT_86	[p7l744t3306r870b3369],
32	the	DT	O	the	det	34	SENT_86	[p7l891t3306r997b3369],
33	ultimate	JJ	O	ultimate	amod	34	SENT_86	[p7l1020t3306r1303b3369],
34	goal	NN	O	goal	nsubj	37	SENT_86	[p7l1326t3306r1467b3390],
35	being	VBG	O	be	cop	37	SENT_86	[p7l1487t3306r1678b3390],
36	the	DT	O	the	det	37	SENT_86	[p7l1699t3306r1805b3369],
37	improvement	NN	O	improvement	conj_and	7	SENT_86	[p7l1828t3312r2138b3389, p7l9t3421r186b3472],
38	of	IN	O	of	_	0	SENT_86	[p7l207t3409r280b3472],
39	patient-speciﬁc	JJ	O	patient-speciﬁc	amod	41	SENT_86	[p7l291t3409r817b3492],
40	treatment	NN	O	treatment	nn	41	SENT_86	[p7l837t3421r1172b3472],
41	decisions	NNS	O	decision	prep_of	37	SENT_86	[p7l1194t3409r1524b3472],
42	.	.	O	.	_	0	SENT_86	[p7l1194t3409r1524b3472],

1	An	DT	O	a	det	2	SENT_87	[p7l82t3516r187b3574],
2	example	NN	O	example	nsubj	10	SENT_87	[p7l211t3512r499b3595],
3	of	IN	O	of	_	0	SENT_87	[p7l523t3512r598b3575],
4	this	DT	O	this	det	5	SENT_87	[p7l611t3512r738b3575],
5	approach	NN	O	approach	prep_of	2	SENT_87	[p7l763t3512r1084b3595],
6	is	VBZ	O	be	cop	10	SENT_87	[p7l1108t3518r1159b3575],
7	the	DT	O	the	det	10	SENT_87	[p7l1182t3512r1290b3575],
8	thrombolytic	JJ	O	thrombolytic	amod	10	SENT_87	[p7l1313t3512r1772b3596],
9	predictive	JJ	O	predictive	amod	10	SENT_87	[p7l1794t3512r2142b3595],
10	instrument	NN	O	instrument	_	0	SENT_87	[p7l10t3621r407b3678],
11	(	CD	NUMBER	(	num	12	SENT_87	[p7l435t3616r644b3692],
12	TPI	NNP	O	TPI	dep	10	SENT_87	[p7l435t3616r644b3692],
13	)	CD	NUMBER	)	num	12	SENT_87	[p7l435t3616r644b3692],
14	,	,	O	,	_	0	SENT_87	[p7l435t3616r644b3692],
15	used	VBN	O	use	partmod	10	SENT_87	[p7l671t3615r835b3678],
16	for	IN	O	for	_	0	SENT_87	[p7l859t3615r960b3678],
17	assessing	VBG	O	assess	prepc_for	15	SENT_87	[p7l986t3621r1306b3699],
18	patient-speciﬁc	JJ	O	patient-speciﬁc	amod	19	SENT_87	[p7l1329t3615r1876b3698],
19	beneﬁt	NN	O	beneﬁt	dobj	17	SENT_87	[p7l1900t3615r2144b3678],
20	of	IN	O	of	_	0	SENT_87	[p7l10t3718r86b3781],
21	coronary	JJ	O	coronary	amod	23	SENT_87	[p7l101t3741r422b3802],
22	reperfusion	NN	O	reperfusion	nn	23	SENT_87	[p7l442t3718r851b3801],
23	therapy	NN	O	therapy	prep_of	19	SENT_87	[p7l875t3718r1145b3802],
24	for	IN	O	for	_	0	SENT_87	[p7l1166t3718r1266b3781],
25	ST	JJ	O	st	amod	28	SENT_87	[p7l1290t3721r1381b3781],
26	elevation	NN	O	elevation	nn	28	SENT_87	[p7l1406t3718r1724b3781],
27	myocardial	JJ	O	myocardial	amod	28	SENT_87	[p7l1748t3718r2144b3802],
28	infarction	NN	O	infarction	prep_for	23	SENT_87	[p8l10t12r436b83],
29	.	.	O	.	_	0	SENT_87	[p8l10t12r436b83],

1	“	NN	O	“	nsubj	43	SENT_88	[p8l10t12r436b83],
2	Created	VBN	O	create	partmod	1	SENT_88	[p8l465t20r738b83],
3	using	VBG	O	use	xcomp	2	SENT_88	[p8l761t26r951b104],
4	data	NNS	O	datum	dobj	3	SENT_88	[p8l973t20r1120b83],
5	from	IN	O	from	_	0	SENT_88	[p8l1143t20r1314b83],
6	multiple	JJ	O	multiple	amod	7	SENT_88	[p8l1337t20r1629b103],
7	trials	NNS	O	trial	prep_from	3	SENT_88	[p8l1652t20r1828b83],
8	and	CC	O	and	_	0	SENT_88	[p8l1853t20r1982b83],
9	registries	NNS	O	registry	conj_and	7	SENT_88	[p8l2005t43r2140b104, p8l9t129r212b186],
10	of	IN	O	of	_	0	SENT_88	[p8l237t123r311b186],
11	patients	NNS	O	patient	prep_of	7	SENT_88	[p8l323t129r595b206],
12	with	IN	O	with	_	0	SENT_88	[p8l617t123r771b186],
13	ST	JJ	O	st	amod	16	SENT_88	[p8l795t126r884b186],
14	elevation	NN	O	elevation	nn	16	SENT_88	[p8l908t123r1219b186],
15	myocardial	JJ	O	myocardial	amod	16	SENT_88	[p8l1242t123r1631b207],
16	infarction	NN	O	infarction	prep_with	11	SENT_88	[p8l1653t123r2013b195],
17	,	,	O	,	_	0	SENT_88	[p8l1653t123r2013b195],
18	the	DT	O	the	det	19	SENT_88	[p8l2036t123r2144b186],
19	TPI	NNP	ORGANIZATION	TPI	poss	24	SENT_88	[p8l9t226r172b289],
20	’s	POS	O	’s	_	0	SENT_88	[p8l9t226r172b289],
21	multivariable	JJ	O	multivariable	amod	24	SENT_88	[p8l191t226r631b289],
22	logistic	JJ	O	logistic	amod	24	SENT_88	[p8l650t226r887b310],
23	regression	NN	O	regression	nn	24	SENT_88	[p8l906t232r1243b310],
24	models	NNS	O	model	appos	16	SENT_88	[p8l1262t226r1501b289],
25	include	VBP	O	include	_	0	SENT_88	[p8l1521t226r1764b289],
26	key	JJ	O	key	amod	28	SENT_88	[p8l1783t226r1899b310],
27	patient	NN	O	patient	nn	28	SENT_88	[p8l1914t232r2146b309],
28	characteristics	NNS	O	characteristic	dobj	25	SENT_88	[p8l10t329r498b392],
29	predictive	JJ	O	predictive	dep	28	SENT_88	[p8l518t329r858b412],
30	of	IN	O	of	_	0	SENT_88	[p8l880t329r953b392],
31	key	JJ	O	key	amod	33	SENT_88	[p8l963t329r1083b413],
32	clinical	JJ	O	clinical	amod	33	SENT_88	[p8l1101t329r1345b392],
33	outcomes	NNS	O	outcome	prep_of	28	SENT_88	[p8l1366t341r1711b401],
34	,	,	O	,	_	0	SENT_88	[p8l1366t341r1711b401],
35	and	CC	O	and	_	0	SENT_88	[p8l1734t329r1860b392],
36	interaction	NN	O	interaction	nn	37	SENT_88	[p8l1879t335r2141b392, p8l8t438r149b495],
37	variables	NNS	O	variable	conj_and	28	SENT_88	[p8l170t432r480b495],
38	to	TO	O	to	aux	39	SENT_88	[p8l503t444r570b495],
39	capture	VB	O	capture	infmod	37	SENT_88	[p8l596t444r853b515],
40	treatment	NN	O	treatment	nn	41	SENT_88	[p8l876t444r1220b495],
41	effects	NNS	O	effect	dobj	39	SENT_88	[p8l1243t432r1460b495],
42	and	CC	O	and	_	0	SENT_88	[p8l1485t432r1614b495],
43	predict	VBP	O	predict	conj_and	25	SENT_88	[p8l1635t432r1884b515],
44	30-day	JJ	DURATION	30-day	amod	45	SENT_88	[p8l1908t432r2147b516],
45	mortality	NN	O	mortality	dobj	43	SENT_88	[p8l9t535r339b619],
46	,	,	O	,	_	0	SENT_88	[p8l9t535r339b619],
47	1-year	JJ	DURATION	1-year	amod	48	SENT_88	[p8l371t542r579b619],
48	mortality	NN	O	mortality	dobj	43	SENT_88	[p8l600t535r931b619],
49	,	,	O	,	_	0	SENT_88	[p8l600t535r931b619],
50	cardiac	JJ	O	cardiac	amod	51	SENT_88	[p8l956t535r1200b598],
51	arrest	NN	O	arrest	conj_and	45	SENT_88	[p8l1223t547r1432b607],
52	,	,	O	,	_	0	SENT_88	[p8l1223t547r1432b607],
53	major	JJ	O	major	amod	54	SENT_88	[p8l1456t541r1659b619],
54	bleeding	NN	O	bleeding	dobj	43	SENT_88	[p8l1678t535r1990b619],
55	,	,	O	,	_	0	SENT_88	[p8l1678t535r1990b619],
56	and	CC	O	and	_	0	SENT_88	[p8l2015t535r2142b598],
57	stroke	NN	O	stroke	dobj	43	SENT_88	[p8l10t638r236b701],
58	.	.	O	.	_	0	SENT_88	[p8l10t638r236b701],

1	When	WRB	O	when	advmod	11	SENT_89	[p8l261t638r473b701],
2	the	DT	O	the	det	3	SENT_89	[p8l495t638r603b701],
3	patient	NN	O	patient	poss	6	SENT_89	[p8l626t638r907b721],
4	’s	POS	O	’s	_	0	SENT_89	[p8l626t638r907b721],
5	individualized	JJ	O	individualized	amod	6	SENT_89	[p8l931t638r1430b701],
6	predictions	NNS	O	prediction	nsubjpass	11	SENT_89	[p8l1451t638r1842b721],
7	of	IN	O	of	_	0	SENT_89	[p8l1867t638r1942b701],
8	treatment	NN	O	treatment	nn	9	SENT_89	[p8l1954t650r2139b701, p8l9t753r183b804],
9	beneﬁts	NNS	O	beneﬁts	prep_of	6	SENT_89	[p8l199t741r460b804],
10	are	VBP	O	be	auxpass	11	SENT_89	[p8l482t764r579b804],
11	printed	VBN	O	print	advcl	23	SENT_89	[p8l599t741r846b824],
12	on	IN	O	on	_	0	SENT_89	[p8l866t764r950b804],
13	text	NN	O	text	nn	14	SENT_89	[p8l969t753r1095b804],
14	headers	NNS	O	header	prep_on	11	SENT_89	[p8l1112t741r1370b804],
15	of	IN	O	of	_	0	SENT_89	[p8l1392t741r1464b804],
16	electrocardiograms	NNS	O	electrocardiogram	prep_of	14	SENT_89	[p8l1475t741r2140b825],
17	,	,	O	,	_	0	SENT_89	[p8l1475t741r2140b825],
18	clinician	NN	O	clinician	nn	19	SENT_89	[p8l10t844r309b907],
19	use	NN	O	use	nsubjpass	23	SENT_89	[p8l332t867r446b907],
20	of	IN	O	of	_	0	SENT_89	[p8l470t844r545b907],
21	reperfusion	NN	O	reperfusion	prep_of	19	SENT_89	[p8l559t844r965b927],
22	is	VBZ	O	be	auxpass	23	SENT_89	[p8l989t850r1040b907],
23	improved	VBN	O	improve	_	0	SENT_89	[p8l1064t844r1402b927],
24	for	IN	O	for	_	0	SENT_89	[p8l1424t844r1524b907],
25	patients	NNS	O	patient	prep_for	23	SENT_89	[p8l1545t850r1821b927],
26	with	IN	O	with	_	0	SENT_89	[p8l1843t844r2000b907],
27	less	JJR	O	less	dep	28	SENT_89	[p8l2021t844r2143b907],
28	obvious	JJ	O	obvious	amod	30	SENT_89	[p8l10t947r280b1010],
29	ST	JJ	O	st	amod	30	SENT_89	[p8l305t950r394b1010],
30	elevation	NN	O	elevation	prep_with	23	SENT_89	[p8l419t947r732b1010],
31	myocardial	JJ	O	myocardial	amod	32	SENT_89	[p8l755t947r1146b1031],
32	infarctions	NNS	O	infarction	dep	30	SENT_89	[p8l1169t947r1563b1019],
33	,	,	O	,	_	0	SENT_89	[p8l1169t947r1563b1019],
34	for	IN	O	for	_	0	SENT_89	[p8l1589t947r1688b1010],
35	women	NNS	O	woman	prep_for	30	SENT_89	[p8l1708t970r1966b1010],
36	with	IN	O	with	_	0	SENT_89	[p8l1987t947r2143b1010],
37	ST	JJ	ORGANIZATION	st	amod	40	SENT_89	[p8l10t1053r99b1113],
38	elevation	NN	O	elevation	nn	40	SENT_89	[p8l124t1050r435b1113],
39	myocardial	JJ	O	myocardial	amod	40	SENT_89	[p8l458t1050r847b1134],
40	infarction	NN	O	infarction	prep_with	35	SENT_89	[p8l869t1050r1230b1122],
41	,	,	O	,	_	0	SENT_89	[p8l869t1050r1230b1122],
42	for	IN	O	for	_	0	SENT_89	[p8l1254t1050r1353b1113],
43	patients	NNS	O	patient	prep_for	23	SENT_89	[p8l1373t1056r1646b1133],
44	in	IN	O	in	_	0	SENT_89	[p8l1670t1056r1737b1112],
45	whom	WP	O	whom	rel	49	SENT_89	[p8l1759t1050r1978b1113],
46	reperfusion	NN	O	reperfusion	nsubj	49	SENT_89	[p8l2001t1072r2140b1133, p8l10t1153r288b1216],
47	typically	RB	O	typically	advmod	49	SENT_89	[p8l308t1153r597b1237],
48	is	VBZ	O	be	cop	49	SENT_89	[p8l614t1159r663b1216],
49	underused	JJ	O	underused	rcmod	43	SENT_89	[p8l684t1153r1063b1225],
50	,	,	O	,	_	0	SENT_89	[p8l684t1153r1063b1225],
51	and	CC	O	and	_	0	SENT_89	[p8l1085t1153r1210b1216],
52	for	IN	O	for	_	0	SENT_89	[p8l1229t1153r1325b1216],
53	patients	NNS	O	patient	prep_for	23	SENT_89	[p8l1343t1159r1609b1236],
54	seen	VBN	O	see	partmod	53	SENT_89	[p8l1630t1176r1778b1216],
55	in	IN	O	in	_	0	SENT_89	[p8l1798t1159r1864b1215],
56	settings	NNS	O	setting	prep_in	54	SENT_89	[p8l1885t1159r2140b1237],
57	with	IN	O	with	_	0	SENT_89	[p8l8t1255r161b1318],
58	limited	JJ	O	limited	amod	61	SENT_89	[p8l182t1255r429b1318],
59	on-site	JJ	O	on-site	amod	61	SENT_89	[p8l452t1261r686b1318],
60	relevant	JJ	O	relevant	amod	61	SENT_89	[p8l709t1255r984b1318],
61	expertise	NN	O	expertise	prep_with	56	SENT_89	[p8l1006t1247r1397b1338],
62	.	.	O	.	_	0	SENT_89	[p8l1006t1247r1397b1338],

1	”	NN	O	”	ccomp	13	SENT_90	[p8l1006t1247r1397b1338],
2	Thereby	RB	O	thereby	advmod	1	SENT_90	[p8l1421t1255r1709b1339],
3	,	,	O	,	_	0	SENT_90	[p8l1421t1255r1709b1339],
4	clinical	JJ	O	clinical	amod	6	SENT_90	[p8l1734t1255r1980b1318],
5	trial	NN	O	trial	nn	6	SENT_90	[p8l2002t1255r2143b1318],
6	data	NNS	O	datum	nsubjpass	13	SENT_90	[p8l10t1359r157b1422],
7	based	VBN	O	base	_	0	SENT_90	[p8l178t1359r379b1422],
8	on	IN	O	on	prepc_based_on	6	SENT_90	[p8l402t1382r490b1422],
9	heterogeneous	JJ	O	heterogeneous	amod	10	SENT_90	[p8l513t1359r1023b1443],
10	samples	NNS	O	sample	pobj	6	SENT_90	[p8l1049t1359r1324b1442],
11	can	MD	O	can	aux	13	SENT_90	[p8l1348t1382r1468b1422],
12	be	VB	O	be	auxpass	13	SENT_90	[p8l1489t1359r1571b1422],
13	used	VBN	O	use	_	0	SENT_90	[p8l1594t1359r1756b1422],
14	to	TO	O	to	aux	15	SENT_90	[p8l1778t1371r1845b1422],
15	support	VB	O	support	xcomp	13	SENT_90	[p8l1871t1371r2143b1442],
16	patient-personalized	JJ	O	patient-personalized	amod	17	SENT_90	[p8l8t1462r708b1545],
17	treatment	NN	O	treatment	dobj	15	SENT_90	[p8l726t1474r1057b1525],
18	by	IN	O	by	_	0	SENT_90	[p8l1074t1462r1157b1546],
19	representing	VBG	O	represent	prepc_by	15	SENT_90	[p8l1174t1468r1597b1546],
20	the	DT	O	the	det	21	SENT_90	[p8l1615t1462r1720b1525],
21	heterogeneity	NN	O	heterogeneity	dobj	19	SENT_90	[p8l1739t1462r2139b1546, p8l9t1571r96b1649],
22	of	IN	O	of	_	0	SENT_90	[p8l113t1565r186b1628],
23	treatment	NN	O	treatment	nn	24	SENT_90	[p8l196t1577r527b1628],
24	effect	NN	O	effect	prep_of	21	SENT_90	[p8l547t1565r726b1628],
25	among	IN	O	among	_	0	SENT_90	[p8l746t1588r978b1649],
26	diverse	JJ	O	diverse	amod	27	SENT_90	[p8l997t1565r1234b1628],
27	patients	NNS	O	patient	prep_among	19	SENT_90	[p8l1253t1571r1535b1648],
28	.	.	O	.	_	0	SENT_90	[p8l1253t1571r1535b1648],

1	Another	DT	O	another	det	2	SENT_91	[p8l1558t1565r1843b1628],
2	example	NN	O	example	nsubj	16	SENT_91	[p8l1863t1565r2142b1648],
3	of	IN	O	of	_	0	SENT_91	[p8l10t1668r85b1731],
4	a	DT	O	a	det	6	SENT_91	[p8l99t1691r135b1731],
5	predictive	JJ	O	predictive	amod	6	SENT_91	[p8l155t1668r504b1751],
6	model	NN	O	model	prep_of	2	SENT_91	[p8l527t1668r748b1731],
7	based	VBN	O	base	partmod	6	SENT_91	[p8l769t1668r969b1731],
8	on	IN	O	on	_	0	SENT_91	[p8l992t1691r1080b1731],
9	trial	NN	O	trial	nn	10	SENT_91	[p8l1102t1668r1246b1731],
10	data	NNS	O	datum	prep_on	7	SENT_91	[p8l1270t1668r1416b1731],
11	from	IN	O	from	_	0	SENT_91	[p8l1438t1668r1609b1731],
12	heterogeneous	JJ	O	heterogeneous	amod	13	SENT_91	[p8l1631t1668r2141b1752],
13	populations	NNS	O	population	prep_from	7	SENT_91	[p8l8t1771r428b1854],
14	is	VBZ	O	be	cop	16	SENT_91	[p8l454t1777r506b1834],
15	the	DT	O	the	det	16	SENT_91	[p8l530t1771r640b1834],
16	Stroke-TPI	NNP	MISC	Stroke-TPI	_	0	SENT_91	[p8l666t1771r1074b1843],
17	,	,	O	,	_	0	SENT_91	[p8l666t1771r1074b1843],
18	which	WDT	O	which	nsubj	19	SENT_91	[p8l1099t1771r1315b1834],
19	identiﬁes	VBZ	O	identiﬁes	rcmod	16	SENT_91	[p8l1340t1771r1662b1834],
20	patients	NNS	O	patient	dobj	19	SENT_91	[p8l1686t1777r1965b1854],
21	who	WP	O	who	nsubj	23	SENT_91	[p8l1989t1771r2139b1834],
22	may	MD	O	may	aux	23	SENT_91	[p8l9t1896r159b1957],
23	beneﬁt	VB	O	beneﬁt	rcmod	20	SENT_91	[p8l177t1873r419b1936],
24	from	IN	O	from	_	0	SENT_91	[p8l441t1873r612b1936],
25	thrombolytic	JJ	O	thrombolytic	amod	26	SENT_91	[p8l634t1873r1096b1957],
26	therapy	NN	O	therapy	prep_from	23	SENT_91	[p8l1118t1873r1387b1957],
27	for	IN	O	for	_	0	SENT_91	[p8l1407t1873r1506b1936],
28	stroke	NN	O	stroke	prep_for	26	SENT_91	[p8l1530t1865r1823b1936],
29	.	.	O	.	_	0	SENT_91	[p8l1530t1865r1823b1936],

1	”	NN	O	”	nsubj	4	SENT_92	[p8l1530t1865r1823b1936],
2	Another	DT	O	another	det	3	SENT_92	[p8l1848t1873r2144b1936],
3	example	NN	O	example	dep	1	SENT_92	[p8l10t1976r292b2059],
4	predicts	VBZ	O	predict	_	0	SENT_92	[p8l314t1976r587b2059],
5	the	DT	O	the	det	6	SENT_92	[p8l609t1976r716b2039],
6	probability	NN	O	probability	dobj	4	SENT_92	[p8l738t1976r1116b2060],
7	that	IN	O	that	complm	15	SENT_92	[p8l1134t1976r1268b2039],
8	a	DT	O	a	det	9	SENT_92	[p8l1290t1999r1325b2039],
9	patient	NN	O	patient	nsubj	15	SENT_92	[p8l1345t1982r1584b2059],
10	receiving	VBG	O	receive	partmod	9	SENT_92	[p8l1606t1982r1918b2060],
11	breast	NN	O	breast	nn	13	SENT_92	[p8l1937t1976r2143b2039],
12	cancer	NN	O	cancer	nn	13	SENT_92	[p8l10t2102r239b2142],
13	chemotherapy	NN	O	chemotherapy	dobj	10	SENT_92	[p8l262t2079r768b2163],
14	will	MD	O	will	aux	15	SENT_92	[p8l786t2079r915b2142],
15	beneﬁt	VB	O	beneﬁt	ccomp	4	SENT_92	[p8l937t2079r1179b2142],
16	from	IN	O	from	_	0	SENT_92	[p8l1201t2079r1373b2142],
17	bone	NN	O	bone	nn	21	SENT_92	[p8l1394t2079r1568b2142],
18	marrow	NN	O	marrow	nn	21	SENT_92	[p8l1592t2102r1871b2142],
19	growth	NN	O	growth	nn	21	SENT_92	[p8l1892t2079r2141b2163],
20	factor	NN	O	factor	nn	21	SENT_92	[p8l9t2182r208b2245],
21	treatment	NN	O	treatment	prep_from	15	SENT_92	[p8l228t2194r564b2245],
22	to	TO	O	to	aux	23	SENT_92	[p8l583t2194r649b2245],
23	counter	VB	O	counter	infmod	21	SENT_92	[p8l673t2194r936b2245],
24	suppression	NN	O	suppression	dobj	23	SENT_92	[p8l957t2188r1361b2265],
25	of	IN	O	of	_	0	SENT_92	[p8l1384t2182r1458b2245],
26	white	JJ	O	white	amod	28	SENT_92	[p8l1469t2182r1657b2245],
27	blood	NN	O	blood	nn	28	SENT_92	[p8l1677t2182r1876b2245],
28	cells	NNS	O	cell	prep_of	24	SENT_92	[p8l1899t2182r2041b2245],
29	by	IN	O	by	_	0	SENT_92	[p8l2063t2182r2146b2266],
30	chemotherapy	NN	O	chemotherapy	prep_by	23	SENT_92	[p8l10t2276r584b2368],
31	.	.	O	.	_	0	SENT_92	[p8l10t2276r584b2368],

1	”	NN	O	”	nsubj	4	SENT_93	[p8l10t2276r584b2368],
2	These	DT	O	these	det	3	SENT_93	[p8l607t2284r803b2347],
3	examples	NNS	O	example	dep	1	SENT_93	[p8l828t2284r1146b2367],
4	show	VBP	O	show	_	0	SENT_93	[p8l1171t2284r1351b2347],
5	how	WRB	O	how	advmod	20	SENT_93	[p8l1370t2284r1520b2347],
6	clinical	JJ	O	clinical	amod	8	SENT_93	[p8l1541t2284r1789b2347],
7	trial	NN	O	trial	nn	8	SENT_93	[p8l1811t2284r1954b2347],
8	data	NNS	O	datum	nsubjpass	20	SENT_93	[p8l1978t2284r2140b2356],
9	,	,	O	,	_	0	SENT_93	[p8l1978t2284r2140b2356],
10	especially	RB	O	especially	amod	8	SENT_93	[p8l10t2387r346b2471],
11	with	IN	O	with	_	0	SENT_93	[p8l363t2387r518b2450],
12	the	DT	O	the	det	13	SENT_93	[p8l540t2387r647b2450],
13	heterogeneity	NN	O	heterogeneity	prep_with	10	SENT_93	[p8l669t2387r1144b2471],
14	of	IN	O	of	_	0	SENT_93	[p8l1165t2387r1239b2450],
15	effectiveness	NN	O	effectiveness	nn	16	SENT_93	[p8l1253t2387r1684b2450],
16	trials	NNS	O	trial	prep_of	13	SENT_93	[p8l1706t2387r1898b2459],
17	,	,	O	,	_	0	SENT_93	[p8l1706t2387r1898b2459],
18	can	MD	O	can	aux	20	SENT_93	[p8l1924t2410r2042b2450],
19	be	VB	O	be	auxpass	20	SENT_93	[p8l2063t2387r2143b2450],
20	used	VBN	O	use	ccomp	4	SENT_93	[p8l9t2490r167b2553],
21	to	TO	O	to	aux	22	SENT_93	[p8l186t2502r252b2553],
22	support	VB	O	support	xcomp	20	SENT_93	[p8l276t2502r541b2573],
23	individualized	JJ	O	individualized	amod	24	SENT_93	[p8l562t2490r1053b2553],
24	treatment	NN	O	treatment	dobj	22	SENT_93	[p8l1073t2502r1424b2553],
25	.	.	O	.	_	0	SENT_93	[p8l1073t2502r1424b2553],

1	As	IN	O	as	mark	7	SENT_94	[p8l82t2597r169b2656],
2	electronic	JJ	O	electronic	amod	4	SENT_94	[p8l194t2593r535b2656],
3	health	NN	O	health	nn	4	SENT_94	[p8l557t2593r773b2656],
4	records	NNS	O	record	nsubj	7	SENT_94	[p8l796t2593r1050b2656],
5	become	VBP	O	become	cop	7	SENT_94	[p8l1073t2593r1342b2656],
6	more	RBR	O	more	advmod	7	SENT_94	[p8l1366t2616r1546b2656],
7	ubiquitous	JJ	O	ubiquitous	advcl	22	SENT_94	[p8l1568t2593r1958b2676],
8	,	,	O	,	_	0	SENT_94	[p8l1568t2593r1958b2676],
9	such	JJ	O	such	amod	11	SENT_94	[p8l1984t2593r2141b2656],
10	predictive	JJ	O	predictive	amod	11	SENT_94	[p8l8t2696r354b2779],
11	models	NNS	O	model	nsubj	22	SENT_94	[p8l377t2696r627b2759],
12	based	VBN	O	base	_	0	SENT_94	[p8l648t2696r848b2759],
13	on	IN	O	on	prepc_based_on	11	SENT_94	[p8l870t2719r957b2759],
14	E2E	NN	O	e2e	nn	16	SENT_94	[p8l980t2701r1117b2758],
15	trial	NN	O	trial	nn	16	SENT_94	[p8l1140t2696r1283b2759],
16	data	NNS	O	datum	pobj	11	SENT_94	[p8l1306t2696r1451b2759],
17	could	MD	O	could	aux	22	SENT_94	[p8l1474t2696r1667b2759],
18	become	VB	O	become	cop	22	SENT_94	[p8l1687t2696r1957b2759],
19	electronic	JJ	O	electronic	amod	22	SENT_94	[p8l1981t2696r2138b2759, p8l8t2804r211b2861],
20	health	NN	O	health	nn	22	SENT_94	[p8l229t2798r439b2861],
21	record	NN	O	record	nn	22	SENT_94	[p8l459t2798r916b2861],
22	—	NN	O	—	ccomp	34	SENT_94	[p8l459t2798r916b2861],
23	based	VBN	O	base	partmod	22	SENT_94	[p8l459t2798r916b2861],
24	clinical	JJ	O	clinical	amod	26	SENT_94	[p8l936t2798r1177b2861],
25	decision	NN	O	decision	nn	26	SENT_94	[p8l1197t2798r1476b2861],
26	support	NN	O	support	dobj	23	SENT_94	[p8l1497t2790r1837b2881],
27	.15	CD	NUMBER	.15	dep	26	SENT_94	[p8l1497t2790r1837b2881],
28	Thereby	RB	O	thereby	advmod	23	SENT_94	[p8l1858t2798r2141b2882],
29	,	,	O	,	_	0	SENT_94	[p8l1858t2798r2141b2882],
30	individual	JJ	O	individual	amod	32	SENT_94	[p8l10t2900r377b2963],
31	treatment	NN	O	treatment	nn	32	SENT_94	[p8l403t2912r755b2963],
32	decisions	NNS	O	decision	nsubj	34	SENT_94	[p8l782t2900r1111b2963],
33	could	MD	O	could	aux	34	SENT_94	[p8l1140t2900r1338b2963],
34	inform	VB	O	inform	_	0	SENT_94	[p8l1366t2900r1614b2963],
35	clinicians	NNS	O	clinician	dobj	34	SENT_94	[p8l1642t2900r1981b2963],
36	and	CC	O	and	_	0	SENT_94	[p8l2011t2900r2142b2963],
37	patients	NNS	O	patient	dobj	34	SENT_94	[p8l8t3009r281b3086],
38	about	IN	O	about	_	0	SENT_94	[p8l305t3003r501b3066],
39	likely	JJ	O	likely	amod	41	SENT_94	[p8l521t3003r710b3087],
40	treatment	NN	O	treatment	nn	41	SENT_94	[p8l728t3015r1068b3066],
41	outcomes	NNS	O	outcome	prep_about	34	SENT_94	[p8l1090t3015r1422b3066],
42	on	IN	O	on	_	0	SENT_94	[p8l1446t3026r1533b3066],
43	the	DT	O	the	det	44	SENT_94	[p8l1555t3003r1663b3066],
44	basis	NN	O	basis	prep_on	34	SENT_94	[p8l1684t3003r1852b3066],
45	of	IN	O	of	_	0	SENT_94	[p8l1876t3003r1951b3066],
46	characteristics	NNS	O	characteristic	prep_of	44	SENT_94	[p8l1965t3003r2140b3066, p8l10t3112r348b3169],
47	acquired	VBN	O	acquire	partmod	46	SENT_94	[p8l372t3106r670b3189],
48	from	IN	O	from	_	0	SENT_94	[p8l691t3106r859b3169],
49	the	DT	O	the	det	52	SENT_94	[p8l881t3106r987b3169],
50	electronic	JJ	O	electronic	amod	52	SENT_94	[p8l1010t3106r1347b3169],
51	health	NN	O	health	nn	52	SENT_94	[p8l1368t3106r1581b3169],
52	record	NN	O	record	prep_from	47	SENT_94	[p8l1604t3106r1841b3169],
53	.	.	O	.	_	0	SENT_94	[p8l1604t3106r1841b3169],

1	In	IN	O	in	_	0	SENT_95	[p8l1867t3111r1938b3168],
2	addition	NN	O	addition	_	0	SENT_95	[p8l1961t3106r2140b3169, p8l8t3215r147b3272],
3	to	TO	O	to	_	0	SENT_95	[p8l169t3221r235b3272],
4	indicating	VBG	O	indicate	prepc_in_addition_to	22	SENT_95	[p8l259t3209r609b3293],
5	when	WRB	O	when	advmod	11	SENT_95	[p8l628t3209r817b3272],
6	one	CD	NUMBER	one	num	8	SENT_95	[p8l840t3232r963b3272],
7	treatment	NN	O	treatment	nn	8	SENT_95	[p8l985t3221r1323b3272],
8	option	NN	O	option	nsubj	11	SENT_95	[p8l1346t3215r1571b3292],
9	is	VBZ	O	be	cop	11	SENT_95	[p8l1594t3215r1644b3272],
10	more	RBR	O	more	advmod	11	SENT_95	[p8l1668t3232r1846b3272],
11	likely	JJ	O	likely	advcl	4	SENT_95	[p8l1868t3209r2055b3293],
12	to	TO	O	to	aux	13	SENT_95	[p8l2073t3221r2140b3272],
13	beneﬁt	VB	O	beneﬁt	xcomp	11	SENT_95	[p8l7t3312r243b3375],
14	the	DT	O	the	det	15	SENT_95	[p8l261t3312r367b3375],
15	patient	NN	O	patient	dobj	13	SENT_95	[p8l386t3318r625b3395],
16	than	IN	O	than	_	0	SENT_95	[p8l643t3312r797b3375],
17	another	DT	O	another	prep_than	13	SENT_95	[p8l819t3312r1095b3384],
18	,	,	O	,	_	0	SENT_95	[p8l819t3312r1095b3384],
19	it	PRP	O	it	nsubj	22	SENT_95	[p8l1117t3318r1162b3375],
20	also	RB	O	also	advmod	22	SENT_95	[p8l1182t3312r1312b3375],
21	could	MD	O	could	aux	22	SENT_95	[p8l1335t3312r1524b3375],
22	help	VB	O	help	_	0	SENT_95	[p8l1543t3312r1687b3395],
23	identify	VB	O	identify	xcomp	22	SENT_95	[p8l1708t3312r1975b3396],
24	situations	NNS	O	situation	dobj	23	SENT_95	[p8l1993t3318r2141b3375, p8l10t3421r217b3478],
25	in	IN	O	in	_	0	SENT_95	[p8l241t3421r309b3477],
26	which	WDT	O	which	rel	28	SENT_95	[p8l330t3415r544b3478],
27	there	EX	O	there	expl	28	SENT_95	[p8l567t3415r744b3478],
28	is	VBZ	O	be	rcmod	24	SENT_95	[p8l768t3421r819b3478],
29	strong	JJ	O	strong	amod	30	SENT_95	[p8l844t3427r1065b3499],
30	uncertainty	NN	O	uncertainty	nsubj	28	SENT_95	[p8l1086t3421r1493b3499],
31	regarding	VBG	O	regard	_	0	SENT_95	[p8l1513t3415r1850b3499],
32	the	DT	O	the	det	34	SENT_95	[p8l1871t3415r1979b3478],
33	best	JJS	O	best	amod	34	SENT_95	[p8l2001t3415r2142b3478],
34	treatment	NN	O	treatment	prep_regarding	30	SENT_95	[p8l8t3530r357b3581],
35	for	IN	O	for	_	0	SENT_95	[p8l381t3518r482b3581],
36	a	DT	O	a	det	37	SENT_95	[p8l507t3541r542b3581],
37	patient	NN	O	patient	prep_for	34	SENT_95	[p8l565t3524r830b3601],
38	.	.	O	.	_	0	SENT_95	[p8l565t3524r830b3601],

1	This	DT	O	this	nsubj	3	SENT_96	[p8l859t3518r1006b3581],
2	is	VBZ	O	be	cop	3	SENT_96	[p8l1032t3524r1084b3581],
3	analogous	JJ	O	analogous	_	0	SENT_96	[p8l1111t3518r1468b3602],
4	to	TO	O	to	_	0	SENT_96	[p8l1493t3530r1561b3581],
5	the	DT	O	the	det	6	SENT_96	[p8l1587t3518r1697b3581],
6	justiﬁcation	NN	O	justiﬁcation	prep_to	3	SENT_96	[p8l1717t3518r2143b3602],
7	for	IN	O	for	_	0	SENT_96	[p8l9t3621r106b3684],
8	conducting	VBG	O	conduct	prepc_for	6	SENT_96	[p8l128t3621r517b3705],
9	a	DT	O	a	dobj	8	SENT_96	[p8l539t3644r573b3684],
10	randomized	VBN	O	randomize	partmod	9	SENT_96	[p8l595t3621r1009b3684],
11	clinical	JJ	O	clinical	amod	12	SENT_96	[p8l1031t3621r1276b3684],
12	trial	NN	O	trial	dobj	10	SENT_96	[p8l1297t3621r1438b3684],
13	when	WRB	O	when	advmod	15	SENT_96	[p8l1458t3621r1645b3684],
14	there	EX	O	there	expl	15	SENT_96	[p8l1667t3621r1841b3684],
15	is	VBZ	O	be	advcl	10	SENT_96	[p8l1864t3627r1914b3684],
16	“	NN	O	“	nn	18	SENT_96	[p8l1938t3621r2140b3684, p8l10t3724r105b3787],
17	clinical	JJ	O	clinical	amod	18	SENT_96	[p8l1938t3621r2140b3684, p8l10t3724r105b3787],
18	equipoise	NN	O	equipoise	nn	19	SENT_96	[p8l128t3724r490b3807],
19	”	NN	O	”	nsubj	15	SENT_96	[p8l128t3724r490b3807],
20	between	IN	O	between	_	0	SENT_96	[p8l513t3724r805b3787],
21	treatment	NN	O	treatment	nn	22	SENT_96	[p8l827t3736r1170b3787],
22	options	NNS	O	option	prep_between	19	SENT_96	[p8l1193t3730r1470b3807],
23	.	.	O	.	_	0	SENT_96	[p8l1193t3730r1470b3807],

1	When	WRB	O	when	advmod	4	SENT_97	[p8l1496t3724r1710b3787],
2	equipoise	NN	O	equipoise	nsubjpass	4	SENT_97	[p8l1734t3730r2066b3807],
3	is	VBZ	O	be	auxpass	4	SENT_97	[p8l2090t3730r2141b3787],
4	based	VBN	O	base	advcl	15	SENT_97	[p9l7t17r208b80],
5	on	IN	O	on	_	0	SENT_97	[p9l231t40r319b80],
6	predictions	NNS	O	prediction	prep_on	4	SENT_97	[p9l341t17r737b100],
7	of	IN	O	of	_	0	SENT_97	[p9l762t17r837b80],
8	model-based	JJ	O	model-based	amod	10	SENT_97	[p9l851t17r1306b80],
9	predictive	JJ	O	predictive	amod	10	SENT_97	[p9l1327t17r1676b100],
10	instruments	NNS	O	instrument	prep_of	6	SENT_97	[p9l1700t23r2143b89],
11	,	,	O	,	_	0	SENT_97	[p9l1700t23r2143b89],
12	this	DT	O	this	nsubjpass	15	SENT_97	[p9l8t119r132b182],
13	has	VBZ	O	have	aux	15	SENT_97	[p9l153t119r265b182],
14	been	VBN	O	be	auxpass	15	SENT_97	[p9l285t119r449b182],
15	termed	VBN	O	term	_	0	SENT_97	[p9l469t119r715b182],
16	“	CD	NUMBER	“	num	18	SENT_97	[p9l737t119r1234b182],
17	mathematical	JJ	O	mathematical	amod	18	SENT_97	[p9l737t119r1234b182],
18	equipoise	NN	O	equipoise	dobj	15	SENT_97	[p9l1255t111r1683b202],
19	.	.	O	.	_	0	SENT_97	[p9l1255t111r1683b202],

1	”	RB	O	”	dep	3	SENT_98	[p9l1255t111r1683b202],
2	15	CD	NUMBER	15	number	3	SENT_98	[p9l1255t111r1683b202],
3	(	CD	NUMBER	(	_	0	SENT_98	[p9l1709t120r1866b203],
4	e.g.	FW	O	e.g.	dep	3	SENT_98	[p9l1709t120r1866b203],
5	,	,	O	,	_	0	SENT_98	[p9l1709t120r1866b203],
6	the	DT	O	the	det	7	SENT_98	[p9l1888t119r1994b182],
7	TPI	NNP	ORGANIZATION	TPI	appos	3	SENT_98	[p9l2015t122r2142b181],
8	has	VBZ	O	have	aux	10	SENT_98	[p9l8t222r118b285],
9	been	VBN	O	be	auxpass	10	SENT_98	[p9l136t222r297b285],
10	modiﬁed	VBN	O	modiﬁed	rcmod	7	SENT_98	[p9l317t222r622b285],
11	to	TO	O	to	aux	12	SENT_98	[p9l640t234r704b285],
12	predict	VB	O	predict	xcomp	10	SENT_98	[p9l724t222r963b305],
13	a	DT	O	a	det	14	SENT_98	[p9l982t245r1016b285],
14	patient	NN	O	patient	poss	16	SENT_98	[p9l1034t222r1305b305],
15	’s	POS	O	’s	_	0	SENT_98	[p9l1034t222r1305b305],
16	risk	NN	O	risk	dobj	12	SENT_98	[p9l1326t222r1453b285],
17	for	IN	O	for	_	0	SENT_98	[p9l1469t222r1564b285],
18	30-day	JJ	DURATION	30-day	amod	19	SENT_98	[p9l1585t222r1814b306],
19	mortality	NN	O	mortality	prep_for	16	SENT_98	[p9l1830t222r2146b306],
20	if	IN	O	if	mark	21	SENT_98	[p9l10t325r65b387],
21	treated	VBN	O	treat	dep	12	SENT_98	[p9l77t325r320b388],
22	and	CC	O	and	_	0	SENT_98	[p9l344t325r472b388],
23	if	IN	O	if	mark	25	SENT_98	[p9l494t325r549b387],
24	not	RB	O	not	neg	25	SENT_98	[p9l563t337r679b388],
25	treated	VBN	O	treat	conj_and	21	SENT_98	[p9l700t325r943b388],
26	(	NN	O	(	dobj	25	SENT_98	[p9l969t325r1042b402],
27	i	FW	O	i	nn	26	SENT_98	[p9l969t325r1042b402],
28	)	FW	O	)	dep	26	SENT_98	[p9l969t325r1042b402],
29	with	IN	O	with	_	0	SENT_98	[p9l1068t325r1223b388],
30	thrombolytic	JJ	O	thrombolytic	amod	31	SENT_98	[p9l1246t325r1705b409],
31	therapy	NN	O	therapy	prep_with	25	SENT_98	[p9l1727t325r1994b409],
32	and	CC	O	and	cc	31	SENT_98	[p9l2015t325r2143b388],

1	STATE	NN	O	state	nn	2	SENT_99	[p9l21t700r163b737],
2	ART	NN	O	art	_	0	SENT_99	[p9l306t700r399b737],

1	(	RB	O	(	dep	15	SENT_100	[p9l11t933r106b1010],
2	ii	LS	O	ii	dep	3	SENT_100	[p9l11t933r106b1010],
3	)	CD	NUMBER	)	pobj	1	SENT_100	[p9l11t933r106b1010],
4	by	IN	O	by	_	0	SENT_100	[p9l129t933r213b1017],
5	an	DT	O	a	det	7	SENT_100	[p9l231t956r311b996],
6	alternative	JJ	O	alternative	amod	7	SENT_100	[p9l333t933r693b996],
7	type	NN	O	type	prep_by	1	SENT_100	[p9l713t945r860b1017],
8	of	IN	O	of	_	0	SENT_100	[p9l881t933r955b996],
9	reperfusion	NN	O	reperfusion	prep_of	7	SENT_100	[p9l967t933r1383b1016],
10	,	,	O	,	_	0	SENT_100	[p9l967t933r1383b1016],
11	namely	RB	O	namely	advmod	1	SENT_100	[p9l1405t933r1666b1017],
12	,	,	O	,	_	0	SENT_100	[p9l1405t933r1666b1017],
13	percutaneous	JJ	O	percutaneous	amod	15	SENT_100	[p9l1688t945r2151b1016],
14	coronary	JJ	O	coronary	amod	15	SENT_100	[p9l8t1059r319b1120],
15	intervention	NN	O	intervention	_	0	SENT_100	[p9l335t1037r804b1112],
16	)	NN	O	)	dep	15	SENT_100	[p9l335t1037r804b1112],
17	.	.	O	.	_	0	SENT_100	[p9l335t1037r804b1112],

1	By	IN	O	by	_	0	SENT_101	[p9l828t1041r917b1120],
2	its	PRP$	O	its	poss	4	SENT_101	[p9l934t1042r1009b1099],
3	simultaneous	JJ	O	simultaneous	amod	4	SENT_101	[p9l1031t1036r1484b1099],
4	predictions	NNS	O	prediction	prep_by	8	SENT_101	[p9l1504t1036r1890b1119],
5	of	IN	O	of	_	0	SENT_101	[p9l1911t1036r1984b1099],
6	both	DT	O	both	det	7	SENT_101	[p9l1993t1036r2152b1099],
7	treatments	NNS	O	treatment	prep_of	4	SENT_101	[p9l7t1139r393b1202],
8	’	VBP	O	’	_	0	SENT_101	[p9l7t1139r393b1202],
9	outcomes	NNS	O	outcome	dobj	8	SENT_101	[p9l418t1151r751b1202],
10	(	RB	O	(	advmod	8	SENT_101	[p9l778t1140r873b1216],
11	in	IN	O	in	_	0	SENT_101	[p9l778t1140r873b1216],
12	addition	NN	O	addition	_	0	SENT_101	[p9l896t1139r1188b1202],
13	to	TO	O	to	_	0	SENT_101	[p9l1210t1151r1277b1202],
14	that	DT	O	that	prep_in_addition_to	8	SENT_101	[p9l1301t1139r1436b1202],
15	from	IN	O	from	_	0	SENT_101	[p9l1458t1139r1628b1202],
16	no	DT	O	no	det	17	SENT_101	[p9l1651t1162r1738b1202],
17	treatment	NN	O	treatment	prep_from	14	SENT_101	[p9l1761t1140r2150b1216],
18	)	NN	O	)	nsubj	8	SENT_101	[p9l1761t1140r2150b1216],
19	,	,	O	,	_	0	SENT_101	[p9l1761t1140r2150b1216],
20	this	DT	O	this	det	21	SENT_101	[p9l7t1242r130b1305],
21	“	NN	O	“	appos	18	SENT_101	[p9l153t1242r642b1325],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_101	[p9l153t1242r642b1325],
23	coronary	JJ	O	coronary	amod	24	SENT_101	[p9l663t1265r974b1326],
24	intervention	NN	O	intervention	dep	21	SENT_101	[p9l991t1242r1621b1305],
25	.	.	O	.	_	0	SENT_101	[p9l991t1242r1621b1305],

1	—	NN	O	—	_	0	SENT_102	[p9l991t1242r1621b1305],
2	.	.	O	.	_	0	SENT_102	[p9l991t1242r1621b1305],

1	TPI	NNP	O	TPI	nsubj	3	SENT_103	[p9l991t1242r1621b1305],
2	”	CD	NUMBER	”	num	1	SENT_103	[p9l991t1242r1621b1305],
3	indicates	VBZ	O	indicate	_	0	SENT_103	[p9l1643t1242r1945b1305],
4	when	WRB	O	when	advmod	12	SENT_103	[p9l1963t1242r2151b1305],
5	one	CD	NUMBER	one	num	6	SENT_103	[p9l8t1368r134b1408],
6	form	NN	O	form	nsubj	12	SENT_103	[p9l158t1345r330b1408],
7	of	IN	O	of	_	0	SENT_103	[p9l355t1345r430b1408],
8	reperfusion	NN	O	reperfusion	prep_of	6	SENT_103	[p9l445t1345r854b1428],
9	has	VBZ	O	have	aux	12	SENT_103	[p9l877t1345r992b1408],
10	a	DT	O	a	dep	11	SENT_103	[p9l1017t1368r1053b1408],
11	better	JJR	O	better	advmod	12	SENT_103	[p9l1073t1345r1281b1408],
12	predicted	VBN	O	predict	advcl	3	SENT_103	[p9l1302t1345r1638b1428],
13	outcome	NN	O	outcome	dobj	12	SENT_103	[p9l1661t1357r1967b1408],
14	than	IN	O	than	_	0	SENT_103	[p9l1990t1345r2149b1408],
15	the	DT	O	the	det	16	SENT_103	[p9l7t1447r113b1511],
16	other	JJ	O	other	prep_than	12	SENT_103	[p9l136t1447r330b1520],
17	,	,	O	,	_	0	SENT_103	[p9l136t1447r330b1520],
18	so	IN	O	so	dep	3	SENT_103	[p9l355t1470r425b1511],
19	it	PRP	O	it	nsubjpass	23	SENT_103	[p9l449t1454r495b1511],
20	can	MD	O	can	aux	23	SENT_103	[p9l516t1470r633b1511],
21	immediately	RB	O	immediately	advmod	23	SENT_103	[p9l656t1447r1087b1532],
22	be	VB	O	be	auxpass	23	SENT_103	[p9l1104t1448r1183b1511],
23	offered	VBN	O	offer	ccomp	3	SENT_103	[p9l1207t1447r1445b1511],
24	to	TO	O	to	_	0	SENT_103	[p9l1465t1459r1531b1511],
25	the	DT	O	the	det	26	SENT_103	[p9l1554t1447r1660b1511],
26	patient	NN	O	patient	prep_to	23	SENT_103	[p9l1682t1439r2080b1531],
27	.15	CD	NUMBER	.15	number	28	SENT_103	[p9l1682t1439r2080b1531],
28	’16	CD	NUMBER	’16	num	26	SENT_103	[p9l1682t1439r2080b1531],
29	It	PRP	O	it	nsubj	32	SENT_103	[p9l2103t1453r2152b1511],
30	also	RB	O	also	advmod	32	SENT_103	[p9l8t1551r141b1614],
31	can	MD	O	can	aux	32	SENT_103	[p9l166t1574r285b1614],
32	indicate	VB	O	indicate	rcmod	26	SENT_103	[p9l309t1551r584b1614],
33	when	WRB	O	when	advmod	35	SENT_103	[p9l606t1551r797b1614],
34	there	EX	O	there	expl	35	SENT_103	[p9l819t1551r996b1614],
35	is	VBZ	O	be	advcl	32	SENT_103	[p9l1020t1557r1071b1614],
36	essentially	RB	O	essentially	advmod	35	SENT_103	[p9l1095t1551r1455b1635],
37	equivalence	JJ	O	equivalence	amod	38	SENT_103	[p9l1476t1551r2147b1634],
38	—	NN	O	—	iobj	35	SENT_103	[p9l1476t1551r2147b1634],
39	equi	FW	O	equi	nn	42	SENT_103	[p9l1476t1551r2147b1634],
40	—	FW	O	—	nn	42	SENT_103	[p9l1476t1551r2147b1634],
41	poise	NN	O	poise	nn	42	SENT_103	[p9l6t1654r554b1737],
42	—	NN	O	—	dep	38	SENT_103	[p9l6t1654r554b1737],
43	between	IN	O	between	_	0	SENT_103	[p9l6t1654r554b1737],
44	the	DT	O	the	det	46	SENT_103	[p9l576t1654r682b1717],
45	two	CD	NUMBER	two	num	46	SENT_103	[p9l704t1666r829b1717],
46	forms	NNS	O	form	prep_between	42	SENT_103	[p9l853t1654r1052b1717],
47	of	IN	O	of	_	0	SENT_103	[p9l1075t1654r1149b1717],
48	reperfusion	NN	O	reperfusion	prep_of	46	SENT_103	[p9l1162t1654r1576b1737],
49	.	.	O	.	_	0	SENT_103	[p9l1162t1654r1576b1737],

1	From	IN	O	from	_	0	SENT_104	[p9l1603t1659r1788b1717],
2	a	DT	O	a	det	4	SENT_104	[p9l1811t1677r1845b1717],
3	research	NN	O	research	nn	4	SENT_104	[p9l1866t1654r2151b1717],
4	perspective	NN	O	perspective	prep_from	17	SENT_104	[p9l6t1764r412b1841],
5	,	,	O	,	_	0	SENT_104	[p9l6t1764r412b1841],
6	where	WRB	O	where	advmod	9	SENT_104	[p9l433t1758r641b1821],
7	such	JJ	O	such	amod	8	SENT_104	[p9l662t1758r817b1821],
8	equivalence	JJ	O	equivalence	nsubj	9	SENT_104	[p9l838t1758r1239b1841],
9	exists	VBZ	O	exist	advcl	17	SENT_104	[p9l1260t1764r1464b1830],
10	,	,	O	,	_	0	SENT_104	[p9l1260t1764r1464b1830],
11	randomization	NN	O	randomization	nsubjpass	17	SENT_104	[p9l1486t1758r1994b1821],
12	into	IN	O	into	_	0	SENT_104	[p9l2014t1764r2148b1821],
13	treatment	NN	O	treatment	nn	14	SENT_104	[p9l7t1873r347b1924],
14	groups	NNS	O	group	prep_into	11	SENT_104	[p9l368t1883r603b1945],
15	may	MD	O	may	aux	17	SENT_104	[p9l627t1884r775b1945],
16	be	VB	O	be	auxpass	17	SENT_104	[p9l792t1861r873b1924],
17	justiﬁed	VBN	O	justiﬁed	_	0	SENT_104	[p9l891t1861r1191b1945],
18	;	:	O	;	_	0	SENT_104	[p9l891t1861r1191b1945],
19	from	IN	O	from	_	0	SENT_104	[p9l1216t1861r1385b1924],
20	a	DT	O	a	det	22	SENT_104	[p9l1409t1884r1444b1924],
21	clinical	JJ	O	clinical	amod	22	SENT_104	[p9l1466t1861r1715b1924],
22	perspective	NN	O	perspective	prep_from	26	SENT_104	[p9l1735t1867r2147b1944],
23	,	,	O	,	_	0	SENT_104	[p9l1735t1867r2147b1944],
24	this	DT	O	this	nsubj	26	SENT_104	[p9l7t1964r129b2028],
25	could	MD	O	could	aux	26	SENT_104	[p9l151t1964r339b2028],
26	foster	VB	O	foster	parataxis	17	SENT_104	[p9l358t1964r548b2028],
27	informed	JJ	O	informed	amod	28	SENT_104	[p9l567t1964r884b2028],
28	conversations	NNS	O	conversation	dobj	26	SENT_104	[p9l904t1970r1366b2028],
29	between	IN	O	between	_	0	SENT_104	[p9l1385t1964r1668b2028],
30	clinicians	NNS	O	clinician	prep_between	28	SENT_104	[p9l1689t1964r2007b2028],
31	and	CC	O	and	_	0	SENT_104	[p9l2029t1964r2153b2028],
32	patients	NNS	O	patient	prep_between	28	SENT_104	[p9l6t2074r284b2151],
33	on	IN	O	on	_	0	SENT_104	[p9l309t2091r397b2131],
34	factors	NNS	O	factor	prep_on	26	SENT_104	[p9l421t2068r657b2131],
35	such	JJ	O	such	_	0	SENT_104	[p9l682t2068r842b2131],
36	as	IN	O	as	_	0	SENT_104	[p9l866t2091r932b2131],
37	risk	NN	O	risk	prep_such_as	34	SENT_104	[p9l957t2068r1105b2140],
38	,	,	O	,	_	0	SENT_104	[p9l957t2068r1105b2140],
39	uncertainty	NN	O	uncertainty	conj_and	37	SENT_104	[p9l1130t2074r1550b2152],
40	,	,	O	,	_	0	SENT_104	[p9l1130t2074r1550b2152],
41	preferences	NNS	O	preference	conj_and	37	SENT_104	[p9l1574t2068r1996b2151],
42	,	,	O	,	_	0	SENT_104	[p9l1574t2068r1996b2151],
43	and	CC	O	and	_	0	SENT_104	[p9l2022t2068r2152b2131],
44	choices	NNS	O	choice	conj_and	37	SENT_104	[p9l8t2171r274b2235],
45	.	.	O	.	_	0	SENT_104	[p9l8t2171r274b2235],

1	DISCUSSION	NN	O	discussion	_	0	SENT_105	[p9l11t2387r455b2443],
2	We	PRP	O	we	nsubj	3	SENT_105	[p9l6t2488r115b2546],
3	propose	VBP	O	propose	rcmod	1	SENT_105	[p9l134t2505r407b2566],
4	an	DT	O	a	det	8	SENT_105	[p9l428t2506r507b2546],
5	integrated	VBN	O	integrate	amod	8	SENT_105	[p9l528t2483r871b2567],
6	E2E	NN	O	e2e	nn	8	SENT_105	[p9l890t2488r1025b2545],
7	trial	NN	O	trial	nn	8	SENT_105	[p9l1044t2483r1184b2546],
8	approach	NN	O	approach	dobj	3	SENT_105	[p9l1204t2483r1518b2566],
9	with	IN	O	with	_	0	SENT_105	[p9l1536t2483r1687b2546],
10	the	DT	O	the	det	12	SENT_105	[p9l1706t2483r1812b2546],
11	following	VBG	O	follow	amod	12	SENT_105	[p9l1832t2483r2152b2567],
12	features	NNS	O	feature	prep_with	3	SENT_105	[p9l7t2586r291b2650],
13	:	:	O	:	_	0	SENT_105	[p9l7t2586r291b2650],

1	o	NN	O	o	nsubj	8	SENT_106	[p9l9t2816r41b2847],
2	The	DT	O	the	det	4	SENT_106	[p9l131t2794r256b2857],
3	ﬁrst	JJ	O	ﬁrst	amod	4	SENT_106	[p9l277t2794r411b2857],
4	portion	NN	O	portion	dep	1	SENT_106	[p9l430t2800r691b2877],
5	will	MD	O	will	aux	8	SENT_106	[p9l711t2794r837b2857],
6	be	VB	O	be	cop	8	SENT_106	[p9l856t2794r936b2857],
7	a	DT	O	a	det	8	SENT_106	[p9l959t2817r993b2857],
8	standard	JJ	O	standard	_	0	SENT_106	[p9l1014t2794r1314b2857],
9	randomized	VBN	O	randomize	dep	8	SENT_106	[p9l1335t2794r1751b2857],
10	controlled	JJ	O	controlled	amod	12	SENT_106	[p9l1773t2794r2124b2857],
11	efﬁcacy	NN	O	efﬁcacy	nn	12	SENT_106	[p9l131t2897r389b2981],
12	trial	NN	O	trial	dobj	9	SENT_106	[p9l407t2897r565b2969],
13	,	,	O	,	_	0	SENT_106	[p9l407t2897r565b2969],
14	conducted	VBN	O	conduct	dep	9	SENT_106	[p9l589t2897r950b2960],
15	with	IN	O	with	_	0	SENT_106	[p9l968t2897r1122b2960],
16	relatively	RB	O	relatively	advmod	17	SENT_106	[p9l1143t2897r1456b2981],
17	homogeneous	JJ	O	homogeneous	amod	18	SENT_106	[p9l1473t2897r1956b2981],
18	populations	NNS	O	population	prep_with	14	SENT_106	[p9l130t3000r556b3083],
19	,	,	O	,	_	0	SENT_106	[p9l130t3000r556b3083],
20	powered	VBN	O	power	dep	9	SENT_106	[p9l578t3000r876b3083],
21	to	TO	O	to	aux	22	SENT_106	[p9l895t3012r961b3063],
22	detect	VB	O	detect	xcomp	20	SENT_106	[p9l985t3000r1191b3063],
23	evidence	NN	O	evidence	dobj	22	SENT_106	[p9l1212t3000r1512b3063],
24	of	IN	O	of	_	0	SENT_106	[p9l1535t3000r1609b3063],
25	superiority	NN	O	superiority	prep_of	23	SENT_106	[p9l1622t3006r2001b3084],
26	over	IN	O	over	_	0	SENT_106	[p9l131t3126r279b3166],
27	placebo	NN	O	placebo	prep_over	9	SENT_106	[p9l299t3103r562b3186],
28	or	CC	O	or	_	0	SENT_106	[p9l586t3126r658b3166],
29	active	JJ	O	active	amod	30	SENT_106	[p9l679t3109r875b3166],
30	control	NN	O	control	conj_or	27	SENT_106	[p9l898t3103r1159b3166],
31	.	.	O	.	_	0	SENT_106	[p9l898t3103r1159b3166],

1	o	NN	O	o	nsubj	9	SENT_107	[p9l9t3228r41b3259],
2	The	DT	O	the	det	4	SENT_107	[p9l131t3206r256b3269],
3	second	JJ	ORDINAL	second	amod	4	SENT_107	[p9l279t3206r518b3269],
4	portion	NN	O	portion	dep	1	SENT_107	[p9l537t3212r798b3289],
5	will	MD	O	will	aux	9	SENT_107	[p9l817t3206r944b3269],
6	be	VB	O	be	cop	9	SENT_107	[p9l963t3206r1043b3269],
7	an	DT	O	a	det	9	SENT_107	[p9l1065t3229r1145b3269],
8	effectiveness	NN	O	effectiveness	nn	9	SENT_107	[p9l1167t3206r1595b3269],
9	trial	NN	O	trial	_	0	SENT_107	[p9l1616t3206r1775b3278],
10	,	,	O	,	_	0	SENT_107	[p9l1616t3206r1775b3278],
11	conducted	VBN	O	conduct	partmod	9	SENT_107	[p9l1799t3229r1949b3269, p9l131t3309r365b3372],
12	in	IN	O	in	_	0	SENT_107	[p9l386t3315r452b3371],
13	usual	JJ	O	usual	amod	15	SENT_107	[p9l474t3309r655b3372],
14	care	NN	O	care	nn	15	SENT_107	[p9l677t3332r814b3372],
15	settings	NNS	O	setting	prep_in	11	SENT_107	[p9l837t3315r1096b3393],
16	using	VBG	O	use	xcomp	11	SENT_107	[p9l1118t3315r1304b3393],
17	a	DT	O	a	det	20	SENT_107	[p9l1325t3332r1359b3372],
18	more	RBR	O	more	advmod	20	SENT_107	[p9l1380t3332r1558b3372],
19	heterogeneous	JJ	O	heterogeneous	amod	20	SENT_107	[p9l1579t3309r1985b3393, p9l131t3435r247b3475],
20	sample	NN	O	sample	dobj	16	SENT_107	[p9l270t3412r508b3495],
21	that	WDT	O	that	nsubj	23	SENT_107	[p9l529t3412r663b3475],
22	is	VBZ	O	be	cop	23	SENT_107	[p9l684t3418r734b3475],
23	representative	NN	O	representative	rcmod	20	SENT_107	[p9l756t3418r1237b3495],
24	of	IN	O	of	_	0	SENT_107	[p9l1260t3412r1333b3475],
25	the	DT	O	the	det	28	SENT_107	[p9l1345t3412r1451b3475],
26	expected	VBN	O	expect	amod	28	SENT_107	[p9l1474t3412r1778b3495],
27	patient	NN	O	patient	nn	28	SENT_107	[p9l1798t3418r2038b3495],
28	spectrum	NN	O	spectrum	prep_of	23	SENT_107	[p10l132t23r473b94],
29	.	.	O	.	_	0	SENT_107	[p10l132t23r473b94],

1	If	IN	O	if	mark	4	SENT_108	[p10l131t114r190b176],
2	it	PRP	O	it	nsubjpass	4	SENT_108	[p10l202t120r248b177],
3	is	VBZ	O	be	auxpass	4	SENT_108	[p10l269t120r319b177],
4	intended	VBN	O	intend	advcl	31	SENT_108	[p10l341t114r646b177],
5	that	IN	O	that	complm	14	SENT_108	[p10l666t114r800b177],
6	a	DT	O	a	det	8	SENT_108	[p10l821t137r856b177],
7	primary	JJ	O	primary	amod	8	SENT_108	[p10l875t120r1159b198],
8	effect	NN	O	effect	nsubj	14	SENT_108	[p10l1178t114r1361b177],
9	seen	VBN	O	see	partmod	8	SENT_108	[p10l1382t137r1531b177],
10	in	IN	O	in	_	0	SENT_108	[p10l1553t120r1620b176],
11	the	DT	O	the	det	13	SENT_108	[p10l1640t114r1747b177],
12	efﬁcacy	NN	O	efﬁcacy	nn	13	SENT_108	[p10l1770t114r2028b198],
13	portion	NN	O	portion	prep_in	9	SENT_108	[p10l130t223r390b300],
14	is	VBZ	O	be	ccomp	4	SENT_108	[p10l412t223r462b280],
15	to	TO	O	to	aux	17	SENT_108	[p10l483t229r549b280],
16	be	VB	O	be	auxpass	17	SENT_108	[p10l570t217r650b280],
17	conﬁrmed	VBN	O	conﬁrmed	xcomp	14	SENT_108	[p10l672t217r1029b280],
18	in	IN	O	in	_	0	SENT_108	[p10l1050t223r1117b279],
19	the	DT	O	the	det	21	SENT_108	[p10l1137t217r1244b280],
20	effectiveness	NN	O	effectiveness	nn	21	SENT_108	[p10l1267t217r1694b280],
21	portion	NN	O	portion	prep_in	17	SENT_108	[p10l1715t223r1994b300],
22	,	,	O	,	_	0	SENT_108	[p10l1715t223r1994b300],
23	the	DT	O	the	det	25	SENT_108	[p10l2016t217r2123b280],
24	sample	NN	O	sample	nn	25	SENT_108	[p10l132t320r369b403],
25	size	NN	O	size	nsubj	31	SENT_108	[p10l392t326r516b383],
26	of	IN	O	of	_	0	SENT_108	[p10l538t320r612b383],
27	the	DT	O	the	det	29	SENT_108	[p10l623t320r730b383],
28	effectiveness	NN	O	effectiveness	nn	29	SENT_108	[p10l752t320r1180b383],
29	component	NN	O	component	prep_of	25	SENT_108	[p10l1203t332r1595b403],
30	will	MD	O	will	aux	31	SENT_108	[p10l1613t320r1740b383],
31	need	VB	O	need	_	0	SENT_108	[p10l1760t320r1925b383],
32	to	TO	O	to	aux	34	SENT_108	[p10l1945t332r2011b383],
33	be	VB	O	be	auxpass	34	SENT_108	[p10l2032t320r2111b383],
34	increased	VBN	O	increase	xcomp	31	SENT_108	[p10l131t423r457b486],
35	because	IN	O	because	mark	47	SENT_108	[p10l476t423r744b486],
36	net	JJ	O	net	amod	38	SENT_108	[p10l766t435r874b486],
37	average	NN	O	average	nn	38	SENT_108	[p10l895t446r1150b507],
38	differences	NNS	O	difference	nsubj	47	SENT_108	[p10l1173t423r1542b486],
39	between	IN	O	between	_	0	SENT_108	[p10l1562t423r1849b486],
40	treated	JJ	O	treated	amod	43	SENT_108	[p10l1869t423r2108b486],
41	and	CC	O	and	_	0	SENT_108	[p10l131t526r258b589],
42	untreated	JJ	O	untreated	amod	43	SENT_108	[p10l279t526r608b589],
43	subjects	NNS	O	subject	prep_between	38	SENT_108	[p10l630t526r901b610],
44	will	MD	O	will	aux	47	SENT_108	[p10l921t526r1047b589],
45	probably	RB	O	probably	advmod	47	SENT_108	[p10l1067t526r1374b610],
46	be	VB	O	be	cop	47	SENT_108	[p10l1390t526r1470b589],
47	smaller	JJR	O	smaller	advcl	34	SENT_108	[p10l1492t526r1744b589],
48	and	CC	O	and	_	0	SENT_108	[p10l1765t526r1892b589],
49	variability	NN	O	variability	nsubj	53	SENT_108	[p10l1909t532r2069b589, p10l131t629r345b713],
50	will	MD	O	will	aux	53	SENT_108	[p10l361t629r488b692],
51	probably	RB	O	probably	advmod	53	SENT_108	[p10l508t629r814b713],
52	be	VB	O	be	cop	53	SENT_108	[p10l830t629r910b692],
53	larger	JJR	O	larger	advcl	34	SENT_108	[p10l931t629r1139b713],
54	.	.	O	.	_	0	SENT_108	[p10l931t629r1139b713],

1	For	IN	O	for	_	0	SENT_109	[p10l131t737r248b795],
2	the	DT	O	the	det	3	SENT_109	[p10l267t732r374b795],
3	intent	NN	O	intent	prep_for	19	SENT_109	[p10l396t738r597b795],
4	of	IN	O	of	_	0	SENT_109	[p10l618t732r692b795],
5	generating	VBG	O	generate	amod	6	SENT_109	[p10l704t738r1069b816],
6	hypotheses	NNS	O	hypothesis	prep_of	3	SENT_109	[p10l1088t732r1469b816],
7	on	IN	O	on	_	0	SENT_109	[p10l1492t755r1578b795],
8	possible	JJ	O	possible	amod	10	SENT_109	[p10l1599t732r1875b815],
9	speciﬁc	JJ	O	speciﬁc	amod	10	SENT_109	[p10l1898t732r2151b815],
10	effects	NNS	O	effect	prep_on	6	SENT_109	[p10l131t835r344b898],
11	based	VBN	O	base	partmod	10	SENT_109	[p10l364t835r561b898],
12	on	IN	O	on	_	0	SENT_109	[p10l583t858r669b898],
13	subpopulations	NNS	O	subpopulation	prep_on	11	SENT_109	[p10l691t835r1217b918],
14	or	CC	O	or	_	0	SENT_109	[p10l1240t858r1312b898],
15	circumstances	NNS	O	circumstance	prep_on	11	SENT_109	[p10l1333t841r1840b907],
16	,	,	O	,	_	0	SENT_109	[p10l1333t841r1840b907],
17	samples	NNS	O	sample	nsubj	19	SENT_109	[p10l1864t835r2134b918],
18	will	MD	O	will	aux	19	SENT_109	[p10l129t938r255b1001],
19	need	VB	O	need	_	0	SENT_109	[p10l276t938r441b1001],
20	to	TO	O	to	aux	21	SENT_109	[p10l460t950r526b1001],
21	include	VB	O	include	xcomp	19	SENT_109	[p10l550t938r801b1001],
22	sufﬁcient	JJ	O	sufﬁcient	amod	23	SENT_109	[p10l824t938r1137b1001],
23	numbers	NNS	O	number	dobj	21	SENT_109	[p10l1157t938r1460b1001],
24	of	IN	O	of	_	0	SENT_109	[p10l1483t938r1557b1001],
25	subjects	NNS	O	subject	prep_of	23	SENT_109	[p10l1570t938r1840b1022],
26	with	IN	O	with	_	0	SENT_109	[p10l1861t938r2014b1001],
27	those	DT	O	those	det	28	SENT_109	[p10l130t1041r313b1104],
28	characteristics	NNS	O	characteristic	prep_with	21	SENT_109	[p10l336t1041r826b1104],
29	that	WDT	O	that	nsubjpass	32	SENT_109	[p10l848t1041r982b1104],
30	may	MD	O	may	aux	32	SENT_109	[p10l1002t1064r1149b1125],
31	be	VB	O	be	auxpass	32	SENT_109	[p10l1165t1041r1245b1104],
32	associated	VBN	O	associate	rcmod	28	SENT_109	[p10l1268t1041r1617b1104],
33	with	IN	O	with	_	0	SENT_109	[p10l1635t1041r1789b1104],
34	treatment	NN	O	treatment	nn	35	SENT_109	[p10l1809t1053r2146b1104],
35	effects	NNS	O	effect	prep_with	32	SENT_109	[p10l131t1144r362b1216],
36	,	,	O	,	_	0	SENT_109	[p10l131t1144r362b1216],
37	to	TO	O	to	aux	38	SENT_109	[p10l385t1156r451b1207],
38	permit	VB	O	permit	xcomp	32	SENT_109	[p10l473t1150r706b1227],
39	detection	NN	O	detection	dobj	38	SENT_109	[p10l728t1144r1048b1207],
40	of	IN	O	of	_	0	SENT_109	[p10l1070t1144r1144b1207],
41	interaction	NN	O	interaction	nn	42	SENT_109	[p10l1156t1150r1532b1207],
42	effects	NNS	O	effect	prep_of	39	SENT_109	[p10l1555t1144r1784b1207],
43	.	.	O	.	_	0	SENT_109	[p10l1555t1144r1784b1207],

1	To	TO	O	to	aux	2	SENT_110	[p10l131t1250r215b1310],
2	enable	VB	O	enable	purpcl	16	SENT_110	[p10l238t1247r457b1310],
3	development	NN	O	development	dobj	2	SENT_110	[p10l480t1247r926b1330],
4	of	IN	O	of	_	0	SENT_110	[p10l947t1247r1021b1310],
5	predictive	JJ	O	predictive	amod	6	SENT_110	[p10l1032t1247r1374b1330],
6	models	NNS	O	model	prep_of	3	SENT_110	[p10l1395t1247r1643b1310],
7	for	IN	O	for	_	0	SENT_110	[p10l1665t1247r1763b1310],
8	use	NN	O	use	prep_for	2	SENT_110	[p10l1783t1270r1894b1310],
9	in	IN	O	in	_	0	SENT_110	[p10l1916t1253r1983b1309],
10	clinical	JJ	O	clinical	amod	11	SENT_110	[p10l131t1350r377b1413],
11	settings	NNS	O	setting	prep_in	8	SENT_110	[p10l399t1356r676b1434],
12	,	,	O	,	_	0	SENT_110	[p10l399t1356r676b1434],
13	effectiveness	NN	O	effectiveness	nn	14	SENT_110	[p10l701t1350r1128b1413],
14	trials	NNS	O	trial	nsubj	16	SENT_110	[p10l1150t1350r1321b1413],
15	should	MD	O	should	aux	16	SENT_110	[p10l1344t1350r1576b1413],
16	include	VB	O	include	_	0	SENT_110	[p10l1597t1350r1848b1413],
17	heterogeneous	JJ	O	heterogeneous	amod	18	SENT_110	[p10l1869t1350r2115b1413, p10l131t1476r408b1537],
18	populations	NNS	O	population	dobj	16	SENT_110	[p10l430t1453r837b1536],
19	and	CC	O	and	_	0	SENT_110	[p10l860t1453r987b1516],
20	analytic	JJ	O	analytic	amod	21	SENT_110	[p10l1009t1453r1275b1537],
21	approaches	NNS	O	approach	conj_and	18	SENT_110	[p10l1297t1453r1682b1536],
22	that	WDT	O	that	nsubj	23	SENT_110	[p10l1704t1453r1838b1516],
23	allow	VBP	O	allow	rcmod	21	SENT_110	[p10l1859t1453r2043b1516],
24	detection	NN	O	detection	dobj	23	SENT_110	[p10l131t1556r451b1619],
25	of	IN	O	of	_	0	SENT_110	[p10l473t1556r547b1619],
26	interactions	NNS	O	interaction	prep_of	24	SENT_110	[p10l559t1562r966b1619],
27	between	IN	O	between	_	0	SENT_110	[p10l986t1556r1274b1619],
28	patient	NN	O	patient	nn	29	SENT_110	[p10l1294t1562r1534b1639],
29	characteristics	NNS	O	characteristic	prep_between	26	SENT_110	[p10l1555t1556r2046b1619],
30	and	CC	O	and	_	0	SENT_110	[p10l131t1659r258b1723],
31	treatment	NN	O	treatment	nn	32	SENT_110	[p10l278t1671r614b1723],
32	effects	NNS	O	effect	prep_between	26	SENT_110	[p10l636t1659r866b1723],
33	.	.	O	.	_	0	SENT_110	[p10l636t1659r866b1723],

1	To	TO	O	to	aux	2	SENT_111	[p10l131t1766r215b1826],
2	improve	VB	O	improve	purpcl	13	SENT_111	[p10l238t1769r521b1846],
3	the	DT	O	the	det	5	SENT_111	[p10l542t1763r649b1826],
4	E2E	NN	O	e2e	nn	5	SENT_111	[p10l670t1768r806b1825],
5	approach	NN	O	approach	dobj	2	SENT_111	[p10l829t1763r1147b1846],
6	to	TO	O	to	_	0	SENT_111	[p10l1167t1775r1233b1826],
7	trials	NNS	O	trial	prep_to	2	SENT_111	[p10l1255t1763r1445b1835],
8	,	,	O	,	_	0	SENT_111	[p10l1255t1763r1445b1835],
9	adaptive	JJ	O	adaptive	amod	10	SENT_111	[p10l1469t1763r1756b1846],
10	designs	NNS	O	design	nsubjpass	13	SENT_111	[p10l1778t1763r2030b1847],
11	could	MD	O	could	aux	13	SENT_111	[p10l131t1866r322b1929],
12	be	VB	O	be	auxpass	13	SENT_111	[p10l340t1866r420b1929],
13	used	VBN	O	use	_	0	SENT_111	[p10l442t1866r601b1929],
14	within	IN	O	within	_	0	SENT_111	[p10l619t1866r843b1929],
15	both	CC	O	both	preconj	17	SENT_111	[p10l863t1866r1023b1929],
16	the	DT	O	the	det	17	SENT_111	[p10l1043t1866r1150b1929],
17	efﬁcacy	NN	O	efﬁcacy	prep_within	13	SENT_111	[p10l1173t1866r1431b1950],
18	and	CC	O	and	_	0	SENT_111	[p10l1450t1866r1576b1929],
19	effectiveness	NN	O	effectiveness	nn	20	SENT_111	[p10l1598t1866r2025b1929],
20	portions	NNS	O	portion	prep_within	13	SENT_111	[p10l130t1975r421b2052],
21	for	IN	O	for	_	0	SENT_111	[p10l443t1969r541b2032],
22	interim	JJ	O	interim	amod	23	SENT_111	[p10l561t1975r816b2032],
23	assessments	NNS	O	assessment	prep_for	13	SENT_111	[p10l838t1981r1247b2032],
24	and	CC	O	and	_	0	SENT_111	[p10l1270t1969r1397b2032],
25	modiﬁcations	NNS	O	modiﬁcations	prep_for	13	SENT_111	[p10l1417t1969r1907b2032],
26	.	.	O	.	_	0	SENT_111	[p10l1417t1969r1907b2032],

1	Although	IN	O	although	mark	6	SENT_112	[p10l80t2177r401b2261],
2	the	DT	O	the	det	4	SENT_112	[p10l419t2177r523b2240],
3	E2E	NN	O	e2e	nn	4	SENT_112	[p10l543t2182r677b2239],
4	concept	NN	O	concept	nsubj	6	SENT_112	[p10l697t2189r959b2260],
5	is	VBZ	O	be	cop	6	SENT_112	[p10l978t2183r1026b2240],
6	simple	JJ	O	simple	advcl	13	SENT_112	[p10l1048t2177r1282b2260],
7	,	,	O	,	_	0	SENT_112	[p10l1048t2177r1282b2260],
8	some	DT	O	some	det	10	SENT_112	[p10l1305t2200r1479b2240],
9	practical	JJ	O	practical	amod	10	SENT_112	[p10l1498t2177r1787b2260],
10	barriers	NNS	O	barrier	nsubj	13	SENT_112	[p10l1805t2177r2066b2240],
11	to	TO	O	to	_	0	SENT_112	[p10l2085t2189r2150b2240],
12	implementation	NN	O	implementation	prep_to	10	SENT_112	[p10l8t2280r558b2363],
13	require	VBP	O	require	_	0	SENT_112	[p10l579t2286r824b2363],
14	consideration	NN	O	consideration	dobj	13	SENT_112	[p10l845t2280r1333b2352],
15	,	,	O	,	_	0	SENT_112	[p10l845t2280r1333b2352],
16	including	VBG	O	include	_	0	SENT_112	[p10l1355t2280r1683b2364],
17	the	DT	O	the	det	19	SENT_112	[p10l1701t2280r1808b2343],
18	following	VBG	O	follow	amod	19	SENT_112	[p10l1829t2280r2153b2364],
19	questions	NNS	O	question	prep_including	14	SENT_112	[p10l8t2389r352b2466],
20	,	,	O	,	_	0	SENT_112	[p10l8t2389r352b2466],
21	which	WDT	O	which	nsubjpass	23	SENT_112	[p10l373t2383r583b2446],
22	are	VBP	O	be	auxpass	23	SENT_112	[p10l606t2406r706b2446],
23	addressed	VBN	O	address	rcmod	19	SENT_112	[p10l729t2383r1070b2446],
24	in	IN	O	in	_	0	SENT_112	[p10l1090t2389r1157b2445],
25	the	DT	O	the	det	27	SENT_112	[p10l1178t2383r1284b2446],
26	next	JJ	O	next	amod	27	SENT_112	[p10l1307t2395r1455b2446],
27	section	NN	O	section	prep_in	23	SENT_112	[p10l1477t2389r1737b2446],
28	:	:	O	:	_	0	SENT_112	[p10l1477t2389r1737b2446],

1	Why	WRB	O	why	advmod	2	SENT_113	[p10l129t2591r298b2675],
2	would	MD	O	would	advcl	20	SENT_113	[p10l314t2591r529b2654],
3	a	DT	O	a	det	4	SENT_113	[p10l551t2614r585b2654],
4	company	NN	O	company	dep	2	SENT_113	[p10l606t2613r923b2675],
5	that	WDT	O	that	nsubj	10	SENT_113	[p10l940t2591r1075b2654],
6	has	VBZ	O	have	aux	7	SENT_113	[p10l1094t2591r1206b2654],
7	obtained	VBN	O	obtain	rcmod	4	SENT_113	[p10l1229t2591r1547b2663],
8	,	,	O	,	_	0	SENT_113	[p10l1229t2591r1547b2663],
9	or	CC	O	or	_	0	SENT_113	[p10l1571t2614r1643b2654],
10	anticipates	VBZ	O	anticipate	conj_or	7	SENT_113	[p10l1664t2597r2028b2674],
11	obtaining	VBG	O	obtain	xcomp	10	SENT_113	[p10l131t2694r478b2778],
12	,	,	O	,	_	0	SENT_113	[p10l131t2694r478b2778],
13	a	DT	O	a	det	15	SENT_113	[p10l502t2717r536b2757],
14	positive	JJ	O	positive	amod	15	SENT_113	[p10l556t2700r823b2777],
15	result	NN	O	result	nsubj	20	SENT_113	[p10l845t2694r1036b2757],
16	from	IN	O	from	_	0	SENT_113	[p10l1056t2694r1224b2757],
17	an	DT	O	a	det	19	SENT_113	[p10l1247t2717r1327b2757],
18	eﬂicacy	NN	O	eﬂicacy	nn	19	SENT_113	[p10l1349t2694r1607b2778],
19	trial	NN	O	trial	prep_from	15	SENT_113	[p10l1624t2694r1766b2757],
20	support	VBP	O	support	_	0	SENT_113	[p10l1788t2706r2054b2777],
21	an	DT	O	a	det	24	SENT_113	[p10l131t2820r211b2860],
22	E2E	NN	O	e2e	nn	24	SENT_113	[p10l233t2802r369b2859],
23	effectiveness	NN	O	effectiveness	nn	24	SENT_113	[p10l392t2797r819b2860],
24	trial	NN	O	trial	dobj	20	SENT_113	[p10l840t2797r982b2860],
25	with	IN	O	with	_	0	SENT_113	[p10l1001t2797r1154b2860],
26	the	DT	O	the	det	28	SENT_113	[p10l1175t2797r1281b2860],
27	attendant	JJ	O	attendant	amod	28	SENT_113	[p10l1304t2797r1628b2860],
28	possibility	NN	O	possibility	prep_with	20	SENT_113	[p10l1648t2797r2003b2881],
29	of	IN	O	of	_	0	SENT_113	[p10l2022t2797r2096b2860],
30	a	DT	O	a	det	32	SENT_113	[p10l2108t2820r2143b2860],
31	null	JJ	O	null	amod	32	SENT_113	[p10l131t2900r264b2964],
32	result	NN	O	result	prep_of	28	SENT_113	[p10l285t2900r505b2964],
33	?	.	O	?	_	0	SENT_113	[p10l285t2900r505b2964],

1	What	WDT	O	what	dobj	3	SENT_114	[p10l129t3004r320b3067],
2	beneﬁts	NNS	O	beneﬁts	nsubj	3	SENT_114	[p10l338t3004r605b3067],
3	would	MD	O	would	_	0	SENT_114	[p10l626t3004r841b3067],
4	the	DT	O	the	det	6	SENT_114	[p10l861t3004r968b3067],
5	EZE	NNP	O	EZE	nn	6	SENT_114	[p10l989t3009r1126b3066],
6	sequence	NN	O	sequence	dobj	3	SENT_114	[p10l1149t3027r1460b3087],
7	provide	VB	O	provide	dep	3	SENT_114	[p10l1481t3004r1743b3087],
8	for	IN	O	for	_	0	SENT_114	[p10l1765t3004r1862b3067],
9	the	DT	O	the	det	10	SENT_114	[p10l1882t3004r1989b3067],
10	public	NN	O	public	prep_for	7	SENT_114	[p10l130t3107r360b3190],
11	,	,	O	,	_	0	SENT_114	[p10l130t3107r360b3190],
12	for	IN	O	for	_	0	SENT_114	[p10l384t3107r481b3170],
13	regulators	NNS	O	regulator	prep_for	7	SENT_114	[p10l502t3107r862b3191],
14	,	,	O	,	_	0	SENT_114	[p10l502t3107r862b3191],
15	and	CC	O	and	_	0	SENT_114	[p10l887t3107r1013b3170],
16	for	IN	O	for	_	0	SENT_114	[p10l1034t3107r1131b3170],
17	payers	NNS	O	payer	prep_for	7	SENT_114	[p10l1151t3111r1401b3191],
18	?	.	O	?	_	0	SENT_114	[p10l1151t3111r1401b3191],

1	What	WDT	O	what	det	2	SENT_115	[p10l130t3524r321b3587],
2	process	NN	O	process	nsubj	4	SENT_115	[p10l340t3546r594b3607],
3	issues	NNS	O	issue	dep	2	SENT_115	[p10l616t3530r812b3587],
4	need	VBP	O	need	_	0	SENT_115	[p10l835t3524r1000b3587],
5	to	TO	O	to	aux	7	SENT_115	[p10l1019t3536r1085b3587],
6	be	VB	O	be	auxpass	7	SENT_115	[p10l1106t3524r1186b3587],
7	addressed	VBN	O	address	xcomp	4	SENT_115	[p10l1208t3524r1550b3587],
8	in	IN	O	in	_	0	SENT_115	[p10l1570t3530r1637b3586],
9	the	DT	O	the	det	10	SENT_115	[p10l1658t3524r1765b3587],
10	implementation	NN	O	implementation	prep_in	7	SENT_115	[p10l1786t3524r2006b3607, p10l131t3633r485b3691],
11	of	IN	O	of	_	0	SENT_115	[p10l507t3627r581b3691],
12	EZE	NNP	O	EZE	nn	13	SENT_115	[p10l593t3632r730b3690],
13	trials	NNS	O	trial	prep_of	10	SENT_115	[p10l751t3627r953b3691],
14	?	.	O	?	_	0	SENT_115	[p10l751t3627r953b3691],

1	o	NN	O	o	_	0	SENT_116	[p11l10t49r42b80],
2	What	WDT	O	what	dep	3	SENT_116	[p11l130t27r321b90],
3	drugs	NNS	O	drug	rcmod	1	SENT_116	[p11l342t27r534b111],
4	and	CC	O	and	_	0	SENT_116	[p11l557t27r710b93],
5	/	:	O	/	punct	10	SENT_116	[p11l557t27r710b93],
6	or	CC	O	or	cc	10	SENT_116	[p11l716t50r788b90],
7	indications	NNS	O	indication	nsubj	10	SENT_116	[p11l809t27r1189b90],
8	would	MD	O	would	aux	10	SENT_116	[p11l1209t27r1425b90],
9	be	VB	O	be	cop	10	SENT_116	[p11l1443t27r1523b90],
10	suitable	JJ	O	suitable	conj_and	3	SENT_116	[p11l1546t27r1807b90],
11	for	IN	O	for	_	0	SENT_116	[p11l1829t27r1927b90],
12	ﬁrst	NN	O	ﬁrst	nn	13	SENT_116	[p11l1947t27r2080b90],
13	applications	NNS	O	application	prep_for	10	SENT_116	[p11l132t130r543b213],
14	of	IN	O	of	_	0	SENT_116	[p11l566t130r640b193],
15	E2E	NN	O	e2e	prep_of	13	SENT_116	[p11l652t134r819b193],
16	?	.	O	?	_	0	SENT_116	[p11l652t134r819b193],

1	Why	WRB	O	why	advmod	6	SENT_117	[p11l7t344r161b417],
2	would	MD	O	would	aux	6	SENT_117	[p11l175t344r389b401],
3	a	DT	O	a	det	5	SENT_117	[p11l408t360r444b401],
4	drug	NN	O	drug	nn	5	SENT_117	[p11l463t344r626b417],
5	manufacturer	NN	O	manufacturer	nsubj	6	SENT_117	[p11l647t343r1125b401],
6	support	VBP	O	support	_	0	SENT_117	[p11l1141t351r1419b416],
7	an	DT	O	a	det	9	SENT_117	[p11l1435t360r1517b401],
8	E2E	NN	O	e2e	nn	9	SENT_117	[p11l1539t346r1659b400],
9	trial	NN	O	trial	dobj	6	SENT_117	[p11l1676t344r1852b401],
10	?	.	O	?	_	0	SENT_117	[p11l1676t344r1852b401],

1	After	IN	O	after	mark	6	SENT_118	[p11l7t441r180b504],
2	an	DT	O	a	det	4	SENT_118	[p11l200t464r278b504],
3	efﬁcacy	NN	O	efﬁcacy	nn	4	SENT_118	[p11l298t441r550b525],
4	trial	NN	O	trial	nsubj	6	SENT_118	[p11l565t441r703b504],
5	has	VBZ	O	have	aux	6	SENT_118	[p11l721t441r830b504],
6	shown	VBN	O	show	advcl	18	SENT_118	[p11l852t441r1069b504],
7	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_118	[p11l1090t441r1437b525],
8	treatment	NN	O	treatment	nn	9	SENT_118	[p11l1454t453r1782b504],
9	effects	NNS	O	effect	dobj	6	SENT_118	[p11l1802t441r2009b504],
10	and	CC	O	and	_	0	SENT_118	[p11l2030t441r2153b504],
11	licensing	NN	O	licensing	nsubjpass	14	SENT_118	[p11l7t544r314b628],
12	has	VBZ	O	have	aux	14	SENT_118	[p11l332t544r444b607],
13	been	VBN	O	be	auxpass	14	SENT_118	[p11l463t544r628b607],
14	granted	VBN	O	grant	conj_and	6	SENT_118	[p11l649t544r927b628],
15	,	,	O	,	_	0	SENT_118	[p11l649t544r927b628],
16	manufacturers	NNS	O	manufacturer	nsubj	18	SENT_118	[p11l950t544r1449b607],
17	are	VBP	O	be	cop	18	SENT_118	[p11l1471t567r1572b607],
18	reluctant	JJ	O	reluctant	_	0	SENT_118	[p11l1592t544r1898b607],
19	to	TO	O	to	aux	20	SENT_118	[p11l1916t556r1982b607],
20	support	VB	O	support	xcomp	18	SENT_118	[p11l2005t566r2150b627, p11l7t659r155b730],
21	follow-up	JJ	O	follow-up	amod	23	SENT_118	[p11l176t647r508b730],
22	effectiveness	NN	O	effectiveness	nn	23	SENT_118	[p11l533t647r961b710],
23	trials	NNS	O	trial	dobj	20	SENT_118	[p11l984t647r1173b710],
24	.	.	O	.	_	0	SENT_118	[p11l984t647r1173b710],

1	If	IN	O	if	mark	5	SENT_119	[p11l1200t647r1258b709],
2	an	DT	O	a	det	4	SENT_119	[p11l1272t670r1353b710],
3	effectiveness	NN	O	effectiveness	nn	4	SENT_119	[p11l1376t647r1804b710],
4	trial	NN	O	trial	nsubj	5	SENT_119	[p11l1827t647r1968b710],
5	were	VBD	O	be	advcl	20	SENT_119	[p11l1988t670r2150b710],
6	to	TO	O	to	aux	7	SENT_119	[p11l7t762r73b813],
7	reveal	VB	O	reveal	xcomp	5	SENT_119	[p11l97t750r300b813],
8	reductions	NNS	O	reduction	dobj	7	SENT_119	[p11l323t750r686b813],
9	in	IN	O	in	_	0	SENT_119	[p11l710t756r777b812],
10	average	JJ	O	average	amod	11	SENT_119	[p11l801t773r1055b834],
11	effects	NNS	O	effect	prep_in	7	SENT_119	[p11l1079t750r1292b813],
12	or	CC	O	or	_	0	SENT_119	[p11l1316t773r1388b813],
13	in	IN	O	in	_	0	SENT_119	[p11l1409t756r1476b812],
14	speciﬁc	NN	O	speciﬁc	nn	15	SENT_119	[p11l1500t750r1753b833],
15	subgroups	NNS	O	subgroup	prep_in	7	SENT_119	[p11l1777t750r2150b834],
16	,	,	O	,	_	0	SENT_119	[p11l1777t750r2150b834],
17	a	DT	O	a	det	18	SENT_119	[p11l9t876r43b916],
18	manufacturer	NN	O	manufacturer	nsubj	20	SENT_119	[p11l61t853r524b916],
19	might	MD	O	might	aux	20	SENT_119	[p11l542t853r743b937],
20	face	VB	O	face	_	0	SENT_119	[p11l761t853r893b916],
21	reductions	NNS	O	reduction	dobj	20	SENT_119	[p11l913t853r1270b916],
22	in	IN	O	in	_	0	SENT_119	[p11l1290t859r1356b915],
23	use	NN	O	use	prep_in	21	SENT_119	[p11l1376t876r1502b925],
24	,	,	O	,	_	0	SENT_119	[p11l1376t876r1502b925],
25	limits	NNS	O	limit	conj_or	21	SENT_119	[p11l1523t853r1713b916],
26	on	IN	O	on	_	0	SENT_119	[p11l1734t876r1819b916],
27	the	DT	O	the	det	28	SENT_119	[p11l1838t853r1943b916],
28	scope	NN	O	scope	prep_on	25	SENT_119	[p11l1964t875r2151b936],
29	of	IN	O	of	_	0	SENT_119	[p11l9t956r82b1019],
30	reimbursements	NNS	O	reimbursement	prep_of	28	SENT_119	[p11l93t956r662b1028],
31	,	,	O	,	_	0	SENT_119	[p11l93t956r662b1028],
32	or	CC	O	or	_	0	SENT_119	[p11l684t979r755b1019],
33	even	RB	O	even	advmod	35	SENT_119	[p11l775t979r930b1019],
34	a	DT	O	a	det	35	SENT_119	[p11l951t979r985b1019],
35	reversal	NN	O	reversal	conj_or	21	SENT_119	[p11l1004t956r1266b1019],
36	of	IN	O	of	_	0	SENT_119	[p11l1286t956r1359b1019],
37	regulatory	JJ	O	regulatory	amod	38	SENT_119	[p11l1370t956r1722b1040],
38	approval	NN	O	approval	prep_of	35	SENT_119	[p11l1739t956r2046b1039],
39	.	.	O	.	_	0	SENT_119	[p11l1739t956r2046b1039],

1	To	TO	O	to	aux	2	SENT_120	[p11l2069t959r2152b1019],
2	create	VB	O	create	purpcl	30	SENT_120	[p11l9t1071r208b1122],
3	incentives	NNS	O	incentive	dobj	2	SENT_120	[p11l231t1065r574b1122],
4	for	IN	O	for	_	0	SENT_120	[p11l596t1059r694b1122],
5	manufacturers	NNS	O	manufacturer	prep_for	3	SENT_120	[p11l714t1059r1215b1122],
6	to	TO	O	to	aux	7	SENT_120	[p11l1236t1071r1302b1122],
7	participate	VB	O	participate	xcomp	2	SENT_120	[p11l1324t1065r1692b1142],
8	in	IN	O	in	_	0	SENT_120	[p11l1714t1065r1781b1121],
9	E2E	NN	O	e2e	nn	10	SENT_120	[p11l1803t1064r1939b1121],
10	trials	NNS	O	trial	prep_in	7	SENT_120	[p11l1960t1059r2150b1131],
11	,	,	O	,	_	0	SENT_120	[p11l1960t1059r2150b1131],
12	a	DT	O	a	det	14	SENT_120	[p11l9t1185r44b1225],
13	balanced	JJ	O	balanced	amod	14	SENT_120	[p11l63t1162r375b1225],
14	solution	NN	O	solution	nsubjpass	30	SENT_120	[p11l398t1162r678b1225],
15	that	WDT	O	that	nsubj	16	SENT_120	[p11l700t1162r836b1225],
16	provides	VBZ	O	provide	rcmod	14	SENT_120	[p11l856t1162r1152b1245],
17	beneﬁts	NNS	O	beneﬁts	dobj	16	SENT_120	[p11l1174t1162r1443b1225],
18	to	TO	O	to	_	0	SENT_120	[p11l1465t1174r1532b1225],
19	manufacturers	NNS	O	manufacturer	prep_to	16	SENT_120	[p11l1556t1162r2060b1225],
20	as	RB	O	as	_	0	SENT_120	[p11l2085t1185r2150b1225],
21	well	RB	O	well	_	0	SENT_120	[p11l7t1265r142b1328],
22	as	IN	O	as	_	0	SENT_120	[p11l162t1288r225b1328],
23	patients	NNS	O	patient	prep_to	16	SENT_120	[p11l244t1271r528b1348],
24	,	,	O	,	_	0	SENT_120	[p11l244t1271r528b1348],
25	payers	NNS	O	payer	prep_to	16	SENT_120	[p11l548t1287r781b1349],
26	,	,	O	,	_	0	SENT_120	[p11l548t1287r781b1349],
27	and	CC	O	and	_	0	SENT_120	[p11l803t1265r928b1328],
28	providers	NNS	O	provider	conj_and	19	SENT_120	[p11l945t1265r1264b1348],
29	is	VBZ	O	be	auxpass	30	SENT_120	[p11l1284t1271r1334b1328],
30	needed	VBN	O	need	_	0	SENT_120	[p11l1354t1265r1612b1328],
31	.	.	O	.	_	0	SENT_120	[p11l1354t1265r1612b1328],

1	Various	JJ	O	various	amod	2	SENT_121	[p11l1634t1270r1892b1328],
2	aspects	NNS	O	aspect	nsubj	6	SENT_121	[p11l1913t1277r2152b1348],
3	of	IN	O	of	_	0	SENT_121	[p11l9t1368r83b1431],
4	this	DT	O	this	det	5	SENT_121	[p11l94t1368r219b1431],
5	problem	NN	O	problem	prep_of	2	SENT_121	[p11l240t1368r530b1451],
6	deserve	VBP	O	deserve	_	0	SENT_121	[p11l552t1368r810b1431],
7	attention	NN	O	attention	dobj	6	SENT_121	[p11l833t1374r1157b1431],
8	:	:	O	:	_	0	SENT_121	[p11l833t1374r1157b1431],

1	1	LS	NUMBER	1	_	0	SENT_122	[p11l15t1583r63b1639],
2	.	.	O	.	_	0	SENT_122	[p11l15t1583r63b1639],

1	Effectiveness	NN	O	effectiveness	nn	2	SENT_123	[p11l131t1576r572b1639],
2	trials	NNS	O	trial	nsubj	13	SENT_123	[p11l593t1576r765b1639],
3	conducted	VBN	O	conduct	partmod	2	SENT_123	[p11l788t1576r1149b1639],
4	in	IN	O	in	_	0	SENT_123	[p11l1169t1582r1236b1638],
5	usual	JJ	O	usual	amod	7	SENT_123	[p11l1258t1576r1439b1639],
6	care	NN	O	care	nn	7	SENT_123	[p11l1460t1599r1598b1639],
7	settings	NNS	O	setting	prep_in	3	SENT_123	[p11l1621t1582r1879b1660],
8	with	IN	O	with	_	0	SENT_123	[p11l1900t1576r2053b1639],
9	heterogeneous	JJ	O	heterogeneous	amod	10	SENT_123	[p11l130t1679r630b1763],
10	populations	NNS	O	population	prep_with	3	SENT_123	[p11l651t1679r1059b1762],
11	will	MD	O	will	aux	13	SENT_123	[p11l1080t1679r1206b1742],
12	typically	RB	O	typically	advmod	13	SENT_123	[p11l1226t1679r1520b1763],
13	show	VB	O	show	_	0	SENT_123	[p11l1539t1679r1717b1742],
14	less	JJR	O	less	amod	16	SENT_123	[p11l1734t1679r1853b1742],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_123	[p11l1875t1679r2079b1742, p11l130t1788r343b1865],
16	effect	NN	O	effect	dobj	13	SENT_123	[p11l365t1782r547b1845],
17	and	CC	O	and	_	0	SENT_123	[p11l568t1782r695b1845],
18	more	JJR	O	more	amod	20	SENT_123	[p11l715t1805r894b1845],
19	adverse	JJ	O	adverse	amod	20	SENT_123	[p11l916t1782r1172b1845],
20	effects	NNS	O	effect	dobj	13	SENT_123	[p11l1195t1782r1407b1845],
21	than	IN	O	than	_	0	SENT_123	[p11l1429t1782r1583b1845],
22	efﬁcacy	NN	O	efﬁcacy	nn	23	SENT_123	[p11l1606t1782r1864b1866],
23	trials	NNS	O	trial	prep_than	13	SENT_123	[p11l1881t1782r2070b1845],
24	.	.	O	.	_	0	SENT_123	[p11l1881t1782r2070b1845],

1	To	TO	O	to	_	0	SENT_124	[p11l131t1888r215b1948],
2	the	DT	O	the	det	3	SENT_124	[p11l237t1885r344b1948],
3	extent	NN	O	extent	prep_to	15	SENT_124	[p11l366t1897r576b1948],
4	appropriate	JJ	O	appropriate	amod	3	SENT_124	[p11l598t1891r1010b1968],
5	,	,	O	,	_	0	SENT_124	[p11l598t1891r1010b1968],
6	established	JJ	O	established	amod	8	SENT_124	[p11l1034t1885r1413b1948],
7	drug	NN	O	drug	nn	8	SENT_124	[p11l1434t1885r1597b1969],
8	approvals	NNS	O	approval	nsubj	15	SENT_124	[p11l1617t1885r1944b1968],
9	based	VBN	O	base	_	0	SENT_124	[p11l129t1988r326b2051],
10	on	IN	O	on	prepc_based_on	8	SENT_124	[p11l348t2011r434b2051],
11	efficacy	NN	O	efficacy	nn	12	SENT_124	[p11l456t1988r714b2072],
12	results	NNS	O	result	pobj	8	SENT_124	[p11l733t1988r953b2051],
13	should	MD	O	should	aux	15	SENT_124	[p11l976t1988r1207b2051],
14	not	RB	O	not	neg	15	SENT_124	[p11l1228t2000r1342b2051],
15	be	VB	O	be	_	0	SENT_124	[p11l1361t1988r1441b2051],
16	at	IN	O	at	_	0	SENT_124	[p11l1463t2000r1523b2051],
17	risk	NN	O	risk	prep_at	15	SENT_124	[p11l1543t1988r1673b2051],
18	for	IN	O	for	_	0	SENT_124	[p11l1691t1988r1789b2051],
19	reversal	NN	O	reversal	prep_for	17	SENT_124	[p11l1809t1988r2075b2051],
20	if	IN	O	if	mark	23	SENT_124	[p11l2097t1988r2151b2050],
21	average	JJ	O	average	amod	22	SENT_124	[p11l132t2114r387b2175],
22	effects	NNS	O	effect	nsubj	23	SENT_124	[p11l409t2091r622b2154],
23	decline	VBP	O	decline	advcl	15	SENT_124	[p11l645t2091r889b2154],
24	in	IN	O	in	_	0	SENT_124	[p11l911t2097r977b2153],
25	effectiveness	NN	O	effectiveness	nn	26	SENT_124	[p11l1000t2091r1427b2154],
26	trials	NNS	O	trial	prep_in	23	SENT_124	[p11l1449t2091r1637b2154],
27	.	.	O	.	_	0	SENT_124	[p11l1449t2091r1637b2154],

1	2	LS	NUMBER	2	_	0	SENT_125	[p11l8t2201r63b2257],
2	.	.	O	.	_	0	SENT_125	[p11l8t2201r63b2257],

1	The	DT	O	the	det	2	SENT_126	[p11l131t2194r256b2257],
2	exploration	NN	O	exploration	nsubj	9	SENT_126	[p11l279t2194r672b2277],
3	of	IN	O	of	_	0	SENT_126	[p11l694t2194r768b2257],
4	heterogeneity	NN	O	heterogeneity	prep_of	2	SENT_126	[p11l780t2194r1251b2278],
5	of	IN	O	of	_	0	SENT_126	[p11l1269t2194r1344b2257],
6	treatment	NN	O	treatment	nn	7	SENT_126	[p11l1355t2206r1692b2257],
7	effects	NNS	O	effect	prep_of	4	SENT_126	[p11l1712t2194r1925b2257],
8	may	MD	O	may	aux	9	SENT_126	[p11l1947t2217r2095b2278],
9	identify	VB	O	identify	_	0	SENT_126	[p11l131t2297r400b2381],
10	special	JJ	O	special	amod	11	SENT_126	[p11l419t2297r651b2380],
11	beneﬁts	NNS	O	beneﬁts	dobj	9	SENT_126	[p11l669t2297r936b2360],
12	and	CC	O	and	cc	9	SENT_126	[p11l960t2297r1113b2363],
13	/	:	O	/	punct	15	SENT_126	[p11l960t2297r1113b2363],
14	or	CC	O	or	advmod	15	SENT_126	[p11l1118t2320r1191b2360],
15	support	VB	O	support	parataxis	9	SENT_126	[p11l1212t2309r1478b2380],
16	development	NN	O	development	dobj	15	SENT_126	[p11l1500t2297r1945b2380],
17	of	IN	O	of	_	0	SENT_126	[p11l1966t2297r2040b2360],
18	predictive	JJ	O	predictive	amod	19	SENT_126	[p11l130t2400r472b2483],
19	instruments	NNS	O	instrument	prep_of	16	SENT_126	[p11l494t2406r909b2463],
20	that	WDT	O	that	nsubj	21	SENT_126	[p11l930t2400r1065b2463],
21	facilitate	VBP	O	facilitate	ccomp	9	SENT_126	[p11l1085t2400r1376b2463],
22	optimal	JJ	O	optimal	amod	23	SENT_126	[p11l1398t2400r1664b2483],
23	use	NN	O	use	dobj	21	SENT_126	[p11l1684t2423r1812b2463],
24	.	.	O	.	_	0	SENT_126	[p11l1684t2423r1812b2463],

1	A	DT	O	a	det	3	SENT_127	[p11l1836t2404r1893b2462],
2	formal	JJ	O	formal	amod	3	SENT_127	[p11l1914t2400r2144b2463],
3	avenue	NN	O	avenue	nsubj	11	SENT_127	[p11l132t2526r369b2566],
4	for	IN	O	for	_	0	SENT_127	[p11l391t2503r488b2566],
5	incorporating	VBG	O	incorporate	prepc_for	3	SENT_127	[p11l509t2509r986b2587],
6	such	JJ	O	such	amod	7	SENT_127	[p11l1007t2503r1162b2566],
7	insights	NNS	O	insight	dobj	5	SENT_127	[p11l1184t2503r1448b2587],
8	into	IN	O	into	_	0	SENT_127	[p11l1471t2509r1605b2566],
9	marketing	NN	O	marketing	prep_into	5	SENT_127	[p11l1628t2503r1982b2587],
10	could	MD	O	could	aux	11	SENT_127	[p11l132t2606r323b2669],
11	improve	VB	O	improve	_	0	SENT_127	[p11l343t2612r627b2689],
12	use	NN	O	use	dobj	11	SENT_127	[p11l649t2629r759b2669],
13	of	IN	O	of	_	0	SENT_127	[p11l782t2606r856b2669],
14	treatments	NNS	O	treatment	prep_of	12	SENT_127	[p11l867t2618r1234b2669],
15	while	IN	O	while	_	0	SENT_127	[p11l1255t2606r1441b2669],
16	creating	VBG	O	create	prepc_while	11	SENT_127	[p11l1464t2612r1740b2690],
17	incentives	NNS	O	incentive	dobj	16	SENT_127	[p11l1760t2612r2103b2669],
18	for	IN	O	for	_	0	SENT_127	[p11l131t2708r229b2772],
19	manufacturers	NNS	O	manufacturer	prep_for	16	SENT_127	[p11l249t2708r767b2772],
20	.	.	O	.	_	0	SENT_127	[p11l249t2708r767b2772],

1	Moreover	RB	O	moreover	advmod	31	SENT_128	[p11l791t2713r1138b2780],
2	,	,	O	,	_	0	SENT_128	[p11l791t2713r1138b2780],
3	as	IN	O	as	_	0	SENT_128	[p11l1162t2731r1227b2772],
4	market	NN	O	market	nn	5	SENT_128	[p11l1249t2708r1492b2772],
5	forces	NNS	O	force	prep_as	31	SENT_128	[p11l1512t2708r1713b2772],
6	in	IN	O	in	_	0	SENT_128	[p11l1735t2714r1801b2771],
7	medical	JJ	O	medical	amod	9	SENT_128	[p11l1823t2708r2024b2772, p11l132t2812r226b2875],
8	care	NN	O	care	nn	9	SENT_128	[p11l247t2835r384b2875],
9	turn	NN	O	turn	prep_in	5	SENT_128	[p11l406t2824r554b2875],
10	from	IN	O	from	_	0	SENT_128	[p11l576t2812r744b2875],
11	fee-for	JJ	O	fee-for	amod	13	SENT_128	[p11l766t2812r1290b2878],
12	—	NN	O	—	nn	13	SENT_128	[p11l766t2812r1290b2878],
13	serVice	NN	O	service	prep_from	9	SENT_128	[p11l766t2812r1290b2878],
14	/	:	O	/	punct	15	SENT_128	[p11l766t2812r1290b2878],
15	product	NN	O	product	dep	5	SENT_128	[p11l1294t2812r1568b2895],
16	to	TO	O	to	_	0	SENT_128	[p11l1587t2824r1653b2875],
17	payment	NN	O	payment	prep_to	15	SENT_128	[p11l1675t2824r1976b2896],
18	for	IN	O	for	_	0	SENT_128	[p11l1996t2812r2094b2875],
19	measured	VBN	O	measure	amod	20	SENT_128	[p11l131t2915r466b2978],
20	outcomes	NNS	O	outcome	prep_for	17	SENT_128	[p11l487t2927r835b2987],
21	,	,	O	,	_	0	SENT_128	[p11l487t2927r835b2987],
22	along	IN	O	along	_	0	SENT_128	[p11l859t2915r1047b2999],
23	with	IN	O	with	_	0	SENT_128	[p11l1065t2915r1219b2978],
24	other	JJ	O	other	amod	25	SENT_128	[p11l1240t2915r1423b2978],
25	entities	NNS	O	entity	prep_along_with	15	SENT_128	[p11l1443t2921r1708b2987],
26	,	,	O	,	_	0	SENT_128	[p11l1443t2921r1708b2987],
27	manufacturers	NNS	O	manufacturer	nsubj	31	SENT_128	[p11l1731t2915r2056b2978, p11l130t3030r330b3081],
28	will	MD	O	will	aux	31	SENT_128	[p11l351t3018r477b3081],
29	become	VB	O	become	cop	31	SENT_128	[p11l495t3018r763b3081],
30	increasingly	RB	O	increasingly	advmod	31	SENT_128	[p11l785t3018r1203b3102],
31	responsible	JJ	O	responsible	_	0	SENT_128	[p11l1221t3018r1609b3101],
32	for	IN	O	for	_	0	SENT_128	[p11l1631t3018r1729b3081],
33	ultimate	JJ	O	ultimate	amod	34	SENT_128	[p11l1749t3018r2033b3081],
34	outcomes	NNS	O	outcome	prep_for	31	SENT_128	[p11l132t3133r478b3184],
35	.	.	O	.	_	0	SENT_128	[p11l132t3133r478b3184],

1	In	IN	O	in	_	0	SENT_129	[p11l503t3126r574b3183],
2	this	DT	O	this	det	3	SENT_129	[p11l595t3121r720b3184],
3	context	NN	O	context	prep_in	16	SENT_129	[p11l742t3133r1012b3193],
4	,	,	O	,	_	0	SENT_129	[p11l742t3133r1012b3193],
5	the	DT	O	the	det	6	SENT_129	[p11l1034t3121r1141b3184],
6	ability	NN	O	ability	nsubj	16	SENT_129	[p11l1164t3121r1378b3205],
7	to	TO	O	to	aux	8	SENT_129	[p11l1395t3133r1461b3184],
8	identify	VB	O	identify	infmod	6	SENT_129	[p11l1484t3121r1752b3205],
9	potentially	RB	O	potentially	advmod	10	SENT_129	[p11l1769t3121r2141b3205],
10	good	JJ	O	good	acomp	8	SENT_129	[p11l131t3225r304b3309],
11	vs.	CC	O	vs.	prep	8	SENT_129	[p11l322t3248r409b3288],
12	poor	JJ	O	poor	amod	13	SENT_129	[p11l433t3247r598b3308],
13	responders	NNS	O	responder	dep	11	SENT_129	[p11l619t3225r997b3308],
14	will	MD	O	will	aux	16	SENT_129	[p11l1017t3225r1144b3288],
15	be	VB	O	be	cop	16	SENT_129	[p11l1162t3225r1242b3288],
16	important	JJ	O	important	_	0	SENT_129	[p11l1264t3231r1629b3308],
17	.	.	O	.	_	0	SENT_129	[p11l1264t3231r1629b3308],

1	3	LS	NUMBER	3	_	0	SENT_130	[p11l10t3335r63b3391],
2	.	.	O	.	_	0	SENT_130	[p11l10t3335r63b3391],

1	Effectiveness	NN	O	effectiveness	nn	2	SENT_131	[p11l131t3328r572b3391],
2	studies	NNS	O	study	nsubj	9	SENT_131	[p11l595t3328r830b3391],
3	based	VBN	O	base	_	0	SENT_131	[p11l851t3328r1048b3391],
4	on	IN	O	on	prepc_based_on	2	SENT_131	[p11l1069t3351r1155b3391],
5	more	JJR	O	more	amod	7	SENT_131	[p11l1177t3351r1355b3391],
6	heterogeneous	JJ	O	heterogeneous	amod	7	SENT_131	[p11l1376t3328r1875b3412],
7	populations	NNS	O	population	pobj	2	SENT_131	[p11l1897t3350r2102b3411, p11l130t3431r357b3494],
8	may	MD	O	may	aux	9	SENT_131	[p11l380t3454r527b3515],
9	provide	VB	O	provide	_	0	SENT_131	[p11l543t3431r805b3514],
10	justiﬁcation	NN	O	justiﬁcation	dobj	9	SENT_131	[p11l823t3431r1233b3515],
11	for	IN	O	for	_	0	SENT_131	[p11l1254t3431r1352b3494],
12	expansion	NN	O	expansion	prep_for	9	SENT_131	[p11l1373t3437r1722b3514],
13	of	IN	O	of	_	0	SENT_131	[p11l1745t3431r1819b3494],
14	original	JJ	O	original	amod	16	SENT_131	[p11l1831t3431r2099b3515],
15	eligibility	NN	O	eligibility	nn	16	SENT_131	[p11l132t3534r454b3618],
16	criteria	NNS	O	criterion	prep_of	12	SENT_131	[p11l473t3540r734b3597],
17	.	.	O	.	_	0	SENT_131	[p11l473t3540r734b3597],

1	If	IN	O	if	mark	6	SENT_132	[p11l759t3534r818b3596],
2	an	DT	O	a	det	4	SENT_132	[p11l831t3557r911b3597],
3	efﬁcacy	NN	O	efﬁcacy	nn	4	SENT_132	[p11l933t3534r1192b3618],
4	trial	NN	O	trial	nsubjpass	6	SENT_132	[p11l1209t3534r1350b3597],
5	is	VBZ	O	be	auxpass	6	SENT_132	[p11l1371t3540r1421b3597],
6	based	VBN	O	base	advcl	22	SENT_132	[p11l1441t3534r1639b3597],
7	on	IN	O	on	_	0	SENT_132	[p11l1660t3557r1746b3597],
8	a	DT	O	a	det	10	SENT_132	[p11l1769t3557r1803b3597],
9	narrow	JJ	O	narrow	amod	10	SENT_132	[p11l1824t3557r2073b3597],
10	population	NN	O	population	prep_on	6	SENT_132	[p11l130t3637r507b3720],
11	that	WDT	O	that	nsubj	12	SENT_132	[p11l528t3637r662b3700],
12	excludes	VBZ	O	exclude	rcmod	10	SENT_132	[p11l684t3637r973b3700],
13	potential	JJ	O	potential	amod	14	SENT_132	[p11l994t3637r1302b3720],
14	beneﬁciaries	NNS	O	beneﬁciaries	dobj	12	SENT_132	[p11l1320t3637r1771b3709],
15	,	,	O	,	_	0	SENT_132	[p11l1320t3637r1771b3709],
16	conducting	VBG	O	conduct	csubj	22	SENT_132	[p11l1795t3637r2100b3700, p11l131t3746r240b3824],
17	a	DT	O	a	det	20	SENT_132	[p11l260t3763r295b3803],
18	broader	JJR	O	broader	amod	20	SENT_132	[p11l313t3740r584b3803],
19	effectiveness	NN	O	effectiveness	nn	20	SENT_132	[p11l606t3740r1033b3803],
20	trial	NN	O	trial	dobj	16	SENT_132	[p11l1055t3740r1196b3803],
21	may	MD	O	may	aux	22	SENT_132	[p11l1216t3763r1364b3824],
22	offer	VB	O	offer	_	0	SENT_132	[p11l1383t3740r1539b3803],
23	a	DT	O	a	det	25	SENT_132	[p11l1561t3763r1595b3803],
24	potential	JJ	O	potential	amod	25	SENT_132	[p11l1614t3740r1922b3823],
25	justiﬁcation	NN	O	justiﬁcation	dobj	22	SENT_132	[p12l127t21r537b105],
26	for	IN	O	for	_	0	SENT_132	[p12l558t21r656b84],
27	expansion	NN	O	expansion	prep_for	25	SENT_132	[p12l677t27r1026b104],
28	of	IN	O	of	_	0	SENT_132	[p12l1049t21r1123b84],
29	use	NN	O	use	prep_of	27	SENT_132	[p12l1134t44r1246b84],
30	without	IN	O	without	_	0	SENT_132	[p12l1266t21r1535b84],
31	risking	VBG	O	risk	prepc_without	22	SENT_132	[p12l1556t21r1794b105],
32	market	NN	O	market	nn	33	SENT_132	[p12l1814t21r2057b84],
33	approval	NN	O	approval	dobj	31	SENT_132	[p12l132t124r444b207],
34	.	.	O	.	_	0	SENT_132	[p12l132t124r444b207],

1	4	LS	NUMBER	4	_	0	SENT_133	[p12l7t234r63b290],
2	.	.	O	.	_	0	SENT_133	[p12l7t234r63b290],

1	Data	NNS	O	datum	nsubj	12	SENT_134	[p12l132t232r295b290],
2	on	IN	O	on	_	0	SENT_134	[p12l315t250r402b290],
3	subgroup-speciﬁc	JJ	O	subgroup-speciﬁc	amod	4	SENT_134	[p12l424t227r1036b311],
4	beneﬁts	NNS	O	beneﬁts	prep_on	1	SENT_134	[p12l1055t227r1322b290],
5	in	IN	O	in	_	0	SENT_134	[p12l1345t233r1411b289],
6	heterogeneous	JJ	O	heterogeneous	amod	7	SENT_134	[p12l1432t227r1932b311],
7	populations	NNS	O	population	prep_in	4	SENT_134	[p12l130t330r538b413],
8	in	IN	O	in	_	0	SENT_134	[p12l561t336r627b392],
9	effectiveness	NN	O	effectiveness	nn	10	SENT_134	[p12l650t330r1077b393],
10	trials	NNS	O	trial	prep_in	7	SENT_134	[p12l1098t330r1270b393],
11	may	MD	O	may	aux	12	SENT_134	[p12l1292t353r1439b414],
12	provide	VB	O	provide	_	0	SENT_134	[p12l1456t330r1718b413],
13	a	DT	O	a	det	14	SENT_134	[p12l1741t353r1775b393],
14	basis	NN	O	basis	dobj	12	SENT_134	[p12l1793t330r1960b393],
15	for	IN	O	for	_	0	SENT_134	[p12l1982t330r2080b393],
16	reexamining	VBG	O	reexamine	prepc_for	12	SENT_134	[p12l132t440r565b518],
17	initial	JJ	O	initial	amod	19	SENT_134	[p12l585t434r786b497],
18	negative	JJ	O	negative	amod	19	SENT_134	[p12l807t440r1090b518],
19	ﬁndings	NNS	O	ﬁndings	dobj	16	SENT_134	[p12l1111t434r1389b518],
20	on	IN	O	on	_	0	SENT_134	[p12l1412t457r1498b497],
21	promising	JJ	O	promising	amod	22	SENT_134	[p12l1518t440r1873b518],
22	drugs	NNS	O	drug	prep_on	16	SENT_134	[p12l1893t434r2086b518],
23	for	IN	O	for	_	0	SENT_134	[p12l131t537r229b600],
24	which	WDT	O	which	rel	30	SENT_134	[p12l247t537r458b600],
25	expected	VBN	O	expect	amod	27	SENT_134	[p12l480t537r784b620],
26	general	JJ	O	general	amod	27	SENT_134	[p12l805t537r1055b621],
27	effects	NNS	O	effect	nsubj	30	SENT_134	[p12l1077t537r1289b600],
28	did	VBD	O	do	aux	30	SENT_134	[p12l1312t537r1424b600],
29	not	RB	O	not	neg	30	SENT_134	[p12l1444t549r1558b600],
30	materialize	VB	O	materialize	rcmod	22	SENT_134	[p12l1579t537r1975b600],
31	.	.	O	.	_	0	SENT_134	[p12l1579t537r1975b600],

1	In	IN	O	in	_	0	SENT_135	[p12l132t645r203b702],
2	an	DT	O	a	det	3	SENT_135	[p12l226t663r305b703],
3	environment	NN	O	environment	prep_in	21	SENT_135	[p12l328t646r772b703],
4	that	WDT	O	that	nsubj	6	SENT_135	[p12l792t640r926b703],
5	increasingly	RB	O	increasingly	advmod	6	SENT_135	[p12l947t640r1364b724],
6	focuses	VBZ	O	focus	rcmod	3	SENT_135	[p12l1382t640r1632b703],
7	on	IN	O	on	_	0	SENT_135	[p12l1655t663r1741b703],
8	patientoptimized	VBN	O	patientoptimize	prepc_on	6	SENT_135	[p12l1761t646r2028b723, p12l132t743r480b826],
9	treatments	NNS	O	treatment	dobj	8	SENT_135	[p12l500t755r867b806],
10	and	CC	O	and	_	0	SENT_135	[p12l890t743r1017b806],
11	cost	NN	O	cost	nn	13	SENT_135	[p12l1038t743r1654b815],
12	—	CD	NUMBER	—	num	13	SENT_135	[p12l1038t743r1654b815],
13	effectiveness	NN	O	effectiveness	conj_and	9	SENT_135	[p12l1038t743r1654b815],
14	,	,	O	,	_	0	SENT_135	[p12l1038t743r1654b815],
15	this	DT	O	this	det	16	SENT_135	[p12l1676t743r1801b806],
16	approach	NN	O	approach	nsubj	21	SENT_135	[p12l1824t743r2142b826],
17	may	MD	O	may	aux	21	SENT_135	[p12l131t869r278b930],
18	become	VB	O	become	cop	21	SENT_135	[p12l294t846r562b909],
19	a	DT	O	a	det	21	SENT_135	[p12l585t869r619b909],
20	helpful	JJ	O	helpful	amod	21	SENT_135	[p12l638t846r879b929],
21	part	NN	O	part	_	0	SENT_135	[p12l899t858r1040b929],
22	of	IN	O	of	_	0	SENT_135	[p12l1061t846r1135b909],
23	introducing	VBG	O	introduce	prepc_of	21	SENT_135	[p12l1147t846r1555b930],
24	and	CC	O	and	_	0	SENT_135	[p12l1576t846r1702b909],
25	sustaining	VBG	O	sustain	prepc_of	21	SENT_135	[p12l1724t852r2075b930],
26	new	JJ	O	new	amod	27	SENT_135	[p12l131t971r275b1012],
27	treatments	NNS	O	treatment	dobj	23	SENT_135	[p12l292t960r676b1012],
28	.	.	O	.	_	0	SENT_135	[p12l292t960r676b1012],

1	One	CD	NUMBER	one	num	2	SENT_136	[p12l83t1160r226b1219],
2	proposal	NN	O	proposal	nsubj	12	SENT_136	[p12l245t1156r544b1239],
3	that	WDT	O	that	nsubj	6	SENT_136	[p12l562t1156r696b1219],
4	could	MD	O	could	aux	6	SENT_136	[p12l715t1156r905b1219],
5	be	VB	O	be	cop	6	SENT_136	[p12l923t1156r1002b1219],
6	attractive	JJ	O	attractive	ccomp	2	SENT_136	[p12l1023t1162r1339b1219],
7	to	TO	O	to	_	0	SENT_136	[p12l1358t1168r1424b1219],
8	manufacturers	NNS	O	manufacturer	prep_to	6	SENT_136	[p12l1445t1156r1942b1219],
9	could	MD	O	could	aux	12	SENT_136	[p12l1964t1156r2153b1219],
10	be	VB	O	be	cop	12	SENT_136	[p12l6t1259r88b1322],
11	the	DT	O	the	det	12	SENT_136	[p12l112t1259r222b1322],
12	combination	NN	O	combination	_	0	SENT_136	[p12l247t1259r698b1322],
13	of	IN	O	of	_	0	SENT_136	[p12l723t1259r799b1322],
14	the	DT	O	the	det	18	SENT_136	[p12l812t1259r922b1322],
15	E2E	NN	O	e2e	nn	18	SENT_136	[p12l947t1264r1087b1321],
16	effectiveness	NN	O	effectiveness	nn	18	SENT_136	[p12l1112t1259r1554b1322],
17	trial	NN	O	trial	nn	18	SENT_136	[p12l1578t1259r1725b1322],
18	component	NN	O	component	prep_of	12	SENT_136	[p12l1749t1271r2153b1342],
19	with	IN	O	with	_	0	SENT_136	[p12l7t1362r158b1425],
20	the	DT	O	the	det	23	SENT_136	[p12l177t1362r282b1425],
21	initial	JJ	O	initial	amod	23	SENT_136	[p12l303t1362r501b1425],
22	authorization	NN	O	authorization	nn	23	SENT_136	[p12l521t1362r979b1425],
23	stage	NN	O	stage	prep_with	18	SENT_136	[p12l1000t1374r1166b1446],
24	of	IN	O	of	_	0	SENT_136	[p12l1186t1362r1260b1425],
25	recent	JJ	O	recent	amod	26	SENT_136	[p12l1271t1374r1479b1425],
26	proposals	NNS	O	proposal	prep_of	23	SENT_136	[p12l1497t1362r1824b1445],
27	for	IN	O	for	_	0	SENT_136	[p12l1844t1362r1941b1425],
28	adaptive	JJ	O	adaptive	amod	29	SENT_136	[p12l1961t1362r2148b1445, p12l7t1471r134b1528],
29	licensing	NN	O	licensing	prep_for	26	SENT_136	[p12l158t1456r560b1549],
30	;	:	O	;	_	0	SENT_136	[p12l158t1456r560b1549],
31	17	CD	NUMBER	17	dep	12	SENT_136	[p12l158t1456r560b1549],
32	this	DT	O	this	nsubjpass	36	SENT_136	[p12l583t1464r712b1528],
33	could	MD	O	could	aux	36	SENT_136	[p12l738t1464r935b1528],
34	be	VB	O	be	auxpass	36	SENT_136	[p12l957t1464r1038b1528],
35	well	RB	O	well	advmod	36	SENT_136	[p12l1061t1464r1204b1528],
36	suited	VBN	O	suit	rcmod	31	SENT_136	[p12l1229t1464r1442b1528],
37	to	TO	O	to	_	0	SENT_136	[p12l1464t1476r1532b1528],
38	the	DT	O	the	det	39	SENT_136	[p12l1557t1464r1667b1528],
39	development	NN	O	development	prep_to	36	SENT_136	[p12l1692t1464r2153b1548],
40	and	CC	O	and	_	0	SENT_136	[p12l9t1568r137b1631],
41	assessment	NN	O	assessment	conj_and	39	SENT_136	[p12l160t1580r543b1631],
42	of	IN	O	of	_	0	SENT_136	[p12l565t1568r640b1631],
43	drugs	NNS	O	drug	prep_of	39	SENT_136	[p12l654t1568r849b1652],
44	with	IN	O	with	_	0	SENT_136	[p12l870t1568r1026b1631],
45	heterogeneous	JJ	O	heterogeneous	amod	46	SENT_136	[p12l1048t1568r1553b1652],
46	effects	NNS	O	effect	prep_with	43	SENT_136	[p12l1578t1568r1810b1631],
47	.	.	O	.	_	0	SENT_136	[p12l1578t1568r1810b1631],

1	If	IN	O	if	mark	5	SENT_137	[p12l1837t1568r1897b1630],
2	an	DT	O	a	det	4	SENT_137	[p12l1911t1591r1992b1631],
3	E2E	NN	O	e2e	nn	4	SENT_137	[p12l2015t1573r2153b1630],
4	approach	NN	O	approach	nsubj	5	SENT_137	[p12l9t1672r317b1755],
5	were	VBD	O	be	_	0	SENT_137	[p12l335t1695r492b1735],
6	to	TO	O	to	aux	8	SENT_137	[p12l511t1684r575b1735],
7	be	VB	O	be	auxpass	8	SENT_137	[p12l593t1672r671b1735],
8	embedded	VBN	O	embed	xcomp	5	SENT_137	[p12l691t1672r1042b1735],
9	in	IN	O	in	_	0	SENT_137	[p12l1061t1678r1126b1734],
10	proposed	VBN	O	propose	amod	12	SENT_137	[p12l1144t1672r1458b1755],
11	adaptive	JJ	O	adaptive	amod	12	SENT_137	[p12l1478t1672r1756b1755],
12	approaches	NNS	O	approach	prep_in	8	SENT_137	[p12l1776t1672r2150b1755],
13	www.nature.com/cpt	VBP	O	www.nature.com/cpt	rcmod	12	SENT_137	[p12l1600t1891r2152b1944],

1	STATE	NN	O	state	nn	2	SENT_138	[p12l1761t2059r1902b2096],
2	ART	NN	O	art	_	0	SENT_138	[p12l2045t2059r2139b2096],

1	to	TO	O	to	_	0	SENT_139	[p12l8t2304r73b2355],
2	drug	NN	O	drug	nn	3	SENT_139	[p12l95t2292r257b2376],
3	licensing	NN	O	licensing	prep_to	8	SENT_139	[p12l274t2292r595b2376],
4	,	,	O	,	_	0	SENT_139	[p12l274t2292r595b2376],
5	sponsors	NNS	O	sponsor	nsubj	8	SENT_139	[p12l617t2314r916b2375],
6	may	MD	O	may	aux	8	SENT_139	[p12l937t2315r1083b2376],
7	be	VB	O	be	cop	8	SENT_139	[p12l1098t2292r1177b2355],
8	able	JJ	O	able	_	0	SENT_139	[p12l1198t2292r1332b2355],
9	to	TO	O	to	aux	10	SENT_139	[p12l1351t2304r1417b2355],
10	secure	VB	O	secure	xcomp	8	SENT_139	[p12l1439t2315r1653b2355],
11	market	NN	O	market	nn	12	SENT_139	[p12l1674t2292r1915b2355],
12	access	NN	O	access	dobj	10	SENT_139	[p12l1935t2315r2139b2355],
13	for	IN	O	for	_	0	SENT_139	[p12l8t2395r105b2458],
14	drugs	NNS	O	drug	prep_for	12	SENT_139	[p12l124t2395r332b2479],
15	,	,	O	,	_	0	SENT_139	[p12l124t2395r332b2479],
16	potentially	RB	O	potentially	advmod	17	SENT_139	[p12l352t2395r717b2479],
17	reinforced	VBN	O	reinforce	amod	14	SENT_139	[p12l734t2395r1083b2458],
18	by	IN	O	by	_	0	SENT_139	[p12l1100t2395r1183b2479],
19	payers	NNS	O	payer	prep_by	10	SENT_139	[p12l1198t2417r1432b2479],
20	,	,	O	,	_	0	SENT_139	[p12l1198t2417r1432b2479],
21	that	WDT	O	that	nsubj	31	SENT_139	[p12l1452t2395r1584b2458],
22	provide	VBP	O	provide	rcmod	19	SENT_139	[p12l1602t2395r1860b2478],
23	beneﬁts	NNS	O	beneﬁts	dobj	22	SENT_139	[p12l1878t2395r2141b2458],
24	for	IN	O	for	_	0	SENT_139	[p12l8t2498r109b2561],
25	speciﬁc	NN	O	speciﬁc	nn	26	SENT_139	[p12l133t2498r394b2581],
26	subgroups	NNS	O	subgroup	prep_for	23	SENT_139	[p12l420t2498r784b2582],
27	but	CC	O	but	_	0	SENT_139	[p12l807t2498r924b2561],
28	do	VBP	O	do	aux	31	SENT_139	[p12l948t2498r1034b2561],
29	not	RB	O	not	neg	31	SENT_139	[p12l1060t2510r1178b2561],
30	now	RB	DATE	now	advmod	31	SENT_139	[p12l1201t2521r1353b2561],
31	pass	VB	O	pass	conj_but	22	SENT_139	[p12l1373t2520r1521b2581],
32	the	DT	O	the	det	34	SENT_139	[p12l1545t2498r1655b2561],
33	usual	JJ	O	usual	amod	34	SENT_139	[p12l1680t2498r1866b2561],
34	thresholds	NNS	O	threshold	dobj	31	SENT_139	[p12l1889t2498r2140b2561, p12l9t2601r147b2664],
35	for	IN	O	for	_	0	SENT_139	[p12l171t2601r269b2664],
36	approval	NN	O	approval	prep_for	34	SENT_139	[p12l291t2601r604b2684],
37	.	.	O	.	_	0	SENT_139	[p12l291t2601r604b2684],

1	From	IN	O	from	_	0	SENT_140	[p12l631t2606r817b2664],
2	the	DT	O	the	det	3	SENT_140	[p12l838t2601r945b2664],
3	perspective	NN	O	perspective	prep_from	8	SENT_140	[p12l968t2607r1359b2684],
4	of	IN	O	of	_	0	SENT_140	[p12l1383t2601r1457b2664],
5	manufacturers	NNS	O	manufacturer	prep_of	3	SENT_140	[p12l1470t2601r1991b2673],
6	,	,	O	,	_	0	SENT_140	[p12l1470t2601r1991b2673],
7	this	DT	O	this	nsubj	8	SENT_140	[p12l2014t2601r2140b2664],
8	creates	VBZ	O	create	_	0	SENT_140	[p12l9t2716r240b2767],
9	an	DT	O	a	det	10	SENT_140	[p12l264t2727r344b2767],
10	opportunity	NN	O	opportunity	dobj	8	SENT_140	[p12l367t2710r783b2788],
11	to	TO	O	to	aux	12	SENT_140	[p12l801t2716r867b2767],
12	salvage	VB	O	salvage	infmod	10	SENT_140	[p12l892t2704r1133b2788],
13	drugs	NNS	O	drug	dobj	12	SENT_140	[p12l1157t2704r1348b2788],
14	that	WDT	O	that	nsubjpass	17	SENT_140	[p12l1370t2704r1504b2767],
15	would	MD	O	would	aux	17	SENT_140	[p12l1524t2704r1739b2767],
16	be	VB	O	be	auxpass	17	SENT_140	[p12l1758t2704r1838b2767],
17	killed	VBN	O	kill	rcmod	13	SENT_140	[p12l1859t2704r2052b2767],
18	in	IN	O	in	_	0	SENT_140	[p12l2073t2710r2140b2766],
19	the	DT	O	the	det	21	SENT_140	[p12l8t2807r115b2870],
20	late	JJ	O	late	amod	21	SENT_140	[p12l136t2807r255b2870],
21	stages	NNS	O	stage	prep_in	17	SENT_140	[p12l280t2819r480b2891],
22	of	IN	O	of	_	0	SENT_140	[p12l503t2807r578b2870],
23	development	NN	O	development	prep_of	21	SENT_140	[p12l592t2807r1039b2890],
24	under	IN	O	under	_	0	SENT_140	[p12l1060t2807r1267b2870],
25	the	DT	O	the	det	28	SENT_140	[p12l1287t2807r1394b2870],
26	current	JJ	DATE	current	amod	28	SENT_140	[p12l1418t2819r1672b2870],
27	development	NN	O	development	nn	28	SENT_140	[p12l1695t2807r2142b2890],
28	paradigm	NN	O	paradigm	prep_under	17	SENT_140	[p12l7t2910r354b2994],
29	.	.	O	.	_	0	SENT_140	[p12l7t2910r354b2994],

1	Disincentives	NNS	O	disincentive	nsubjpass	6	SENT_141	[p12l82t3017r533b3075],
2	to	TO	O	to	_	0	SENT_141	[p12l552t3024r617b3075],
3	manufacturers	NNS	O	manufacturer	prep_to	1	SENT_141	[p12l637t3012r1127b3075],
4	could	MD	O	could	aux	6	SENT_141	[p12l1147t3012r1334b3075],
5	be	VB	O	be	auxpass	6	SENT_141	[p12l1350t3012r1429b3075],
6	reduced	VBN	O	reduce	_	0	SENT_141	[p12l1449t3012r1719b3075],
7	in	IN	O	in	_	0	SENT_141	[p12l1738t3018r1803b3074],
8	a	DT	O	a	det	10	SENT_141	[p12l1823t3035r1858b3075],
9	number	NN	O	number	nn	10	SENT_141	[p12l1876t3012r2144b3075],
10	ofways	NNS	O	ofway	prep_in	6	SENT_141	[p13l9t27r267b111],
11	.	.	O	.	_	0	SENT_141	[p13l9t27r267b111],

1	If	IN	O	if	mark	5	SENT_142	[p13l290t27r347b89],
2	there	EX	O	there	expl	5	SENT_142	[p13l356t27r526b90],
3	are	VBP	O	be	cop	5	SENT_142	[p13l546t50r644b90],
4	few	JJ	O	few	amod	5	SENT_142	[p13l663t27r782b90],
5	agents	NNS	O	agent	advcl	38	SENT_142	[p13l799t39r1006b111],
6	in	IN	O	in	_	0	SENT_142	[p13l1026t33r1091b89],
7	the	DT	O	the	det	8	SENT_142	[p13l1110t27r1214b90],
8	marketplace	NN	O	marketplace	prep_in	5	SENT_142	[p13l1233t27r1658b110],
9	,	,	O	,	_	0	SENT_142	[p13l1233t27r1658b110],
10	and	CC	O	and	cc	5	SENT_142	[p13l1680t27r1803b90],
11	especially	RB	O	especially	advmod	5	SENT_142	[p13l1822t27r2146b111],
12	if	IN	O	if	mark	20	SENT_142	[p13l9t130r64b192],
13	understanding	VBG	O	understand	csubj	20	SENT_142	[p13l80t130r598b214],
14	heterogeneity	NN	O	heterogeneity	dobj	13	SENT_142	[p13l620t130r1104b214],
15	of	IN	O	of	_	0	SENT_142	[p13l1126t130r1201b193],
16	treatment	NN	O	treatment	nn	17	SENT_142	[p13l1216t142r1561b193],
17	effects	NNS	O	effect	prep_of	14	SENT_142	[p13l1586t130r1804b193],
18	might	MD	O	might	aux	20	SENT_142	[p13l1829t130r2038b214],
19	be	VB	O	be	cop	20	SENT_142	[p13l2060t130r2141b193],
20	critical	JJ	O	critical	advcl	5	SENT_142	[p13l9t233r240b296],
21	to	TO	O	to	_	0	SENT_142	[p13l258t245r323b296],
22	the	DT	O	the	det	23	SENT_142	[p13l343t233r448b296],
23	use	NN	O	use	prep_to	20	SENT_142	[p13l467t256r577b296],
24	and	CC	O	and	_	0	SENT_142	[p13l598t233r723b296],
25	marketing	NN	O	marketing	conj_and	23	SENT_142	[p13l741t233r1090b317],
26	of	IN	O	of	_	0	SENT_142	[p13l1109t233r1182b296],
27	a	DT	O	a	det	28	SENT_142	[p13l1192t256r1226b296],
28	drug	NN	O	drug	prep_of	23	SENT_142	[p13l1246t233r1422b317],
29	,	,	O	,	_	0	SENT_142	[p13l1246t233r1422b317],
30	the	DT	O	the	det	34	SENT_142	[p13l1442t233r1548b296],
31	E2E	NN	O	e2e	nn	34	SENT_142	[p13l1567t238r1702b295],
32	effectiveness	NN	O	effectiveness	nn	34	SENT_142	[p13l1722t233r2142b296],
33	trial	NN	O	trial	nn	34	SENT_142	[p13l8t336r143b399],
34	portion	NN	O	portion	nsubj	38	SENT_142	[p13l160t342r410b419],
35	might	MD	O	might	aux	38	SENT_142	[p13l429t336r626b420],
36	well	RB	O	well	advmod	38	SENT_142	[p13l642t336r775b399],
37	be	VB	O	be	cop	38	SENT_142	[p13l791t336r868b399],
38	attractive	JJ	O	attractive	_	0	SENT_142	[p13l888t342r1207b399],
39	.	.	O	.	_	0	SENT_142	[p13l888t342r1207b399],

1	For	IN	O	for	_	0	SENT_143	[p13l1230t341r1342b399],
2	example	NN	O	example	prep_for	14	SENT_143	[p13l1360t336r1650b419],
3	,	,	O	,	_	0	SENT_143	[p13l1360t336r1650b419],
4	in	IN	O	in	_	0	SENT_143	[p13l1671t342r1735b398],
5	Alzheimer	NN	O	alzheimer	poss	7	SENT_143	[p13l1753t336r2140b399],
6	’s	POS	O	’s	_	0	SENT_143	[p13l1753t336r2140b399],
7	disease	NN	O	disease	prep_in	14	SENT_143	[p13l9t439r243b502],
8	and	CC	O	and	_	0	SENT_143	[p13l263t439r387b502],
9	traumatic	JJ	O	traumatic	amod	11	SENT_143	[p13l404t445r728b502],
10	brain	NN	O	brain	nn	11	SENT_143	[p13l745t439r921b502],
11	injury	NN	O	injury	prep_in	14	SENT_143	[p13l940t445r1152b523],
12	,	,	O	,	_	0	SENT_143	[p13l940t445r1152b523],
13	there	EX	O	there	expl	14	SENT_143	[p13l1172t439r1341b502],
14	are	VBP	O	be	_	0	SENT_143	[p13l1362t462r1460b502],
15	no	DT	O	no	det	19	SENT_143	[p13l1479t462r1563b502],
16	highly	RB	O	highly	advmod	17	SENT_143	[p13l1583t439r1796b523],
17	successful	JJ	O	successful	amod	19	SENT_143	[p13l1813t439r2144b502],
18	agents	NNS	O	agent	nn	19	SENT_143	[p13l9t554r218b626],
19	today	NN	DATE	today	nsubj	14	SENT_143	[p13l237t542r434b626],
20	.	.	O	.	_	0	SENT_143	[p13l237t542r434b626],

1	A	DT	O	a	det	4	SENT_144	[p13l456t546r512b604],
2	broad	JJ	O	broad	amod	4	SENT_144	[p13l529t542r728b605],
3	effectiveness	NN	O	effectiveness	nn	4	SENT_144	[p13l747t542r1165b605],
4	trial	NN	O	trial	nsubj	40	SENT_144	[p13l1184t542r1322b605],
5	that	WDT	O	that	nsubj	6	SENT_144	[p13l1340t542r1472b605],
6	collected	VBD	O	collect	rcmod	4	SENT_144	[p13l1490t542r1789b605],
7	indicators	NNS	O	indicator	dobj	6	SENT_144	[p13l1807t542r2141b605],
8	of	IN	O	of	_	0	SENT_144	[p13l9t645r84b708],
9	heterogeneity	NN	O	heterogeneity	prep_of	7	SENT_144	[p13l96t645r574b729],
10	that	WDT	O	that	nsubjpass	13	SENT_144	[p13l592t645r729b708],
11	could	MD	O	could	aux	13	SENT_144	[p13l751t645r944b708],
12	be	VB	O	be	auxpass	13	SENT_144	[p13l964t645r1045b708],
13	used	VBN	O	use	rcmod	7	SENT_144	[p13l1068t645r1229b708],
14	for	IN	O	for	_	0	SENT_144	[p13l1251t645r1350b708],
15	subsequent	JJ	O	subsequent	amod	16	SENT_144	[p13l1372t645r1764b728],
16	identiﬁcation	NN	O	identiﬁcation	prep_for	13	SENT_144	[p13l1786t645r2138b708, p13l8t754r141b811],
17	of	IN	O	of	_	0	SENT_144	[p13l160t748r232b811],
18	therapeutic	JJ	O	therapeutic	amod	19	SENT_144	[p13l240t748r616b831],
19	responders	NNS	O	responder	prep_of	16	SENT_144	[p13l635t748r1016b831],
20	,	,	O	,	_	0	SENT_144	[p13l635t748r1016b831],
21	(	CD	NUMBER	(	prep_of	16	SENT_144	[p13l1040t748r1216b824],
22	such	JJ	O	such	_	0	SENT_144	[p13l1040t748r1216b824],
23	as	IN	O	as	_	0	SENT_144	[p13l1236t771r1298b811],
24	speciﬁc	NN	O	speciﬁc	nn	25	SENT_144	[p13l1318t748r1563b831],
25	types	NNS	O	type	prep_such_as	21	SENT_144	[p13l1580t760r1752b832],
26	of	IN	O	of	_	0	SENT_144	[p13l1772t748r1844b811],
27	illnesses	NNS	O	illness	prep_of	25	SENT_144	[p13l1853t748r2140b820],
28	,	,	O	,	_	0	SENT_144	[p13l1853t748r2140b820],
29	comorbidities	NNS	O	comorbidity	appos	27	SENT_144	[p13l9t851r504b923],
30	,	,	O	,	_	0	SENT_144	[p13l9t851r504b923],
31	biomarkers	NNS	O	biomarker	appos	29	SENT_144	[p13l526t851r936b923],
32	,	,	O	,	_	0	SENT_144	[p13l526t851r936b923],
33	and	CC	O	and	_	0	SENT_144	[p13l961t851r1115b917],
34	/	:	O	/	punct	37	SENT_144	[p13l961t851r1115b917],
35	or	CC	O	or	dep	37	SENT_144	[p13l1120t874r1193b914],
36	genetic	JJ	O	genetic	dep	37	SENT_144	[p13l1214t857r1459b935],
37	information	NN	O	information	dep	19	SENT_144	[p13l1481t851r1924b928],
38	)	NN	O	)	prep_of	16	SENT_144	[p13l1481t851r1924b928],
39	could	MD	O	could	aux	40	SENT_144	[p13l1952t851r2144b914],
40	support	VB	O	support	_	0	SENT_144	[p13l9t967r270b1038],
41	access	NN	O	access	dobj	40	SENT_144	[p13l289t978r491b1018],
42	to	TO	O	to	_	0	SENT_144	[p13l510t967r575b1018],
43	effective	JJ	O	effective	amod	44	SENT_144	[p13l596t955r871b1018],
44	treatment	NN	O	treatment	prep_to	40	SENT_144	[p13l889t967r1219b1018],
45	for	IN	O	for	_	0	SENT_144	[p13l1237t955r1333b1018],
46	targeted	VBN	O	target	amod	48	SENT_144	[p13l1350t955r1624b1039],
47	patient	NN	O	patient	nn	48	SENT_144	[p13l1641t961r1876b1038],
48	groups	NNS	O	group	prep_for	44	SENT_144	[p13l1894t977r2139b1039],
49	.	.	O	.	_	0	SENT_144	[p13l1894t977r2139b1039],

1	This	DT	O	this	nsubj	6	SENT_145	[p13l8t1057r150b1120],
2	also	RB	O	also	advmod	6	SENT_145	[p13l172t1057r301b1120],
3	would	MD	O	would	aux	6	SENT_145	[p13l320t1057r533b1120],
4	be	VB	O	be	cop	6	SENT_145	[p13l549t1057r628b1120],
5	the	DT	O	the	det	6	SENT_145	[p13l647t1057r753b1120],
6	case	NN	O	case	_	0	SENT_145	[p13l774t1080r911b1120],
7	in	IN	O	in	_	0	SENT_145	[p13l931t1063r997b1119],
8	areas	NNS	O	area	prep_in	6	SENT_145	[p13l1018t1080r1186b1120],
9	in	IN	O	in	_	0	SENT_145	[p13l1206t1063r1272b1119],
10	which	WDT	O	which	rel	12	SENT_145	[p13l1290t1057r1498b1120],
11	there	EX	O	there	expl	12	SENT_145	[p13l1516t1057r1689b1120],
12	are	VBP	O	be	rcmod	8	SENT_145	[p13l1710t1080r1809b1120],
13	some	DT	O	some	num	18	SENT_145	[p13l1830t1080r2006b1120],
14	less	JJR	O	less	quantmod	13	SENT_145	[p13l2024t1057r2142b1120],
15	than	IN	O	than	quantmod	13	SENT_145	[p13l8t1160r164b1223],
16	fully	RB	O	fully	quantmod	13	SENT_145	[p13l186t1160r343b1244],
17	satisfactory	JJ	O	satisfactory	amod	18	SENT_145	[p13l362t1160r759b1244],
18	agents	NNS	O	agent	nsubj	12	SENT_145	[p13l778t1172r1012b1244],
19	,	,	O	,	_	0	SENT_145	[p13l778t1172r1012b1244],
20	such	JJ	O	such	_	0	SENT_145	[p13l1037t1160r1193b1223],
21	as	IN	O	as	_	0	SENT_145	[p13l1216t1183r1281b1223],
22	in	IN	O	in	prepc_such_as	18	SENT_145	[p13l1304t1166r1371b1222],
23	Parkinson	NNP	O	Parkinson	poss	25	SENT_145	[p13l1395t1160r1780b1223],
24	’s	POS	O	’s	_	0	SENT_145	[p13l1395t1160r1780b1223],
25	disease	NN	O	disease	pobj	22	SENT_145	[p13l1804t1160r2046b1223],
26	or	CC	O	or	_	0	SENT_145	[p13l2070t1183r2142b1223],
27	metastatic	JJ	O	metastatic	amod	28	SENT_145	[p13l8t1269r354b1326],
28	cancer	NN	O	cancer	pobj	22	SENT_145	[p13l376t1286r606b1326],
29	.	.	O	.	_	0	SENT_145	[p13l376t1286r606b1326],

1	Furthermore	RB	O	furthermore	advmod	22	SENT_146	[p13l632t1263r1086b1335],
2	,	,	O	,	_	0	SENT_146	[p13l632t1263r1086b1335],
3	explanatory	JJ	O	explanatory	amod	4	SENT_146	[p13l1110t1263r1513b1347],
4	factors	NNS	O	factor	nsubj	22	SENT_146	[p13l1531t1263r1757b1326],
5	for	IN	O	for	_	0	SENT_146	[p13l1780t1263r1876b1326],
6	heterogeneity	NN	O	heterogeneity	prep_for	4	SENT_146	[p13l1895t1263r2138b1326, p13l8t1372r257b1450],
7	of	IN	O	of	_	0	SENT_146	[p13l276t1366r350b1429],
8	effects	NNS	O	effect	prep_of	6	SENT_146	[p13l363t1366r594b1438],
9	,	,	O	,	_	0	SENT_146	[p13l363t1366r594b1438],
10	identiﬁable	JJ	O	identiﬁable	amod	4	SENT_146	[p13l617t1366r1000b1429],
11	by	IN	O	by	_	0	SENT_146	[p13l1021t1366r1105b1450],
12	biomarkers	NNS	O	biomarker	prep_by	10	SENT_146	[p13l1121t1366r1528b1438],
13	,	,	O	,	_	0	SENT_146	[p13l1121t1366r1528b1438],
14	genetics	NNS	O	genetics	prep_by	10	SENT_146	[p13l1552t1372r1844b1450],
15	,	,	O	,	_	0	SENT_146	[p13l1552t1372r1844b1450],
16	or	CC	O	or	_	0	SENT_146	[p13l1869t1389r1941b1429],
17	other	JJ	O	other	amod	18	SENT_146	[p13l1963t1366r2144b1429],
18	characteristics	NNS	O	characteristic	conj_or	12	SENT_146	[p13l9t1469r510b1541],
19	,	,	O	,	_	0	SENT_146	[p13l9t1469r510b1541],
20	might	MD	O	might	aux	22	SENT_146	[p13l532t1469r734b1553],
21	be	VB	O	be	cop	22	SENT_146	[p13l751t1469r830b1532],
22	attractive	JJ	O	attractive	_	0	SENT_146	[p13l852t1475r1163b1532],
23	to	TO	O	to	_	0	SENT_146	[p13l1184t1481r1249b1532],
24	all	DT	O	all	prep_to	22	SENT_146	[p13l1272t1469r1349b1532],
25	involved	VBN	O	involve	partmod	24	SENT_146	[p13l1369t1469r1672b1532],
26	.	.	O	.	_	0	SENT_146	[p13l1369t1469r1672b1532],

1	How	WRB	O	how	advmod	2	SENT_147	[p13l11t1684r164b1739],
2	would	MD	O	would	_	0	SENT_147	[p13l178t1682r391b1739],
3	patients	NNS	O	patient	nsubj	2	SENT_147	[p13l412t1682r714b1754],
4	,	,	O	,	_	0	SENT_147	[p13l412t1682r714b1754],
5	providers	NNS	O	provider	appos	3	SENT_147	[p13l733t1682r1082b1754],
6	,	,	O	,	_	0	SENT_147	[p13l733t1682r1082b1754],
7	payers	NNS	O	payer	conj_and	5	SENT_147	[p13l1102t1698r1348b1755],
8	,	,	O	,	_	0	SENT_147	[p13l1102t1698r1348b1755],
9	and	CC	O	and	_	0	SENT_147	[p13l1365t1682r1494b1739],
10	regulators	NNS	O	regulator	conj_and	5	SENT_147	[p13l1514t1682r1871b1755],
11	benefit	VBP	O	benefit	rcmod	10	SENT_147	[p13l1890t1681r2138b1739],
12	from	IN	O	from	_	0	SENT_147	[p13l7t1784r171b1842],
13	E2E	NN	O	e2e	nn	14	SENT_147	[p13l193t1787r313b1841],
14	trials	NNS	O	trial	prep_from	11	SENT_147	[p13l329t1784r538b1842],
15	?	.	O	?	_	0	SENT_147	[p13l329t1784r538b1842],

1	Information	NN	O	information	nsubj	11	SENT_148	[p13l9t1882r428b1945],
2	on	IN	O	on	_	0	SENT_148	[p13l451t1905r537b1945],
3	the	DT	O	the	det	5	SENT_148	[p13l559t1882r665b1945],
4	optimal	JJ	O	optimal	amod	5	SENT_148	[p13l689t1882r954b1965],
5	use	NN	O	use	prep_on	1	SENT_148	[p13l975t1905r1086b1945],
6	of	IN	O	of	_	0	SENT_148	[p13l1110t1882r1184b1945],
7	treatments	NNS	O	treatment	prep_of	5	SENT_148	[p13l1196t1894r1562b1945],
8	is	VBZ	O	be	cop	11	SENT_148	[p13l1585t1888r1635b1945],
9	a	DT	O	a	dep	11	SENT_148	[p13l1659t1905r1694b1945],
10	public	JJ	O	public	amod	11	SENT_148	[p13l1714t1882r1926b1965],
11	good	JJ	O	good	_	0	SENT_148	[p13l1949t1882r2138b1966],
12	,	,	O	,	_	0	SENT_148	[p13l1949t1882r2138b1966],
13	with	IN	O	with	_	0	SENT_148	[p13l7t1985r161b2048],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_148	[p13l185t1985r544b2069],
15	value	NN	O	value	prep_with	11	SENT_148	[p13l564t1985r746b2048],
16	to	TO	O	to	_	0	SENT_148	[p13l769t1997r835b2048],
17	patients	NNS	O	patient	prep_to	11	SENT_148	[p13l858t1991r1150b2068],
18	,	,	O	,	_	0	SENT_148	[p13l858t1991r1150b2068],
19	providers	NNS	O	provider	conj_and	17	SENT_148	[p13l1173t1985r1520b2068],
20	,	,	O	,	_	0	SENT_148	[p13l1173t1985r1520b2068],
21	payers	NNS	O	payer	conj_and	17	SENT_148	[p13l1544t2007r1783b2069],
22	,	,	O	,	_	0	SENT_148	[p13l1544t2007r1783b2069],
23	and	CC	O	and	_	0	SENT_148	[p13l1809t1985r1937b2048],
24	regulators	NNS	O	regulator	prep_to	11	SENT_148	[p13l1959t2008r2139b2069, p13l7t2088r216b2151],
25	.	.	O	.	_	0	SENT_148	[p13l1959t2008r2139b2069, p13l7t2088r216b2151],

1	As	IN	O	as	prep	8	SENT_149	[p13l242t2092r330b2151],
2	with	IN	O	with	pcomp	1	SENT_149	[p13l352t2088r508b2151],
3	many	JJ	O	many	amod	5	SENT_149	[p13l530t2111r727b2172],
4	public	JJ	O	public	amod	5	SENT_149	[p13l745t2088r962b2171],
5	goods	NNS	O	goods	pobj	2	SENT_149	[p13l985t2088r1210b2172],
6	,	,	O	,	_	0	SENT_149	[p13l985t2088r1210b2172],
7	there	EX	O	there	expl	8	SENT_149	[p13l1234t2088r1412b2151],
8	is	VBZ	O	be	_	0	SENT_149	[p13l1435t2094r1486b2151],
9	underprovision	NN	O	underprovision	nsubj	8	SENT_149	[p13l1510t2088r2052b2171],
10	of	IN	O	of	_	0	SENT_149	[p13l2076t2088r2151b2151],
11	information	NN	O	information	prep_of	9	SENT_149	[p13l9t2191r423b2254],
12	on	IN	O	on	_	0	SENT_149	[p13l446t2214r533b2254],
13	the	DT	O	the	det	14	SENT_149	[p13l554t2191r660b2254],
14	effects	NNS	O	effect	prep_on	11	SENT_149	[p13l684t2191r896b2254],
15	of	IN	O	of	_	0	SENT_149	[p13l920t2191r994b2254],
16	treatments	NNS	O	treatment	prep_of	14	SENT_149	[p13l1006t2203r1372b2254],
17	in	IN	O	in	_	0	SENT_149	[p13l1395t2197r1462b2253],
18	actual	JJ	O	actual	amod	19	SENT_149	[p13l1485t2191r1689b2254],
19	use	NN	O	use	prep_in	16	SENT_149	[p13l1710t2214r1839b2263],
20	,	,	O	,	_	0	SENT_149	[p13l1710t2214r1839b2263],
21	particularly	RB	O	particularly	advmod	22	SENT_149	[p13l1862t2197r2139b2274, p13l7t2294r162b2378],
22	with	IN	O	with	dep	8	SENT_149	[p13l180t2294r335b2357],
23	respect	NN	O	respect	pobj	22	SENT_149	[p13l358t2306r604b2377],
24	to	TO	O	to	_	0	SENT_149	[p13l625t2306r691b2357],
25	understanding	NN	O	understanding	prep_to	8	SENT_149	[p13l715t2294r1225b2378],
26	of	IN	O	of	_	0	SENT_149	[p13l1247t2294r1322b2357],
27	rare	JJ	O	rare	amod	29	SENT_149	[p13l1335t2317r1469b2357],
28	adverse	JJ	O	adverse	amod	29	SENT_149	[p13l1493t2294r1752b2357],
29	events	NNS	O	event	prep_of	25	SENT_149	[p13l1776t2306r1990b2357],
30	and	CC	O	and	_	0	SENT_149	[p13l2015t2294r2143b2357],
31	the	DT	O	the	det	32	SENT_149	[p13l8t2397r114b2460],
32	beneﬁts	NNS	O	beneﬁts	conj_and	25	SENT_149	[p13l133t2397r399b2460],
33	and	CC	O	and	_	0	SENT_149	[p13l422t2397r548b2460],
34	risks	NNS	O	risk	conj_and	32	SENT_149	[p13l569t2397r726b2460],
35	for	IN	O	for	_	0	SENT_149	[p13l747t2397r845b2460],
36	large	JJ	O	large	amod	39	SENT_149	[p13l864t2397r1028b2481],
37	but	CC	O	but	_	0	SENT_149	[p13l1048t2397r1161b2460],
38	vulnerable	JJ	O	vulnerable	conj_but	36	SENT_149	[p13l1179t2397r1540b2460],
39	subgroups	NNS	O	subgroup	prep_for	32	SENT_149	[p13l1563t2397r1932b2481],
40	.	.	O	.	_	0	SENT_149	[p13l1563t2397r1932b2481],

1	The	DT	O	the	det	2	SENT_150	[p13l82t2500r204b2563],
2	use	NN	O	use	nsubj	15	SENT_150	[p13l223t2523r331b2563],
3	of	IN	O	of	_	0	SENT_150	[p13l351t2500r423b2563],
4	larger	JJR	O	larger	amod	8	SENT_150	[p13l432t2500r623b2584],
5	and	CC	O	and	_	0	SENT_150	[p13l642t2500r765b2563],
6	more	RBR	O	more	advmod	7	SENT_150	[p13l783t2523r956b2563],
7	varied	JJ	O	varied	amod	8	SENT_150	[p13l972t2500r1182b2563],
8	samples	NNS	O	sample	prep_of	2	SENT_150	[p13l1201t2500r1461b2583],
9	in	IN	O	in	_	0	SENT_150	[p13l1481t2506r1546b2562],
10	the	DT	O	the	det	13	SENT_150	[p13l1564t2500r1667b2563],
11	EZE	NNP	O	EZE	nn	13	SENT_150	[p13l1687t2505r1819b2562],
12	effectiveness	NN	O	effectiveness	nn	13	SENT_150	[p13l1839t2500r2139b2563, p13l8t2626r150b2666],
13	portion	NN	O	portion	prep_in	8	SENT_150	[p13l170t2609r428b2686],
14	may	MD	O	may	aux	15	SENT_150	[p13l448t2626r594b2687],
15	facilitate	VB	O	facilitate	_	0	SENT_150	[p13l611t2603r899b2666],
16	the	DT	O	the	det	17	SENT_150	[p13l918t2603r1024b2666],
17	detection	NN	O	detection	dobj	15	SENT_150	[p13l1045t2603r1362b2666],
18	of	IN	O	of	_	0	SENT_150	[p13l1383t2603r1456b2666],
19	uncommon	JJ	O	uncommon	amod	21	SENT_150	[p13l1467t2626r1865b2666],
20	adverse	JJ	O	adverse	amod	21	SENT_150	[p13l1886t2603r2140b2666],
21	effects	NNS	O	effect	prep_of	17	SENT_150	[p13l9t2706r242b2769],
22	.	.	O	.	_	0	SENT_150	[p13l9t2706r242b2769],

1	The	DT	O	the	det	3	SENT_151	[p13l269t2706r395b2769],
2	larger	JJR	O	larger	amod	3	SENT_151	[p13l417t2706r619b2790],
3	numbers	NNS	O	number	nsubj	5	SENT_151	[p13l641t2706r948b2769],
4	will	MD	O	will	aux	5	SENT_151	[p13l970t2706r1098b2769],
5	help	VB	O	help	_	0	SENT_151	[p13l1120t2706r1266b2789],
6	uncover	VB	O	uncover	xcomp	5	SENT_151	[p13l1291t2729r1573b2769],
7	rare	JJ	O	rare	amod	8	SENT_151	[p13l1596t2729r1730b2769],
8	events	NNS	O	event	dobj	6	SENT_151	[p13l1755t2718r1990b2778],
9	,	,	O	,	_	0	SENT_151	[p13l1755t2718r1990b2778],
10	and	CC	O	and	_	0	SENT_151	[p13l2016t2706r2144b2769],
11	inclusion	NN	O	inclusion	nsubj	24	SENT_151	[p13l9t2809r322b2872],
12	of	IN	O	of	_	0	SENT_151	[p13l345t2809r419b2872],
13	a	DT	O	a	det	15	SENT_151	[p13l432t2832r467b2872],
14	wider	JJR	O	wider	amod	15	SENT_151	[p13l486t2809r682b2872],
15	range	NN	O	range	prep_of	11	SENT_151	[p13l704t2832r891b2893],
16	of	IN	O	of	_	0	SENT_151	[p13l915t2809r988b2872],
17	individuals	NNS	O	individual	prep_of	15	SENT_151	[p13l1001t2809r1399b2881],
18	,	,	O	,	_	0	SENT_151	[p13l1001t2809r1399b2881],
19	ages	NNS	O	age	conj_and	17	SENT_151	[p13l1424t2832r1583b2893],
20	,	,	O	,	_	0	SENT_151	[p13l1424t2832r1583b2893],
21	and	CC	O	and	_	0	SENT_151	[p13l1608t2809r1733b2872],
22	comorbidities	NNS	O	comorbidity	prep_of	15	SENT_151	[p13l1756t2809r2139b2872, p13l8t2918r126b2975],
23	may	MD	O	may	aux	24	SENT_151	[p13l151t2935r302b2996],
24	expose	VB	O	expose	conj_and	5	SENT_151	[p13l323t2934r562b2995],
25	propensities	NNS	O	propensity	dobj	24	SENT_151	[p13l585t2918r1016b2995],
26	for	IN	O	for	_	0	SENT_151	[p13l1041t2912r1141b2975],
27	adverse	JJ	O	adverse	amod	28	SENT_151	[p13l1166t2912r1428b2975],
28	effects	NNS	O	effect	prep_for	25	SENT_151	[p13l1454t2912r1690b2975],
29	.	.	O	.	_	0	SENT_151	[p13l1454t2912r1690b2975],

1	Conducting	VBG	O	conduct	csubj	14	SENT_152	[p13l1719t2912r2142b2996],
2	the	DT	O	the	det	4	SENT_152	[p13l8t3015r116b3078],
3	effectiveness	NN	O	effectiveness	nn	4	SENT_152	[p13l140t3015r574b3078],
4	phase	NN	O	phase	dobj	1	SENT_152	[p13l597t3015r795b3098],
5	of	IN	O	of	_	0	SENT_152	[p13l819t3015r894b3078],
6	the	DT	O	the	det	8	SENT_152	[p13l907t3015r1015b3078],
7	EZE	NNP	O	EZE	nn	8	SENT_152	[p13l1038t3020r1176b3077],
8	trial	NN	O	trial	prep_of	4	SENT_152	[p13l1199t3015r1342b3078],
9	as	RB	O	as	advmod	10	SENT_152	[p13l1366t3038r1431b3078],
10	soon	RB	O	soon	advmod	1	SENT_152	[p13l1456t3038r1621b3078],
11	as	IN	O	as	_	0	SENT_152	[p13l1646t3038r1711b3078],
12	feasible	JJ	O	feasible	prep_as	10	SENT_152	[p13l1735t3015r1992b3078],
13	will	MD	O	will	aux	14	SENT_152	[p13l2014t3015r2142b3078],
14	increase	VB	O	increase	_	0	SENT_152	[p13l9t3124r284b3181],
15	the	DT	O	the	det	16	SENT_152	[p13l304t3118r409b3181],
16	likelihood	NN	O	likelihood	dobj	14	SENT_152	[p13l429t3118r775b3181],
17	of	IN	O	of	_	0	SENT_152	[p13l795t3118r869b3181],
18	early	JJ	O	early	amod	19	SENT_152	[p13l880t3118r1045b3202],
19	detection	NN	O	detection	prep_of	16	SENT_152	[p13l1062t3118r1379b3181],
20	of	IN	O	of	_	0	SENT_152	[p13l1399t3118r1473b3181],
21	rare	JJ	O	rare	amod	23	SENT_152	[p13l1484t3141r1615b3181],
22	adverse	JJ	O	adverse	amod	23	SENT_152	[p13l1637t3118r1890b3181],
23	effects	NNS	O	effect	prep_of	19	SENT_152	[p13l1911t3118r2140b3190],
24	,	,	O	,	_	0	SENT_152	[p13l1911t3118r2140b3190],
25	to	TO	O	to	_	0	SENT_152	[p13l8t3233r72b3284],
26	the	DT	O	the	det	27	SENT_152	[p13l92t3221r197b3284],
27	beneﬁt	NN	O	beneﬁt	prep_to	14	SENT_152	[p13l214t3221r446b3284],
28	of	IN	O	of	_	0	SENT_152	[p13l465t3221r538b3284],
29	the	DT	O	the	det	30	SENT_152	[p13l547t3221r652b3284],
30	public	JJ	O	public	prep_of	27	SENT_152	[p13l670t3221r879b3304],
31	and	CC	O	and	_	0	SENT_152	[p13l899t3221r1023b3284],
32	all	DT	O	all	det	34	SENT_152	[p13l1043t3221r1120b3284],
33	other	JJ	O	other	amod	34	SENT_152	[p13l1139t3221r1317b3284],
34	stakeholders	NNS	O	stakeholder	prep_of	27	SENT_152	[p13l1337t3221r1772b3284],
35	.	.	O	.	_	0	SENT_152	[p13l1337t3221r1772b3284],

1	This	DT	O	this	nsubj	6	SENT_153	[p13l1794t3221r1935b3284],
2	could	MD	O	could	aux	6	SENT_153	[p13l1956t3221r2143b3284],
3	be	VB	O	be	cop	6	SENT_153	[p13l7t3324r86b3387],
4	a	DT	O	a	det	6	SENT_153	[p13l109t3347r144b3387],
5	useful	JJ	O	useful	amod	6	SENT_153	[p13l165t3324r371b3387],
6	adjunct	NN	O	adjunct	_	0	SENT_153	[p13l394t3324r651b3408],
7	to	TO	O	to	_	0	SENT_153	[p13l671t3336r737b3387],
8	the	DT	O	the	det	9	SENT_153	[p13l760t3324r866b3387],
9	use	NN	O	use	prep_to	6	SENT_153	[p13l889t3347r999b3387],
10	of	IN	O	of	_	0	SENT_153	[p13l1023t3324r1097b3387],
11	registries	NNS	O	registry	prep_of	9	SENT_153	[p13l1110t3330r1419b3408],
12	and	CC	O	and	_	0	SENT_153	[p13l1443t3324r1569b3387],
13	monitoring	VBG	O	monitor	amod	14	SENT_153	[p13l1590t3330r1983b3408],
14	networks	NNS	O	network	prep_to	6	SENT_153	[p13l2004t3336r2138b3387, p13l7t3427r211b3490],
15	that	WDT	O	that	nsubj	16	SENT_153	[p13l233t3427r367b3490],
16	seek	VBP	O	seek	rcmod	14	SENT_153	[p13l388t3427r535b3490],
17	to	TO	O	to	aux	18	SENT_153	[p13l552t3439r618b3490],
18	detect	VB	O	detect	xcomp	16	SENT_153	[p13l641t3427r847b3490],
19	such	JJ	O	such	amod	20	SENT_153	[p13l868t3427r1023b3490],
20	effects	NNS	O	effect	dobj	18	SENT_153	[p13l1045t3427r1256b3490],
21	in	IN	O	in	_	0	SENT_153	[p13l1279t3433r1345b3489],
22	general	JJ	O	general	amod	23	SENT_153	[p13l1367t3427r1616b3511],
23	use	NN	O	use	prep_in	18	SENT_153	[p13l1636t3450r1763b3490],
24	.	.	O	.	_	0	SENT_153	[p13l1636t3450r1763b3490],

1	Prelicensing	VBG	O	prelicense	amod	3	SENT_154	[p13l83t3530r490b3614],
2	eﬂicacy	NN	O	eﬂicacy	nn	3	SENT_154	[p13l509t3530r759b3614],
3	trials	NNS	O	trial	nsubj	5	SENT_154	[p13l774t3530r940b3593],
4	often	RB	O	often	advmod	5	SENT_154	[p13l961t3530r1129b3593],
5	fail	VBP	O	fail	_	0	SENT_154	[p13l1148t3530r1250b3593],
6	to	TO	O	to	aux	7	SENT_154	[p13l1268t3542r1332b3593],
7	provide	VB	O	provide	xcomp	5	SENT_154	[p13l1352t3530r1606b3613],
8	useful	JJ	O	useful	amod	9	SENT_154	[p13l1625t3530r1826b3593],
9	information	NN	O	information	dobj	7	SENT_154	[p13l1845t3530r2140b3593, p13l8t3638r146b3695],
10	on	IN	O	on	_	0	SENT_154	[p13l170t3655r257b3695],
11	the	DT	O	the	det	12	SENT_154	[p13l278t3632r386b3695],
12	beneﬁts	NNS	O	beneﬁts	prep_on	7	SENT_154	[p13l407t3632r676b3695],
13	and	CC	O	and	_	0	SENT_154	[p13l700t3632r827b3695],
14	risks	NNS	O	risk	prep_on	7	SENT_154	[p13l850t3632r1008b3695],
15	of	IN	O	of	_	0	SENT_154	[p13l1032t3632r1106b3695],
16	treatment	NN	O	treatment	prep_of	12	SENT_154	[p13l1119t3644r1458b3695],
17	to	TO	O	to	_	0	SENT_154	[p13l1479t3644r1545b3695],
18	the	DT	O	the	det	20	SENT_154	[p13l1569t3632r1676b3695],
19	most	RBS	O	most	advmod	20	SENT_154	[p13l1699t3644r1870b3695],
20	vulnerable	JJ	O	vulnerable	prep_to	7	SENT_154	[p13l1889t3632r2139b3695, p14l9t27r146b90],

1	subgroups	NNS	O	subgroup	_	0	SENT_155	[p14l171t27r548b111],
2	.	.	O	.	_	0	SENT_155	[p14l171t27r548b111],

1	The	DT	O	the	det	2	SENT_156	[p14l575t27r702b90],
2	elderly	JJ	O	elderly	nsubj	15	SENT_156	[p14l726t27r972b111],
3	,	,	O	,	_	0	SENT_156	[p14l726t27r972b111],
4	the	DT	O	the	det	5	SENT_156	[p14l996t27r1104b90],
5	frail	JJ	O	frail	conj_and	2	SENT_156	[p14l1128t27r1286b99],
6	,	,	O	,	_	0	SENT_156	[p14l1128t27r1286b99],
7	and	CC	O	and	_	0	SENT_156	[p14l1312t27r1441b90],
8	those	DT	O	those	conj_and	2	SENT_156	[p14l1462t27r1649b90],
9	with	IN	O	with	_	0	SENT_156	[p14l1671t27r1826b90],
10	multiple	JJ	O	multiple	amod	11	SENT_156	[p14l1849t27r2140b110],
11	comorbidities	NNS	O	comorbidity	prep_with	8	SENT_156	[p14l9t131r485b194],
12	are	VBP	O	be	cop	15	SENT_156	[p14l510t154r610b194],
13	an	DT	O	a	det	15	SENT_156	[p14l634t154r714b194],
14	increasing	VBG	O	increase	amod	15	SENT_156	[p14l738t137r1093b215],
15	segment	NN	O	segment	_	0	SENT_156	[p14l1115t143r1403b215],
16	of	IN	O	of	_	0	SENT_156	[p14l1425t131r1499b194],
17	target	NN	O	target	nn	18	SENT_156	[p14l1511t143r1709b215],
18	populations	NNS	O	population	prep_of	15	SENT_156	[p14l1730t131r2139b214],
19	in	IN	O	in	_	0	SENT_156	[p14l9t240r74b296],
20	actual	JJ	O	actual	amod	21	SENT_156	[p14l95t234r295b297],
21	care	NN	O	care	prep_in	18	SENT_156	[p14l316t257r468b306],
22	,	,	O	,	_	0	SENT_156	[p14l316t257r468b306],
23	but	CC	O	but	_	0	SENT_156	[p14l488t234r600b297],
24	these	DT	O	these	det	25	SENT_156	[p14l618t234r791b297],
25	groups	NNS	O	group	nsubjpass	28	SENT_156	[p14l811t256r1041b318],
26	are	VBP	O	be	auxpass	28	SENT_156	[p14l1062t257r1161b297],
27	often	RB	O	often	advmod	28	SENT_156	[p14l1182t234r1352b297],
28	excluded	VBN	O	exclude	conj_but	15	SENT_156	[p14l1373t234r1673b297],
29	from	IN	O	from	_	0	SENT_156	[p14l1693t234r1858b297],
30	populations	NNS	O	population	prep_from	28	SENT_156	[p14l1877t234r2138b317, p14l8t343r176b400],
31	in	IN	O	in	_	0	SENT_156	[p14l200t343r266b399],
32	efﬁcacy	NN	O	efﬁcacy	nn	33	SENT_156	[p14l290t337r548b421],
33	trials	NNS	O	trial	prep_in	30	SENT_156	[p14l566t337r756b400],
34	.	.	O	.	_	0	SENT_156	[p14l566t337r756b400],

1	Together	RB	O	together	_	0	SENT_157	[p14l781t337r1087b421],
2	with	IN	O	with	_	0	SENT_157	[p14l1107t337r1261b400],
3	providers	NNS	O	provider	prep_together_with	13	SENT_157	[p14l1282t337r1607b420],
4	and	CC	O	and	_	0	SENT_157	[p14l1631t337r1758b400],
5	regulators	NNS	O	regulator	conj_and	3	SENT_157	[p14l1780t337r2141b421],
6	,	,	O	,	_	0	SENT_157	[p14l1780t337r2141b421],
7	both	DT	O	both	det	11	SENT_157	[p14l7t440r171b503],
8	private	JJ	O	private	amod	11	SENT_157	[p14l195t446r440b523],
9	and	CC	O	and	_	0	SENT_157	[p14l467t440r597b503],
10	public	JJ	O	public	amod	11	SENT_157	[p14l620t440r841b523],
11	payers	NNS	O	payer	nsubj	13	SENT_157	[p14l865t462r1091b524],
12	have	VBP	O	have	aux	13	SENT_157	[p14l1116t440r1277b503],
13	expressed	VBN	O	express	_	0	SENT_157	[p14l1304t440r1648b523],
14	an	DT	O	a	det	15	SENT_157	[p14l1674t463r1756b503],
15	interest	NN	O	interest	dobj	13	SENT_157	[p14l1782t446r2046b503],
16	in	IN	O	in	_	0	SENT_157	[p14l2071t446r2140b502],
17	extending	VBG	O	extend	prepc_in	13	SENT_157	[p14l9t543r362b627],
18	the	DT	O	the	det	20	SENT_157	[p14l385t543r495b606],
19	evidence	NN	O	evidence	nn	20	SENT_157	[p14l522t543r832b606],
20	base	NN	O	base	dobj	17	SENT_157	[p14l856t543r1010b606],
21	in	IN	O	in	_	0	SENT_157	[p14l1036t549r1104b605],
22	trials	NNS	O	trial	prep_in	17	SENT_157	[p14l1129t543r1307b606],
23	to	TO	O	to	aux	24	SENT_157	[p14l1333t555r1400b606],
24	include	VB	O	include	xcomp	17	SENT_157	[p14l1427t543r1688b606],
25	such	JJ	O	such	amod	27	SENT_157	[p14l1715t543r1875b606],
26	underrepresented	JJ	O	underrepresented	amod	27	SENT_157	[p14l1900t543r2139b606, p14l9t647r417b730],
27	groups	NNS	O	group	dobj	24	SENT_157	[p14l439t669r677b731],
28	to	TO	O	to	aux	29	SENT_157	[p14l699t659r767b710],
29	improve	VB	O	improve	xcomp	24	SENT_157	[p14l792t653r1079b730],
30	assessments	NNS	O	assessment	dobj	29	SENT_157	[p14l1104t659r1519b710],
31	of	IN	O	of	_	0	SENT_157	[p14l1544t647r1619b710],
32	efficacy	NN	O	efficacy	prep_of	30	SENT_157	[p14l1633t647r1904b731],
33	,	,	O	,	_	0	SENT_157	[p14l1633t647r1904b731],
34	safety	NN	O	safety	conj_and	32	SENT_157	[p14l1930t647r2139b731],
35	,	,	O	,	_	0	SENT_157	[p14l1930t647r2139b731],
36	and	CC	O	and	_	0	SENT_157	[p14l9t749r135b812],
37	effectiveness	NN	O	effectiveness	conj_and	32	SENT_157	[p14l156t749r599b812],
38	.	.	O	.	_	0	SENT_157	[p14l156t749r599b812],

1	For	IN	O	for	_	0	SENT_158	[p14l83t857r202b915],
2	examples	NNS	O	example	pobj	1	SENT_158	[p14l227t852r553b935],
3	of	IN	O	of	_	0	SENT_158	[p14l579t852r655b915],
4	how	WRB	O	how	advmod	7	SENT_158	[p14l670t852r822b915],
5	E2E	NN	O	e2e	nsubj	7	SENT_158	[p14l845t857r985b914],
6	may	MD	O	may	aux	7	SENT_158	[p14l1010t875r1161b936],
7	enable	VB	O	enable	prepc_of	2	SENT_158	[p14l1184t852r1410b915],
8	better	JJR	O	better	amod	9	SENT_158	[p14l1434t852r1643b915],
9	identiﬁcation	NN	O	identiﬁcation	dobj	7	SENT_158	[p14l1667t852r2142b915],
10	of	IN	O	of	_	0	SENT_158	[p14l9t956r83b1019],
11	a	DT	O	a	det	13	SENT_158	[p14l97t979r132b1019],
12	responder	NN	O	responder	nn	13	SENT_158	[p14l154t956r503b1039],
13	population	NN	O	population	prep_of	9	SENT_158	[p14l523t956r920b1039],
14	,	,	O	,	_	0	SENT_158	[p14l523t956r920b1039],
15	consider	VB	O	consider	dep	7	SENT_158	[p14l945t956r1239b1019],
16	the	DT	O	the	det	17	SENT_158	[p14l1259t956r1366b1019],
17	use	NN	O	use	dobj	15	SENT_158	[p14l1390t979r1501b1019],
18	of	IN	O	of	_	0	SENT_158	[p14l1525t956r1599b1019],
19	estrogen	NN	O	estrogen	nn	21	SENT_158	[p14l1613t968r1903b1040],
20	receptor	NN	O	receptor	nn	21	SENT_158	[p14l1927t978r2138b1039, p14l8t1071r108b1122],
21	testing	NN	O	testing	prep_of	17	SENT_158	[p14l129t1065r362b1143],
22	to	TO	O	to	aux	23	SENT_158	[p14l382t1071r449b1122],
23	direct	VB	O	direct	xcomp	15	SENT_158	[p14l474t1059r673b1122],
24	hormone	NN	O	hormone	nn	25	SENT_158	[p14l694t1059r1246b1122],
25	—	NN	O	—	dobj	23	SENT_158	[p14l694t1059r1246b1122],
26	based	VBN	O	base	prep	23	SENT_158	[p14l694t1059r1246b1122],
27	treatments	NNS	O	treatment	dep	26	SENT_158	[p14l1267t1071r1637b1122],
28	and	CC	O	and	_	0	SENT_158	[p14l1662t1059r1789b1122],
29	the	DT	O	the	det	30	SENT_158	[p14l1810t1059r1918b1122],
30	use	NN	O	use	dep	26	SENT_158	[p14l1941t1082r2053b1122],
31	of	IN	O	of	_	0	SENT_158	[p14l2077t1059r2152b1122],
32	immunocytochemistry	NN	O	immunocytochemistry	nn	36	SENT_158	[p14l9t1162r793b1246],
33	and	CC	O	and	_	0	SENT_158	[p14l810t1162r935b1225],
34	gene	NN	O	gene	conj_and	32	SENT_158	[p14l954t1185r1108b1246],
35	ampliﬁcation	NN	O	ampliﬁcation	nn	36	SENT_158	[p14l1130t1162r1575b1245],
36	studies	NNS	O	study	prep_of	30	SENT_158	[p14l1596t1162r1828b1225],
37	to	TO	O	to	aux	38	SENT_158	[p14l1848t1174r1913b1225],
38	deﬁne	VB	O	deﬁne	infmod	30	SENT_158	[p14l1935t1162r2140b1225],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_159	[p14l9t1380r257b1423],
2	PHARMACOLOGY	NN	O	pharmacology	_	0	SENT_159	[p14l275t1380r740b1423],
3	&	CC	O	&	cc	4	SENT_159	[p14l755t1380r1211b1423],
4	THERAPEUTlCS	NN	O	therapeutlc	dep	2	SENT_159	[p14l755t1380r1211b1423],

1	the	DT	O	the	det	2	SENT_160	[p14l8t1463r113b1526],
2	worth	NN	O	worth	_	0	SENT_160	[p14l132t1463r334b1526],
3	of	IN	O	of	_	0	SENT_160	[p14l354t1463r427b1526],
4	trastuzumab	NN	O	trastuzumab	prep_of	2	SENT_160	[p14l436t1463r859b1526],
5	(	CD	NUMBER	(	num	4	SENT_160	[p14l884t1464r1272b1546],
6	Herceptin	NNP	O	Herceptin	nsubj	9	SENT_160	[p14l884t1464r1272b1546],
7	)	CD	NUMBER	)	num	6	SENT_160	[p14l884t1464r1272b1546],
8	to	TO	O	to	aux	9	SENT_160	[p14l1296t1475r1360b1526],
9	treat	VB	O	treat	infmod	2	SENT_160	[p14l1381t1475r1534b1526],
10	breast	NN	O	breast	nn	11	SENT_160	[p14l1551t1463r1754b1526],
11	cancer	NN	O	cancer	dobj	9	SENT_160	[p14l1773t1486r2002b1526],
12	.	.	O	.	_	0	SENT_160	[p14l1773t1486r2002b1526],

1	The	DT	O	the	det	2	SENT_161	[p14l2025t1463r2148b1526],
2	use	NN	O	use	nsubj	22	SENT_161	[p14l9t1589r120b1629],
3	of	IN	O	of	_	0	SENT_161	[p14l144t1566r217b1629],
4	a	DT	O	a	det	7	SENT_161	[p14l231t1589r266b1629],
5	companion	NN	O	companion	nn	7	SENT_161	[p14l288t1572r677b1649],
6	diagnostic	JJ	O	diagnostic	amod	7	SENT_161	[p14l700t1566r1053b1650],
7	test	NN	O	test	prep_of	2	SENT_161	[p14l1074t1578r1193b1629],
8	for	IN	O	for	_	0	SENT_161	[p14l1214t1566r1312b1629],
9	either	CC	O	either	preconj	11	SENT_161	[p14l1334t1566r1532b1629],
10	estrogen	NN	O	estrogen	nn	11	SENT_161	[p14l1554t1578r1843b1650],
11	receptor	NN	O	receptor	prep_for	7	SENT_161	[p14l1867t1578r2151b1649],
12	or	CC	O	or	_	0	SENT_161	[p14l10t1692r81b1732],
13	human	JJ	O	human	amod	20	SENT_161	[p14l98t1669r338b1732],
14	epidermal	JJ	O	epidermal	dep	15	SENT_161	[p14l358t1669r700b1752],
15	growth	NN	O	growth	amod	20	SENT_161	[p14l719t1669r959b1753],
16	factor	NN	O	factor	nn	20	SENT_161	[p14l978t1669r1175b1732],
17	receptor-2	NN	O	receptor-2	nn	20	SENT_161	[p14l1194t1676r1540b1752],
18	(	CD	NUMBER	(	num	20	SENT_161	[p14l1565t1669r1820b1746],
19	HER2	NN	O	her2	nn	20	SENT_161	[p14l1565t1669r1820b1746],
20	)	NN	O	)	prep_for	7	SENT_161	[p14l1565t1669r1820b1746],
21	may	MD	O	may	aux	22	SENT_161	[p14l1844t1692r1989b1753],
22	help	VB	O	help	_	0	SENT_161	[p14l2004t1669r2147b1752],
23	identify	VB	O	identify	xcomp	22	SENT_161	[p14l9t1772r276b1856],
24	susceptible	JJ	O	susceptible	amod	25	SENT_161	[p14l293t1772r665b1855],
25	tumors	NNS	O	tumor	dobj	23	SENT_161	[p14l684t1784r945b1835],
26	.	.	O	.	_	0	SENT_161	[p14l684t1784r945b1835],

1	Trastuzumab	NNP	O	Trastuzumab	nsubjpass	3	SENT_162	[p14l968t1772r1414b1835],
2	was	VBD	O	be	auxpass	3	SENT_162	[p14l1433t1795r1558b1835],
3	developed	VBN	O	develop	_	0	SENT_162	[p14l1580t1772r1928b1855],
4	with	IN	O	with	_	0	SENT_162	[p14l1945t1772r2097b1835],
5	a	DT	O	a	det	7	SENT_162	[p14l2118t1795r2152b1835],
6	development	NN	O	development	nn	7	SENT_162	[p14l10t1875r447b1958],
7	plan	NN	O	plan	prep_with	3	SENT_162	[p14l465t1875r611b1958],
8	to	TO	O	to	_	0	SENT_162	[p14l630t1887r695b1938],
9	screen-in	JJ	O	screen-in	amod	11	SENT_162	[p14l717t1881r1030b1938],
10	potential	JJ	O	potential	amod	11	SENT_162	[p14l1048t1875r1350b1958],
11	responders	NNS	O	responder	prep_to	3	SENT_162	[p14l1369t1875r1739b1958],
12	and	CC	O	and	_	0	SENT_162	[p14l1761t1875r1885b1938],
13	screenout	NN	O	screenout	nsubj	14	SENT_162	[p14l1905t1898r2145b1938, p14l10t1991r122b2042],
14	expected	VBD	O	expect	conj_and	3	SENT_162	[p14l143t1979r448b2062],
15	nonresponders	NNS	O	nonresponder	dobj	14	SENT_162	[p14l470t1979r1003b2062],
16	.	.	O	.	_	0	SENT_162	[p14l470t1979r1003b2062],

1	Yet	RB	O	yet	advmod	2	SENT_163	[p14l1027t1984r1134b2042],
2	correlating	VBG	O	correlate	_	0	SENT_163	[p14l1156t1979r1529b2063],
3	estrogen	NN	O	estrogen	nn	4	SENT_163	[p14l1551t1991r1841b2063],
4	receptor	NN	O	receptor	dobj	2	SENT_163	[p14l1864t1991r2149b2062],
5	or	CC	O	or	_	0	SENT_163	[p14l10t2105r80b2145],
6	HER2	NN	O	her2	nn	7	SENT_163	[p14l99t2087r300b2145],
7	positivity	NN	O	positivity	conj_or	4	SENT_163	[p14l320t2088r636b2166],
8	and	CC	O	and	_	0	SENT_163	[p14l653t2082r776b2145],
9	hormone	NN	O	hormone	nn	12	SENT_163	[p14l794t2082r1103b2145],
10	or	CC	O	or	_	0	SENT_163	[p14l1124t2105r1194b2145],
11	trastuzumab	NN	O	trastuzumab	conj_or	9	SENT_163	[p14l1211t2082r1631b2145],
12	responsiveness	NN	O	responsiveness	conj_and	4	SENT_163	[p14l1652t2088r2148b2165],
13	remains	VBZ	O	remain	dep	2	SENT_163	[p14l10t2191r285b2248],
14	a	DT	O	a	det	16	SENT_163	[p14l309t2208r344b2248],
15	complex	JJ	O	complex	amod	16	SENT_163	[p14l367t2185r660b2268],
16	process	NN	O	process	nsubj	2	SENT_163	[p14l680t2207r955b2268],
17	,	,	O	,	_	0	SENT_163	[p14l680t2207r955b2268],
18	reﬂecting	VBG	O	reﬂecting	amod	19	SENT_163	[p14l980t2185r1307b2269],
19	variability	NN	O	variability	appos	16	SENT_163	[p14l1325t2185r1679b2269],
20	in	IN	O	in	_	0	SENT_163	[p14l1698t2191r1766b2247],
21	the	DT	O	the	det	23	SENT_163	[p14l1788t2185r1895b2248],
22	testing	NN	O	testing	nn	23	SENT_163	[p14l1918t2191r2150b2269],
23	process	NN	O	process	prep_in	19	SENT_163	[p14l8t2310r263b2371],
24	and	CC	O	and	_	0	SENT_163	[p14l287t2288r414b2351],
25	other	JJ	O	other	amod	26	SENT_163	[p14l436t2288r618b2351],
26	factors	NNS	O	factor	conj_and	19	SENT_163	[p14l640t2288r870b2351],
27	in	IN	O	in	_	0	SENT_163	[p14l893t2294r960b2350],
28	the	DT	O	the	det	29	SENT_163	[p14l982t2288r1089b2351],
29	population	NN	O	population	prep_in	26	SENT_163	[p14l1111t2288r1489b2371],
30	that	WDT	O	that	nsubj	32	SENT_163	[p14l1511t2288r1645b2351],
31	may	MD	O	may	aux	32	SENT_163	[p14l1666t2311r1814b2372],
32	inﬂuence	VB	O	inﬂuence	rcmod	29	SENT_163	[p14l1833t2288r2149b2351],
33	outcomes	NNS	O	outcome	dobj	32	SENT_163	[p14l10t2382r516b2454],
34	.18	CD	NUMBER	.18	num	33	SENT_163	[p14l10t2382r516b2454],
35	‘	CD	NUMBER	‘	number	36	SENT_163	[p14l10t2382r516b2454],
36	21	CD	NUMBER	21	num	39	SENT_163	[p14l10t2382r516b2454],
37	The	DT	O	the	det	39	SENT_163	[p14l543t2390r669b2454],
38	effectiveness	NN	O	effectiveness	nn	39	SENT_163	[p14l693t2390r1123b2454],
39	portion	NN	O	portion	nsubj	45	SENT_163	[p14l1145t2397r1407b2474],
40	of	IN	O	of	_	0	SENT_163	[p14l1431t2390r1505b2454],
41	an	DT	O	a	det	43	SENT_163	[p14l1519t2413r1600b2454],
42	E2E	NN	O	e2e	nn	43	SENT_163	[p14l1622t2396r1760b2453],
43	trial	NN	O	trial	prep_of	39	SENT_163	[p14l1782t2390r1924b2454],
44	might	MD	O	might	aux	45	SENT_163	[p14l1946t2390r2151b2475],
45	provide	VB	O	provide	rcmod	33	SENT_163	[p14l8t2494r273b2577],
46	an	DT	O	a	det	47	SENT_163	[p14l297t2517r378b2557],
47	opportunity	NN	O	opportunity	dobj	45	SENT_163	[p14l401t2500r824b2578],
48	to	TO	O	to	aux	50	SENT_163	[p14l842t2506r909b2557],
49	better	JJR	O	better	advmod	50	SENT_163	[p14l931t2494r1135b2557],
50	identify	VB	O	identify	infmod	47	SENT_163	[p14l1157t2494r1429b2578],
51	a	DT	O	a	det	53	SENT_163	[p14l1449t2517r1483b2557],
52	responder	NN	O	responder	nn	53	SENT_163	[p14l1506t2494r1858b2577],
53	population	NN	O	population	dobj	50	SENT_163	[p14l1878t2494r2147b2577, p14l8t2602r146b2659],
54	in	IN	O	in	_	0	SENT_163	[p14l168t2602r234b2658],
55	this	DT	O	this	det	56	SENT_163	[p14l255t2596r379b2659],
56	case	NN	O	case	prep_in	53	SENT_163	[p14l402t2619r558b2659],
57	.	.	O	.	_	0	SENT_163	[p14l402t2619r558b2659],

1	Finally	RB	O	finally	advmod	6	SENT_164	[p14l84t2699r343b2783],
2	,	,	O	,	_	0	SENT_164	[p14l84t2699r343b2783],
3	there	EX	O	there	expl	6	SENT_164	[p14l372t2699r555b2762],
4	may	MD	O	may	aux	6	SENT_164	[p14l583t2722r735b2783],
5	be	VB	O	be	cop	6	SENT_164	[p14l758t2699r840b2762],
6	beneﬁts	NNS	O	beneﬁts	_	0	SENT_164	[p14l866t2699r1146b2762],
7	to	TO	O	to	_	0	SENT_164	[p14l1174t2711r1242b2762],
8	patients	NNS	O	patient	prep_to	6	SENT_164	[p14l1270t2705r1575b2782],
9	,	,	O	,	_	0	SENT_164	[p14l1270t2705r1575b2782],
10	providers	NNS	O	provider	prep_to	6	SENT_164	[p14l1604t2699r1966b2782],
11	,	,	O	,	_	0	SENT_164	[p14l1604t2699r1966b2782],
12	payers	NNS	O	payer	prep_to	6	SENT_164	[p14l1994t2721r2148b2783, p14l10t2825r128b2874],
13	,	,	O	,	_	0	SENT_164	[p14l1994t2721r2148b2783, p14l10t2825r128b2874],
14	and	CC	O	and	_	0	SENT_164	[p14l155t2802r285b2865],
15	regulators	NNS	O	regulator	prep_to	6	SENT_164	[p14l310t2802r882b2886],
16	—	CD	NUMBER	—	num	15	SENT_164	[p14l310t2802r882b2886],
17	and	CC	O	and	_	0	SENT_164	[p14l310t2802r882b2886],
18	to	TO	O	to	_	0	SENT_164	[p14l904t2814r972b2865],
19	manufacturers	NNS	O	manufacturer	conj_and	8	SENT_164	[p14l998t2802r1671b2865],
20	—	VBP	O	—	rcmod	19	SENT_164	[p14l998t2802r1671b2865],
21	in	IN	O	in	_	0	SENT_164	[p14l998t2802r1671b2865],
22	aligning	VBG	O	align	prepc_in	20	SENT_164	[p14l1697t2802r1986b2886],
23	E2E	NN	O	e2e	dobj	22	SENT_164	[p14l2009t2807r2149b2864],
24	with	IN	O	with	_	0	SENT_164	[p14l8t2905r168b2968],
25	proposed	VBN	O	propose	amod	27	SENT_164	[p14l197t2905r538b2988],
26	adaptive	JJ	O	adaptive	amod	27	SENT_164	[p14l567t2905r871b2988],
27	approaches	NNS	O	approach	prep_with	22	SENT_164	[p14l901t2905r1308b2988],
28	to	TO	O	to	_	0	SENT_164	[p14l1337t2917r1406b2968],
29	drug	NN	O	drug	nn	30	SENT_164	[p14l1438t2905r1609b2989],
30	licensing	NN	O	licensing	prep_to	27	SENT_164	[p14l1635t2905r1979b2989],
31	.	.	O	.	_	0	SENT_164	[p14l1635t2905r1979b2989],

1	The	DT	O	the	det	3	SENT_165	[p14l2011t2905r2150b2968],
2	E2E	NN	O	e2e	nn	3	SENT_165	[p14l9t3013r147b3070],
3	approach	NN	O	approach	nsubjpass	5	SENT_165	[p14l171t3008r492b3091],
4	is	VBZ	O	be	auxpass	5	SENT_165	[p14l515t3014r566b3071],
5	premised	VBN	O	premise	_	0	SENT_165	[p14l588t3008r912b3091],
6	on	IN	O	on	_	0	SENT_165	[p14l936t3031r1022b3071],
7	gathering	VBG	O	gather	conj_but	7	SENT_165	[p14l1046t3008r1378b3092],
8	information	NN	O	information	dobj	7	SENT_165	[p14l1399t3008r1820b3071],
9	on	IN	O	on	_	0	SENT_165	[p14l1844t3031r1931b3071],
10	wider	JJR	O	wider	amod	11	SENT_165	[p14l1952t3008r2151b3071],
11	effectiveness	NN	O	effectiveness	prep_on	7	SENT_165	[p14l10t3111r436b3174],
12	as	RB	O	as	advmod	13	SENT_165	[p14l458t3134r522b3174],
13	early	RB	O	early	advmod	11	SENT_165	[p14l544t3111r710b3195],
14	as	IN	O	as	_	0	SENT_165	[p14l728t3134r793b3174],
15	possible	JJ	O	possible	prep_as	13	SENT_165	[p14l812t3111r1106b3194],
16	,	,	O	,	_	0	SENT_165	[p14l812t3111r1106b3194],
17	before	IN	O	before	_	0	SENT_165	[p14l1126t3111r1341b3174],
18	full	JJ	O	full	amod	19	SENT_165	[p14l1362t3111r1475b3174],
19	licensing	NN	O	licensing	prep_before	7	SENT_165	[p14l1494t3111r1817b3195],
20	,	,	O	,	_	0	SENT_165	[p14l1494t3111r1817b3195],
21	but	CC	O	but	_	0	SENT_165	[p14l1837t3111r1950b3174],
22	without	IN	O	without	_	0	SENT_165	[p14l1968t3111r2149b3174, p14l10t3226r126b3277],
23	delaying	VBG	O	delay	prepc_without	7	SENT_165	[p14l152t3214r454b3298],
24	market	NN	O	market	nn	25	SENT_165	[p14l478t3214r731b3277],
25	authorization	NN	O	authorization	dobj	23	SENT_165	[p14l758t3214r1260b3277],
26	.	.	O	.	_	0	SENT_165	[p14l758t3214r1260b3277],

1	Under	IN	O	under	_	0	SENT_166	[p14l1290t3214r1517b3277],
2	current	JJ	DATE	current	amod	4	SENT_166	[p14l1543t3226r1808b3277],
3	licensing	NN	O	licensing	nn	4	SENT_166	[p14l1832t3214r2153b3298],
4	pathways	NNS	O	pathway	prep_under	12	SENT_166	[p14l8t3318r351b3402],
5	,	,	O	,	_	0	SENT_166	[p14l8t3318r351b3402],
6	binary	JJ	O	binary	amod	7	SENT_166	[p14l375t3318r606b3402],
7	approval	NN	O	approval	nsubjpass	12	SENT_166	[p14l627t3318r929b3401],
8	or	CC	O	or	_	0	SENT_166	[p14l953t3341r1026b3381],
9	disapproval	NN	O	disapproval	nn	10	SENT_166	[p14l1049t3318r1454b3401],
10	decisions	NNS	O	decision	nsubjpass	12	SENT_166	[p14l1478t3318r1799b3381],
11	are	VBP	O	be	auxpass	12	SENT_166	[p14l1824t3341r1926b3381],
12	based	VBN	O	base	_	0	SENT_166	[p14l1948t3318r2149b3381],
13	largely	RB	O	largely	advmod	12	SENT_166	[p14l8t3421r236b3505],
14	on	IN	O	on	_	0	SENT_166	[p14l253t3444r339b3484],
15	randomized	VBN	O	randomize	prepc_on	12	SENT_166	[p14l360t3421r774b3484],
16	efﬁcacy	NN	O	efﬁcacy	nn	17	SENT_166	[p14l794t3421r1051b3505],
17	trials	NNS	O	trial	dobj	15	SENT_166	[p14l1067t3421r1237b3484],
18	with	IN	O	with	_	0	SENT_166	[p14l1256t3421r1408b3484],
19	confounder	NN	O	confounder	npadvmod	21	SENT_166	[p14l1430t3421r2149b3484],
20	—	CD	NUMBER	—	num	19	SENT_166	[p14l1430t3421r2149b3484],
21	cleansed	JJ	O	cleansed	amod	22	SENT_166	[p14l1430t3421r2149b3484],
22	populations	NNS	O	population	prep_with	15	SENT_166	[p14l8t3524r437b3607],
23	.	.	O	.	_	0	SENT_166	[p14l8t3524r437b3607],

1	Adaptive	JJ	O	adaptive	amod	2	SENT_167	[p14l462t3524r772b3607],
2	approaches	NNS	O	approach	nsubjpass	6	SENT_167	[p14l796t3524r1184b3607],
3	to	TO	O	to	_	0	SENT_167	[p14l1206t3536r1273b3587],
4	licensing	NN	O	licensing	prep_to	2	SENT_167	[p14l1296t3524r1606b3608],
5	are	VBP	O	be	auxpass	6	SENT_167	[p14l1628t3547r1729b3587],
6	intended	VBN	O	intend	_	0	SENT_167	[p14l1752t3524r2060b3587],
7	to	TO	O	to	aux	8	SENT_167	[p14l2080t3536r2147b3587],
8	create	VB	O	create	xcomp	6	SENT_167	[p14l10t3639r215b3690],
9	a	DT	O	a	det	12	SENT_167	[p14l241t3650r276b3690],
10	more	RBR	O	more	advmod	11	SENT_167	[p14l299t3650r481b3690],
11	ﬂexible	JJ	O	ﬂexible	amod	12	SENT_167	[p14l506t3627r758b3690],
12	option	NN	O	option	dobj	8	SENT_167	[p14l783t3633r1014b3710],
13	between	IN	O	between	_	0	SENT_167	[p14l1036t3627r1330b3690],
14	approval	NN	O	approval	prep_between	12	SENT_167	[p14l1356t3627r1660b3710],
15	and	CC	O	and	_	0	SENT_167	[p14l1685t3627r1815b3690],
16	rejection	NN	O	rejection	prep_between	12	SENT_167	[p14l1838t3633r2149b3711],
17	of	IN	O	of	_	0	SENT_167	[p14l10t3730r86b3793],
18	drugs	NNS	O	drug	prep_of	12	SENT_167	[p14l103t3730r320b3814],
19	.	.	O	.	_	0	SENT_167	[p14l103t3730r320b3814],

1	Eichler	NNP	PERSON	Eichler	nsubj	5	SENT_168	[p14l349t3730r602b3793],
2	et	FW	O	et	nn	3	SENT_168	[p14l628t3741r689b3793],
3	al.	FW	O	al.	dep	1	SENT_168	[p14l711t3730r787b3793],
4	have	VBP	O	have	aux	5	SENT_168	[p14l818t3730r979b3793],
5	assessed	VBN	O	assess	_	0	SENT_168	[p14l1006t3730r1299b3793],
6	the	DT	O	the	det	7	SENT_168	[p14l1322t3730r1432b3793],
7	beneﬁts	NNS	O	beneﬁts	dobj	5	SENT_168	[p14l1456t3730r1733b3793],
8	of	IN	O	of	_	0	SENT_168	[p14l1760t3730r1836b3793],
9	adaptive	JJ	O	adaptive	amod	10	SENT_168	[p14l1852t3730r2150b3813],
10	approaches	NNS	O	approach	prep_of	7	SENT_168	[p15l10t16r396b99],
11	to	TO	O	to	_	0	SENT_168	[p15l419t28r485b79],
12	licensing	NN	O	licensing	prep_to	5	SENT_168	[p15l507t16r816b100],
13	with	IN	O	with	_	0	SENT_168	[p15l835t16r989b79],
14	iterative	JJ	O	iterative	amod	15	SENT_168	[p15l1012t22r1288b79],
15	phases	NNS	O	phase	prep_with	12	SENT_168	[p15l1310t16r1537b99],
16	of	IN	O	of	_	0	SENT_168	[p15l1561t16r1636b79],
17	evidence	NN	O	evidence	nn	18	SENT_168	[p15l1649t16r1950b79],
18	gathering	NN	O	gathering	prep_of	15	SENT_168	[p15l1973t16r2148b100, p15l10t125r193b203],
19	and	CC	O	and	_	0	SENT_168	[p15l216t118r346b182],
20	reassessment	NN	O	reassessment	conj_and	18	SENT_168	[p15l370t130r832b182],
21	over	IN	O	over	_	0	SENT_168	[p15l856t141r1008b182],
22	the	DT	O	the	det	24	SENT_168	[p15l1030t118r1140b182],
23	life	NN	O	life	nn	24	SENT_168	[p15l1163t118r1271b182],
24	cycle	NN	O	cycle	prep_over	5	SENT_168	[p15l1296t118r1469b203],
25	of	IN	O	of	_	0	SENT_168	[p15l1494t118r1570b182],
26	drugs	NNS	O	drug	prep_of	24	SENT_168	[p15l1585t110r1869b203],
27	.	.	O	.	_	0	SENT_168	[p15l1585t110r1869b203],

1	”	NNP	O	”	dep	14	SENT_169	[p15l1585t110r1869b203],
2	During	IN	O	during	_	0	SENT_169	[p15l1893t124r2151b203],
3	the	DT	O	the	det	6	SENT_169	[p15l8t222r117b285],
4	initial	JJ	O	initial	amod	6	SENT_169	[p15l142t222r348b285],
5	authorization	NN	O	authorization	nn	6	SENT_169	[p15l372t222r847b285],
6	phase	NN	O	phase	prep_during	14	SENT_169	[p15l869t222r1088b305],
7	,	,	O	,	_	0	SENT_169	[p15l869t222r1088b305],
8	patient	NN	O	patient	nn	9	SENT_169	[p15l1112t228r1359b305],
9	access	NN	O	access	nsubjpass	14	SENT_169	[p15l1382t245r1594b285],
10	to	TO	O	to	_	0	SENT_169	[p15l1617t234r1685b285],
11	drugs	NNS	O	drug	prep_to	9	SENT_169	[p15l1711t222r1908b306],
12	would	MD	O	would	aux	14	SENT_169	[p15l1930t222r2150b285],
13	be	VB	O	be	auxpass	14	SENT_169	[p15l7t325r86b388],
14	managed	VBN	O	manage	_	0	SENT_169	[p15l107t325r419b409],
15	to	TO	O	to	aux	16	SENT_169	[p15l437t337r503b388],
16	limit	VB	O	limit	xcomp	14	SENT_169	[p15l523t325r685b388],
17	exposure	NN	O	exposure	dobj	16	SENT_169	[p15l706t347r1013b408],
18	to	TO	O	to	_	0	SENT_169	[p15l1032t337r1098b388],
19	risks	NNS	O	risk	prep_to	16	SENT_169	[p15l1120t325r1276b388],
20	while	IN	O	while	mark	32	SENT_169	[p15l1296t325r1481b388],
21	information	NN	O	information	nsubjpass	32	SENT_169	[p15l1502t325r1915b388],
22	on	IN	O	on	_	0	SENT_169	[p15l1936t348r2022b388],
23	the	DT	O	the	det	24	SENT_169	[p15l2041t325r2148b388],
24	efficacy	NN	O	efficacy	prep_on	21	SENT_169	[p15l10t428r274b512],
25	and	CC	O	and	_	0	SENT_169	[p15l295t428r424b491],
26	safety	NN	O	safety	conj_and	24	SENT_169	[p15l447t428r649b512],
27	of	IN	O	of	_	0	SENT_169	[p15l669t428r745b491],
28	drugs	NNS	O	drug	prep_of	24	SENT_169	[p15l760t428r956b512],
29	in	IN	O	in	_	0	SENT_169	[p15l980t434r1048b490],
30	use	NN	O	use	prep_in	28	SENT_169	[p15l1072t451r1186b491],
31	is	VBZ	O	be	auxpass	32	SENT_169	[p15l1210t434r1261b491],
32	accumulated	VBN	O	accumulate	advcl	16	SENT_169	[p15l1286t428r1750b491],
33	.	.	O	.	_	0	SENT_169	[p15l1286t428r1750b491],

1	Regulators	NNS	O	regulator	nsubj	14	SENT_170	[p15l1777t428r2150b512],
2	in	IN	O	in	_	0	SENT_170	[p15l9t537r77b593],
3	Europe	NNP	LOCATION	Europe	nn	7	SENT_170	[p15l99t536r366b614],
4	,	,	O	,	_	0	SENT_170	[p15l99t536r366b614],
5	Singapore	NNP	LOCATION	Singapore	appos	7	SENT_170	[p15l392t535r752b615],
6	,	,	O	,	_	0	SENT_170	[p15l392t535r752b615],
7	Canada	NNP	LOCATION	Canada	prep_in	1	SENT_170	[p15l778t531r1058b603],
8	,	,	O	,	_	0	SENT_170	[p15l778t531r1058b603],
9	and	CC	O	and	_	0	SENT_170	[p15l1084t531r1211b594],
10	elsewhere	RB	O	elsewhere	prep_in	1	SENT_170	[p15l1233t531r1570b594],
11	are	VBP	O	be	aux	14	SENT_170	[p15l1594t554r1695b594],
12	now	RB	DATE	now	advmod	14	SENT_170	[p15l1718t554r1868b594],
13	actively	RB	O	actively	advmod	14	SENT_170	[p15l1889t531r2152b615],
14	considering	VBG	O	consider	_	0	SENT_170	[p15l10t634r420b718],
15	initiation	NN	O	initiation	dobj	14	SENT_170	[p15l441t640r762b697],
16	of	IN	O	of	_	0	SENT_170	[p15l786t634r861b697],
17	pilot	NN	O	pilot	nn	20	SENT_170	[p15l873t634r1033b717],
18	adaptive	JJ	O	adaptive	amod	20	SENT_170	[p15l1056t634r1345b717],
19	licensing	NN	O	licensing	nn	20	SENT_170	[p15l1367t634r1679b718],
20	projects	NNS	O	project	prep_of	15	SENT_170	[p15l1699t640r1973b718],
21	with	IN	O	with	_	0	SENT_170	[p15l1995t634r2150b697],
22	initial	JJ	O	initial	amod	24	SENT_170	[p15l10t737r215b800],
23	authorization	NN	O	authorization	nn	24	SENT_170	[p15l239t737r713b800],
24	phases	NNS	O	phase	prep_with	14	SENT_170	[p15l735t737r985b820],
25	.	.	O	.	_	0	SENT_170	[p15l735t737r985b820],

1	If	IN	O	if	mark	4	SENT_171	[p15l1013t737r1073b799],
2	pilots	NNS	O	pilot	nsubjpass	4	SENT_171	[p15l1086t737r1278b820],
3	are	VBP	O	be	auxpass	4	SENT_171	[p15l1304t760r1406b800],
4	initiated	VBN	O	initiate	advcl	13	SENT_171	[p15l1430t737r1740b809],
5	,	,	O	,	_	0	SENT_171	[p15l1430t737r1740b809],
6	then	RB	O	then	advmod	9	SENT_171	[p15l1765t737r1922b800],
7	initial	JJ	O	initial	amod	9	SENT_171	[p15l1946t737r2152b800],
8	authorization	NN	O	authorization	nn	9	SENT_171	[p15l10t840r464b903],
9	periods	NNS	O	period	nsubjpass	13	SENT_171	[p15l482t840r735b923],
10	could	MD	O	could	aux	13	SENT_171	[p15l757t840r944b903],
11	potentially	RB	O	potentially	advmod	13	SENT_171	[p15l962t840r1326b924],
12	be	VB	O	be	auxpass	13	SENT_171	[p15l1340t840r1418b903],
13	structured	VBN	O	structure	_	0	SENT_171	[p15l1439t840r1789b903],
14	to	TO	O	to	aux	15	SENT_171	[p15l1807t852r1872b903],
15	provide	VB	O	provide	xcomp	13	SENT_171	[p15l1892t840r2149b923],
16	information	NN	O	information	dobj	15	SENT_171	[p15l9t943r420b1006],
17	on	IN	O	on	_	0	SENT_171	[p15l441t966r526b1006],
18	effectiveness	NN	O	effectiveness	prep_on	15	SENT_171	[p15l547t943r968b1006],
19	along	IN	O	along	_	0	SENT_171	[p15l990t943r1176b1027],
20	with	IN	O	with	_	0	SENT_171	[p15l1192t943r1344b1006],
21	efficacy	NN	O	efficacy	prep_along_with	18	SENT_171	[p15l1364t943r1620b1027],
22	and	CC	O	and	_	0	SENT_171	[p15l1637t943r1762b1006],
23	safety	NN	O	safety	conj_and	21	SENT_171	[p15l1782t943r1983b1027],
24	.	.	O	.	_	0	SENT_171	[p15l1782t943r1983b1027],

1	This	DT	O	this	nsubj	3	SENT_172	[p15l2006t943r2148b1006],
2	will	MD	O	will	aux	3	SENT_172	[p15l8t1046r138b1109],
3	require	VB	O	require	_	0	SENT_172	[p15l164t1052r418b1129],
4	consideration	NN	O	consideration	dobj	3	SENT_172	[p15l445t1046r932b1109],
5	of	IN	O	of	_	0	SENT_172	[p15l959t1046r1035b1109],
6	the	DT	O	the	det	7	SENT_172	[p15l1049t1046r1160b1109],
7	extent	NN	O	extent	prep_of	4	SENT_172	[p15l1186t1058r1404b1109],
8	to	TO	O	to	_	0	SENT_172	[p15l1428t1058r1496b1109],
9	which	WDT	O	which	rel	12	SENT_172	[p15l1520t1046r1738b1109],
10	E2E	NN	O	e2e	nsubj	12	SENT_172	[p15l1763t1051r1904b1108],
11	would	MD	O	would	aux	12	SENT_172	[p15l1928t1046r2150b1109],
12	provide	VB	O	provide	rcmod	7	SENT_172	[p15l8t1149r269b1232],
13	data	NNS	O	datum	dobj	12	SENT_172	[p15l292t1149r436b1212],
14	needed	VBN	O	need	partmod	13	SENT_172	[p15l456t1149r704b1212],
15	for	IN	O	for	_	0	SENT_172	[p15l725t1149r822b1212],
16	licensing	NN	O	licensing	prep_for	14	SENT_172	[p15l841t1149r1163b1233],
17	.	.	O	.	_	0	SENT_172	[p15l841t1149r1163b1233],

1	What	WDT	O	what	det	2	SENT_173	[p15l8t1362r191b1419],
2	design	NN	O	design	nsubjpass	6	SENT_173	[p15l208t1362r438b1435],
3	issues	NNS	O	issue	dep	2	SENT_173	[p15l459t1362r665b1419],
4	must	MD	O	must	aux	6	SENT_173	[p15l684t1369r855b1419],
5	be	VB	O	be	auxpass	6	SENT_173	[p15l874t1362r957b1419],
6	addressed	VBN	O	address	_	0	SENT_173	[p15l973t1362r1331b1419],
7	to	TO	O	to	aux	8	SENT_173	[p15l1349t1369r1420b1419],
8	implement	VB	O	implement	xcomp	6	SENT_173	[p15l1439t1362r1817b1434],
9	E2E	NN	O	e2e	nn	10	SENT_173	[p15l1837t1364r1957b1418],
10	trials	NNS	O	trial	dobj	8	SENT_173	[p15l8t1465r217b1522],
11	?	.	O	?	_	0	SENT_173	[p15l8t1465r217b1522],

1	Although	IN	O	although	mark	3	SENT_174	[p15l8t1562r328b1646],
2	there	EX	O	there	expl	3	SENT_174	[p15l346t1562r516b1625],
3	are	VBP	O	be	advcl	17	SENT_174	[p15l536t1585r634b1625],
4	many	JJ	O	many	amod	5	SENT_174	[p15l654t1585r843b1646],
5	nuances	NNS	O	nuance	nsubj	3	SENT_174	[p15l859t1585r1146b1634],
6	,	,	O	,	_	0	SENT_174	[p15l859t1585r1146b1634],
7	the	DT	O	the	det	9	SENT_174	[p15l1167t1562r1271b1625],
8	key	JJ	O	key	amod	9	SENT_174	[p15l1289t1562r1407b1646],
9	issues	NNS	O	issue	nsubjpass	17	SENT_174	[p15l1423t1568r1613b1625],
10	for	IN	O	for	_	0	SENT_174	[p15l1633t1562r1729b1625],
11	efﬁcacy	NN	O	efﬁcacy	nn	13	SENT_174	[p15l1747t1562r1999b1646],
12	trial	NN	O	trial	nn	13	SENT_174	[p15l2014t1562r2151b1625],
13	design	NN	O	design	prep_for	9	SENT_174	[p15l10t1665r226b1749],
14	are	VBP	O	be	auxpass	17	SENT_174	[p15l246t1688r344b1728],
15	generally	RB	O	generally	advmod	17	SENT_174	[p15l364t1665r671b1749],
16	well	RB	O	well	advmod	17	SENT_174	[p15l685t1665r820b1728],
17	understood	VBN	O	understand	_	0	SENT_174	[p15l839t1665r1241b1728],
18	.	.	O	.	_	0	SENT_174	[p15l839t1665r1241b1728],

1	By	IN	O	by	_	0	SENT_175	[p15l1264t1670r1352b1749],
2	contrast	NN	O	contrast	agent	17	SENT_175	[p15l1369t1677r1655b1737],
3	,	,	O	,	_	0	SENT_175	[p15l1369t1677r1655b1737],
4	the	DT	O	the	det	7	SENT_175	[p15l1675t1665r1779b1728],
5	more	RBR	O	more	advmod	7	SENT_175	[p15l1799t1688r1973b1728],
6	variable	JJ	O	variable	amod	7	SENT_175	[p15l1990t1671r2146b1728, p15l10t1768r141b1831],
7	design	NN	O	design	nsubj	29	SENT_175	[p15l161t1768r376b1852],
8	and	CC	O	and	_	0	SENT_175	[p15l396t1768r519b1831],
9	implementation	NN	O	implementation	nn	10	SENT_175	[p15l538t1768r1071b1851],
10	aspects	NNS	O	aspect	nsubjpass	17	SENT_175	[p15l1091t1780r1326b1851],
11	of	IN	O	of	_	0	SENT_175	[p15l1348t1768r1420b1831],
12	effectiveness	NN	O	effectiveness	nn	13	SENT_175	[p15l1430t1768r1844b1831],
13	trials	NNS	O	trial	prep_of	10	SENT_175	[p15l1863t1768r2029b1831],
14	are	VBP	O	be	auxpass	17	SENT_175	[p15l2050t1791r2147b1831],
15	less	RBR	O	less	advmod	16	SENT_175	[p15l8t1871r129b1934],
16	well	RB	O	well	advmod	17	SENT_175	[p15l151t1871r292b1934],
17	understood	VBN	O	understand	_	0	SENT_175	[p15l315t1871r722b1934],
18	and	CC	O	and	_	0	SENT_175	[p15l745t1871r890b1943],
19	,	,	O	,	_	0	SENT_175	[p15l745t1871r890b1943],
20	in	IN	O	in	dep	17	SENT_175	[p15l916t1877r984b1933],
21	the	DT	O	the	det	22	SENT_175	[p15l1006t1871r1115b1934],
22	context	NN	O	context	pobj	20	SENT_175	[p15l1140t1883r1398b1934],
23	of	IN	O	of	_	0	SENT_175	[p15l1421t1871r1496b1934],
24	the	DT	O	the	det	26	SENT_175	[p15l1509t1871r1617b1934],
25	E2E	NN	O	e2e	nn	26	SENT_175	[p15l1641t1876r1780b1933],
26	approach	NN	O	approach	prep_of	22	SENT_175	[p15l1804t1871r2146b1954],
27	,	,	O	,	_	0	SENT_175	[p15l1804t1871r2146b1954],
28	will	MD	O	will	aux	29	SENT_175	[p15l8t1974r134b2037],
29	require	VB	O	require	conj_and	17	SENT_175	[p15l155t1980r399b2057],
30	further	JJ	O	further	amod	31	SENT_175	[p15l421t1974r666b2037],
31	research	NN	O	research	dobj	29	SENT_175	[p15l686t1974r987b2037],
32	.	.	O	.	_	0	SENT_175	[p15l686t1974r987b2037],

1	First	RB	ORDINAL	first	advmod	4	SENT_176	[p15l84t2082r260b2149],
2	,	,	O	,	_	0	SENT_176	[p15l84t2082r260b2149],
3	there	EX	O	there	expl	4	SENT_176	[p15l285t2077r464b2140],
4	is	VBZ	O	be	_	0	SENT_176	[p15l488t2083r539b2140],
5	no	DT	O	no	det	6	SENT_176	[p15l563t2100r651b2140],
6	agreement	NN	O	agreement	nsubj	4	SENT_176	[p15l677t2089r1046b2161],
7	on	IN	O	on	_	0	SENT_176	[p15l1069t2100r1157b2140],
8	how	WRB	O	how	advmod	10	SENT_176	[p15l1180t2077r1331b2140],
9	to	TO	O	to	aux	10	SENT_176	[p15l1351t2089r1418b2140],
10	secure	VB	O	secure	conj_and	10	SENT_176	[p15l1444t2100r1665b2140],
11	generalizable	JJ	O	generalizable	amod	12	SENT_176	[p15l1689t2077r2150b2161],
12	results	NNS	O	result	dobj	10	SENT_176	[p15l10t2180r225b2243],
13	through	IN	O	through	_	0	SENT_176	[p15l245t2180r518b2264],
14	wider	JJR	O	wider	amod	15	SENT_176	[p15l536t2180r730b2243],
15	inclusion	NN	O	inclusion	prep_through	10	SENT_176	[p15l749t2180r1058b2243],
16	and	CC	O	and	_	0	SENT_176	[p15l1095t2180r1245b2246],
17	/	:	O	/	punct	19	SENT_176	[p15l1095t2180r1245b2246],
18	or	CC	O	or	dep	19	SENT_176	[p15l1250t2203r1321b2243],
19	on	IN	O	on	prep	10	SENT_176	[p15l1340t2203r1425b2243],
20	basing	VBG	O	base	amod	22	SENT_176	[p15l1443t2180r1664b2264],
21	study	NN	O	study	nn	22	SENT_176	[p15l1683t2180r1866b2264],
22	samples	NNS	O	sample	npadvmod	10	SENT_176	[p15l1884t2180r2148b2263],
23	on	IN	O	on	_	0	SENT_176	[p15l10t2306r96b2346],
24	standards	NNS	O	standard	prep_on	22	SENT_176	[p15l118t2283r447b2346],
25	of	IN	O	of	_	0	SENT_176	[p15l470t2283r544b2346],
26	usual	JJ	O	usual	amod	27	SENT_176	[p15l555t2283r736b2346],
27	care	NN	O	care	prep_of	10	SENT_176	[p15l757t2306r911b2346],
28	.	.	O	.	_	0	SENT_176	[p15l757t2306r911b2346],

1	Protocols	NNS	O	protocol	nsubj	2	SENT_177	[p15l936t2283r1258b2346],
2	range	VBP	O	range	_	0	SENT_177	[p15l1280t2306r1468b2367],
3	from	IN	O	from	_	0	SENT_177	[p15l1490t2283r1658b2346],
4	what	WP	O	what	nsubj	9	SENT_177	[p15l1677t2283r1845b2346],
5	is	VBZ	O	be	cop	9	SENT_177	[p15l1866t2289r1916b2346],
6	essentially	RB	O	essentially	advmod	9	SENT_177	[p15l1938t2306r2146b2346, p15l8t2386r178b2470],
7	an	DT	O	a	det	9	SENT_177	[p15l195t2409r274b2449],
8	efficacy	NN	O	efficacy	nn	9	SENT_177	[p15l294t2386r547b2470],
9	trial	NN	O	trial	prepc_from	2	SENT_177	[p15l563t2386r701b2449],
10	in	IN	O	in	_	0	SENT_177	[p15l720t2392r786b2448],
11	usual	JJ	O	usual	amod	13	SENT_177	[p15l806t2386r983b2449],
12	care	NN	O	care	nn	13	SENT_177	[p15l1003t2409r1138b2449],
13	settings	NNS	O	setting	prep_in	9	SENT_177	[p15l1159t2392r1412b2470],
14	to	TO	O	to	_	0	SENT_177	[p15l1432t2398r1497b2449],
15	the	DT	O	the	det	17	SENT_177	[p15l1517t2386r1622b2449],
16	broader	JJR	O	broader	amod	17	SENT_177	[p15l1640t2386r1905b2449],
17	enrollments	NNS	O	enrollment	prep_to	9	SENT_177	[p15l1925t2386r2147b2449, p15l9t2500r211b2552],
18	of	IN	O	of	_	0	SENT_177	[p15l232t2488r305b2552],
19	“	NN	O	“	nn	21	SENT_177	[p15l316t2488r682b2573],
20	pragmatic	JJ	O	pragmatic	amod	21	SENT_177	[p15l316t2488r682b2573],
21	trials	NNS	O	trial	prep_of	17	SENT_177	[p15l701t2480r970b2552],
22	.	.	O	.	_	0	SENT_177	[p15l701t2480r970b2552],

1	”	NN	O	”	npadvmod	20	SENT_178	[p15l701t2480r970b2552],
2	22	CD	NUMBER	22	num	1	SENT_178	[p15l701t2480r970b2552],
3	In	IN	O	in	_	0	SENT_178	[p15l991t2494r1060b2551],
4	the	DT	O	the	det	7	SENT_178	[p15l1079t2488r1184b2552],
5	E2E	NN	O	e2e	nn	7	SENT_178	[p15l1203t2494r1336b2551],
6	effectiveness	NN	O	effectiveness	nn	7	SENT_178	[p15l1357t2488r1773b2552],
7	portion	NN	O	portion	prep_in	20	SENT_178	[p15l1792t2495r2063b2572],
8	,	,	O	,	_	0	SENT_178	[p15l1792t2495r2063b2572],
9	to	TO	O	to	aux	10	SENT_178	[p15l2084t2500r2148b2552],
10	minimize	VB	O	minimize	purpcl	20	SENT_178	[p15l9t2599r340b2656],
11	participant	NN	O	participant	nn	12	SENT_178	[p15l362t2599r745b2676],
12	exposure	NN	O	exposure	dobj	10	SENT_178	[p15l767t2615r1078b2676],
13	to	TO	O	to	_	0	SENT_178	[p15l1100t2605r1167b2656],
14	unnecessary	JJ	O	unnecessary	amod	15	SENT_178	[p15l1191t2616r1621b2677],
15	risk	NN	O	risk	prep_to	10	SENT_178	[p15l1641t2593r1786b2665],
16	,	,	O	,	_	0	SENT_178	[p15l1641t2593r1786b2665],
17	treatment	NN	O	treatment	nsubjpass	20	SENT_178	[p15l1810t2605r2149b2656],
18	should	MD	O	should	aux	20	SENT_178	[p15l10t2696r242b2759],
19	be	VB	O	be	auxpass	20	SENT_178	[p15l262t2696r342b2759],
20	limited	VBN	O	limit	_	0	SENT_178	[p15l364t2696r611b2759],
21	to	TO	O	to	_	0	SENT_178	[p15l632t2708r698b2759],
22	subgroups	NNS	O	subgroup	prep_to	20	SENT_178	[p15l723t2696r1078b2780],
23	wherein	WRB	O	wherein	advmod	32	SENT_178	[p15l1100t2696r1380b2759],
24	previous	JJ	O	previous	amod	25	SENT_178	[p15l1402t2702r1698b2779],
25	probabilities	NNS	O	probability	nsubj	32	SENT_178	[p15l1720t2696r2150b2779],
26	of	IN	O	of	_	0	SENT_178	[p15l10t2799r82b2862],
27	effectiveness	NN	O	effectiveness	prep_of	25	SENT_178	[p15l93t2799r512b2862],
28	and	CC	O	and	_	0	SENT_178	[p15l533t2799r657b2862],
29	risk	NN	O	risk	prep_of	25	SENT_178	[p15l677t2799r803b2862],
30	are	VBP	O	be	cop	32	SENT_178	[p15l820t2822r919b2862],
31	most	RBS	O	most	advmod	32	SENT_178	[p15l939t2811r1106b2862],
32	promising	JJ	O	promising	rcmod	22	SENT_178	[p15l1123t2805r1485b2883],
33	.	.	O	.	_	0	SENT_178	[p15l1123t2805r1485b2883],

1	Trade-offs	NNS	O	trade-off	nsubj	13	SENT_179	[p15l1508t2799r1850b2862],
2	between	IN	O	between	_	0	SENT_179	[p15l1869t2799r2150b2862],
3	these	DT	O	these	det	4	SENT_179	[p15l8t2902r185b2965],
4	goals	NNS	O	goal	prep_between	1	SENT_179	[p15l208t2902r381b2986],
5	will	MD	O	will	aux	6	SENT_179	[p15l403t2902r530b2965],
6	vary	VB	O	vary	_	0	SENT_179	[p15l550t2925r705b2986],
7	from	IN	O	from	_	0	SENT_179	[p15l724t2902r893b2965],
8	case	NN	O	case	prep_from	6	SENT_179	[p15l916t2925r1056b2965],
9	to	TO	O	to	_	0	SENT_179	[p15l1078t2914r1145b2965],
10	case	NN	O	case	prep_to	6	SENT_179	[p15l1170t2925r1310b2965],
11	and	CC	O	and	_	0	SENT_179	[p15l1333t2902r1460b2965],
12	will	MD	O	will	aux	13	SENT_179	[p15l1481t2902r1608b2965],
13	require	VB	O	require	conj_and	6	SENT_179	[p15l1630t2908r1876b2985],
14	institutional	JJ	O	institutional	amod	16	SENT_179	[p15l1899t2908r2147b2965, p15l8t3005r207b3068],
15	review	NN	O	review	nn	16	SENT_179	[p15l228t3011r456b3068],
16	board	NN	O	board	dobj	13	SENT_179	[p15l473t3005r692b3077],
17	,	,	O	,	_	0	SENT_179	[p15l473t3005r692b3077],
18	DSMB	NN	O	dsmb	conj_and	16	SENT_179	[p15l715t3009r960b3077],
19	,	,	O	,	_	0	SENT_179	[p15l715t3009r960b3077],
20	and	CC	O	and	_	0	SENT_179	[p15l984t3005r1110b3068],
21	regulatory	JJ	O	regulatory	amod	22	SENT_179	[p15l1131t3005r1487b3089],
22	review	NN	O	review	dobj	13	SENT_179	[p15l1506t3011r1741b3068],
23	.	.	O	.	_	0	SENT_179	[p15l1506t3011r1741b3068],

1	Second	RB	ORDINAL	second	advmod	11	SENT_180	[p15l84t3108r349b3180],
2	,	,	O	,	_	0	SENT_180	[p15l84t3108r349b3180],
3	issues	NNS	O	issue	nsubj	11	SENT_180	[p15l373t3114r569b3171],
4	of	IN	O	of	_	0	SENT_180	[p15l592t3108r666b3171],
5	patient	NN	O	patient	nn	6	SENT_180	[p15l677t3114r917b3191],
6	access	NN	O	access	prep_of	3	SENT_180	[p15l939t3131r1145b3171],
7	to	TO	O	to	_	0	SENT_180	[p15l1167t3120r1233b3171],
8	E2E	NN	O	e2e	nn	9	SENT_180	[p15l1256t3113r1392b3170],
9	trials	NNS	O	trial	prep_to	6	SENT_180	[p15l1413t3108r1584b3171],
10	will	MD	O	will	aux	11	SENT_180	[p15l1606t3108r1732b3171],
11	require	VB	O	require	_	0	SENT_180	[p15l1753t3114r1998b3191],
12	further	JJ	O	further	amod	13	SENT_180	[p15l2020t3108r2147b3171, p15l8t3211r150b3274],
13	analysis	NN	O	analysis	dobj	11	SENT_180	[p15l173t3211r460b3295],
14	.	.	O	.	_	0	SENT_180	[p15l173t3211r460b3295],

1	Could	MD	O	could	aux	3	SENT_181	[p15l487t3211r702b3274],
2	regulators	NNS	O	regulator	nsubj	3	SENT_181	[p15l725t3211r1070b3295],
3	approve	VB	O	approve	_	0	SENT_181	[p15l1095t3233r1369b3294],
4	a	DT	O	a	det	5	SENT_181	[p15l1393t3234r1428b3274],
5	label	NN	O	label	dobj	3	SENT_181	[p15l1449t3211r1612b3274],
6	with	IN	O	with	_	0	SENT_181	[p15l1633t3211r1788b3274],
7	phased	JJ	O	phased	amod	10	SENT_181	[p15l1810t3211r2055b3294],
8	or	CC	O	or	_	0	SENT_181	[p15l2078t3234r2151b3274],
9	conditional	JJ	O	conditional	amod	10	SENT_181	[p15l10t3314r395b3377],
10	limitations	NNS	O	limitation	prep_with	3	SENT_181	[p15l414t3314r778b3377],
11	on	IN	O	on	_	0	SENT_181	[p15l799t3337r884b3377],
12	access	NN	O	access	prep_on	10	SENT_181	[p15l905t3337r1108b3377],
13	at	IN	O	at	_	0	SENT_181	[p15l1129t3326r1188b3377],
14	stages	NNS	O	stage	prep_at	3	SENT_181	[p15l1208t3326r1404b3398],
15	of	IN	O	of	_	0	SENT_181	[p15l1425t3314r1498b3377],
16	effectiveness	NN	O	effectiveness	nn	17	SENT_181	[p15l1509t3314r1930b3377],
17	trials	NNS	O	trial	prep_of	14	SENT_181	[p15l1949t3314r2149b3377],
18	?	.	O	?	_	0	SENT_181	[p15l1949t3314r2149b3377],

1	STATE	NN	O	state	nn	2	SENT_182	[p15l21t3691r163b3728],
2	ART	NN	O	art	_	0	SENT_182	[p15l306t3691r399b3728],

1	Would	MD	O	would	aux	3	SENT_183	[p16l8t130r233b193],
2	this	DT	O	this	nsubj	3	SENT_183	[p16l250t130r371b193],
3	take	VB	O	take	_	0	SENT_183	[p16l390t130r527b193],
4	the	DT	O	the	det	5	SENT_183	[p16l545t130r649b193],
5	form	NN	O	form	dobj	3	SENT_183	[p16l668t130r831b193],
6	of	IN	O	of	_	0	SENT_183	[p16l851t130r923b193],
7	clinical	JJ	O	clinical	amod	9	SENT_183	[p16l933t130r1170b193],
8	practice	NN	O	practice	nn	9	SENT_183	[p16l1188t136r1451b213],
9	guidelines	NNS	O	guideline	prep_of	5	SENT_183	[p16l1471t130r1825b214],
10	,	,	O	,	_	0	SENT_183	[p16l1471t130r1825b214],
11	or	CC	O	or	_	0	SENT_183	[p16l1847t153r1917b193],
12	would	MD	O	would	aux	18	SENT_183	[p16l1933t130r2142b193],
13	a	DT	O	a	det	16	SENT_183	[p16l10t256r45b296],
14	more	RBR	O	more	advmod	15	SENT_183	[p16l68t256r249b296],
15	complex	JJ	O	complex	amod	16	SENT_183	[p16l274t233r571b316],
16	approach	NN	O	approach	nsubjpass	18	SENT_183	[p16l594t233r918b316],
17	be	VB	O	be	auxpass	18	SENT_183	[p16l939t233r1020b296],
18	required	VBN	O	require	conj_or	3	SENT_183	[p16l1044t233r1373b316],
19	?	.	O	?	_	0	SENT_183	[p16l1044t233r1373b316],

1	More	RBR	O	more	advmod	2	SENT_184	[p16l1399t238r1585b296],
2	generally	RB	O	generally	ccomp	23	SENT_184	[p16l1609t233r1939b317],
3	,	,	O	,	_	0	SENT_184	[p16l1609t233r1939b317],
4	if	IN	O	if	mark	8	SENT_184	[p16l1965t233r2020b295],
5	the	DT	O	the	det	7	SENT_184	[p16l2033t233r2142b296],
6	effectiveness	NN	O	effectiveness	nn	7	SENT_184	[p16l10t336r446b399],
7	trial	NN	O	trial	nsubj	8	SENT_184	[p16l469t336r614b399],
8	takes	VBZ	O	take	csubjpass	23	SENT_184	[p16l635t336r811b399],
9	place	NN	O	place	dobj	8	SENT_184	[p16l834t336r1013b419],
10	before	IN	O	before	_	0	SENT_184	[p16l1035t336r1255b399],
11	licensing	NN	O	licensing	prep_before	8	SENT_184	[p16l1277t336r1608b420],
12	,	,	O	,	_	0	SENT_184	[p16l1277t336r1608b420],
13	what	WDT	O	what	dep	14	SENT_184	[p16l1631t336r1802b399],
14	degree	NN	O	degree	rcmod	11	SENT_184	[p16l1825t336r2053b420],
15	of	IN	O	of	_	0	SENT_184	[p16l2077t336r2153b399],
16	discretion	NN	O	discretion	prep_of	14	SENT_184	[p16l10t439r358b502],
17	in	IN	O	in	_	0	SENT_184	[p16l381t445r449b501],
18	controlling	VBG	O	control	amod	20	SENT_184	[p16l472t439r858b523],
19	patient	NN	O	patient	nn	20	SENT_184	[p16l878t445r1122b522],
20	access	NN	O	access	prep_in	8	SENT_184	[p16l1145t462r1354b502],
21	should	MD	O	should	aux	23	SENT_184	[p16l1379t439r1613b502],
22	be	VB	O	be	auxpass	23	SENT_184	[p16l1634t439r1714b502],
23	accorded	VBN	O	accord	_	0	SENT_184	[p16l1738t439r2054b502],
24	to	TO	O	to	_	0	SENT_184	[p16l2075t451r2142b502],
25	sponsors	NNS	O	sponsor	prep_to	23	SENT_184	[p16l10t564r302b625],
26	and	CC	O	and	_	0	SENT_184	[p16l323t542r446b605],
27	regulators	NNS	O	regulator	prep_to	23	SENT_184	[p16l465t542r825b626],
28	?	.	O	?	_	0	SENT_184	[p16l465t542r825b626],

1	And	CC	O	and	cc	7	SENT_185	[p16l846t542r992b605],
2	how	WRB	O	how	advmod	7	SENT_185	[p16l1010t542r1154b605],
3	can	MD	O	can	aux	7	SENT_185	[p16l1171t565r1285b605],
4	this	DT	O	this	det	5	SENT_185	[p16l1303t542r1424b605],
5	approach	NN	O	approach	nsubjpass	7	SENT_185	[p16l1445t542r1752b625],
6	be	VB	O	be	auxpass	7	SENT_185	[p16l1769t542r1847b605],
7	adjusted	VBN	O	adjust	_	0	SENT_185	[p16l1867t542r2145b626],
8	to	TO	O	to	aux	9	SENT_185	[p16l9t657r74b708],
9	respond	VB	O	respond	xcomp	7	SENT_185	[p16l95t645r369b728],
10	to	TO	O	to	_	0	SENT_185	[p16l387t657r452b708],
11	the	DT	O	the	det	12	SENT_185	[p16l472t645r577b708],
12	presence	NN	O	presence	prep_to	9	SENT_185	[p16l597t667r891b728],
13	or	CC	O	or	_	0	SENT_185	[p16l912t668r983b708],
14	absence	NN	O	absence	conj_or	12	SENT_185	[p16l1003t645r1265b708],
15	of	IN	O	of	_	0	SENT_185	[p16l1286t645r1359b708],
16	viable	JJ	O	viable	amod	18	SENT_185	[p16l1367t645r1565b708],
17	alternative	JJ	O	alternative	amod	18	SENT_185	[p16l1587t645r1940b708],
18	treatments	NNS	O	treatment	prep_of	12	SENT_185	[p16l1959t657r2139b708, p16l9t760r234b820],
19	,	,	O	,	_	0	SENT_185	[p16l1959t657r2139b708, p16l9t760r234b820],
20	especially	RB	O	especially	advmod	9	SENT_185	[p16l258t748r590b832],
21	for	IN	O	for	_	0	SENT_185	[p16l608t748r705b811],
22	life-threatening	JJ	O	life-threatening	amod	23	SENT_185	[p16l724t748r1258b832],
23	conditions	NNS	O	condition	prep_for	9	SENT_185	[p16l1279t748r1670b811],
24	?	.	O	?	_	0	SENT_185	[p16l1279t748r1670b811],

1	Third	NNP	ORDINAL	Third	nsubjpass	5	SENT_186	[p16l83t851r291b923],
2	,	,	O	,	_	0	SENT_186	[p16l83t851r291b923],
3	work	NN	O	work	appos	1	SENT_186	[p16l314t851r494b914],
4	is	VBZ	O	be	auxpass	5	SENT_186	[p16l513t857r564b914],
5	needed	VBN	O	need	_	0	SENT_186	[p16l587t851r837b914],
6	on	IN	O	on	_	0	SENT_186	[p16l860t874r946b914],
7	whether	IN	O	whether	complm	14	SENT_186	[p16l968t851r1254b914],
8	public	NN	O	public	amod	11	SENT_186	[p16l1275t851r1490b934],
9	and	CC	O	and	_	0	SENT_186	[p16l1513t851r1641b914],
10	private	JJ	O	private	amod	11	SENT_186	[p16l1661t857r1900b934],
11	payers	NNS	O	payer	nsubjpass	14	SENT_186	[p16l1922t873r2142b935],
12	should	MD	O	should	aux	14	SENT_186	[p16l10t954r240b1017],
13	be	VB	O	be	auxpass	14	SENT_186	[p16l258t954r337b1017],
14	required	VBN	O	require	prepc_on	5	SENT_186	[p16l358t954r666b1037],
15	,	,	O	,	_	0	SENT_186	[p16l358t954r666b1037],
16	or	CC	O	or	_	0	SENT_186	[p16l689t977r760b1017],
17	permitted	VBN	O	permit	conj_or	14	SENT_186	[p16l778t954r1135b1037],
18	,	,	O	,	_	0	SENT_186	[p16l778t954r1135b1037],
19	to	TO	O	to	aux	20	SENT_186	[p16l1157t966r1222b1017],
20	pay	VB	O	pay	prepc_on	5	SENT_186	[p16l1243t976r1365b1038],
21	for	IN	O	for	_	0	SENT_186	[p16l1382t954r1479b1017],
22	care	NN	O	care	prep_for	20	SENT_186	[p16l1500t977r1636b1017],
23	during	IN	O	during	_	0	SENT_186	[p16l1658t954r1888b1038],
24	an	DT	O	a	det	26	SENT_186	[p16l1908t977r1987b1017],
25	E2E	NN	O	e2e	nn	26	SENT_186	[p16l2008t959r2144b1016],
26	trial	NN	O	trial	prep_during	20	SENT_186	[p16l9t1057r159b1120],
27	.	.	O	.	_	0	SENT_186	[p16l9t1057r159b1120],

1	Before	IN	O	before	mark	2	SENT_187	[p16l182t1057r396b1120],
2	and	CC	O	and	advcl	14	SENT_187	[p16l416t1057r539b1120],
3	after	IN	O	after	dep	2	SENT_187	[p16l557t1057r705b1120],
4	licensing	NN	O	licensing	pobj	3	SENT_187	[p16l722t1057r1034b1141],
5	,	,	O	,	_	0	SENT_187	[p16l722t1057r1034b1141],
6	how	WRB	O	how	advmod	14	SENT_187	[p16l1054t1057r1198b1120],
7	should	MD	O	should	aux	14	SENT_187	[p16l1216t1057r1439b1120],
8	the	DT	O	the	det	9	SENT_187	[p16l1456t1057r1559b1120],
9	costs	NNS	O	cost	nsubjpass	14	SENT_187	[p16l1579t1069r1739b1120],
10	of	IN	O	of	_	0	SENT_187	[p16l1760t1057r1832b1120],
11	effectiveness	NN	O	effectiveness	nn	12	SENT_187	[p16l1842t1057r2140b1120, p16l9t1183r151b1223],
12	trials	NNS	O	trial	prep_of	9	SENT_187	[p16l172t1160r342b1223],
13	be	VB	O	be	auxpass	14	SENT_187	[p16l361t1160r440b1223],
14	supported	VBN	O	support	_	0	SENT_187	[p16l462t1160r838b1243],
15	?	.	O	?	_	0	SENT_187	[p16l462t1160r838b1243],

1	As	IN	O	as	mark	3	SENT_188	[p16l859t1164r945b1223],
2	data	NNS	O	datum	nsubj	3	SENT_188	[p16l967t1160r1110b1223],
3	emerge	VBP	O	emerge	advcl	21	SENT_188	[p16l1131t1183r1377b1244],
4	on	IN	O	on	_	0	SENT_188	[p16l1398t1183r1484b1223],
5	safety	NN	O	safety	prep_on	3	SENT_188	[p16l1505t1160r1709b1244],
6	,	,	O	,	_	0	SENT_188	[p16l1505t1160r1709b1244],
7	efficacy	NN	O	efficacy	prep_on	3	SENT_188	[p16l1732t1160r1996b1244],
8	,	,	O	,	_	0	SENT_188	[p16l1732t1160r1996b1244],
9	and	CC	O	and	_	0	SENT_188	[p16l2019t1160r2145b1223],
10	effectiveness	NN	O	effectiveness	prep_on	3	SENT_188	[p16l10t1263r435b1326],
11	of	IN	O	of	_	0	SENT_188	[p16l458t1263r532b1326],
12	drugs	NNS	O	drug	prep_of	5	SENT_188	[p16l544t1263r735b1347],
13	in	IN	O	in	_	0	SENT_188	[p16l756t1269r823b1325],
14	use	NN	O	use	prep_in	12	SENT_188	[p16l844t1286r972b1335],
15	,	,	O	,	_	0	SENT_188	[p16l844t1286r972b1335],
16	how	WRB	O	how	advmod	21	SENT_188	[p16l994t1263r1141b1326],
17	should	MD	O	should	aux	21	SENT_188	[p16l1161t1263r1390b1326],
18	payer	NN	O	payer	nsubj	21	SENT_188	[p16l1409t1285r1598b1347],
19	reimbursement	NN	O	reimbursement	nn	20	SENT_188	[p16l1618t1263r2144b1326],
20	obligations	NNS	O	obligation	dep	18	SENT_188	[p16l10t1366r375b1450],
21	change	VB	O	change	_	0	SENT_188	[p16l396t1366r658b1450],
22	?	.	O	?	_	0	SENT_188	[p16l396t1366r658b1450],

1	In	IN	O	in	_	0	SENT_189	[p16l680t1371r749b1428],
2	what	WDT	O	what	det	3	SENT_189	[p16l767t1366r931b1429],
3	form	NN	O	form	prep_in	8	SENT_189	[p16l949t1366r1113b1429],
4	must	MD	O	must	aux	8	SENT_189	[p16l1132t1378r1298b1429],
5	such	JJ	O	such	amod	6	SENT_189	[p16l1317t1366r1469b1429],
6	information	NN	O	information	nsubjpass	8	SENT_189	[p16l1488t1366r1892b1429],
7	be	VB	O	be	auxpass	8	SENT_189	[p16l1909t1366r1987b1429],
8	presented	VBN	O	present	_	0	SENT_189	[p16l2006t1388r2139b1449, p16l10t1469r230b1532],
9	to	TO	O	to	aux	10	SENT_189	[p16l250t1481r315b1532],
10	affect	VB	O	affect	xcomp	8	SENT_189	[p16l340t1469r521b1532],
11	payer	NN	O	payer	nn	12	SENT_189	[p16l541t1491r729b1553],
12	obligations	NNS	O	obligation	dobj	10	SENT_189	[p16l750t1469r1157b1553],
13	?	.	O	?	_	0	SENT_189	[p16l750t1469r1157b1553],

1	And	CC	O	and	_	0	SENT_190	[p16l1180t1469r1330b1532],
2	then	RB	O	then	dep	1	SENT_190	[p16l1349t1469r1503b1532],
3	how	WRB	O	how	advmod	11	SENT_190	[p16l1524t1469r1672b1532],
4	could	MD	O	could	aux	11	SENT_190	[p16l1691t1469r1908b1535],
5	/	:	O	/	punct	6	SENT_190	[p16l1691t1469r1908b1535],
6	should	MD	O	should	parataxis	11	SENT_190	[p16l1914t1469r2144b1532],
7	emerging	VBG	O	emerge	xcomp	6	SENT_190	[p16l10t1579r338b1657],
8	EZE	NNP	O	EZE	nn	9	SENT_190	[p16l359t1578r497b1635],
9	evidence	NN	O	evidence	dobj	7	SENT_190	[p16l521t1573r824b1636],
10	be	VB	O	be	auxpass	11	SENT_190	[p16l845t1573r926b1636],
11	used	VBN	O	use	dep	2	SENT_190	[p16l948t1573r1109b1636],
12	to	TO	O	to	aux	13	SENT_190	[p16l1130t1585r1196b1636],
13	set	VB	O	set	xcomp	11	SENT_190	[p16l1222t1585r1315b1636],
14	coverage	NN	O	coverage	dobj	13	SENT_190	[p16l1338t1596r1639b1657],
15	and	CC	O	and	_	0	SENT_190	[p16l1663t1573r1790b1636],
16	pricing	NN	O	pricing	dobj	13	SENT_190	[p16l1812t1579r2061b1657],
17	at	IN	O	at	_	0	SENT_190	[p16l2083t1585r2143b1636],
18	the	DT	O	the	det	19	SENT_190	[p16l9t1676r115b1739],
19	early	JJ	O	early	prep_at	13	SENT_190	[p16l137t1676r311b1760],
20	,	,	O	,	_	0	SENT_190	[p16l137t1676r311b1760],
21	middle	JJ	O	middle	prep_at	13	SENT_190	[p16l334t1676r592b1748],
22	,	,	O	,	_	0	SENT_190	[p16l334t1676r592b1748],
23	and	CC	O	and	_	0	SENT_190	[p16l616t1676r742b1739],
24	late	JJ	O	late	amod	25	SENT_190	[p16l762t1676r879b1739],
25	stages	NNS	O	stage	prep_at	13	SENT_190	[p16l902t1688r1101b1760],
26	of	IN	O	of	_	0	SENT_190	[p16l1123t1676r1197b1739],
27	the	DT	O	the	det	28	SENT_190	[p16l1208t1676r1314b1739],
28	process	NN	O	process	prep_of	25	SENT_190	[p16l1335t1680r1619b1759],
29	?	.	O	?	_	0	SENT_190	[p16l1335t1680r1619b1759],

1	To	TO	O	to	dep	4	SENT_191	[p16l1643t1679r1726b1739],
2	what	WP	O	what	pobj	1	SENT_191	[p16l1747t1676r1915b1739],
3	extent	NN	O	extent	nsubj	4	SENT_191	[p16l1936t1688r2144b1739],
4	could	MD	O	could	_	0	SENT_191	[p16l10t1779r232b1845],
5	/	:	O	/	punct	4	SENT_191	[p16l10t1779r232b1845],
6	should	MD	O	should	aux	7	SENT_191	[p16l239t1779r475b1842],
7	market	VB	O	market	dep	4	SENT_191	[p16l497t1779r746b1842],
8	exclusivity	NN	O	exclusivity	nn	9	SENT_191	[p16l769t1779r1140b1863],
9	horizons	NNS	O	horizon	nsubjpass	11	SENT_191	[p16l1159t1779r1466b1842],
10	be	VB	O	be	auxpass	11	SENT_191	[p16l1488t1779r1569b1842],
11	modiﬁed	VBN	O	modiﬁed	ccomp	7	SENT_191	[p16l1593t1779r1911b1842],
12	if	IN	O	if	mark	15	SENT_191	[p16l1934t1779r1989b1841],
13	E2E	NN	O	e2e	nn	14	SENT_191	[p16l2003t1784r2142b1841],
14	trial	NN	O	trial	nsubj	15	SENT_191	[p16l9t1882r149b1945],
15	results	VBZ	O	result	advcl	11	SENT_191	[p16l171t1882r390b1945],
16	affect	VB	O	affect	xcomp	15	SENT_191	[p16l413t1882r595b1945],
17	the	DT	O	the	det	18	SENT_191	[p16l614t1882r720b1945],
18	timing	NN	O	timing	dobj	16	SENT_191	[p16l741t1888r970b1966],
19	and	CC	O	and	_	0	SENT_191	[p16l991t1882r1117b1945],
20	coverage	NN	O	coverage	conj_and	18	SENT_191	[p16l1138t1905r1435b1966],
21	of	IN	O	of	_	0	SENT_191	[p16l1457t1882r1531b1945],
22	reimbursement	NN	O	reimbursement	prep_of	18	SENT_191	[p16l1543t1882r2099b1945],
23	?	.	O	?	_	0	SENT_191	[p16l1543t1882r2099b1945],

1	Fourth	JJ	ORDINAL	fourth	advmod	8	SENT_192	[p16l84t1985r343b2057],
2	,	,	O	,	_	0	SENT_192	[p16l84t1985r343b2057],
3	linked	VBN	O	link	csubj	8	SENT_192	[p16l367t1985r589b2048],
4	to	TO	O	to	_	0	SENT_192	[p16l611t1997r678b2048],
5	this	DT	O	this	prep_to	3	SENT_192	[p16l702t1985r829b2048],
6	is	VBZ	O	be	cop	8	SENT_192	[p16l854t1991r905b2048],
7	the	DT	O	the	det	8	SENT_192	[p16l929t1985r1038b2048],
8	question	NN	O	question	_	0	SENT_192	[p16l1062t1991r1363b2068],
9	of	IN	O	of	_	0	SENT_192	[p16l1388t1985r1463b2048],
10	how	WRB	O	how	advmod	16	SENT_192	[p16l1476t1985r1627b2048],
11	emerging	VBG	O	emerge	csubjpass	16	SENT_192	[p16l1649t1991r1981b2069],
12	E2E	NN	O	e2e	nn	13	SENT_192	[p16l2003t1990r2142b2047],
13	evidence	NN	O	evidence	dobj	11	SENT_192	[p16l10t2088r307b2151],
14	should	MD	O	should	aux	16	SENT_192	[p16l328t2088r558b2151],
15	be	VB	O	be	auxpass	16	SENT_192	[p16l575t2088r654b2151],
16	used	VBN	O	use	prepc_of	8	SENT_192	[p16l674t2088r831b2151],
17	to	TO	O	to	aux	18	SENT_192	[p16l850t2100r915b2151],
18	affect	VB	O	affect	conj_and	18	SENT_192	[p16l937t2088r1118b2151],
19	provider	NN	O	provider	nn	20	SENT_192	[p16l1136t2088r1429b2171],
20	practices	NNS	O	practice	dobj	18	SENT_192	[p16l1447t2094r1748b2171],
21	during	IN	O	during	_	0	SENT_192	[p16l1769t2088r1999b2172],
22	and	CC	O	and	_	0	SENT_192	[p16l2018t2088r2143b2151],
23	after	IN	O	after	_	0	SENT_192	[p16l10t2191r162b2254],
24	an	DT	O	a	det	26	SENT_192	[p16l181t2214r261b2254],
25	E2E	NN	O	e2e	nn	26	SENT_192	[p16l281t2196r416b2253],
26	trial	NN	O	trial	prep_after	18	SENT_192	[p16l436t2191r575b2254],
27	and	CC	O	and	_	0	SENT_192	[p16l596t2191r721b2254],
28	how	WRB	O	how	advmod	32	SENT_192	[p16l740t2191r886b2254],
29	it	PRP	O	it	nsubjpass	32	SENT_192	[p16l904t2197r950b2254],
30	might	MD	O	might	aux	32	SENT_192	[p16l968t2191r1170b2275],
31	be	VB	O	be	auxpass	32	SENT_192	[p16l1188t2191r1267b2254],
32	used	VBN	O	use	conj_and	16	SENT_192	[p16l1287t2191r1444b2254],
33	to	TO	O	to	aux	34	SENT_192	[p16l1462t2203r1528b2254],
34	enhance	VB	O	enhance	xcomp	32	SENT_192	[p16l1550t2191r1831b2254],
35	communications	NNS	O	communication	dobj	34	SENT_192	[p16l1852t2214r2139b2254, p16l9t2300r319b2357],
36	with	IN	O	with	_	0	SENT_192	[p16l341t2294r493b2357],
37	patients	NNS	O	patient	prep_with	34	SENT_192	[p16l514t2300r783b2377],
38	about	IN	O	about	_	0	SENT_192	[p16l806t2294r999b2357],
39	what	WP	O	what	nsubjpass	41	SENT_192	[p16l1018t2294r1185b2357],
40	is	VBZ	O	be	auxpass	41	SENT_192	[p16l1206t2300r1256b2357],
41	known	VBN	O	know	prep_about	37	SENT_192	[p16l1277t2294r1514b2357],
42	and	CC	O	and	_	0	SENT_192	[p16l1537t2294r1663b2357],
43	what	WP	O	what	nsubj	45	SENT_192	[p16l1682t2294r1849b2357],
44	remains	VBZ	O	remain	cop	45	SENT_192	[p16l1871t2300r2142b2357],
45	uncertain	JJ	O	uncertain	conj_and	41	SENT_192	[p16l9t2403r371b2460],
46	.	.	O	.	_	0	SENT_192	[p16l9t2403r371b2460],

1	Postauthorization	NN	O	postauthorization	nn	2	SENT_193	[p16l402t2397r1038b2460],
2	measures	NNS	O	measure	nsubj	4	SENT_193	[p16l1064t2420r1395b2460],
3	may	MD	O	may	aux	4	SENT_193	[p16l1422t2420r1573b2481],
4	include	VB	O	include	conj_and	4	SENT_193	[p16l1596t2397r1858b2460],
5	clinical	JJ	O	clinical	amod	7	SENT_193	[p16l1885t2397r2141b2460],
6	practice	NN	O	practice	nn	7	SENT_193	[p16l8t2506r282b2583],
7	guidelines	NNS	O	guideline	dobj	4	SENT_193	[p16l305t2500r674b2584],
8	,	,	O	,	_	0	SENT_193	[p16l305t2500r674b2584],
9	changes	NNS	O	change	appos	7	SENT_193	[p16l699t2500r969b2584],
10	to	TO	O	to	_	0	SENT_193	[p16l992t2512r1058b2563],
11	labels	NNS	O	label	prep_to	4	SENT_193	[p16l1081t2500r1292b2572],
12	,	,	O	,	_	0	SENT_193	[p16l1081t2500r1292b2572],
13	controls	NNS	O	control	appos	11	SENT_193	[p16l1317t2500r1594b2563],
14	of	IN	O	of	_	0	SENT_193	[p16l1618t2500r1692b2563],
15	off-label	JJ	O	off-label	amod	16	SENT_193	[p16l1706t2500r1988b2563],
16	use	NN	O	use	prep_of	13	SENT_193	[p16l2011t2523r2140b2572],
17	,	,	O	,	_	0	SENT_193	[p16l2011t2523r2140b2572],
18	control	NN	O	control	appos	16	SENT_193	[p16l10t2603r255b2666],
19	of	IN	O	of	_	0	SENT_193	[p16l276t2603r349b2666],
20	qualiﬁed	JJ	O	qualiﬁed	amod	21	SENT_193	[p16l362t2603r660b2686],
21	prescribers	NNS	O	prescriber	prep_of	18	SENT_193	[p16l679t2603r1056b2686],
22	or	CC	O	or	_	0	SENT_193	[p16l1079t2626r1151b2666],
23	facilities	NNS	O	facility	conj_or	21	SENT_193	[p16l1170t2603r1471b2675],
24	,	,	O	,	_	0	SENT_193	[p16l1170t2603r1471b2675],
25	mandatory	JJ	O	mandatory	amod	26	SENT_193	[p16l1493t2603r1873b2687],
26	participation	NN	O	participation	appos	16	SENT_193	[p16l1890t2609r2140b2686, p16l8t2712r228b2789],
27	in	IN	O	in	_	0	SENT_193	[p16l248t2712r315b2768],
28	registry	NN	O	registry	prep_in	26	SENT_193	[p16l336t2712r599b2790],
29	or	CC	O	or	_	0	SENT_193	[p16l616t2729r688b2769],
30	observational	JJ	O	observational	amod	31	SENT_193	[p16l708t2706r1171b2769],
31	study	NN	O	study	appos	16	SENT_193	[p16l1193t2706r1387b2790],
32	,	,	O	,	_	0	SENT_193	[p16l1193t2706r1387b2790],
33	and	CC	O	and	_	0	SENT_193	[p16l1410t2706r1562b2772],
34	/	:	O	/	punct	36	SENT_193	[p16l1410t2706r1562b2772],
35	or	CC	O	or	dep	36	SENT_193	[p16l1568t2729r1639b2769],
36	other	JJ	O	other	dep	4	SENT_193	[p16l1659t2706r1841b2769],
37	forms	NNS	O	form	dep	36	SENT_193	[p16l1860t2706r2057b2769],
38	of	IN	O	of	_	0	SENT_193	[p16l2079t2706r2153b2769],
39	enhanced	VBN	O	enhance	amod	40	SENT_193	[p16l10t2809r340b2872],
40	monitoring	NN	O	monitoring	prep_of	4	SENT_193	[p16l360t2815r753b2893],
41	of	IN	O	of	_	0	SENT_193	[p16l773t2809r847b2872],
42	safety	NN	O	safety	prep_of	40	SENT_193	[p16l860t2809r1056b2893],
43	and	CC	O	and	_	0	SENT_193	[p16l1075t2809r1200b2872],
44	efﬁcacy	NN	O	efﬁcacy	prep_of	40	SENT_193	[p16l1222t2809r1485b2893],
45	.	.	O	.	_	0	SENT_193	[p16l1222t2809r1485b2893],

1	Fifth	NNP	ORDINAL	Fifth	nsubj	12	SENT_194	[p16l84t2912r268b2984],
2	,	,	O	,	_	0	SENT_194	[p16l84t2912r268b2984],
3	in	IN	O	in	_	0	SENT_194	[p16l294t2918r362b2974],
4	designing	VBG	O	design	prepc_in	12	SENT_194	[p16l386t2912r728b2996],
5	an	DT	O	a	det	7	SENT_194	[p16l751t2935r832b2975],
6	E2E	NN	O	e2e	nn	7	SENT_194	[p16l856t2917r995b2974],
7	trial	NN	O	trial	dobj	4	SENT_194	[p16l1018t2912r1181b2984],
8	,	,	O	,	_	0	SENT_194	[p16l1018t2912r1181b2984],
9	key	NN	O	key	nsubj	12	SENT_194	[p16l1204t2912r1328b2996],
10	will	MD	O	will	aux	12	SENT_194	[p16l1346t2912r1475b2975],
11	be	VB	O	be	aux	12	SENT_194	[p16l1497t2912r1578b2975],
12	deciding	VBG	O	decide	_	0	SENT_194	[p16l1602t2912r1906b2996],
13	which	WDT	O	which	dobj	21	SENT_194	[p16l1926t2912r2141b2975],
14	data	NNS	O	datum	nsubj	21	SENT_194	[p16l10t3015r153b3078],
15	collected	VBN	O	collect	partmod	14	SENT_194	[p16l174t3015r477b3078],
16	in	IN	O	in	_	0	SENT_194	[p16l496t3021r563b3077],
17	the	DT	O	the	det	19	SENT_194	[p16l582t3015r688b3078],
18	efficacy	NN	O	efficacy	nn	19	SENT_194	[p16l710t3015r966b3099],
19	portion	NN	O	portion	prep_in	15	SENT_194	[p16l982t3021r1241b3098],
20	should	MD	O	should	aux	21	SENT_194	[p16l1263t3015r1493b3078],
21	continue	VB	O	continue	ccomp	12	SENT_194	[p16l1513t3021r1811b3078],
22	to	TO	O	to	aux	24	SENT_194	[p16l1831t3027r1896b3078],
23	be	VB	O	be	auxpass	24	SENT_194	[p16l1916t3015r1995b3078],
24	collected	VBN	O	collect	dep	21	SENT_194	[p16l2017t3015r2142b3078, p16l8t3118r209b3181],
25	in	IN	O	in	_	0	SENT_194	[p16l229t3124r295b3180],
26	the	DT	O	the	det	28	SENT_194	[p16l314t3118r420b3181],
27	effectiveness	NN	O	effectiveness	nn	28	SENT_194	[p16l440t3118r862b3181],
28	portion	NN	O	portion	prep_in	24	SENT_194	[p16l882t3124r1157b3201],
29	,	,	O	,	_	0	SENT_194	[p16l882t3124r1157b3201],
30	and	CC	O	and	_	0	SENT_194	[p16l1180t3118r1305b3181],
31	which	WDT	O	which	dobj	41	SENT_194	[p16l1322t3118r1529b3181],
32	data	NNS	O	datum	nsubjpass	41	SENT_194	[p16l1550t3118r1693b3181],
33	not	RB	O	not	neg	34	SENT_194	[p16l1711t3130r1824b3181],
34	collected	VBN	O	collect	partmod	32	SENT_194	[p16l1844t3118r2145b3181],
35	in	IN	O	in	_	0	SENT_194	[p16l10t3227r76b3283],
36	the	DT	O	the	det	38	SENT_194	[p16l95t3221r200b3284],
37	efficacy	NN	O	efficacy	nn	38	SENT_194	[p16l222t3221r477b3305],
38	portion	NN	O	portion	prep_in	34	SENT_194	[p16l492t3227r750b3304],
39	should	MD	O	should	aux	41	SENT_194	[p16l771t3221r1000b3284],
40	be	VB	O	be	auxpass	41	SENT_194	[p16l1017t3221r1096b3284],
41	added	VBN	O	add	conj_and	24	SENT_194	[p16l1117t3221r1324b3284],
42	in	IN	O	in	_	0	SENT_194	[p16l1344t3227r1410b3283],
43	the	DT	O	the	det	45	SENT_194	[p16l1429t3221r1534b3284],
44	effectiveness	NN	O	effectiveness	nn	45	SENT_194	[p16l1556t3221r1978b3284],
45	portion	NN	O	portion	prep_in	41	SENT_194	[p16l1998t3243r2140b3304, p16l9t3330r169b3396],
46	,	,	O	,	_	0	SENT_194	[p16l1998t3243r2140b3304, p16l9t3330r169b3396],
47	including	VBG	O	include	conj_and	24	SENT_194	[p16l196t3324r534b3408],
48	potentially	RB	O	potentially	advmod	49	SENT_194	[p16l555t3324r939b3408],
49	quality	NN	O	quality	pobj	47	SENT_194	[p16l961t3324r1207b3408],
50	of	IN	O	of	_	0	SENT_194	[p16l1228t3324r1304b3387],
51	life	NN	O	life	nn	54	SENT_194	[p16l1317t3324r1425b3387],
52	and	CC	O	and	_	0	SENT_194	[p16l1451t3324r1581b3387],
53	economic	JJ	O	economic	nn	54	SENT_194	[p16l1605t3330r1949b3387],
54	data	NNS	O	datum	prep_of	49	SENT_194	[p16l1974t3324r2139b3387],
55	.	.	O	.	_	0	SENT_194	[p16l1974t3324r2139b3387],

1	This	DT	O	this	det	2	SENT_195	[p16l9t3427r154b3490],
2	complexity	NN	O	complexity	nsubj	4	SENT_195	[p16l179t3427r566b3511],
3	will	MD	O	will	aux	4	SENT_195	[p16l583t3427r711b3490],
4	need	VB	O	need	_	0	SENT_195	[p16l734t3427r901b3490],
5	to	TO	O	to	aux	7	SENT_195	[p16l922t3439r989b3490],
6	be	VB	O	be	auxpass	7	SENT_195	[p16l1011t3427r1091b3490],
7	addressed	VBN	O	address	xcomp	4	SENT_195	[p16l1116t3427r1462b3490],
8	in	IN	O	in	_	0	SENT_195	[p16l1484t3433r1551b3489],
9	order	NN	O	order	prep_in	7	SENT_195	[p16l1575t3427r1763b3490],
10	to	TO	O	to	aux	11	SENT_195	[p16l1784t3439r1851b3490],
11	identify	VB	O	identify	ccomp	7	SENT_195	[p16l1876t3427r2148b3511],
12	subgroup-speciﬁc	JJ	O	subgroup-speciﬁc	amod	13	SENT_195	[p16l10t3530r619b3614],
13	effects	NNS	O	effect	dobj	11	SENT_195	[p16l641t3530r852b3593],
14	and	CC	O	and	_	0	SENT_195	[p16l875t3530r1000b3593],
15	to	TO	O	to	aux	16	SENT_195	[p16l1020t3542r1085b3593],
16	create	VB	O	create	ccomp	7	SENT_195	[p16l1108t3542r1307b3593],
17	multivariable	JJ	O	multivariable	amod	19	SENT_195	[p16l1328t3530r1782b3593],
18	predictive	JJ	O	predictive	amod	19	SENT_195	[p16l1802t3530r2143b3613],
19	models	NNS	O	model	nsubj	20	SENT_195	[p16l9t3633r257b3696],
20	(	VBP	O	(	ccomp	16	SENT_195	[p16l285t3634r424b3709],
21	See	VB	O	see	xcomp	20	SENT_195	[p16l285t3634r424b3709],
22	Supplementary	NNP	O	Supplementary	nn	23	SENT_195	[p16l448t3634r1002b3716],
23	Appendix	NNP	O	Appendix	dobj	21	SENT_195	[p16l1020t3634r1376b3715],
24	online	NN	O	online	dep	21	SENT_195	[p16l1397t3633r1614b3696],
25	for	IN	O	for	_	0	SENT_195	[p16l1637t3633r1734b3696],
26	Example	NN	O	example	prep_for	21	SENT_195	[p16l1756t3633r2054b3716],
27	of	IN	O	of	_	0	SENT_195	[p16l2078t3633r2152b3696],
28	Such	PDT	O	such	predet	31	SENT_195	[p16l10t3736r174b3800],
29	a	DT	O	a	det	31	SENT_195	[p16l196t3759r230b3799],
30	Trial	NN	O	trial	nn	31	SENT_195	[p16l250t3736r455b3813],
31	)	NN	O	)	prep_of	26	SENT_195	[p16l250t3736r455b3813],
32	.	.	O	.	_	0	SENT_195	[p16l250t3736r455b3813],

1	Finally	RB	O	finally	advmod	9	SENT_196	[p17l84t22r339b106],
2	,	,	O	,	_	0	SENT_196	[p17l84t22r339b106],
3	the	DT	O	the	det	4	SENT_196	[p17l366t22r476b85],
4	heart	NN	O	heart	nsubj	9	SENT_196	[p17l501t22r686b85],
5	of	IN	O	of	_	0	SENT_196	[p17l712t22r788b85],
6	the	DT	O	the	det	8	SENT_196	[p17l803t22r913b85],
7	E2E	NN	O	e2e	nn	8	SENT_196	[p17l939t27r1079b84],
8	approach	NN	O	approach	prep_of	4	SENT_196	[p17l1107t22r1435b105],
9	rests	VBZ	O	rest	_	0	SENT_196	[p17l1461t34r1620b85],
10	on	IN	O	on	_	0	SENT_196	[p17l1647t45r1735b85],
11	generation	NN	O	generation	prep_on	9	SENT_196	[p17l1762t28r2142b106],
12	and	CC	O	and	_	0	SENT_196	[p17l10t125r141b188],
13	analysis	NN	O	analysis	conj_and	11	SENT_196	[p17l166t125r442b209],
14	of	IN	O	of	_	0	SENT_196	[p17l469t125r546b188],
15	data	NNS	O	datum	prep_of	11	SENT_196	[p17l563t125r712b188],
16	on	IN	O	on	_	0	SENT_196	[p17l737t148r826b188],
17	the	DT	O	the	det	18	SENT_196	[p17l851t125r961b188],
18	effectiveness	NN	O	effectiveness	prep_on	15	SENT_196	[p17l988t125r1451b197],
19	,	,	O	,	_	0	SENT_196	[p17l988t125r1451b197],
20	safety	NN	O	safety	prep_on	15	SENT_196	[p17l1480t125r1694b209],
21	,	,	O	,	_	0	SENT_196	[p17l1480t125r1694b209],
22	and	CC	O	and	_	0	SENT_196	[p17l1723t125r1853b188],
23	efficacy	NN	O	efficacy	prep_on	15	SENT_196	[p17l1878t125r2145b209],
24	of	IN	O	of	_	0	SENT_196	[p17l10t228r85b291],
25	drugs	NNS	O	drug	prep_of	18	SENT_196	[p17l100t228r294b312],
26	that	WDT	O	that	nsubj	29	SENT_196	[p17l318t228r454b291],
27	may	MD	O	may	aux	29	SENT_196	[p17l476t251r625b312],
28	be	VB	O	be	aux	29	SENT_196	[p17l643t228r724b291],
29	undergoing	VBG	O	undergo	rcmod	25	SENT_196	[p17l747t228r1153b312],
30	sponsor-administered	JJ	O	sponsor-administered	amod	31	SENT_196	[p17l1175t228r1946b311],
31	trials	NNS	O	trial	dobj	29	SENT_196	[p17l1967t228r2141b291],
32	and	CC	O	and	_	0	SENT_196	[p17l10t331r167b397],
33	/	:	O	/	punct	37	SENT_196	[p17l10t331r167b397],
34	or	CC	O	or	nsubj	37	SENT_196	[p17l173t354r246b394],
35	may	MD	O	may	aux	37	SENT_196	[p17l268t354r418b415],
36	already	RB	O	already	advmod	37	SENT_196	[p17l438t331r695b415],
37	be	VB	O	be	dobj	29	SENT_196	[p17l713t331r794b394],
38	in	IN	O	in	_	0	SENT_196	[p17l818t337r885b393],
39	use	NN	O	use	prep_in	37	SENT_196	[p17l909t354r1039b394],
40	.	.	O	.	_	0	SENT_196	[p17l909t354r1039b394],

1	Who	WP	O	who	nsubj	3	SENT_197	[p17l1065t331r1237b394],
2	should	MD	O	should	aux	3	SENT_197	[p17l1263t331r1499b394],
3	have	VB	O	have	_	0	SENT_197	[p17l1520t331r1679b394],
4	the	DT	O	the	det	5	SENT_197	[p17l1702t331r1811b394],
5	power	NN	O	power	dobj	3	SENT_197	[p17l1834t353r2053b414],
6	to	TO	O	to	aux	7	SENT_197	[p17l2074t343r2142b394],
7	compel	VB	O	compel	infmod	5	SENT_197	[p17l10t434r262b517],
8	generation	NN	O	generation	dobj	7	SENT_197	[p17l285t440r654b518],
9	and	CC	O	and	_	0	SENT_197	[p17l678t434r805b497],
10	analysis	NN	O	analysis	dobj	7	SENT_197	[p17l828t434r1095b518],
11	of	IN	O	of	_	0	SENT_197	[p17l1119t434r1194b497],
12	data	NNS	O	datum	prep_of	8	SENT_197	[p17l1208t434r1383b497],
13	?	.	O	?	_	0	SENT_197	[p17l1208t434r1383b497],

1	Who	WP	O	who	nsubj	3	SENT_198	[p17l1407t434r1578b497],
2	should	MD	O	should	aux	3	SENT_198	[p17l1603t434r1836b497],
3	have	VB	O	have	_	0	SENT_198	[p17l1857t434r2013b497],
4	the	DT	O	the	det	5	SENT_198	[p17l2036t434r2143b497],
5	obligation	NN	O	obligation	dobj	3	SENT_198	[p17l10t537r353b621],
6	to	TO	O	to	aux	7	SENT_198	[p17l372t549r438b600],
7	pay	VB	O	pay	infmod	5	SENT_198	[p17l458t541r607b621],
8	?	.	O	?	_	0	SENT_198	[p17l458t541r607b621],

1	Who	WP	O	who	nsubj	3	SENT_199	[p17l629t537r797b600],
2	should	MD	O	should	aux	3	SENT_199	[p17l819t537r1049b600],
3	own	VB	O	own	_	0	SENT_199	[p17l1068t560r1213b600],
4	data	NNS	O	datum	dobj	3	SENT_199	[p17l1234t537r1377b600],
5	on	IN	O	on	_	0	SENT_199	[p17l1397t560r1482b600],
6	safety	NN	O	safety	prep_on	3	SENT_199	[p17l1504t537r1706b621],
7	,	,	O	,	_	0	SENT_199	[p17l1504t537r1706b621],
8	efﬁcacy	NN	O	efﬁcacy	prep_on	3	SENT_199	[p17l1729t537r1993b621],
9	,	,	O	,	_	0	SENT_199	[p17l1729t537r1993b621],
10	and	CC	O	and	_	0	SENT_199	[p17l2016t537r2142b600],
11	effectiveness	NN	O	effectiveness	conj_and	6	SENT_199	[p17l10t640r441b703],
12	of	IN	O	of	_	0	SENT_199	[p17l465t640r540b703],
13	drugs	NNS	O	drug	prep_of	6	SENT_199	[p17l554t640r747b724],
14	in	IN	O	in	_	0	SENT_199	[p17l771t646r839b702],
15	use	NN	O	use	prep_in	13	SENT_199	[p17l861t644r1004b703],
16	?	.	O	?	_	0	SENT_199	[p17l861t644r1004b703],

1	What	WDT	O	what	det	2	SENT_200	[p17l1028t640r1220b703],
2	adjustments	NNS	O	adjustment	nsubjpass	11	SENT_200	[p17l1243t640r1661b724],
3	or	CC	O	or	_	0	SENT_200	[p17l1685t663r1758b703],
4	changes	NNS	O	change	nsubjpass	11	SENT_200	[p17l1781t640r2052b724],
5	in	IN	O	in	_	0	SENT_200	[p17l2076t646r2143b702],
6	intellectual	JJ	O	intellectual	amod	8	SENT_200	[p17l10t743r395b806],
7	property	NN	O	property	nn	8	SENT_200	[p17l416t755r723b827],
8	rights	NNS	O	rights	prep_in	4	SENT_200	[p17l743t743r941b827],
9	may	MD	O	may	aux	11	SENT_200	[p17l965t766r1114b827],
10	be	VB	O	be	auxpass	11	SENT_200	[p17l1132t743r1212b806],
11	needed	VBN	O	need	_	0	SENT_200	[p17l1235t743r1487b806],
12	to	TO	O	to	aux	13	SENT_200	[p17l1508t755r1575b806],
13	secure	VB	O	secure	xcomp	11	SENT_200	[p17l1600t766r1819b806],
14	access	NN	O	access	dobj	13	SENT_200	[p17l1844t766r2053b806],
15	to	TO	O	to	_	0	SENT_200	[p17l2076t755r2143b806],
16	data	NNS	O	datum	prep_to	13	SENT_200	[p17l10t845r154b908],
17	needed	VBN	O	need	partmod	16	SENT_200	[p17l176t845r424b908],
18	for	IN	O	for	_	0	SENT_200	[p17l445t845r543b908],
19	evaluation	NN	O	evaluation	prep_for	17	SENT_200	[p17l566t845r922b908],
20	of	IN	O	of	_	0	SENT_200	[p17l945t845r1019b908],
21	effectiveness	NN	O	effectiveness	prep_of	19	SENT_200	[p17l1033t845r1492b908],
22	?	.	O	?	_	0	SENT_200	[p17l1033t845r1492b908],

1	These	DT	O	these	det	2	SENT_201	[p17l1517t845r1712b908],
2	issues	NNS	O	issue	nsubj	6	SENT_201	[p17l1735t851r1931b908],
3	are	VBP	O	be	cop	6	SENT_201	[p17l1955t868r2056b908],
4	as	RB	O	as	advmod	6	SENT_201	[p17l2079t868r2144b908],
5	yet	RB	O	yet	advmod	6	SENT_201	[p17l7t960r109b1032],
6	unresolved	JJ	O	unresolved	_	0	SENT_201	[p17l129t948r521b1011],
7	.	.	O	.	_	0	SENT_201	[p17l129t948r521b1011],

1	At	IN	O	at	_	0	SENT_202	[p17l82t1055r162b1114],
2	this	DT	O	this	det	3	SENT_202	[p17l180t1051r303b1114],
3	juncture	NN	O	juncture	prep_at	8	SENT_202	[p17l318t1057r623b1135],
4	,	,	O	,	_	0	SENT_202	[p17l318t1057r623b1135],
5	it	PRP	O	it	nsubj	8	SENT_202	[p17l645t1057r690b1114],
6	is	VBZ	O	be	cop	8	SENT_202	[p17l709t1057r758b1114],
7	not	RB	O	not	neg	8	SENT_202	[p17l779t1063r892b1114],
8	clear	JJ	O	clear	_	0	SENT_202	[p17l911t1051r1070b1114],
9	whether	IN	O	whether	complm	12	SENT_202	[p17l1087t1051r1366b1114],
10	current	JJ	DATE	current	amod	11	SENT_202	[p17l1386t1063r1635b1114],
11	statutes	NNS	O	statute	nsubj	14	SENT_202	[p17l1655t1063r1905b1114],
12	enable	VBP	O	enable	ccomp	8	SENT_202	[p17l1927t1051r2142b1114],
13	or	CC	O	or	_	0	SENT_202	[p17l10t1177r81b1217],
14	impede	VBP	O	impede	ccomp	8	SENT_202	[p17l99t1154r348b1237],
15	action	NN	O	action	dobj	12	SENT_202	[p17l369t1160r575b1217],
16	on	IN	O	on	_	0	SENT_202	[p17l595t1177r679b1217],
17	the	DT	O	the	det	19	SENT_202	[p17l698t1154r802b1217],
18	speciﬁc	JJ	O	speciﬁc	amod	19	SENT_202	[p17l823t1154r1070b1237],
19	elements	NNS	O	element	prep_on	15	SENT_202	[p17l1090t1154r1385b1217],
20	of	IN	O	of	_	0	SENT_202	[p17l1406t1154r1478b1217],
21	EZE	NN	O	eze	nn	22	SENT_202	[p17l1488t1159r1621b1216],
22	trials	NNS	O	trial	prep_of	19	SENT_202	[p17l1641t1154r1808b1217],
23	treated	VBN	O	treat	partmod	22	SENT_202	[p17l1827t1154r2060b1217],
24	in	IN	O	in	_	0	SENT_202	[p17l2079t1160r2144b1216],
25	this	DT	O	this	det	26	SENT_202	[p17l9t1257r133b1320],
26	article	NN	O	article	prep_in	23	SENT_202	[p17l157t1257r383b1320],
27	.	.	O	.	_	0	SENT_202	[p17l157t1257r383b1320],

1	Oye	NNP	O	Oye	nsubjpass	29	SENT_203	[p17l410t1261r546b1341],
2	et	FW	O	et	nn	4	SENT_203	[p17l570t1268r630b1320],
3	al.	FW	O	al.	nn	4	SENT_203	[p17l649t1257r722b1320],
4	address	NN	O	address	dep	1	SENT_203	[p17l751t1257r1006b1320],
5	the	DT	O	the	det	7	SENT_203	[p17l1028t1257r1135b1320],
6	legal	JJ	O	legal	amod	7	SENT_203	[p17l1156t1257r1313b1341],
7	foundations	NNS	O	foundation	dep	1	SENT_203	[p17l1335t1257r1745b1320],
8	of	IN	O	of	_	0	SENT_203	[p17l1769t1257r1843b1320],
9	adaptive	JJ	O	adaptive	amod	10	SENT_203	[p17l1857t1257r2142b1340],
10	licensing	NN	O	licensing	prep_of	7	SENT_203	[p17l8t1360r325b1444],
11	with	IN	O	with	_	0	SENT_203	[p17l346t1360r504b1423],
12	attention	NN	O	attention	prep_with	10	SENT_203	[p17l529t1366r846b1423],
13	to	TO	O	to	_	0	SENT_203	[p17l869t1372r937b1423],
14	reimbursement	NN	O	reimbursement	prep_to	12	SENT_203	[p17l963t1360r1507b1423],
15	in	IN	O	in	_	0	SENT_203	[p17l1531t1366r1599b1422],
16	initial	JJ	O	initial	amod	17	SENT_203	[p17l1624t1360r1832b1423],
17	authorization	NN	O	authorization	prep_in	29	SENT_203	[p17l1856t1360r2141b1423, p17l10t1454r304b1525],
18	.23	CD	NUMBER	.23	num	20	SENT_203	[p17l1856t1360r2141b1423, p17l10t1454r304b1525],
19	Parallel	JJ	O	parallel	amod	20	SENT_203	[p17l330t1462r587b1525],
20	work	NN	O	work	nsubjpass	29	SENT_203	[p17l608t1462r788b1525],
21	on	IN	O	on	_	0	SENT_203	[p17l808t1485r896b1525],
22	the	DT	O	the	det	24	SENT_203	[p17l918t1462r1026b1525],
23	legal	JJ	O	legal	amod	24	SENT_203	[p17l1048t1462r1208b1546],
24	foundations	NNS	O	foundation	prep_on	20	SENT_203	[p17l1231t1462r1648b1525],
25	of	IN	O	of	_	0	SENT_203	[p17l1673t1462r1747b1525],
26	E2E	NN	O	e2e	prep_of	24	SENT_203	[p17l1761t1467r1898b1524],
27	is	VBZ	O	be	auxpass	29	SENT_203	[p17l1922t1468r1973b1525],
28	now	RB	DATE	now	advmod	29	SENT_203	[p17l1997t1485r2147b1525],
29	needed	VBN	O	need	_	0	SENT_203	[p17l9t1564r271b1627],
30	.	.	O	.	_	0	SENT_203	[p17l9t1564r271b1627],

1	Potential	JJ	O	potential	amod	3	SENT_204	[p17l12t1777r321b1834],
2	candidate	NN	O	candidate	nn	3	SENT_204	[p17l341t1776r686b1834],
3	treatments	NNS	O	treatment	nsubj	19	SENT_204	[p17l701t1784r1085b1834],
4	for	IN	O	for	_	0	SENT_204	[p17l1101t1776r1200b1834],
5	testing	NN	O	testing	prep_for	3	SENT_204	[p17l1215t1777r1456b1850],
6	in	IN	O	in	_	0	SENT_204	[p17l1478t1777r1537b1833],
7	E2E	NN	O	e2e	nn	9	SENT_204	[p17l1559t1779r1679b1833],
8	trials	NNS	O	trial	nn	9	SENT_204	[p17l1695t1777r1869b1834],
9	Factors	NNS	O	factor	prep_in	5	SENT_204	[p17l10t1879r272b1937],
10	relating	VBG	O	relate	partmod	5	SENT_204	[p17l301t1874r579b1958],
11	to	TO	O	to	_	0	SENT_204	[p17l605t1886r674b1937],
12	detection	NN	O	detection	prep_to	10	SENT_204	[p17l704t1874r1043b1937],
13	of	IN	O	of	_	0	SENT_204	[p17l1072t1874r1149b1937],
14	heterogeneity	NN	O	heterogeneity	prep_of	12	SENT_204	[p17l1166t1874r1667b1958],
15	of	IN	O	of	_	0	SENT_204	[p17l1692t1874r1769b1937],
16	treatment	NN	O	treatment	nn	17	SENT_204	[p17l1787t1886r2143b1937],
17	effects	NNS	O	effect	prep_of	14	SENT_204	[p17l10t1977r238b2040],
18	could	MD	O	could	aux	19	SENT_204	[p17l270t1977r474b2040],
19	inﬂuence	VB	O	inﬂuence	_	0	SENT_204	[p17l504t1977r842b2040],
20	the	DT	O	the	det	21	SENT_204	[p17l871t1977r985b2040],
21	choice	NN	O	choice	dobj	19	SENT_204	[p17l1016t1977r1249b2040],
22	of	IN	O	of	_	0	SENT_204	[p17l1281t1977r1359b2040],
23	therapeutic	JJ	O	therapeutic	amod	24	SENT_204	[p17l1378t1977r1800b2060],
24	area	NN	O	area	prep_of	21	SENT_204	[p17l1832t2000r1981b2040],
25	and	CC	O	and	cc	24	SENT_204	[p17l2012t1977r2145b2040],

1	6	CD	NUMBER	6	num	2	SENT_205	[p17l9t2196r39b2237],
2	agent	NN	O	agent	_	0	SENT_205	[p17l9t2288r221b2360],
3	,	,	O	,	_	0	SENT_205	[p17l9t2288r221b2360],
4	in	IN	O	in	dep	2	SENT_205	[p17l249t2282r319b2338],
5	addition	NN	O	addition	pobj	4	SENT_205	[p17l346t2276r651b2339],
6	to	TO	O	to	_	0	SENT_205	[p17l676t2288r745b2339],
7	plans	NNS	O	plan	prep_to	5	SENT_205	[p17l772t2276r961b2359],
8	for	IN	O	for	_	0	SENT_205	[p17l989t2276r1091b2339],
9	E2E	NN	O	e2e	nn	10	SENT_205	[p17l1117t2281r1258b2338],
10	trials	NNS	O	trial	prep_for	7	SENT_205	[p17l1285t2276r1487b2339],
11	.	.	O	.	_	0	SENT_205	[p17l1285t2276r1487b2339],

1	Prime	NNP	O	Prime	nn	2	SENT_206	[p17l1517t2281r1734b2339],
2	candidates	NNS	O	candidate	nsubj	3	SENT_206	[p17l1762t2276r2144b2339],
3	include	VBP	O	include	_	0	SENT_206	[p17l8t2379r268b2442],
4	drugs	NNS	O	drug	dobj	3	SENT_206	[p17l293t2379r491b2463],
5	for	IN	O	for	_	0	SENT_206	[p17l516t2379r616b2442],
6	which	WDT	O	which	rel	16	SENT_206	[p17l638t2379r853b2442],
7	heterogeneity	NN	O	heterogeneity	nsubjpass	16	SENT_206	[p17l877t2379r1363b2463],
8	in	IN	O	in	_	0	SENT_206	[p17l1384t2385r1452b2441],
9	safety	NN	O	safety	prep_in	7	SENT_206	[p17l1478t2379r1690b2463],
10	,	,	O	,	_	0	SENT_206	[p17l1478t2379r1690b2463],
11	efﬁcacy	NN	O	efﬁcacy	conj_and	9	SENT_206	[p17l1717t2379r1990b2463],
12	,	,	O	,	_	0	SENT_206	[p17l1717t2379r1990b2463],
13	and	CC	O	and	_	0	SENT_206	[p17l2018t2379r2147b2442],
14	effectiveness	NN	O	effectiveness	conj_and	9	SENT_206	[p17l9t2482r431b2545],
15	are	VBP	O	be	auxpass	16	SENT_206	[p17l453t2505r552b2545],
16	anticipated	VBN	O	anticipate	rcmod	4	SENT_206	[p17l575t2482r950b2565],
17	within	IN	O	within	_	0	SENT_206	[p17l968t2482r1189b2545],
18	a	DT	O	a	det	19	SENT_206	[p17l1211t2505r1244b2545],
19	diagnosis	NN	O	diagnosis	prep_within	16	SENT_206	[p17l1265t2482r1599b2566],
20	.	.	O	.	_	0	SENT_206	[p17l1265t2482r1599b2566],

1	Subgroups	NNS	O	subgroup	nsubjpass	4	SENT_207	[p17l1624t2482r1981b2566],
2	may	MD	O	may	aux	4	SENT_207	[p17l2003t2505r2147b2566],
3	be	VB	O	be	auxpass	4	SENT_207	[p17l6t2585r85b2648],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_207	[p17l108t2585r364b2648],
5	by	IN	O	by	_	0	SENT_207	[p17l383t2585r466b2669],
6	biomarkers	NNS	O	biomarker	agent	4	SENT_207	[p17l482t2585r892b2657],
7	,	,	O	,	_	0	SENT_207	[p17l482t2585r892b2657],
8	genetics	NNS	O	genetics	appos	6	SENT_207	[p17l915t2591r1211b2669],
9	,	,	O	,	_	0	SENT_207	[p17l915t2591r1211b2669],
10	clinical	JJ	O	clinical	amod	11	SENT_207	[p17l1235t2585r1482b2648],
11	characteristics	NNS	O	characteristic	appos	6	SENT_207	[p17l1504t2585r2017b2657],
12	,	,	O	,	_	0	SENT_207	[p17l1504t2585r2017b2657],
13	the	DT	O	the	det	14	SENT_207	[p17l2039t2585r2146b2648],
14	presence	NN	O	presence	appos	6	SENT_207	[p17l7t2710r322b2771],
15	of	IN	O	of	_	0	SENT_207	[p17l350t2688r427b2751],
16	other	JJ	O	other	amod	17	SENT_207	[p17l444t2688r635b2751],
17	indications	NNS	O	indication	prep_of	14	SENT_207	[p17l661t2688r1083b2760],
18	,	,	O	,	_	0	SENT_207	[p17l661t2688r1083b2760],
19	and	CC	O	and	cc	4	SENT_207	[p17l1112t2688r1272b2754],
20	/	:	O	/	punct	21	SENT_207	[p17l1112t2688r1272b2754],
21	or	CC	O	or	dep	4	SENT_207	[p17l1280t2711r1354b2751],
22	the	DT	O	the	det	23	SENT_207	[p17l1379t2688r1490b2751],
23	presence	NN	O	presence	dep	21	SENT_207	[p17l1516t2710r1831b2771],
24	of	IN	O	of	_	0	SENT_207	[p17l1859t2688r1935b2751],
25	other	JJ	O	other	amod	26	SENT_207	[p17l1953t2688r2144b2751],
26	drugs	NNS	O	drug	prep_of	23	SENT_207	[p17l9t2791r206b2875],
27	or	CC	O	or	_	0	SENT_207	[p17l232t2814r306b2854],
28	supplements	NNS	O	supplement	conj_or	26	SENT_207	[p17l331t2791r775b2874],
29	that	WDT	O	that	nsubj	31	SENT_207	[p17l799t2791r937b2854],
30	may	MD	O	may	aux	31	SENT_207	[p17l961t2814r1111b2875],
31	generate	VB	O	generate	ccomp	4	SENT_207	[p17l1132t2803r1429b2875],
32	positive	JJ	O	positive	amod	36	SENT_207	[p17l1453t2797r1730b2874],
33	or	CC	O	or	_	0	SENT_207	[p17l1755t2814r1829b2854],
34	negative	JJ	O	negative	amod	36	SENT_207	[p17l1853t2797r2144b2875],
35	interaction	NN	O	interaction	nn	36	SENT_207	[p17l8t2900r390b2957],
36	effects	NNS	O	effect	dobj	31	SENT_207	[p17l413t2894r646b2957],
37	.	.	O	.	_	0	SENT_207	[p17l413t2894r646b2957],

1	Alternatively	RB	O	alternatively	advmod	6	SENT_208	[p17l670t2894r1133b2978],
2	,	,	O	,	_	0	SENT_208	[p17l670t2894r1133b2978],
3	the	DT	O	the	det	4	SENT_208	[p17l1155t2894r1263b2957],
4	approach	NN	O	approach	nsubj	6	SENT_208	[p17l1286t2894r1607b2977],
5	could	MD	O	could	aux	6	SENT_208	[p17l1629t2894r1822b2957],
6	be	VB	O	be	_	0	SENT_208	[p17l1841t2894r1921b2957],
7	to	TO	O	to	aux	8	SENT_208	[p17l1942t2906r2008b2957],
8	use	VB	O	use	xcomp	6	SENT_208	[p17l2031t2917r2144b2957],
9	E2E	NN	O	e2e	nn	10	SENT_208	[p17l8t3002r149b3059],
10	trials	NNS	O	trial	dobj	8	SENT_208	[p17l174t2997r355b3060],
11	of	IN	O	of	_	0	SENT_208	[p17l382t2997r459b3060],
12	drugs	NNS	O	drug	prep_of	10	SENT_208	[p17l476t2997r676b3081],
13	that	WDT	O	that	nsubjpass	15	SENT_208	[p17l702t2997r842b3060],
14	were	VBD	O	be	auxpass	15	SENT_208	[p17l865t3020r1033b3060],
15	expected	VBN	O	expect	rcmod	12	SENT_208	[p17l1059t2997r1378b3080],
16	to	TO	O	to	aux	17	SENT_208	[p17l1402t3009r1470b3060],
17	have	VB	O	have	xcomp	15	SENT_208	[p17l1496t2997r1659b3060],
18	effects	NNS	O	effect	dobj	17	SENT_208	[p17l1685t2997r1908b3060],
19	in	IN	O	in	_	0	SENT_208	[p17l1934t3003r2003b3059],
20	trials	NNS	O	trial	prep_in	18	SENT_208	[p17l2028t3003r2142b3060, p17l9t3100r100b3163],
21	of	IN	O	of	_	0	SENT_208	[p17l126t3100r202b3163],
22	homogeneous	JJ	O	homogeneous	amod	23	SENT_208	[p17l217t3100r718b3184],
23	samples	NNS	O	sample	prep_of	20	SENT_208	[p17l745t3100r1025b3183],
24	but	CC	O	but	_	0	SENT_208	[p17l1049t3100r1167b3163],
25	wherein	WRB	O	wherein	advmod	30	SENT_208	[p17l1189t3100r1480b3163],
26	the	DT	O	the	det	27	SENT_208	[p17l1505t3100r1615b3163],
27	effects	NNS	O	effect	nsubj	30	SENT_208	[p17l1641t3100r1863b3163],
28	did	VBD	O	do	aux	30	SENT_208	[p17l1890t3100r2005b3163],
29	not	RB	O	not	neg	30	SENT_208	[p17l2029t3112r2147b3163],
30	materialize	VB	O	materialize	conj_but	15	SENT_208	[p17l8t3203r418b3266],
31	.	.	O	.	_	0	SENT_208	[p17l8t3203r418b3266],

1	Study	NN	O	study	nsubj	7	SENT_209	[p17l447t3203r648b3287],
2	in	IN	O	in	_	0	SENT_209	[p17l669t3209r737b3265],
3	more	JJR	O	more	amod	5	SENT_209	[p17l762t3226r945b3266],
4	heterogeneous	JJ	O	heterogeneous	amod	5	SENT_209	[p17l969t3203r1484b3287],
5	samples	NNS	O	sample	prep_in	1	SENT_209	[p17l1511t3203r1788b3286],
6	may	MD	O	may	aux	7	SENT_209	[p17l1813t3226r1963b3287],
7	have	VB	O	have	_	0	SENT_209	[p17l1984t3203r2144b3266],
8	signals	NNS	O	signal	dobj	7	SENT_209	[p17l9t3306r244b3390],
9	of	IN	O	of	_	0	SENT_209	[p17l268t3306r343b3369],
10	effects	NNS	O	effect	prep_of	8	SENT_209	[p17l357t3306r573b3369],
11	in	IN	O	in	_	0	SENT_209	[p17l597t3312r664b3368],
12	subgroups	NNS	O	subgroup	prep_in	10	SENT_209	[p17l689t3306r1066b3390],
13	.	.	O	.	_	0	SENT_209	[p17l689t3306r1066b3390],

1	For	IN	O	for	_	0	SENT_210	[p17l83t3414r199b3472],
2	early	JJ	O	early	amod	4	SENT_210	[p17l223t3409r390b3493],
3	EZE	NN	O	eze	nn	4	SENT_210	[p17l411t3414r547b3471],
4	trials	NNS	O	trial	prep_for	12	SENT_210	[p17l570t3409r762b3481],
5	,	,	O	,	_	0	SENT_210	[p17l570t3409r762b3481],
6	and	CC	O	and	cc	4	SENT_210	[p17l789t3409r916b3472],
7	perhaps	RB	O	perhaps	advmod	4	SENT_210	[p17l937t3409r1210b3492],
8	in	IN	O	in	amod	4	SENT_210	[p17l1235t3415r1302b3471],
9	general	JJ	O	general	dep	4	SENT_210	[p17l1325t3409r1595b3493],
10	,	,	O	,	_	0	SENT_210	[p17l1325t3409r1595b3493],
11	we	PRP	O	we	nsubj	12	SENT_210	[p17l1618t3432r1712b3472],
12	suggest	VBP	O	suggest	_	0	SENT_210	[p17l1736t3421r1988b3493],
13	that	IN	O	that	complm	16	SENT_210	[p17l2010t3409r2145b3472],
14	study	NN	O	study	nn	15	SENT_210	[p17l9t3512r200b3596],
15	end	NN	O	end	nsubj	16	SENT_210	[p17l222t3512r351b3575],
16	points	VBZ	O	point	ccomp	12	SENT_210	[p17l372t3518r592b3595],
17	not	RB	O	not	neg	16	SENT_210	[p17l616t3524r733b3575],
18	be	VB	O	be	auxpass	19	SENT_210	[p17l754t3512r835b3575],
19	focused	VBN	O	focus	dep	16	SENT_210	[p17l859t3512r1132b3575],
20	on	IN	O	on	_	0	SENT_210	[p17l1156t3535r1243b3575],
21	mortality	NN	O	mortality	prep_on	19	SENT_210	[p17l1267t3512r1606b3596],
22	.	.	O	.	_	0	SENT_210	[p17l1267t3512r1606b3596],

1	In	IN	O	in	_	0	SENT_211	[p17l1635t3517r1707b3574],
2	considering	VBG	O	consider	prepc_in	24	SENT_211	[p17l1732t3512r2147b3596],
3	the	DT	O	the	det	4	SENT_211	[p17l7t3615r116b3678],
4	transition	NN	O	transition	dobj	2	SENT_211	[p17l140t3621r486b3678],
5	from	IN	O	from	_	0	SENT_211	[p17l510t3615r682b3678],
6	the	DT	O	the	det	7	SENT_211	[p17l706t3615r815b3678],
7	end	NN	O	end	prep_from	2	SENT_211	[p17l840t3615r970b3678],
8	of	IN	O	of	_	0	SENT_211	[p17l993t3615r1069b3678],
9	the	DT	O	the	det	11	SENT_211	[p17l1082t3615r1192b3678],
10	efficacy	NN	O	efficacy	nn	11	SENT_211	[p17l1217t3615r1482b3699],
11	trial	NN	O	trial	prep_of	7	SENT_211	[p17l1502t3615r1648b3678],
12	to	TO	O	to	_	0	SENT_211	[p17l1670t3627r1738b3678],
13	the	DT	O	the	det	14	SENT_211	[p17l1762t3615r1872b3678],
14	start	NN	O	start	prep_to	2	SENT_211	[p17l1897t3627r2054b3678],
15	of	IN	O	of	_	0	SENT_211	[p17l2077t3615r2153b3678],
16	the	DT	O	the	det	18	SENT_211	[p17l7t3718r117b3781],
17	effectiveness	NN	O	effectiveness	nn	18	SENT_211	[p17l144t3718r588b3781],
18	component	NN	O	component	prep_of	14	SENT_211	[p17l614t3730r1038b3801],
19	,	,	O	,	_	0	SENT_211	[p17l614t3730r1038b3801],
20	it	PRP	O	it	nsubj	24	SENT_211	[p17l1065t3724r1112b3781],
21	would	MD	O	would	aux	24	SENT_211	[p17l1134t3718r1357b3781],
22	be	VB	O	be	cop	24	SENT_211	[p17l1379t3718r1461b3781],
23	ethically	RB	O	ethically	advmod	24	SENT_211	[p17l1487t3718r1791b3802],
24	problematic	JJ	O	problematic	_	0	SENT_211	[p17l1811t3718r2141b3801, p18l9t22r133b79],

1	to	TO	O	to	aux	2	SENT_212	[p18l158t28r226b79],
2	conduct	VB	O	conduct	csubj	6	SENT_212	[p18l254t16r544b79],
3	a	DT	O	a	det	5	SENT_212	[p18l570t39r605b79],
4	placebo	NN	O	placebo	nn	5	SENT_212	[p18l629t16r1311b99],
5	—	NN	O	—	dobj	2	SENT_212	[p18l629t16r1311b99],
6	controlled	VBN	O	control	_	0	SENT_212	[p18l629t16r1311b99],
7	randomized	JJ	O	randomized	amod	8	SENT_212	[p18l1336t16r1770b79],
8	trial	NN	O	trial	dobj	6	SENT_212	[p18l1794t16r1942b79],
9	of	IN	O	of	_	0	SENT_212	[p18l1968t16r2045b79],
10	an	DT	O	a	det	11	SENT_212	[p18l2062t39r2144b79],
11	agent	NN	O	agent	prep_of	8	SENT_212	[p18l9t131r190b203],
12	that	WDT	O	that	nsubjpass	15	SENT_212	[p18l208t119r341b182],
13	has	VBZ	O	have	aux	15	SENT_212	[p18l359t119r469b182],
14	been	VBN	O	be	auxpass	15	SENT_212	[p18l489t119r651b182],
15	shown	VBN	O	show	rcmod	11	SENT_212	[p18l672t119r892b182],
16	in	IN	O	in	_	0	SENT_212	[p18l913t125r978b181],
17	an	DT	O	a	det	19	SENT_212	[p18l1000t142r1079b182],
18	efﬁcacy	NN	O	efﬁcacy	nn	19	SENT_212	[p18l1100t119r1354b203],
19	portion	NN	O	portion	prep_in	15	SENT_212	[p18l1370t125r1627b202],
20	to	TO	O	to	aux	22	SENT_212	[p18l1647t131r1712b182],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	22	SENT_212	[p18l1734t119r2149b203],
22	reduce	VB	O	reduce	xcomp	6	SENT_212	[p18l9t222r236b285],
23	mortality	NN	O	mortality	dobj	22	SENT_212	[p18l257t222r586b306],
24	.	.	O	.	_	0	SENT_212	[p18l257t222r586b306],

1	Exceptions	NNS	O	exception	nsubj	3	SENT_213	[p18l610t227r984b305],
2	might	MD	O	might	aux	3	SENT_213	[p18l1006t222r1209b306],
3	be	VB	O	be	_	0	SENT_213	[p18l1227t222r1306b285],
4	when	WRB	O	when	advmod	15	SENT_213	[p18l1325t222r1513b285],
5	the	DT	O	the	det	7	SENT_213	[p18l1533t222r1638b285],
6	target	NN	O	target	nn	7	SENT_213	[p18l1659t234r1856b306],
7	population	NN	O	population	nsubj	15	SENT_213	[p18l1875t222r2142b305, p18l7t331r147b388],
8	for	IN	O	for	_	0	SENT_213	[p18l171t325r270b388],
9	the	DT	O	the	det	11	SENT_213	[p18l291t325r399b388],
10	effectiveness	NN	O	effectiveness	nn	11	SENT_213	[p18l424t325r858b388],
11	portion	NN	O	portion	prep_for	7	SENT_213	[p18l881t331r1145b408],
12	is	VBZ	O	be	cop	15	SENT_213	[p18l1170t331r1220b388],
13	so	RB	O	so	quantmod	14	SENT_213	[p18l1245t348r1317b388],
14	much	JJ	O	much	num	15	SENT_213	[p18l1342t325r1538b388],
15	broader	JJR	O	broader	dep	3	SENT_213	[p18l1560t325r1834b388],
16	than	IN	O	than	_	0	SENT_213	[p18l1856t325r2013b388],
17	the	DT	O	the	det	19	SENT_213	[p18l2036t325r2144b388],
18	efﬁcacy	NN	O	efﬁcacy	nn	19	SENT_213	[p18l9t428r277b512],
19	trial	NN	O	trial	prep_than	15	SENT_213	[p18l298t428r446b491],
20	that	WDT	O	that	dobj	24	SENT_213	[p18l470t428r609b491],
21	equipoise	NN	O	equipoise	nsubj	24	SENT_213	[p18l635t434r975b511],
22	is	VBZ	O	be	cop	24	SENT_213	[p18l1001t434r1053b491],
23	still	RB	O	still	advmod	24	SENT_213	[p18l1080t428r1208b491],
24	credible	JJ	O	credible	ccomp	15	SENT_213	[p18l1234t428r1518b491],
25	or	CC	O	or	_	0	SENT_213	[p18l1544t451r1619b491],
26	when	WRB	O	when	advmod	30	SENT_213	[p18l1641t428r1836b491],
27	the	DT	O	the	det	29	SENT_213	[p18l1860t428r1971b491],
28	trial	NN	O	trial	nn	29	SENT_213	[p18l1996t428r2144b491],
29	design	NN	O	design	nsubj	30	SENT_213	[p18l9t531r238b615],
30	includes	VBZ	O	include	dep	3	SENT_213	[p18l263t531r556b594],
31	an	DT	O	a	det	33	SENT_213	[p18l583t554r665b594],
32	enrollment	NN	O	enrollment	nn	33	SENT_213	[p18l690t531r1084b594],
33	protocol	NN	O	protocol	dobj	30	SENT_213	[p18l1105t531r1406b614],
34	such	JJ	O	such	prep	30	SENT_213	[p18l1431t531r1591b594],
35	that	IN	O	that	complm	46	SENT_213	[p18l1614t531r1753b594],
36	only	RB	O	only	advmod	37	SENT_213	[p18l1777t531r1934b615],
37	those	DT	O	those	nsubjpass	46	SENT_213	[p18l1953t531r2143b594],
38	for	IN	O	for	_	0	SENT_213	[p18l8t634r106b697],
39	whom	WP	O	whom	dobj	41	SENT_213	[p18l125t634r344b697],
40	there	EX	O	there	expl	41	SENT_213	[p18l365t634r541b697],
41	was	VBD	O	be	prepc_for	37	SENT_213	[p18l561t657r687b697],
42	true	JJ	O	true	amod	43	SENT_213	[p18l709t646r850b697],
43	equipoise	NN	O	equipoise	nsubj	41	SENT_213	[p18l873t640r1201b717],
44	would	MD	O	would	aux	46	SENT_213	[p18l1221t634r1438b697],
45	be	VB	O	be	auxpass	46	SENT_213	[p18l1456t634r1536b697],
46	randomized	VBN	O	randomize	ccomp	30	SENT_213	[p18l1558t634r1994b706],
47	,	,	O	,	_	0	SENT_213	[p18l1558t634r1994b706],
48	and	CC	O	and	_	0	SENT_213	[p18l2018t634r2146b697],
49	those	DT	O	those	nsubj	57	SENT_213	[p18l7t737r193b800],
50	for	IN	O	for	_	0	SENT_213	[p18l217t737r315b800],
51	whom	WP	O	whom	nsubj	52	SENT_213	[p18l336t737r556b800],
52	equipoise	VBP	O	equipoise	prepc_for	49	SENT_213	[p18l580t743r911b820],
53	has	VBZ	O	have	aux	55	SENT_213	[p18l934t737r1047b800],
54	been	VBN	O	be	auxpass	55	SENT_213	[p18l1069t737r1235b800],
55	dislodged	VBN	O	dislodge	ccomp	52	SENT_213	[p18l1260t737r1597b821],
56	would	MD	O	would	aux	57	SENT_213	[p18l1617t737r1835b800],
57	get	VB	O	get	conj_and	3	SENT_213	[p18l1857t749r1959b821],
58	their	PRP$	O	they	poss	60	SENT_213	[p18l1981t737r2146b800],
59	preferred	JJ	O	preferred	amod	60	SENT_213	[p18l7t839r329b922],
60	treatment	NN	O	treatment	dobj	57	SENT_213	[p18l350t831r770b902],
61	.	.	O	.	_	0	SENT_213	[p18l350t831r770b902],

1	”	NN	O	”	nsubj	12	SENT_214	[p18l350t831r770b902],
2	However	RB	O	however	advmod	1	SENT_214	[p18l795t844r1117b911],
3	,	,	O	,	_	0	SENT_214	[p18l795t844r1117b911],
4	at	IN	O	at	advmod	12	SENT_214	[p18l1142t851r1202b902],
5	least	JJS	O	least	pobj	4	SENT_214	[p18l1222t839r1377b902],
6	in	IN	O	in	_	0	SENT_214	[p18l1399t845r1466b901],
7	early	JJ	O	early	amod	9	SENT_214	[p18l1490t839r1658b923],
8	E2E	NN	O	e2e	nn	9	SENT_214	[p18l1677t844r1814b901],
9	trials	NNS	O	trial	prep_in	12	SENT_214	[p18l1836t839r2028b911],
10	,	,	O	,	_	0	SENT_214	[p18l1836t839r2028b911],
11	we	PRP	O	we	nsubj	12	SENT_214	[p18l2051t862r2144b902],
12	suggest	VBP	O	suggest	_	0	SENT_214	[p18l9t954r254b1026],
13	using	VBG	O	use	xcomp	12	SENT_214	[p18l274t948r457b1026],
14	easily	RB	O	easily	advmod	15	SENT_214	[p18l476t942r664b1026],
15	quantiﬁable	JJ	O	quantiﬁable	amod	16	SENT_214	[p18l682t942r1080b1025],
16	outcomes	NNS	O	outcome	dobj	13	SENT_214	[p18l1101t954r1424b1005],
17	other	JJ	O	other	amod	16	SENT_214	[p18l1446t942r1625b1005],
18	than	IN	O	than	_	0	SENT_214	[p18l1643t942r1795b1005],
19	mortality	NN	O	mortality	prep_than	17	SENT_214	[p18l1815t942r2140b1026],
20	.	.	O	.	_	0	SENT_214	[p18l1815t942r2140b1026],

1	In	IN	O	in	_	0	SENT_215	[p18l83t1050r156b1107],
2	addition	NN	O	addition	prep_in	12	SENT_215	[p18l181t1045r497b1117],
3	,	,	O	,	_	0	SENT_215	[p18l181t1045r497b1117],
4	to	TO	O	to	aux	5	SENT_215	[p18l523t1057r591b1108],
5	learn	VB	O	learn	purpcl	12	SENT_215	[p18l615t1045r795b1108],
6	from	IN	O	from	_	0	SENT_215	[p18l820t1045r992b1108],
7	early	JJ	O	early	amod	9	SENT_215	[p18l1017t1045r1190b1129],
8	E2E	NN	O	e2e	nn	9	SENT_215	[p18l1211t1050r1350b1107],
9	trials	NNS	O	trial	prep_from	5	SENT_215	[p18l1374t1045r1572b1117],
10	,	,	O	,	_	0	SENT_215	[p18l1374t1045r1572b1117],
11	we	PRP	O	we	nsubj	12	SENT_215	[p18l1596t1068r1692b1108],
12	recommend	VBP	O	recommend	_	0	SENT_215	[p18l1717t1045r2146b1108],
13	that	IN	O	that	complm	22	SENT_215	[p18l7t1148r141b1211],
14	time	NN	O	time	nn	15	SENT_215	[p18l161t1154r315b1211],
15	lines	NNS	O	line	nsubj	22	SENT_215	[p18l335t1148r493b1211],
16	for	IN	O	for	_	0	SENT_215	[p18l515t1148r612b1211],
17	study	NN	O	study	nn	19	SENT_215	[p18l634t1148r820b1232],
18	end	NN	O	end	nn	19	SENT_215	[p18l839t1148r965b1211],
19	points	NNS	O	point	prep_for	15	SENT_215	[p18l985t1154r1197b1231],
20	be	VB	O	be	cop	22	SENT_215	[p18l1217t1148r1297b1211],
21	relatively	RB	O	relatively	advmod	22	SENT_215	[p18l1319t1148r1631b1232],
22	short	JJ	O	short	ccomp	12	SENT_215	[p18l1650t1148r1843b1220],
23	,	,	O	,	_	0	SENT_215	[p18l1650t1148r1843b1220],
24	with	IN	O	with	_	0	SENT_215	[p18l1864t1148r2017b1211],
25	the	DT	O	the	det	26	SENT_215	[p18l2038t1148r2144b1211],
26	potential	NN	O	potential	prep_with	22	SENT_215	[p18l7t1251r317b1334],
27	of	IN	O	of	_	0	SENT_215	[p18l340t1251r415b1314],
28	showing	VBG	O	show	prepc_of	26	SENT_215	[p18l429t1251r719b1335],
29	impact	NN	O	impact	dobj	28	SENT_215	[p18l741t1257r981b1334],
30	within	IN	O	within	_	0	SENT_215	[p18l1001t1251r1227b1314],
31	a	DT	O	a	det	35	SENT_215	[p18l1251t1274r1285b1314],
32	1-year	JJ	DURATION	1-year	amod	35	SENT_215	[p18l1314t1258r1525b1335],
33	effectiveness	NN	O	effectiveness	nn	35	SENT_215	[p18l1548t1251r1980b1314],
34	trial	NN	O	trial	nn	35	SENT_215	[p18l2002t1251r2146b1314],
35	component	NN	O	component	prep_within	28	SENT_215	[p18l9t1366r415b1437],
36	.	.	O	.	_	0	SENT_215	[p18l9t1366r415b1437],

1	We	PRP	O	we	nsubj	3	SENT_216	[p18l439t1359r548b1417],
2	also	RB	O	also	advmod	3	SENT_216	[p18l572t1354r702b1417],
3	suggest	VBP	O	suggest	_	0	SENT_216	[p18l726t1366r975b1438],
4	that	IN	O	that	complm	9	SENT_216	[p18l995t1354r1129b1417],
5	early	JJ	O	early	amod	7	SENT_216	[p18l1151t1354r1317b1438],
6	E2E	NN	O	e2e	nn	7	SENT_216	[p18l1335t1359r1471b1416],
7	trials	NNS	O	trial	nsubjpass	9	SENT_216	[p18l1492t1354r1663b1417],
8	be	VB	O	be	auxpass	9	SENT_216	[p18l1684t1354r1764b1417],
9	conducted	VBN	O	conduct	ccomp	3	SENT_216	[p18l1786t1354r2146b1417],
10	in	IN	O	in	_	0	SENT_216	[p18l8t1463r75b1519],
11	clinical	JJ	O	clinical	amod	12	SENT_216	[p18l96t1457r341b1520],
12	domains	NNS	O	domain	prep_in	9	SENT_216	[p18l362t1457r655b1520],
13	not	RB	O	not	neg	16	SENT_216	[p18l677t1469r791b1520],
14	already	RB	O	already	advmod	15	SENT_216	[p18l811t1457r1061b1541],
15	heavily	RB	O	heavily	advmod	16	SENT_216	[p18l1078t1457r1323b1541],
16	populated	VBN	O	populate	partmod	12	SENT_216	[p18l1339t1457r1685b1540],
17	by	IN	O	by	_	0	SENT_216	[p18l1702t1457r1787b1541],
18	successful	JJ	O	successful	amod	19	SENT_216	[p18l1805t1457r2146b1520],
19	agents	NNS	O	agent	agent	16	SENT_216	[p18l9t1572r239b1644],
20	.	.	O	.	_	0	SENT_216	[p18l9t1572r239b1644],

1	For	IN	O	for	_	0	SENT_217	[p18l265t1565r381b1623],
2	example	NN	O	example	prep_for	17	SENT_217	[p18l403t1560r704b1643],
3	,	,	O	,	_	0	SENT_217	[p18l403t1560r704b1643],
4	doing	VBG	O	do	csubj	17	SENT_217	[p18l729t1560r925b1644],
5	a	DT	O	a	det	6	SENT_217	[p18l947t1583r981b1623],
6	trial	NN	O	trial	dobj	4	SENT_217	[p18l1001t1560r1142b1623],
7	of	IN	O	of	_	0	SENT_217	[p18l1165t1560r1239b1623],
8	a	DT	O	a	det	11	SENT_217	[p18l1253t1583r1287b1623],
9	new	JJ	O	new	amod	11	SENT_217	[p18l1308t1583r1451b1623],
10	proton	NN	O	proton	nn	11	SENT_217	[p18l1470t1572r1701b1643],
11	inhibitor	NN	O	inhibitor	prep_of	6	SENT_217	[p18l1724t1560r2027b1623],
12	for	IN	O	for	_	0	SENT_217	[p18l2049t1560r2146b1623],
13	gastroesophageal	NN	O	gastroesophageal	nn	15	SENT_217	[p18l8t1663r613b1747],
14	reﬂux	NN	O	reﬂux	nn	15	SENT_217	[p18l636t1663r840b1726],
15	disorder	NN	O	disorder	prep_for	11	SENT_217	[p18l862t1663r1157b1726],
16	would	MD	O	would	aux	17	SENT_217	[p18l1178t1663r1398b1726],
17	ﬁt	VB	O	ﬁt	_	0	SENT_217	[p18l1420t1663r1492b1726],
18	the	DT	O	the	det	19	SENT_217	[p18l1513t1663r1622b1726],
19	criteria	NNS	O	criterion	dobj	17	SENT_217	[p18l1647t1669r1899b1726],
20	above	IN	O	above	prep	17	SENT_217	[p18l1923t1663r2143b1735],
21	,	,	O	,	_	0	SENT_217	[p18l1923t1663r2143b1735],
22	but	CC	O	but	_	0	SENT_217	[p18l6t1766r123b1829],
23	considering	VBG	O	consider	csubj	44	SENT_217	[p18l146t1766r563b1850],
24	the	DT	O	the	det	26	SENT_217	[p18l584t1766r693b1829],
25	large	JJ	O	large	amod	26	SENT_217	[p18l716t1766r886b1850],
26	number	NN	O	number	dobj	23	SENT_217	[p18l910t1766r1190b1829],
27	of	IN	O	of	_	0	SENT_217	[p18l1214t1766r1289b1829],
28	successful	JJ	O	successful	amod	29	SENT_217	[p18l1305t1766r1656b1829],
29	agents	NNS	O	agent	prep_of	26	SENT_217	[p18l1680t1778r1899b1850],
30	in	IN	O	in	_	0	SENT_217	[p18l1924t1772r1992b1828],
31	this	DT	O	this	det	33	SENT_217	[p18l2015t1766r2143b1829],
32	therapeutic	JJ	O	therapeutic	amod	33	SENT_217	[p18l7t1869r392b1952],
33	area	NN	O	area	prep_in	23	SENT_217	[p18l413t1892r567b1941],
34	,	,	O	,	_	0	SENT_217	[p18l413t1892r567b1941],
35	the	DT	O	the	det	36	SENT_217	[p18l588t1869r693b1932],
36	beneﬁt	NN	O	beneﬁt	appos	33	SENT_217	[p18l712t1869r945b1932],
37	in	IN	O	in	_	0	SENT_217	[p18l964t1875r1030b1931],
38	conducting	VBG	O	conduct	prepc_in	36	SENT_217	[p18l1050t1869r1435b1953],
39	such	PDT	O	such	predet	41	SENT_217	[p18l1454t1869r1607b1932],
40	a	DT	O	a	det	41	SENT_217	[p18l1628t1892r1662b1932],
41	trial	NN	O	trial	dobj	38	SENT_217	[p18l1679t1869r1819b1932],
42	would	MD	O	would	aux	44	SENT_217	[p18l1836t1869r2048b1932],
43	be	VB	O	be	cop	44	SENT_217	[p18l2066t1869r2144b1932],
44	minimal	JJ	O	minimal	conj_but	17	SENT_217	[p18l8t1972r320b2035],
45	.	.	O	.	_	0	SENT_217	[p18l8t1972r320b2035],

1	Alternatively	RB	O	alternatively	advmod	37	SENT_218	[p18l345t1972r806b2056],
2	,	,	O	,	_	0	SENT_218	[p18l345t1972r806b2056],
3	for	IN	O	for	_	0	SENT_218	[p18l831t1972r930b2035],
4	clinical	JJ	O	clinical	amod	5	SENT_218	[p18l953t1972r1201b2035],
5	areas	NNS	O	area	prep_for	37	SENT_218	[p18l1224t1995r1396b2035],
6	with	IN	O	with	_	0	SENT_218	[p18l1418t1972r1573b2035],
7	few	JJ	O	few	amod	10	SENT_218	[p18l1596t1972r1718b2035],
8	good	JJ	O	good	amod	10	SENT_218	[p18l1738t1972r1913b2056],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_218	[p18l1934t1972r2141b2035, p18l7t2081r217b2158],
10	options	NNS	O	option	prep_with	5	SENT_218	[p18l237t2081r508b2158],
11	,	,	O	,	_	0	SENT_218	[p18l237t2081r508b2158],
12	such	JJ	O	such	_	0	SENT_218	[p18l530t2075r684b2138],
13	as	IN	O	as	_	0	SENT_218	[p18l705t2098r768b2138],
14	Alzheimer	NN	O	alzheimer	poss	16	SENT_218	[p18l788t2075r1186b2138],
15	’s	POS	O	’s	_	0	SENT_218	[p18l788t2075r1186b2138],
16	disease	NN	O	disease	prep_such_as	5	SENT_218	[p18l1207t2075r1445b2138],
17	or	CC	O	or	_	0	SENT_218	[p18l1467t2098r1538b2138],
18	various	JJ	O	various	amod	21	SENT_218	[p18l1554t2081r1804b2138],
19	advanced	JJ	O	advanced	amod	21	SENT_218	[p18l1825t2075r2146b2138],
20	metastatic	JJ	O	metastatic	amod	21	SENT_218	[p18l8t2185r372b2242],
21	cancers	NNS	O	cancer	prep_such_as	5	SENT_218	[p18l398t2202r680b2251],
22	,	,	O	,	_	0	SENT_218	[p18l398t2202r680b2251],
23	the	DT	O	the	det	24	SENT_218	[p18l706t2179r817b2242],
24	beneﬁt	NN	O	beneﬁt	nsubj	37	SENT_218	[p18l841t2179r1085b2242],
25	of	IN	O	of	_	0	SENT_218	[p18l1110t2179r1187b2242],
26	assessing	VBG	O	assess	prepc_of	24	SENT_218	[p18l1203t2185r1524b2263],
27	a	DT	O	a	det	30	SENT_218	[p18l1549t2202r1584b2242],
28	promising	JJ	O	promising	amod	30	SENT_218	[p18l1608t2185r1974b2263],
29	new	JJ	O	new	amod	30	SENT_218	[p18l1998t2202r2145b2242],
30	agent	NN	O	agent	dobj	26	SENT_218	[p18l9t2294r192b2366],
31	in	IN	O	in	_	0	SENT_218	[p18l212t2288r278b2344],
32	an	DT	O	a	det	34	SENT_218	[p18l301t2305r381b2345],
33	EZE	NN	MISC	eze	nn	34	SENT_218	[p18l402t2287r538b2344],
34	trial	NN	O	trial	prep_in	26	SENT_218	[p18l559t2282r700b2345],
35	would	MD	O	would	aux	37	SENT_218	[p18l719t2282r933b2345],
36	be	VB	O	be	cop	37	SENT_218	[p18l952t2282r1031b2345],
37	substantial	JJ	O	substantial	_	0	SENT_218	[p18l1054t2282r1438b2345],
38	.	.	O	.	_	0	SENT_218	[p18l1054t2282r1438b2345],

1	CONCLUSION	NN	O	conclusion	_	0	SENT_219	[p18l9t2496r485b2552],

1	We	PRP	O	we	nsubj	2	SENT_220	[p18l7t2597r122b2655],
2	believe	VBP	O	believe	_	0	SENT_220	[p18l155t2592r420b2655],
3	that	IN	O	that	complm	8	SENT_220	[p18l454t2592r602b2655],
4	the	DT	O	the	det	7	SENT_220	[p18l634t2592r750b2655],
5	EZE	NNP	O	EZE	nn	7	SENT_220	[p18l785t2597r931b2654],
6	trial	NN	O	trial	nn	7	SENT_220	[p18l965t2592r1124b2655],
7	approach	NN	O	approach	nsubj	8	SENT_220	[p18l1159t2592r1507b2675],
8	has	VBZ	O	have	ccomp	2	SENT_220	[p18l1541t2592r1662b2655],
9	promise	NN	O	promise	dobj	8	SENT_220	[p18l1697t2598r2003b2675],
10	for	IN	O	for	_	0	SENT_220	[p18l2038t2592r2144b2655],
11	improving	VBG	O	improve	prepc_for	9	SENT_220	[p18l9t2701r387b2779],
12	the	DT	O	the	det	14	SENT_220	[p18l411t2695r522b2758],
13	evidentiary	JJ	O	evidentiary	amod	14	SENT_220	[p18l549t2695r963b2779],
14	basis	NN	O	basis	dobj	11	SENT_220	[p18l984t2695r1159b2758],
15	for	IN	O	for	_	0	SENT_220	[p18l1186t2695r1288b2758],
16	adopting	VBG	O	adopt	prepc_for	11	SENT_220	[p18l1314t2695r1637b2779],
17	treatments	NNS	O	treatment	dobj	16	SENT_220	[p18l1661t2707r2048b2758],
18	in	IN	O	in	_	0	SENT_220	[p18l2075t2701r2144b2757],
19	practice	NN	O	practice	prep_in	16	SENT_220	[p18l7t2804r308b2881],
20	,	,	O	,	_	0	SENT_220	[p18l7t2804r308b2881],
21	accelerating	VBG	O	accelerate	conj_and	11	SENT_220	[p18l335t2798r759b2882],
22	understandings	NNS	O	understanding	dobj	21	SENT_220	[p18l783t2798r1333b2882],
23	of	IN	O	of	_	0	SENT_220	[p18l1360t2798r1435b2861],
24	treatment	NN	O	treatment	nn	25	SENT_220	[p18l1450t2810r1796b2861],
25	effectiveness	NN	O	effectiveness	prep_of	22	SENT_220	[p18l1821t2798r2140b2861, p18l8t2924r156b2964],
26	in	IN	O	in	_	0	SENT_220	[p18l182t2907r251b2963],
27	subgroups	NNS	O	subgroup	prep_in	21	SENT_220	[p18l278t2901r644b2985],
28	with	IN	O	with	_	0	SENT_220	[p18l669t2901r827b2964],
29	particular	JJ	O	particular	amod	31	SENT_220	[p18l852t2901r1206b2984],
30	clinical	JJ	O	clinical	amod	31	SENT_220	[p18l1232t2901r1489b2964],
31	features	NNS	O	feature	prep_with	27	SENT_220	[p18l1514t2901r1811b2973],
32	,	,	O	,	_	0	SENT_220	[p18l1514t2901r1811b2973],
33	and	CC	O	and	_	0	SENT_220	[p18l1840t2901r1969b2964],
34	providing	VBG	O	provide	conj_and	11	SENT_220	[p18l1993t2923r2143b2984, p18l6t3004r236b3088],
35	a	DT	O	a	det	36	SENT_220	[p18l260t3027r295b3067],
36	framework	NN	O	framework	dobj	34	SENT_220	[p18l319t3004r715b3067],
37	for	IN	O	for	_	0	SENT_220	[p18l738t3004r839b3067],
38	incorporating	VBG	O	incorporate	prepc_for	34	SENT_220	[p18l864t3010r1362b3088],
39	this	DT	O	this	det	40	SENT_220	[p18l1385t3004r1516b3067],
40	information	NN	O	information	dobj	38	SENT_220	[p18l1542t3004r1976b3067],
41	into	IN	O	into	_	0	SENT_220	[p18l2002t3010r2141b3067],
42	the	DT	O	the	det	44	SENT_220	[p18l7t3107r119b3170],
43	regulatory	JJ	O	regulatory	amod	44	SENT_220	[p18l146t3107r523b3191],
44	process	NN	O	process	prep_into	38	SENT_220	[p18l544t3129r831b3190],
45	.	.	O	.	_	0	SENT_220	[p18l544t3129r831b3190],

1	It	PRP	O	it	nsubj	4	SENT_221	[p18l861t3112r913b3170],
2	also	RB	O	also	advmod	4	SENT_221	[p18l939t3107r1077b3170],
3	should	MD	O	should	aux	4	SENT_221	[p18l1105t3107r1348b3170],
4	allow	VB	O	allow	_	0	SENT_221	[p18l1374t3107r1567b3170],
5	investigators	NNS	O	investigator	nsubj	7	SENT_221	[p18l1591t3113r2048b3191],
6	to	TO	O	to	aux	7	SENT_221	[p18l2075t3119r2143b3170],
7	reﬁne	VB	O	reﬁne	xcomp	4	SENT_221	[p18l9t3210r211b3273],
8	the	DT	O	the	det	9	SENT_221	[p18l236t3210r346b3273],
9	use	NN	O	use	dobj	7	SENT_221	[p18l372t3233r488b3273],
10	of	IN	O	of	_	0	SENT_221	[p18l515t3210r591b3273],
11	an	DT	O	a	det	12	SENT_221	[p18l608t3233r690b3273],
12	agent	NN	O	agent	prep_of	9	SENT_221	[p18l717t3222r925b3294],
13	.	.	O	.	_	0	SENT_221	[p18l717t3222r925b3294],

1	In	IN	O	in	_	0	SENT_222	[p18l955t3215r1028b3272],
2	addition	NN	O	addition	prep_in	5	SENT_222	[p18l1055t3210r1376b3282],
3	,	,	O	,	_	0	SENT_222	[p18l1055t3210r1376b3282],
4	we	PRP	O	we	nsubj	5	SENT_222	[p18l1402t3233r1498b3273],
5	see	VBP	O	see	_	0	SENT_222	[p18l1525t3233r1631b3273],
6	E2E	NN	O	e2e	nn	8	SENT_222	[p18l1657t3215r1797b3272],
7	trial	NN	O	trial	nn	8	SENT_222	[p18l1822t3210r1971b3273],
8	data	NNS	O	datum	dobj	5	SENT_222	[p18l1997t3210r2147b3273],
9	as	IN	O	as	_	0	SENT_222	[p18l9t3336r74b3376],
10	a	DT	O	a	det	11	SENT_222	[p18l98t3336r133b3376],
11	basis	NN	O	basis	prep_as	5	SENT_222	[p18l152t3313r322b3376],
12	for	IN	O	for	_	0	SENT_222	[p18l346t3313r445b3376],
13	generating	VBG	O	generate	prepc_for	11	SENT_222	[p18l467t3319r839b3397],
14	multivariable	JJ	O	multivariable	amod	16	SENT_222	[p18l860t3313r1327b3376],
15	predictive	JJ	O	predictive	amod	16	SENT_222	[p18l1349t3313r1699b3396],
16	instruments	NNS	O	instrument	dobj	13	SENT_222	[p18l1722t3319r2145b3376],
17	that	WDT	O	that	nsubjpass	20	SENT_222	[p18l7t3416r145b3479],
18	could	MD	O	could	aux	20	SENT_222	[p18l170t3416r365b3479],
19	be	VB	O	be	auxpass	20	SENT_222	[p18l387t3416r468b3479],
20	used	VBN	O	use	ccomp	13	SENT_222	[p18l494t3416r656b3479],
21	as	IN	O	as	_	0	SENT_222	[p18l681t3439r746b3479],
22	decision	NN	O	decision	nn	23	SENT_222	[p18l772t3416r1065b3479],
23	support	NN	O	support	prep_as	20	SENT_222	[p18l1091t3428r1364b3499],
24	for	IN	O	for	_	0	SENT_222	[p18l1388t3416r1489b3479],
25	treatment	NN	O	treatment	prep_for	23	SENT_222	[p18l1511t3428r1858b3479],
26	of	IN	O	of	_	0	SENT_222	[p18l1883t3416r1958b3479],
27	indiVidual	JJ	O	individual	amod	28	SENT_222	[p18l1973t3416r2141b3479, p18l6t3519r223b3582],
28	patients	NNS	O	patient	prep_of	25	SENT_222	[p18l245t3525r520b3602],
29	and	CC	O	and	_	0	SENT_222	[p18l544t3519r672b3582],
30	that	IN	O	that	complm	31	SENT_222	[p18l692t3519r828b3582],
31	reﬂect	VBP	O	reﬂect	conj_and	20	SENT_222	[p18l850t3519r1066b3582],
32	the	DT	O	the	det	33	SENT_222	[p18l1086t3519r1194b3582],
33	heterogeneity	NN	O	heterogeneity	dobj	31	SENT_222	[p18l1216t3519r1696b3603],
34	of	IN	O	of	_	0	SENT_222	[p18l1716t3519r1790b3582],
35	treatment	NN	O	treatment	nn	36	SENT_222	[p18l1802t3531r2144b3582],
36	effects	NNS	O	effect	prep_of	33	SENT_222	[p18l9t3622r246b3685],
37	.	.	O	.	_	0	SENT_222	[p18l9t3622r246b3685],

1	Finally	RB	O	finally	advmod	4	SENT_223	[p18l273t3622r526b3706],
2	,	,	O	,	_	0	SENT_223	[p18l273t3622r526b3706],
3	we	PRP	O	we	nsubj	4	SENT_223	[p18l550t3645r644b3685],
4	see	VBP	O	see	_	0	SENT_223	[p18l668t3645r772b3685],
5	it	PRP	O	it	dobj	4	SENT_223	[p18l795t3628r842b3685],
6	as	IN	O	as	_	0	SENT_223	[p18l865t3645r930b3685],
7	promoting	VBG	O	promote	prepc_as	4	SENT_223	[p18l953t3628r1331b3706],
8	the	DT	O	the	det	10	SENT_223	[p18l1352t3622r1461b3685],
9	public	JJ	O	public	amod	10	SENT_223	[p18l1483t3622r1702b3705],
10	good	NN	O	good	dobj	7	SENT_223	[p18l1725t3622r1901b3706],
11	of	IN	O	of	_	0	SENT_223	[p18l1923t3622r1999b3685],
12	getting	VBG	O	get	prepc_of	10	SENT_223	[p18l2012t3634r2143b3706, p18l7t3731r148b3809],
13	the	DT	O	the	det	15	SENT_223	[p18l171t3725r280b3788],
14	right	JJ	O	right	amod	15	SENT_223	[p18l307t3725r478b3809],
15	treatment	NN	O	treatment	dobj	12	SENT_223	[p18l501t3737r850b3788],
16	to	TO	O	to	_	0	SENT_223	[p18l873t3737r941b3788],
17	the	DT	O	the	det	19	SENT_223	[p18l966t3725r1076b3788],
18	right	JJ	O	right	amod	19	SENT_223	[p18l1102t3725r1273b3809],
19	patient	NN	O	patient	prep_to	12	SENT_223	[p18l1296t3731r1545b3808],
20	at	IN	O	at	_	0	SENT_223	[p18l1570t3737r1632b3788],
21	the	DT	O	the	det	23	SENT_223	[p18l1655t3725r1765b3788],
22	right	JJ	O	right	amod	23	SENT_223	[p18l1790t3725r1962b3809],
23	time	NN	O	time	prep_at	19	SENT_223	[p18l1985t3731r2144b3788],
24	as	IN	O	as	_	0	SENT_223	[p19l9t40r75b80],
25	early	JJ	O	early	prep_as	23	SENT_223	[p19l100t17r271b101],
26	as	IN	O	as	_	0	SENT_223	[p19l293t40r358b80],
27	possible	JJ	O	possible	prep_as	12	SENT_223	[p19l382t17r684b100],
28	.	.	O	.	_	0	SENT_223	[p19l382t17r684b100],

1	SUPPLEMENTARY	NNP	O	SUPPLEMENTARY	nn	2	SENT_224	[p19l9t255r559b304],
2	MATERIAL	NN	O	material	nsubjpass	4	SENT_224	[p19l575t256r892b303],
3	is	VBZ	O	be	auxpass	4	SENT_224	[p19l909t256r946b304],
4	linked	VBN	O	link	_	0	SENT_224	[p19l964t254r1130b304],
5	to	TO	O	to	_	0	SENT_224	[p19l1147t261r1203b304],
6	the	DT	O	the	det	10	SENT_224	[p19l1217t254r1310b304],
7	online	JJ	O	online	amod	10	SENT_224	[p19l1325t254r1501b304],
8	version	NN	O	version	nn	10	SENT_224	[p19l1515t256r1718b304],
9	ofthe	NN	O	ofthe	nn	10	SENT_224	[p19l1736t253r1896b304],
10	paper	NN	O	paper	prep_to	4	SENT_224	[p19l1913t268r2076b317],
11	at	IN	O	at	_	0	SENT_224	[p19l2090t261r2142b304],
12	http://www.nature.com/cpt	JJ	O	http://www.nature.com/cpt	amod	13	SENT_224	[p19l11t339r793b402],
13	www.nature.com/cpt	NN	O	www.nature.com/cpt	prep_at	10	SENT_224	[p19l1595t545r2145b598],

1	STATE	NN	O	state	nn	2	SENT_225	[p19l1761t713r1902b750],
2	ART	NN	O	art	_	0	SENT_225	[p19l2045t713r2139b750],

1	ACKNOWLEDGMENTS	NNS	O	acknowledgment	nsubj	4	SENT_226	[p19l8t946r693b995],
2	The	DT	O	the	det	3	SENT_226	[p19l6t1030r111b1081],
3	authors	NNS	O	author	dep	1	SENT_226	[p19l126t1030r341b1081],
4	thank	VBP	O	thank	_	0	SENT_226	[p19l356t1030r520b1081],
5	Aaron	NNP	PERSON	Aaron	nn	6	SENT_226	[p19l532t1032r699b1081],
6	Kirby	NNP	PERSON	Kirby	dobj	4	SENT_226	[p19l720t1030r863b1095],
7	for	IN	O	for	_	0	SENT_226	[p19l875t1029r953b1081],
8	facilitating	VBG	O	facilitate	prepc_for	6	SENT_226	[p19l965t1029r1263b1095],
9	and	CC	O	and	_	0	SENT_226	[p19l1281t1030r1384b1081],
10	managing	VBG	O	manage	prepc_for	6	SENT_226	[p19l1405t1033r1689b1095],
11	this	DT	O	this	det	12	SENT_226	[p19l1705t1030r1806b1081],
12	investigation	NN	O	investigation	dobj	8	SENT_226	[p19l10t1119r374b1181],
13	and	CC	O	and	_	0	SENT_226	[p19l391t1116r495b1167],
14	report	NN	O	report	conj_and	12	SENT_226	[p19l515t1124r703b1180],
15	,	,	O	,	_	0	SENT_226	[p19l515t1124r703b1180],
16	Abdmoain	NNP	PERSON	Abdmoain	nn	17	SENT_226	[p19l717t1116r1014b1167],
17	Abudabrh	NNP	PERSON	Abudabrh	conj_and	12	SENT_226	[p19l1031t1116r1317b1167],
18	for	IN	O	for	_	0	SENT_226	[p19l1333t1116r1411b1167],
19	very	RB	O	very	advmod	20	SENT_226	[p19l1424t1131r1546b1181],
20	helpful	JJ	O	helpful	amod	22	SENT_226	[p19l1562t1116r1755b1180],
21	background	NN	O	background	nn	22	SENT_226	[p19l1775t1116r2114b1181],
22	research	NN	O	research	prep_for	17	SENT_226	[p19l11t1203r244b1254],
23	for	IN	O	for	_	0	SENT_226	[p19l260t1202r338b1254],
24	this	DT	O	this	det	25	SENT_226	[p19l351t1203r451b1254],
25	project	NN	O	project	prep_for	22	SENT_226	[p19l469t1205r681b1267],
26	,	,	O	,	_	0	SENT_226	[p19l469t1205r681b1267],
27	and	CC	O	and	_	0	SENT_226	[p19l696t1203r800b1254],
28	Muriel	NNP	PERSON	Muriel	nn	29	SENT_226	[p19l819t1203r994b1254],
29	Powers	NNP	PERSON	Powers	conj_and	12	SENT_226	[p19l1015t1205r1214b1254],
30	for	IN	O	for	_	0	SENT_226	[p19l1228t1202r1306b1254],
31	expert	JJ	O	expert	amod	33	SENT_226	[p19l1321t1210r1503b1267],
32	manuscript	NN	O	manuscript	nn	33	SENT_226	[p19l1520t1205r1840b1267],
33	preparation	NN	O	preparation	prep_for	29	SENT_226	[p19l11t1288r470b1352],
34	.	.	O	.	_	0	SENT_226	[p19l11t1288r470b1352],

1	The	DT	O	the	det	2	SENT_227	[p19l11t1288r470b1352],
2	project	NN	O	project	nsubjpass	4	SENT_227	[p19l488t1291r686b1353],
3	was	VBD	O	be	auxpass	4	SENT_227	[p19l700t1303r807b1339],
4	supported	VBN	O	support	_	0	SENT_227	[p19l824t1288r1118b1352],
5	by	IN	O	by	_	0	SENT_227	[p19l1138t1288r1204b1353],
6	the	DT	O	the	det	8	SENT_227	[p19l1217t1288r1309b1339],
7	National	NNP	ORGANIZATION	National	nn	8	SENT_227	[p19l1328t1288r1560b1339],
8	Center	NNP	ORGANIZATION	Center	agent	4	SENT_227	[p19l1578t1290r1766b1339],
9	for	IN	ORGANIZATION	for	_	0	SENT_227	[p19l1779t1287r1857b1339],
10	Research	NNP	ORGANIZATION	Research	nn	11	SENT_227	[p19l1874t1288r2122b1339],
11	Resources	NNPS	ORGANIZATION	Resources	prep_for	4	SENT_227	[p19l11t1376r292b1425],
12	of	IN	ORGANIZATION	of	_	0	SENT_227	[p19l308t1374r367b1425],
13	the	DT	ORGANIZATION	the	det	21	SENT_227	[p19l376t1374r469b1425],
14	National	NNP	ORGANIZATION	National	dep	21	SENT_227	[p19l487t1374r719b1425],
15	Institutes	NNPS	ORGANIZATION	Institutes	dep	14	SENT_227	[p19l740t1377r998b1425],
16	of	IN	ORGANIZATION	of	_	0	SENT_227	[p19l1014t1374r1073b1425],
17	Health	NNP	ORGANIZATION	Health	prep_of	14	SENT_227	[p19l1086t1374r1266b1425],
18	under	IN	O	under	_	0	SENT_227	[p19l1286t1374r1453b1425],
19	grant	NN	O	grant	prep_under	14	SENT_227	[p19l1467t1382r1618b1439],
20	UL1	NN	O	ul1	nn	21	SENT_227	[p19l1635t1377r1730b1425],
21	RRO25752	NN	O	rro25752	prep_of	11	SENT_227	[p19l1759t1376r2037b1425],
22	and	CC	O	and	_	0	SENT_227	[p19l8t1461r112b1512],
23	the	DT	O	the	det	25	SENT_227	[p19l129t1461r221b1512],
24	National	NNP	ORGANIZATION	National	nn	25	SENT_227	[p19l239t1461r472b1512],
25	Centerfor	NNP	ORGANIZATION	Centerfor	conj_and	21	SENT_227	[p19l490t1460r769b1512],
26	Advancing	VBG	ORGANIZATION	advance	partmod	25	SENT_227	[p19l782t1461r1084b1525],
27	Translational	JJ	ORGANIZATION	translational	amod	28	SENT_227	[p19l1096t1461r1456b1512],
28	Sciences	NNPS	ORGANIZATION	Sciences	dobj	26	SENT_227	[p19l1475t1462r1716b1512],
29	under	IN	O	under	_	0	SENT_227	[p19l1734t1461r1901b1512],
30	grant	NN	O	grant	nn	32	SENT_227	[p19l1915t1468r2065b1525],
31	UL1	NN	O	ul1	nn	32	SENT_227	[p19l11t1548r106b1597],
32	TRO0OO73	NN	O	tro0oo73	prep_under	26	SENT_227	[p19l127t1546r537b1597],
33	.	.	O	.	_	0	SENT_227	[p19l127t1546r537b1597],

1	The	DT	O	the	det	2	SENT_228	[p19l127t1546r537b1597],
2	content	NN	O	content	nsubj	6	SENT_228	[p19l553t1554r773b1597],
3	is	VBZ	O	be	cop	6	SENT_228	[p19l789t1549r826b1597],
4	solely	RB	O	solely	advmod	6	SENT_228	[p19l842t1546r1003b1611],
5	the	DT	O	the	det	6	SENT_228	[p19l1016t1546r1108b1597],
6	responsibility	NN	O	responsibility	_	0	SENT_228	[p19l1126t1546r1506b1611],
7	of	IN	O	of	_	0	SENT_228	[p19l1520t1545r1578b1597],
8	the	DT	O	the	det	9	SENT_228	[p19l1587t1546r1680b1597],
9	authors	NNS	O	author	prep_of	6	SENT_228	[p19l1695t1546r1910b1597],
10	and	CC	O	and	_	0	SENT_228	[p19l1926t1546r2030b1597],
11	does	VBZ	O	do	aux	14	SENT_228	[p19l9t1632r142b1683],
12	not	RB	O	not	neg	14	SENT_228	[p19l160t1640r253b1683],
13	necessarily	RB	O	necessarily	advmod	14	SENT_228	[p19l270t1632r578b1697],
14	represent	VB	O	represent	conj_and	6	SENT_228	[p19l593t1640r862b1696],
15	the	DT	O	the	det	17	SENT_228	[p19l875t1632r968b1683],
16	official	JJ	O	official	amod	17	SENT_228	[p19l983t1632r1166b1683],
17	views	NNS	O	view	dobj	14	SENT_228	[p19l1183t1635r1341b1683],
18	of	IN	O	of	_	0	SENT_228	[p19l1357t1632r1415b1683],
19	the	DT	O	the	det	22	SENT_228	[p19l1424t1632r1517b1683],
20	European	JJ	ORGANIZATION	european	amod	22	SENT_228	[p19l1535t1635r1802b1696],
21	Medicines	NNP	ORGANIZATION	Medicines	nn	22	SENT_228	[p19l1821t1632r2106b1683],
22	Agency	NNP	ORGANIZATION	Agency	prep_of	17	SENT_228	[p19l8t1721r232b1784],
23	,	,	O	,	_	0	SENT_228	[p19l8t1721r232b1784],
24	the	DT	O	the	det	26	SENT_228	[p19l247t1719r339b1770],
25	US	NNP	ORGANIZATION	US	nn	26	SENT_228	[p19l357t1720r429b1770],
26	Food	NNP	ORGANIZATION	Food	appos	17	SENT_228	[p19l447t1719r584b1770],
27	and	CC	ORGANIZATION	and	_	0	SENT_228	[p19l602t1719r706b1770],
28	Drug	NNP	ORGANIZATION	Drug	nn	29	SENT_228	[p19l726t1721r862b1783],
29	Administration	NNP	ORGANIZATION	Administration	appos	17	SENT_228	[p19l879t1719r1317b1777],
30	,	,	O	,	_	0	SENT_228	[p19l879t1719r1317b1777],
31	orthe	NNP	O	orthe	nn	33	SENT_228	[p19l1332t1719r1495b1770],
32	National	NNP	ORGANIZATION	National	nn	33	SENT_228	[p19l1513t1719r1746b1770],
33	Institutes	NNPS	ORGANIZATION	Institutes	appos	17	SENT_228	[p19l1766t1721r2024b1770],
34	of	IN	ORGANIZATION	of	_	0	SENT_228	[p19l2040t1718r2099b1770],
35	Health	NNP	ORGANIZATION	Health	prep_of	33	SENT_228	[p19l11t1803r208b1854],
36	.	.	O	.	_	0	SENT_228	[p19l11t1803r208b1854],

1	CONFLICT	NN	O	conflict	nsubj	6	SENT_229	[p19l9t1965r323b2014],
2	OF	IN	O	of	_	0	SENT_229	[p19l337t1965r420b2014],
3	INTEREST	NN	O	interest	nn	4	SENT_229	[p19l439t1965r738b2014],
4	J.K.E.	NN	O	j.k.e.	prep_of	1	SENT_229	[p19l6t2052r143b2100],
5	is	VBZ	O	be	aux	6	SENT_229	[p19l160t2052r197b2100],
6	participating	VBG	O	participate	_	0	SENT_229	[p19l215t2052r575b2114],
7	in	IN	O	in	_	0	SENT_229	[p19l595t2052r641b2100],
8	accrual	NN	O	accrual	nn	9	SENT_229	[p19l659t2049r856b2100],
9	ofsubjects	NNS	O	ofsubject	prep_in	6	SENT_229	[p19l874t2049r1175b2114],
10	to	TO	O	to	_	0	SENT_229	[p19l1190t2057r1247b2100],
11	clinical	JJ	O	clinical	amod	14	SENT_229	[p19l1263t2049r1453b2100],
12	trial	NN	O	trial	nn	14	SENT_229	[p19l1469t2049r1575b2100],
13	NSABP	NN	O	nsabp	nn	14	SENT_229	[p19l1595t2051r1783b2100],
14	B47	NN	O	b47	prep_to	6	SENT_229	[p19l1802t2052r1917b2100],
15	.	.	O	.	_	0	SENT_229	[p19l1802t2052r1917b2100],

1	P.K.H.	NNP	O	P.K.H.	nsubjpass	14	SENT_230	[p19l1935t2052r2081b2100],
2	is	VBZ	O	be	cop	5	SENT_230	[p19l10t2137r47b2186],
3	an	DT	O	a	det	5	SENT_230	[p19l63t2150r128b2186],
4	associate	JJ	O	associate	amod	5	SENT_230	[p19l146t2137r403b2186],
5	editor	NN	O	editor	_	0	SENT_230	[p19l419t2135r588b2186],
6	for	IN	O	for	_	0	SENT_230	[p19l600t2134r678b2186],
7	Clinical	JJ	ORGANIZATION	clinical	prep_for	5	SENT_230	[p19l693t2135r893b2186],
8	Pharmacology	NNP	ORGANIZATION	Pharmacology	dep	7	SENT_230	[p19l903t2135r1355b2200],
9	&	CC	ORGANIZATION	&	_	0	SENT_230	[p19l903t2135r1355b2200],
10	Therapeutics	NNPS	ORGANIZATION	Therapeutics	dep	7	SENT_230	[p19l1368t2135r1715b2199],
11	but	CC	O	but	_	0	SENT_230	[p19l1732t2135r1826b2186],
12	was	VBD	O	be	auxpass	14	SENT_230	[p19l1840t2150r1947b2186],
13	not	RB	O	not	neg	14	SENT_230	[p19l1965t2143r2058b2186],
14	involved	VBN	O	involve	conj_but	5	SENT_230	[p19l10t2221r247b2272],
15	in	IN	O	in	_	0	SENT_230	[p19l267t2224r312b2272],
16	the	DT	O	the	det	20	SENT_230	[p19l329t2221r422b2272],
17	review	NN	O	review	nn	20	SENT_230	[p19l439t2224r625b2272],
18	or	CC	O	or	_	0	SENT_230	[p19l639t2236r697b2272],
19	decision	NN	O	decision	nn	20	SENT_230	[p19l711t2221r943b2272],
20	process	NN	O	process	prep_in	14	SENT_230	[p19l963t2236r1174b2285],
21	for	IN	O	for	_	0	SENT_230	[p19l1188t2221r1267b2272],
22	this	DT	O	this	det	23	SENT_230	[p19l1280t2221r1380b2272],
23	article	NN	O	article	prep_for	20	SENT_230	[p19l1396t2221r1582b2272],
24	.	.	O	.	_	0	SENT_230	[p19l1396t2221r1582b2272],

1	The	DT	O	the	det	3	SENT_231	[p19l1592t2221r1697b2272],
2	other	JJ	O	other	amod	3	SENT_231	[p19l1713t2221r1866b2272],
3	authors	NNS	O	author	nsubj	4	SENT_231	[p19l1880t2221r2095b2272],
4	declared	VBD	O	declare	_	0	SENT_231	[p19l9t2306r250b2357],
5	no	DT	O	no	det	6	SENT_231	[p19l270t2321r340b2357],
6	conflict	NN	O	conflict	dobj	4	SENT_231	[p19l356t2306r565b2357],
7	of	IN	O	of	_	0	SENT_231	[p19l580t2306r638b2357],
8	interest	NN	O	interest	prep_of	6	SENT_231	[p19l651t2309r875b2357],
9	.	.	O	.	_	0	SENT_231	[p19l651t2309r875b2357],

1	©	RB	O	©	dep	2	SENT_232	[p19l8t2496r48b2536],
2	2013	CD	DATE	2013	dep	4	SENT_232	[p19l64t2495r191b2539],
3	American	NNP	ORGANIZATION	American	nn	4	SENT_232	[p19l208t2494r462b2539],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_232	[p19l480t2493r675b2552],
5	for	IN	O	for	_	0	SENT_232	[p19l687t2491r761b2539],
6	Clinical	JJ	O	clinical	amod	7	SENT_232	[p19l775t2492r964b2539],
7	Pharmacology	NN	O	pharmacology	prep_for	4	SENT_232	[p19l984t2492r1371b2552],
8	and	CC	O	and	_	0	SENT_232	[p19l1384t2492r1482b2539],
9	Therapeutics	NNS	O	therapeutics	prep_for	4	SENT_232	[p19l1494t2492r1843b2551],

1	1	LS	NUMBER	1	_	0	SENT_233	[p19l13t2675r50b2720],
2	.	.	O	.	_	0	SENT_233	[p19l13t2675r50b2720],

1	Grines	NNP	LOCATION	Grines	nn	3	SENT_234	[p19l130t2673r308b2728],
2	,	,	O	,	_	0	SENT_234	[p19l130t2673r308b2728],
3	C.L.	NNP	O	C.L.	_	0	SENT_234	[p19l322t2673r411b2721],
4	et	FW	O	et	nn	5	SENT_234	[p19l426t2678r474b2721],
5	al.	FW	O	al.	dep	3	SENT_234	[p19l483t2671r540b2720],
6	.	.	O	.	_	0	SENT_234	[p19l483t2671r540b2720],

1	A	DT	O	a	det	2	SENT_235	[p19l554t2673r591b2720],
2	comparison	NN	O	comparison	_	0	SENT_235	[p19l605t2673r913b2733],
3	of	IN	O	of	_	0	SENT_235	[p19l930t2670r984b2720],
4	immediate	JJ	O	immediate	amod	5	SENT_235	[p19l995t2671r1277b2721],
5	angioplasty	NN	O	angioplasty	prep_of	2	SENT_235	[p19l1291t2671r1598b2734],
6	with	IN	O	with	_	0	SENT_235	[p19l1610t2671r1724b2720],
7	thrombolytic	JJ	O	thrombolytic	amod	8	SENT_235	[p19l1739t2671r2081b2734],
8	therapy	NN	O	therapy	prep_with	2	SENT_235	[p19l130t2749r334b2813],
9	for	IN	O	for	_	0	SENT_235	[p19l345t2748r418b2798],
10	acute	JJ	O	acute	amod	12	SENT_235	[p19l431t2756r574b2799],
11	myocardial	JJ	O	myocardial	amod	12	SENT_235	[p19l590t2749r875b2812],
12	infarction	NN	O	infarction	prep_for	2	SENT_235	[p19l893t2748r1262b2799],
13	.	.	O	.	_	0	SENT_235	[p19l893t2748r1262b2799],

1	The	DT	O	the	det	3	SENT_236	[p19l893t2748r1262b2799],
2	Primary	JJ	O	primary	amod	3	SENT_236	[p19l1279t2751r1479b2813],
3	Angioplasty	NN	O	angioplasty	_	0	SENT_236	[p19l1491t2749r1807b2813],
4	in	IN	O	in	_	0	SENT_236	[p19l1822t2751r1864b2798],
5	Myocardial	JJ	O	myocardial	amod	8	SENT_236	[p19l133t2827r417b2890],
6	Infarction	NN	O	infarction	nn	8	SENT_236	[p19l436t2826r683b2877],
7	Study	NNP	O	Study	nn	8	SENT_236	[p19l701t2827r851b2891],
8	Group	NNP	O	Group	prep_in	3	SENT_236	[p19l864t2829r1039b2889],
9	.	.	O	.	_	0	SENT_236	[p19l864t2829r1039b2889],

1	N.	NNP	O	N.	nn	2	SENT_237	[p19l1053t2829r1101b2876],
2	Engl	NNP	O	Engl	_	0	SENT_237	[p19l1116t2827r1234b2890],
3	.	.	O	.	_	0	SENT_237	[p19l1116t2827r1234b2890],

1	J.	NNP	O	J.	nn	2	SENT_238	[p19l1245t2829r1279b2877],
2	Med	NNP	O	Med	_	0	SENT_238	[p19l1293t2827r1416b2876],
3	.	.	O	.	_	0	SENT_238	[p19l1293t2827r1416b2876],

1	328	CD	NUMBER	328	_	0	SENT_239	[p19l1430t2830r1546b2884],
2	,	,	O	,	_	0	SENT_239	[p19l1430t2830r1546b2884],
3	673-679	CD	NUMBER	673-679	number	4	SENT_239	[p19l1560t2830r1784b2876],
4	(	CD	NUMBER	(	appos	1	SENT_239	[p19l1800t2828r1974b2884],
5	1993	CD	DATE	1993	num	6	SENT_239	[p19l1800t2828r1974b2884],
6	)	NN	O	)	dep	4	SENT_239	[p19l1800t2828r1974b2884],
7	.	.	O	.	_	0	SENT_239	[p19l1800t2828r1974b2884],

1	2	LS	NUMBER	2	_	0	SENT_240	[p19l9t2908r50b2954],
2	.	.	O	.	_	0	SENT_240	[p19l9t2908r50b2954],

1	Zijlstra	NNP	PERSON	Zijlstra	_	0	SENT_241	[p19l129t2905r317b2968],
2	,	,	O	,	_	0	SENT_241	[p19l129t2905r317b2968],
3	F.	NNP	O	F.	appos	1	SENT_241	[p19l333t2907r378b2962],
4	,	,	O	,	_	0	SENT_241	[p19l333t2907r378b2962],
5	de	FW	PERSON	de	nn	6	SENT_241	[p19l392t2905r456b2955],
6	Boer	FW	PERSON	boer	appos	1	SENT_241	[p19l473t2907r599b2962],
7	,	,	O	,	_	0	SENT_241	[p19l473t2907r599b2962],
8	M.J.	NNP	LOCATION	M.J.	appos	6	SENT_241	[p19l614t2907r723b2962],
9	,	,	O	,	_	0	SENT_241	[p19l614t2907r723b2962],
10	Hoorntje	NNP	LOCATION	Hoorntje	appos	6	SENT_241	[p19l739t2907r981b2968],
11	,	,	O	,	_	0	SENT_241	[p19l739t2907r981b2968],
12	J.C.	NNP	LOCATION	J.C.	appos	6	SENT_241	[p19l993t2907r1091b2962],
13	,	,	O	,	_	0	SENT_241	[p19l993t2907r1091b2962],
14	Reiffers	NNP	O	Reiffers	appos	6	SENT_241	[p19l1107t2904r1309b2962],
15	,	,	O	,	_	0	SENT_241	[p19l1107t2904r1309b2962],
16	5.	LS	NUMBER	5.	dep	8	SENT_241	[p19l1324t2907r1377b2962],
17	,	,	O	,	_	0	SENT_241	[p19l1324t2907r1377b2962],
18	Reiber	NNP	PERSON	Reiber	appos	6	SENT_241	[p19l1393t2905r1567b2962],
19	,	,	O	,	_	0	SENT_241	[p19l1393t2905r1567b2962],
20	J.H.	NNP	ORGANIZATION	J.H.	conj_and	8	SENT_241	[p19l1579t2907r1668b2955],
21	&	CC	ORGANIZATION	&	_	0	SENT_241	[p19l1682t2907r1719b2954],
22	Suryapranata	NNP	ORGANIZATION	Suryapranata	conj_and	8	SENT_241	[p19l1732t2906r2095b2969],
23	,	,	O	,	_	0	SENT_241	[p19l1732t2906r2095b2969],

1	H.	NNP	O	H.	nn	3	SENT_242	[p19l134t2985r182b3032],
2	A	NNP	O	A	nn	3	SENT_242	[p19l196t2985r232b3032],
3	comparison	NN	O	comparison	_	0	SENT_242	[p19l246t2985r555b3045],
4	of	IN	O	of	_	0	SENT_242	[p19l571t2982r626b3032],
5	immediate	JJ	O	immediate	amod	7	SENT_242	[p19l637t2983r919b3033],
6	coronary	JJ	O	coronary	amod	7	SENT_242	[p19l933t2998r1167b3046],
7	angioplasty	NN	O	angioplasty	prep_of	3	SENT_242	[p19l1180t2983r1487b3047],
8	with	IN	O	with	_	0	SENT_242	[p19l1499t2983r1612b3032],
9	intravenous	JJ	O	intravenous	amod	10	SENT_242	[p19l1631t2985r1939b3033],
10	streptokinase	NNP	O	streptokinase	prep_with	3	SENT_242	[p19l132t3061r486b3123],
11	in	IN	O	in	_	0	SENT_242	[p19l502t3063r545b3110],
12	acute	JJ	O	acute	amod	14	SENT_242	[p19l561t3068r704b3111],
13	myocardial	JJ	O	myocardial	amod	14	SENT_242	[p19l721t3061r1005b3125],
14	infarction	NN	O	infarction	prep_in	3	SENT_242	[p19l1023t3060r1285b3111],
15	.	.	O	.	_	0	SENT_242	[p19l1023t3060r1285b3111],

1	N.	NNP	O	N.	nn	2	SENT_243	[p19l1300t3063r1347b3110],
2	Engl	NNP	O	Engl	_	0	SENT_243	[p19l1362t3061r1480b3124],
3	.	.	O	.	_	0	SENT_243	[p19l1362t3061r1480b3124],

1	J.	NNP	O	J.	nn	2	SENT_244	[p19l1491t3063r1526b3110],
2	Med	NNP	O	Med	_	0	SENT_244	[p19l1539t3061r1662b3111],
3	.	.	O	.	_	0	SENT_244	[p19l1539t3061r1662b3111],

1	328	CD	NUMBER	328	_	0	SENT_245	[p19l1677t3064r1792b3118],
2	,	,	O	,	_	0	SENT_245	[p19l1677t3064r1792b3118],
3	680-684	CD	NUMBER	680-684	number	4	SENT_245	[p19l1806t3064r2031b3111],
4	(	CD	NUMBER	(	appos	1	SENT_245	[p19l133t3139r307b3194],
5	1993	CD	DATE	1993	num	6	SENT_245	[p19l133t3139r307b3194],
6	)	NN	O	)	dep	4	SENT_245	[p19l133t3139r307b3194],
7	.	.	O	.	_	0	SENT_245	[p19l133t3139r307b3194],

1	3	LS	NUMBER	3	_	0	SENT_246	[p19l9t3219r50b3265],
2	.	.	O	.	_	0	SENT_246	[p19l9t3219r50b3265],

1	The	DT	O	the	det	3	SENT_247	[p19l127t3216r224b3265],
2	Global	JJ	O	global	amod	3	SENT_247	[p19l239t3216r405b3265],
3	Use	NN	O	use	_	0	SENT_247	[p19l425t3218r517b3265],
4	of	IN	O	of	_	0	SENT_247	[p19l531t3215r585b3265],
5	Strategies	NNS	O	strategy	prep_of	3	SENT_247	[p19l595t3217r853b3279],
6	to	TO	O	to	aux	7	SENT_247	[p19l867t3223r920b3265],
7	Open	VB	MISC	open	infmod	5	SENT_247	[p19l934t3217r1076b3278],
8	Occluded	JJ	MISC	occluded	amod	10	SENT_247	[p19l1092t3216r1341b3265],
9	Coronary	JJ	MISC	coronary	amod	10	SENT_247	[p19l1358t3217r1600b3280],
10	Arteries	NN	MISC	artery	dobj	7	SENT_247	[p19l1612t3218r1815b3266],
11	in	IN	O	in	_	0	SENT_247	[p19l1832t3218r1874b3265],
12	Acute	JJ	O	acute	prep_in	7	SENT_247	[p19l1890t3218r2041b3266],

1	Coronary	JJ	O	coronary	amod	2	SENT_248	[p19l131t3295r374b3357],
2	Syndromes	NNS	O	syndrome	nsubj	3	SENT_248	[p19l387t3294r680b3357],
3	(	VBP	O	(	_	0	SENT_248	[p19l696t3295r896b3351],
4	GUSTO	NN	O	gusto	nn	9	SENT_248	[p19l696t3295r896b3351],
5	llb	NN	O	llb	nn	9	SENT_248	[p19l913t3294r990b3351],
6	)	CD	NUMBER	)	num	9	SENT_248	[p19l913t3294r990b3351],
7	Angioplasty	NNP	O	Angioplasty	nn	9	SENT_248	[p19l1005t3294r1321b3357],
8	Substudy	NNP	O	Substudy	nn	9	SENT_248	[p19l1334t3294r1582b3358],
9	Investigators	NNS	O	investigator	dep	3	SENT_248	[p19l1597t3296r1944b3357],
10	.	.	O	.	_	0	SENT_248	[p19l1597t3296r1944b3357],

1	A	DT	O	a	det	3	SENT_249	[p19l131t3374r167b3421],
2	clinical	JJ	O	clinical	amod	3	SENT_249	[p19l181t3372r357b3421],
3	trial	NN	O	trial	_	0	SENT_249	[p19l372t3372r470b3421],
4	comparing	VBG	O	compare	partmod	3	SENT_249	[p19l486t3374r771b3435],
5	primary	JJ	O	primary	amod	7	SENT_249	[p19l789t3374r994b3435],
6	coronary	JJ	O	coronary	amod	7	SENT_249	[p19l1006t3386r1241b3436],
7	angioplasty	NN	O	angioplasty	dobj	4	SENT_249	[p19l1253t3372r1561b3436],
8	with	IN	O	with	_	0	SENT_249	[p19l1572t3372r1685b3421],
9	tissue	NN	O	tissue	nn	11	SENT_249	[p19l1701t3374r1851b3421],
10	plasminogen	NN	O	plasminogen	nn	11	SENT_249	[p19l133t3450r474b3513],
11	activator	NN	O	activator	prep_with	4	SENT_249	[p19l490t3452r721b3500],
12	for	IN	O	for	_	0	SENT_249	[p19l732t3449r804b3499],
13	acute	JJ	O	acute	amod	15	SENT_249	[p19l817t3457r960b3499],
14	myocardial	JJ	O	myocardial	amod	15	SENT_249	[p19l977t3450r1261b3514],
15	infarction	NN	O	infarction	prep_for	11	SENT_249	[p19l1279t3449r1542b3499],
16	.	.	O	.	_	0	SENT_249	[p19l1279t3449r1542b3499],

1	N.	NNP	O	N.	nn	2	SENT_250	[p19l1556t3452r1604b3499],
2	Engl	NNP	O	Engl	_	0	SENT_250	[p19l1618t3450r1737b3513],
3	.	.	O	.	_	0	SENT_250	[p19l1618t3450r1737b3513],

1	J.	NNP	O	J.	nn	2	SENT_251	[p19l1748t3452r1782b3500],
2	Med	NNP	O	Med	_	0	SENT_251	[p19l1796t3450r1919b3499],
3	.	.	O	.	_	0	SENT_251	[p19l1796t3450r1919b3499],

1	336	CD	NUMBER	336	_	0	SENT_252	[p19l1933t3453r2048b3507],
2	,	,	O	,	_	0	SENT_252	[p19l1933t3453r2048b3507],
3	1621-1628	CD	DATE	1621-1628	number	4	SENT_252	[p19l136t3530r421b3576],
4	(	CD	NUMBER	(	appos	1	SENT_252	[p19l437t3528r611b3583],
5	1997	CD	DATE	1997	num	6	SENT_252	[p19l437t3528r611b3583],
6	)	NN	O	)	dep	4	SENT_252	[p19l437t3528r611b3583],
7	.	.	O	.	_	0	SENT_252	[p19l437t3528r611b3583],

1	4	LS	NUMBER	4	_	0	SENT_253	[p19l7t3608r50b3653],
2	.	.	O	.	_	0	SENT_253	[p19l7t3608r50b3653],

1	Aversano	NNP	PERSON	Aversano	nn	4	SENT_254	[p19l129t3606r384b3660],
2	,	,	O	,	_	0	SENT_254	[p19l129t3606r384b3660],
3	T.	NNP	O	T.	appos	4	SENT_254	[p19l393t3606r432b3653],
4	etal.	NNP	O	etal.	_	0	SENT_254	[p19l447t3604r575b3660],
5	;	:	O	;	_	0	SENT_254	[p19l447t3604r575b3660],
6	Atlantic	NNP	ORGANIZATION	Atlantic	nn	10	SENT_254	[p19l588t3604r790b3653],
7	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	10	SENT_254	[p19l804t3604r1190b3653],
8	Patient	NNP	ORGANIZATION	Patient	nn	10	SENT_254	[p19l1205t3606r1386b3653],
9	Outcomes	NNP	ORGANIZATION	Outcomes	nn	10	SENT_254	[p19l1400t3606r1669b3653],
10	Research	NNP	ORGANIZATION	Research	dep	4	SENT_254	[p19l1686t3604r1916b3653],

1	Team	NNP	O	Team	_	0	SENT_255	[p20l129t20r268b67],
2	(	CD	NUMBER	(	num	1	SENT_255	[p20l286t18r897b82],
3	C-PORT	NNP	O	C-PORT	dep	1	SENT_255	[p20l286t18r897b82],
4	)	CD	NUMBER	)	num	3	SENT_255	[p20l286t18r897b82],
5	.	.	O	.	_	0	SENT_255	[p20l286t18r897b82],

1	Thrombo	NNP	O	Thrombo	_	0	SENT_256	[p20l286t18r897b82],
2	|	CD	NUMBER	|	num	1	SENT_256	[p20l286t18r897b82],
3	ytic	JJ	O	ytic	amod	4	SENT_256	[p20l286t18r897b82],
4	therapy	NN	O	therapy	dep	1	SENT_256	[p20l910t18r1114b81],
5	vs	CC	O	vs	_	0	SENT_256	[p20l1126t32r1178b67],
6	primary	JJ	O	primary	amod	9	SENT_256	[p20l1195t20r1399b82],
7	percutaneous	JJ	O	percutaneous	amod	9	SENT_256	[p20l1414t25r1774b80],
8	coronary	JJ	O	coronary	amod	9	SENT_256	[p20l1789t32r2023b82],
9	intervention	NN	O	intervention	conj_vs	1	SENT_256	[p20l133t98r453b145],
10	for	IN	O	for	_	0	SENT_256	[p20l468t95r540b146],
11	myocardial	JJ	O	myocardial	amod	12	SENT_256	[p20l556t96r840b160],
12	infarction	NN	O	infarction	prep_for	9	SENT_256	[p20l858t95r1105b146],
13	in	IN	O	in	_	0	SENT_256	[p20l1123t98r1166b145],
14	patients	NNS	O	patient	prep_in	12	SENT_256	[p20l1184t98r1394b158],
15	presenting	VBG	O	present	partmod	1	SENT_256	[p20l1411t98r1690b159],
16	to	TO	O	to	_	0	SENT_256	[p20l1705t103r1758b145],
17	hospitals	NNS	O	hospital	prep_to	15	SENT_256	[p20l1775t96r2007b158],
18	without	IN	O	without	_	0	SENT_256	[p20l130t174r337b223],
19	on-site	JJ	O	on-site	amod	21	SENT_256	[p20l351t176r529b223],
20	cardiac	JJ	O	cardiac	amod	21	SENT_256	[p20l544t174r729b223],
21	surgery	NN	O	surgery	prep_without	15	SENT_256	[p20l744t188r954b237],
22	:	:	O	:	_	0	SENT_256	[p20l744t188r954b237],
23	a	DT	O	a	dobj	15	SENT_256	[p20l969t188r994b223],
24	randomized	VBN	O	randomize	partmod	23	SENT_256	[p20l1012t174r1325b223],
25	controlled	JJ	O	controlled	amod	27	SENT_256	[p20l1341t174r1607b223],
26	tria	NN	O	trium	nn	27	SENT_256	[p20l1622t174r1889b223],
27	|	NN	O	|	dobj	24	SENT_256	[p20l1622t174r1889b223],
28	.	.	O	.	_	0	SENT_256	[p20l1622t174r1889b223],

1	JAMA	NN	O	jama	_	0	SENT_257	[p20l1622t174r1889b223],
2	287	CD	NUMBER	287	num	1	SENT_257	[p20l1904t177r2020b231],
3	,	,	O	,	_	0	SENT_257	[p20l1904t177r2020b231],
4	1943-1951	CD	DATE	1943-1951	number	5	SENT_257	[p20l136t254r410b300],
5	(	CD	NUMBER	(	appos	1	SENT_257	[p20l437t252r611b307],
6	2002	CD	DATE	2002	num	7	SENT_257	[p20l437t252r611b307],
7	)	NN	O	)	dep	5	SENT_257	[p20l437t252r611b307],
8	.	.	O	.	_	0	SENT_257	[p20l437t252r611b307],

1	Hassett	NNP	PERSON	Hassett	nn	5	SENT_258	[p20l132t331r333b386],
2	,	,	O	,	_	0	SENT_258	[p20l132t331r333b386],
3	M.J.	NNP	LOCATION	M.J.	appos	5	SENT_258	[p20l348t331r455b386],
4	,	,	O	,	_	0	SENT_258	[p20l348t331r455b386],
5	O’Mal	NNP	O	O’Mal	_	0	SENT_258	[p20l468t329r704b392],
6	|	CD	NUMBER	|	num	5	SENT_258	[p20l468t329r704b392],
7	ey	NN	O	ey	dep	5	SENT_258	[p20l468t329r704b392],
8	,	,	O	,	_	0	SENT_258	[p20l468t329r704b392],
9	A.J.	NNP	PERSON	A.J.	conj_and	7	SENT_258	[p20l717t331r813b386],
10	,	,	O	,	_	0	SENT_258	[p20l717t331r813b386],
11	Pakes	NNP	LOCATION	Pakes	conj_and	9	SENT_258	[p20l829t329r983b386],
12	,	,	O	,	_	0	SENT_258	[p20l829t329r983b386],
13	J.R.	NNP	LOCATION	J.R.	conj_and	9	SENT_258	[p20l995t331r1088b386],
14	,	,	O	,	_	0	SENT_258	[p20l995t331r1088b386],
15	Newhouse	NNP	ORGANIZATION	Newhouse	conj_and	7	SENT_258	[p20l1104t329r1391b386],
16	,	,	O	,	_	0	SENT_258	[p20l1104t329r1391b386],
17	J.P.	NNP	ORGANIZATION	J.P.	conj_and	9	SENT_258	[p20l1403t331r1474b378],
18	&	CC	ORGANIZATION	&	_	0	SENT_258	[p20l1487t330r1524b378],
19	Earle	NNP	ORGANIZATION	Earle	conj_and	9	SENT_258	[p20l1538t329r1673b386],
20	,	,	O	,	_	0	SENT_258	[p20l1538t329r1673b386],
21	C.C.	NNP	O	C.C.	nn	22	SENT_258	[p20l1686t330r1781b378],
22	Frequency	NNP	O	Frequency	conj_and	7	SENT_258	[p20l1798t331r2070b392],
23	and	CC	O	and	_	0	SENT_258	[p20l131t407r227b456],
24	cost	NN	O	cost	dep	5	SENT_258	[p20l242t414r348b457],
25	of	IN	O	of	_	0	SENT_258	[p20l361t406r415b457],
26	chemotherapy-related	JJ	O	chemotherapy-related	amod	29	SENT_258	[p20l424t407r1006b471],
27	serious	JJ	O	serious	amod	29	SENT_258	[p20l1022t409r1204b457],
28	adverse	JJ	O	adverse	amod	29	SENT_258	[p20l1217t407r1418b457],
29	effects	NNS	O	effect	prep_of	5	SENT_258	[p20l1432t406r1602b457],
30	in	IN	O	in	_	0	SENT_258	[p20l1617t409r1660b456],
31	a	DT	O	a	det	33	SENT_258	[p20l1676t422r1701b456],
32	population	NN	O	population	nn	33	SENT_258	[p20l1718t407r2002b469],
33	sample	NN	O	sample	prep_in	29	SENT_258	[p20l131t484r318b546],
34	of	IN	O	of	_	0	SENT_258	[p20l332t483r385b534],
35	women	NNS	O	woman	prep_of	33	SENT_258	[p20l393t499r589b534],
36	with	IN	O	with	_	0	SENT_258	[p20l604t484r717b534],
37	breast	NN	O	breast	nn	38	SENT_258	[p20l735t484r893b534],
38	cancer	NN	O	cancer	prep_with	35	SENT_258	[p20l906t499r1085b534],
39	.	.	O	.	_	0	SENT_258	[p20l906t499r1085b534],

1	J.	NNP	O	J.	nn	3	SENT_259	[p20l1094t486r1129b534],
2	Natl.	NNP	O	Natl.	nn	3	SENT_259	[p20l1143t484r1256b534],
3	Cancerlnst	NNP	O	Cancerlnst	_	0	SENT_259	[p20l1271t486r1555b534],
4	.	.	O	.	_	0	SENT_259	[p20l1271t486r1555b534],

1	98	CD	NUMBER	98	_	0	SENT_260	[p20l1568t487r1648b541],
2	,	,	O	,	_	0	SENT_260	[p20l1568t487r1648b541],
3	1	CD	NUMBER	1	num	4	SENT_260	[p20l1666t488r1680b533],
4	108-1	CD	NUMBER	108-1	appos	1	SENT_260	[p20l1698t487r1841b534],
5	1	CD	NUMBER	1	number	6	SENT_260	[p20l1859t488r1874b533],
6	17	CD	NUMBER	17	dep	4	SENT_260	[p20l1891t488r1948b533],
7	(	CD	NUMBER	(	num	9	SENT_260	[p20l1964t485r2136b541],
8	2006	CD	DATE	2006	num	9	SENT_260	[p20l1964t485r2136b541],
9	)	NN	O	)	dep	6	SENT_260	[p20l1964t485r2136b541],
10	.	.	O	.	_	0	SENT_260	[p20l1964t485r2136b541],

1	Kent	NNP	LOCATION	Kent	_	0	SENT_261	[p20l132t564r261b619],
2	,	,	O	,	_	0	SENT_261	[p20l132t564r261b619],
3	D.M.	NNP	ORGANIZATION	D.M.	conj_and	1	SENT_261	[p20l278t564r389b612],
4	&	CC	ORGANIZATION	&	_	0	SENT_261	[p20l404t564r440b612],
5	Hayward	NNP	ORGANIZATION	Hayward	conj_and	1	SENT_261	[p20l456t562r698b626],
6	,	,	O	,	_	0	SENT_261	[p20l456t562r698b626],
7	R.A.	NNP	O	R.A.	nn	8	SENT_261	[p20l714t564r807b612],
8	Limitations	NNPS	O	Limitations	appos	1	SENT_261	[p20l825t564r1113b612],
9	of	IN	O	of	_	0	SENT_261	[p20l1128t561r1182b612],
10	applying	VBG	O	apply	prepc_of	8	SENT_261	[p20l1192t562r1420b626],
11	summary	NN	O	summary	nn	12	SENT_261	[p20l1437t577r1684b626],
12	results	NNS	O	result	dobj	10	SENT_261	[p20l1699t562r1866b612],
13	of	IN	O	of	_	0	SENT_261	[p20l1881t561r1935b612],
14	clinical	JJ	O	clinical	amod	15	SENT_261	[p20l131t640r307b690],
15	trials	NNS	O	trial	prep_of	12	SENT_261	[p20l323t640r447b690],
16	to	TO	O	to	_	0	SENT_261	[p20l461t648r513b690],
17	individual	JJ	O	individual	amod	18	SENT_261	[p20l530t640r784b690],
18	patients	NNS	O	patient	prep_to	10	SENT_261	[p20l804t642r1026b702],
19	:	:	O	:	_	0	SENT_261	[p20l804t642r1026b702],
20	the	DT	O	the	det	21	SENT_261	[p20l1039t640r1125b690],
21	need	NN	O	need	dep	1	SENT_261	[p20l1141t640r1269b690],
22	for	IN	O	for	_	0	SENT_261	[p20l1284t639r1356b690],
23	risk	NN	O	risk	nn	24	SENT_261	[p20l1371t640r1458b690],
24	stratiﬁcation	NN	O	stratiﬁcation	prep_for	21	SENT_261	[p20l1471t639r1965b690],
25	.	.	O	.	_	0	SENT_261	[p20l1471t639r1965b690],

1	JAMA	NN	O	jama	_	0	SENT_262	[p20l1471t639r1965b690],
2	298	CD	NUMBER	298	num	1	SENT_262	[p20l1981t643r2096b697],
3	,	,	O	,	_	0	SENT_262	[p20l1981t643r2096b697],
4	1209-1212	CD	DATE	1209-1212	number	5	SENT_262	[p20l135t720r420b766],
5	(	CD	NUMBER	(	appos	1	SENT_262	[p20l437t718r610b773],
6	2007	CD	DATE	2007	num	7	SENT_262	[p20l437t718r610b773],
7	)	NN	O	)	dep	5	SENT_262	[p20l437t718r610b773],
8	.	.	O	.	_	0	SENT_262	[p20l437t718r610b773],

1	Kent	NNP	PERSON	Kent	nn	7	SENT_263	[p20l132t797r261b852],
2	,	,	O	,	_	0	SENT_263	[p20l132t797r261b852],
3	D.M.	NNP	PERSON	D.M.	appos	7	SENT_263	[p20l278t797r402b852],
4	,	,	O	,	_	0	SENT_263	[p20l278t797r402b852],
5	Rothwell	NNP	PERSON	Rothwell	appos	7	SENT_263	[p20l419t795r658b852],
6	,	,	O	,	_	0	SENT_263	[p20l419t795r658b852],
7	P.M.	NNP	O	P.M.	_	0	SENT_263	[p20l675t797r784b852],
8	,	,	O	,	_	0	SENT_263	[p20l675t797r784b852],
9	loannidis	NN	O	loannidi	appos	7	SENT_263	[p20l801t795r1049b852],
10	,	,	O	,	_	0	SENT_263	[p20l801t795r1049b852],
11	J.P.	NNP	ORGANIZATION	J.P.	appos	7	SENT_263	[p20l1062t797r1147b852],
12	,	,	O	,	_	0	SENT_263	[p20l1062t797r1147b852],
13	Altman	NNP	PERSON	Altman	conj_and	11	SENT_263	[p20l1160t795r1364b852],
14	,	,	O	,	_	0	SENT_263	[p20l1160t795r1364b852],
15	D.G.	NNP	ORGANIZATION	D.G.	conj_and	11	SENT_263	[p20l1381t797r1482b845],
16	&	CC	ORGANIZATION	&	_	0	SENT_263	[p20l1496t797r1533b845],
17	Hayward	NNP	ORGANIZATION	Hayward	conj_and	11	SENT_263	[p20l1548t795r1791b859],
18	,	,	O	,	_	0	SENT_263	[p20l1548t795r1791b859],
19	R.A.	NNP	O	R.A.	nn	20	SENT_263	[p20l1807t797r1900b845],
20	Assessing	NNP	O	Assessing	appos	7	SENT_263	[p20l131t875r382b936],
21	and	CC	O	and	_	0	SENT_263	[p20l398t873r495b923],
22	reporting	VBG	O	report	amod	23	SENT_263	[p20l513t875r757b936],
23	heterogeneity	NN	O	heterogeneity	conj_and	9	SENT_263	[p20l776t873r1148b937],
24	in	IN	O	in	_	0	SENT_263	[p20l1162t875r1205b922],
25	treatment	NN	O	treatment	nn	26	SENT_263	[p20l1220t880r1484b923],
26	effects	NNS	O	effect	prep_in	23	SENT_263	[p20l1498t872r1669b923],
27	in	IN	O	in	_	0	SENT_263	[p20l1685t875r1728b922],
28	clinical	JJ	O	clinical	amod	29	SENT_263	[p20l1744t873r1921b923],
29	trials	NNS	O	trial	prep_in	26	SENT_263	[p20l1936t873r2074b923],
30	:	:	O	:	_	0	SENT_263	[p20l1936t873r2074b923],
31	a	DT	O	a	det	32	SENT_263	[p20l2088t888r2114b923],
32	proposal	NN	O	proposal	dep	26	SENT_263	[p20l133t951r373b1013],
33	.	.	O	.	_	0	SENT_263	[p20l133t951r373b1013],

1	Trials	NNS	O	trial	_	0	SENT_264	[p20l389t951r517b1001],
2	1	CD	NUMBER	1	number	3	SENT_264	[p20l534t955r553b1000],
3	1	CD	NUMBER	1	dep	1	SENT_264	[p20l569t955r611b1008],
4	,	,	O	,	_	0	SENT_264	[p20l569t955r611b1008],
5	85	CD	NUMBER	85	number	6	SENT_264	[p20l625t954r684b1001],
6	(	CD	NUMBER	(	appos	1	SENT_264	[p20l703t952r877b1008],
7	2010	CD	DATE	2010	num	8	SENT_264	[p20l703t952r877b1008],
8	)	NN	O	)	dep	6	SENT_264	[p20l703t952r877b1008],
9	.	.	O	.	_	0	SENT_264	[p20l703t952r877b1008],

1	Kent	NNP	PERSON	Kent	nsubjpass	28	SENT_265	[p20l132t1031r261b1086],
2	,	,	O	,	_	0	SENT_265	[p20l132t1031r261b1086],
3	D.M.	NNP	PERSON	D.M.	nsubjpass	28	SENT_265	[p20l278t1031r402b1086],
4	,	,	O	,	_	0	SENT_265	[p20l278t1031r402b1086],
5	Vijan	NNP	PERSON	Vijan	nsubjpass	28	SENT_265	[p20l413t1031r554b1092],
6	,	,	O	,	_	0	SENT_265	[p20l413t1031r554b1092],
7	S.	NNP	O	S.	nsubjpass	28	SENT_265	[p20l569t1031r622b1086],
8	,	,	O	,	_	0	SENT_265	[p20l569t1031r622b1086],
9	Hayward	NNP	PERSON	Hayward	nsubjpass	28	SENT_265	[p20l639t1029r881b1093],
10	,	,	O	,	_	0	SENT_265	[p20l639t1029r881b1093],
11	R.A.	NNP	LOCATION	R.A.	nsubjpass	28	SENT_265	[p20l898t1031r1004b1086],
12	,	,	O	,	_	0	SENT_265	[p20l898t1031r1004b1086],
13	Grifﬁth	NNP	LOCATION	Grifﬁth	nsubjpass	28	SENT_265	[p20l1018t1028r1213b1086],
14	,	,	O	,	_	0	SENT_265	[p20l1018t1028r1213b1086],
15	J.L.	NNP	PERSON	J.L.	nsubjpass	28	SENT_265	[p20l1226t1031r1316b1086],
16	,	,	O	,	_	0	SENT_265	[p20l1226t1031r1316b1086],
17	Beshansky	NNP	PERSON	Beshansky	nsubjpass	28	SENT_265	[p20l1332t1029r1616b1093],
18	,	,	O	,	_	0	SENT_265	[p20l1332t1029r1616b1093],
19	J.R.	NNP	ORGANIZATION	J.R.	nsubjpass	28	SENT_265	[p20l1628t1031r1709b1079],
20	&	CC	ORGANIZATION	&	_	0	SENT_265	[p20l1724t1031r1760b1079],
21	Selker	NNP	ORGANIZATION	Selker	nsubjpass	28	SENT_265	[p20l1774t1029r1940b1086],
22	,	,	O	,	_	0	SENT_265	[p20l1774t1029r1940b1086],
23	H.P.	NNP	O	H.P.	nn	26	SENT_265	[p20l1957t1031r2043b1079],
24	Tissue	NN	O	tissue	nn	26	SENT_265	[p20l129t1109r290b1157],
25	plasminogen	NN	O	plasminogen	nn	26	SENT_265	[p20l307t1107r647b1170],
26	activator	NN	O	activator	appos	1	SENT_265	[p20l663t1109r894b1157],
27	was	VBD	O	be	auxpass	28	SENT_265	[p20l906t1122r1005b1157],
28	cost	VBN	O	cost	_	0	SENT_265	[p20l1020t1106r1373b1157],
29	—	RB	O	—	advmod	30	SENT_265	[p20l1020t1106r1373b1157],
30	effective	JJ	O	effective	acomp	28	SENT_265	[p20l1020t1106r1373b1157],
31	compared	VBN	O	compare	_	0	SENT_265	[p20l1387t1107r1653b1169],
32	to	TO	O	to	prepc_compared_to	28	SENT_265	[p20l1667t1115r1721b1157],
33	streptokinase	NNP	O	streptokinase	pobj	28	SENT_265	[p20l1735t1107r2090b1169],
34	in	IN	O	in	_	0	SENT_265	[p20l2106t1109r2149b1156],
35	only	RB	O	only	advmod	37	SENT_265	[p20l131t1185r244b1249],
36	selected	VBN	O	select	amod	37	SENT_265	[p20l257t1185r473b1235],
37	patients	NNS	O	patient	prep_in	33	SENT_265	[p20l491t1187r700b1247],
38	with	IN	O	with	_	0	SENT_265	[p20l714t1185r827b1235],
39	acute	JJ	O	acute	amod	41	SENT_265	[p20l844t1193r987b1235],
40	myocardial	JJ	O	myocardial	amod	41	SENT_265	[p20l1003t1185r1287b1249],
41	infarction	NN	O	infarction	prep_with	37	SENT_265	[p20l1306t1184r1613b1235],
42	.	.	O	.	_	0	SENT_265	[p20l1306t1184r1613b1235],

1	J.	NNP	PERSON	J.	nn	2	SENT_266	[p20l1306t1184r1613b1235],
2	Clin	NNP	PERSON	Clin	_	0	SENT_266	[p20l1629t1185r1733b1235],
3	.	.	O	.	_	0	SENT_266	[p20l1629t1185r1733b1235],

1	Epidemiol	NNP	PERSON	Epidemiol	_	0	SENT_267	[p20l1748t1185r2011b1247],
2	.	.	O	.	_	0	SENT_267	[p20l1748t1185r2011b1247],

1	57	CD	NUMBER	57	_	0	SENT_268	[p20l2026t1189r2105b1242],
2	,	,	O	,	_	0	SENT_268	[p20l2026t1189r2105b1242],
3	843-852	CD	NUMBER	843-852	number	4	SENT_268	[p20l131t1265r354b1311],
4	(	CD	NUMBER	(	appos	1	SENT_268	[p20l371t1263r545b1319],
5	2004	CD	DATE	2004	num	6	SENT_268	[p20l371t1263r545b1319],
6	)	NN	O	)	dep	4	SENT_268	[p20l371t1263r545b1319],
7	.	.	O	.	_	0	SENT_268	[p20l371t1263r545b1319],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_269	[p20l9t1475r258b1518],
2	PHARMACOLOGY	NN	O	pharmacology	_	0	SENT_269	[p20l277t1475r744b1518],
3	&	CC	O	&	_	0	SENT_269	[p20l759t1475r796b1518],
4	TH	NN	O	th	nn	5	SENT_269	[p20l808t1475r877b1517],
5	ERAPEUTICS	NNS	O	erapeutic	conj_and	2	SENT_269	[p20l887t1475r1217b1518],
6	9	CD	NUMBER	9	amod	2	SENT_269	[p20l9t1550r51b1596],
7	.	.	O	.	_	0	SENT_269	[p20l9t1550r51b1596],

1	Mehta	NNP	PERSON	Mehta	_	0	SENT_270	[p20l132t1547r310b1604],
2	,	,	O	,	_	0	SENT_270	[p20l132t1547r310b1604],
3	C.	NNP	O	C.	conj_and	1	SENT_270	[p20l324t1548r383b1604],
4	,	,	O	,	_	0	SENT_270	[p20l324t1548r383b1604],
5	Gao	NNP	O	Gao	conj_and	1	SENT_270	[p20l398t1549r513b1604],
6	,	,	O	,	_	0	SENT_270	[p20l398t1549r513b1604],
7	P.	NNP	O	P.	conj_and	1	SENT_270	[p20l530t1549r575b1604],
8	,	,	O	,	_	0	SENT_270	[p20l530t1549r575b1604],
9	Bhatt	NNP	PERSON	Bhatt	conj_and	1	SENT_270	[p20l591t1547r740b1604],
10	,	,	O	,	_	0	SENT_270	[p20l591t1547r740b1604],
11	D.L.	NNP	O	D.L.	conj_and	1	SENT_270	[p20l757t1549r860b1604],
12	,	,	O	,	_	0	SENT_270	[p20l757t1549r860b1604],
13	Harrington	NNP	PERSON	Harrington	conj_and	1	SENT_270	[p20l877t1549r1175b1610],
14	,	,	O	,	_	0	SENT_270	[p20l877t1549r1175b1610],
15	R.A.	NNP	LOCATION	R.A.	conj_and	1	SENT_270	[p20l1191t1549r1298b1604],
16	,	,	O	,	_	0	SENT_270	[p20l1191t1549r1298b1604],
17	Skerjanec	NNP	O	Skerjanec	conj_and	1	SENT_270	[p20l1312t1547r1576b1610],
18	,	,	O	,	_	0	SENT_270	[p20l1312t1547r1576b1610],
19	S.	NNP	ORGANIZATION	S.	conj_and	1	SENT_270	[p20l1591t1548r1631b1597],
20	&	CC	ORGANIZATION	&	_	0	SENT_270	[p20l1645t1548r1836b1604],
21	Ware	NNP	ORGANIZATION	Ware	conj_and	1	SENT_270	[p20l1645t1548r1836b1604],
22	,	,	O	,	_	0	SENT_270	[p20l1645t1548r1836b1604],
23	J.H.	NNP	PERSON	J.H.	nn	26	SENT_270	[p20l1848t1549r1936b1597],
24	Optimizing	NNP	PERSON	Optimizing	nn	26	SENT_270	[p20l132t1627r423b1688],
25	trial	NN	O	trial	nn	26	SENT_270	[p20l438t1625r535b1675],
26	design	NN	O	design	appos	1	SENT_270	[p20l552t1625r740b1688],
27	:	:	O	:	_	0	SENT_270	[p20l552t1625r740b1688],
28	sequential	JJ	O	sequential	dep	1	SENT_270	[p20l755t1625r1039b1687],
29	,	,	O	,	_	0	SENT_270	[p20l755t1625r1039b1687],
30	adaptive	JJ	O	adaptive	conj_and	28	SENT_270	[p20l1053t1625r1293b1687],
31	,	,	O	,	_	0	SENT_270	[p20l1053t1625r1293b1687],
32	and	CC	O	and	_	0	SENT_270	[p20l1307t1625r1404b1675],
33	enrichment	NN	O	enrichment	nn	34	SENT_270	[p20l1420t1625r1725b1675],
34	strategies	NNS	O	strategy	dep	1	SENT_270	[p20l1739t1627r2004b1688],
35	.	.	O	.	_	0	SENT_270	[p20l1739t1627r2004b1688],

1	Circulation	NN	O	circulation	_	0	SENT_271	[p20l132t1702r406b1751],
2	1	CD	NUMBER	1	number	3	SENT_271	[p20l425t1706r444b1750],
3	19	CD	NUMBER	19	dep	1	SENT_271	[p20l460t1705r536b1758],
4	,	,	O	,	_	0	SENT_271	[p20l460t1705r536b1758],
5	597-605	CD	NUMBER	597-605	number	6	SENT_271	[p20l552t1705r773b1751],
6	(	CD	NUMBER	(	appos	1	SENT_271	[p20l791t1703r966b1758],
7	2009	CD	DATE	2009	num	8	SENT_271	[p20l791t1703r966b1758],
8	)	NN	O	)	dep	6	SENT_271	[p20l791t1703r966b1758],
9	.	.	O	.	_	0	SENT_271	[p20l791t1703r966b1758],

1	Orloff	NNP	PERSON	Orloff	_	0	SENT_272	[p20l130t1778r289b1837],
2	,	,	O	,	_	0	SENT_272	[p20l130t1778r289b1837],
3	J.	NNP	O	J.	nn	4	SENT_272	[p20l302t1781r335b1829],
4	etal	NNP	O	etal	appos	1	SENT_272	[p20l350t1779r464b1829],
5	.	.	O	.	_	0	SENT_272	[p20l350t1779r464b1829],

1	The	DT	DATE	the	det	2	SENT_273	[p20l474t1779r571b1829],
2	future	NN	DATE	future	_	0	SENT_273	[p20l584t1778r743b1829],
3	of	IN	O	of	_	0	SENT_273	[p20l758t1778r812b1829],
4	drug	NN	O	drug	nn	5	SENT_273	[p20l822t1779r943b1842],
5	development	NN	O	development	prep_of	2	SENT_273	[p20l960t1779r1326b1841],
6	:	:	O	:	_	0	SENT_273	[p20l960t1779r1326b1841],
7	advancing	VBG	O	advance	dep	5	SENT_273	[p20l1340t1779r1612b1842],
8	clinical	JJ	O	clinical	amod	10	SENT_273	[p20l1629t1779r1804b1829],
9	trial	NN	O	trial	nn	10	SENT_273	[p20l1820t1779r1917b1829],
10	design	NN	O	design	dobj	7	SENT_273	[p20l1934t1779r2122b1842],
11	.	.	O	.	_	0	SENT_273	[p20l1934t1779r2122b1842],

1	Nat	NN	PERSON	nat	_	0	SENT_274	[p20l132t1858r232b1905],
2	.	.	O	.	_	0	SENT_274	[p20l132t1858r232b1905],

1	Rev.	NNP	O	Rev.	nn	3	SENT_275	[p20l247t1858r343b1905],
2	Drug	NNP	PERSON	Drug	nn	3	SENT_275	[p20l358t1858r483b1918],
3	Discov	NNP	PERSON	Discov	_	0	SENT_275	[p20l495t1858r673b1905],
4	.	.	O	.	_	0	SENT_275	[p20l495t1858r673b1905],

1	8	CD	NUMBER	8	_	0	SENT_276	[p20l687t1859r731b1912],
2	,	,	O	,	_	0	SENT_276	[p20l687t1859r731b1912],
3	949-957	CD	NUMBER	949-957	number	4	SENT_276	[p20l746t1859r970b1905],
4	(	CD	NUMBER	(	appos	1	SENT_276	[p20l986t1857r1160b1912],
5	2009	CD	DATE	2009	num	6	SENT_276	[p20l986t1857r1160b1912],
6	)	NN	O	)	dep	4	SENT_276	[p20l986t1857r1160b1912],
7	.	.	O	.	_	0	SENT_276	[p20l986t1857r1160b1912],

1	Selker	NNP	PERSON	Selker	nn	3	SENT_277	[p20l131t1934r297b1991],
2	,	,	O	,	_	0	SENT_277	[p20l131t1934r297b1991],
3	H.P.	NNP	O	H.P.	_	0	SENT_277	[p20l314t1936r400b1984],
4	et	FW	O	et	nn	5	SENT_277	[p20l414t1942r463b1984],
5	al.	FW	O	al.	dep	3	SENT_277	[p20l472t1934r529b1984],
6	.	.	O	.	_	0	SENT_277	[p20l472t1934r529b1984],

1	Patient	NN	O	patient	_	0	SENT_278	[p20l546t1933r944b1997],
2	—	CD	NUMBER	—	num	4	SENT_278	[p20l546t1933r944b1997],
3	speciﬁc	NN	O	speciﬁc	nn	4	SENT_278	[p20l546t1933r944b1997],
4	predictions	NNS	O	prediction	dep	1	SENT_278	[p20l960t1934r1253b1996],
5	of	IN	O	of	_	0	SENT_278	[p20l1268t1933r1322b1984],
6	outcomes	NNS	O	outcome	prep_of	4	SENT_278	[p20l1332t1942r1592b1984],
7	in	IN	O	in	_	0	SENT_278	[p20l1608t1936r1651b1983],
8	myocardial	JJ	O	myocardial	amod	9	SENT_278	[p20l1669t1934r1954b1998],
9	infarction	NN	O	infarction	prep_in	6	SENT_278	[p20l133t2011r380b2062],
10	for	IN	O	for	_	0	SENT_278	[p20l395t2011r468b2062],
11	real	JJ	O	real	amod	15	SENT_278	[p20l483t2012r715b2062],
12	—	JJ	O	—	amod	15	SENT_278	[p20l483t2012r715b2062],
13	time	NN	O	time	nn	15	SENT_278	[p20l483t2012r715b2062],
14	emergency	NN	O	emergency	nn	15	SENT_278	[p20l730t2027r1027b2076],
15	use	NN	O	use	prep_for	9	SENT_278	[p20l1042t2027r1141b2062],
16	:	:	O	:	_	0	SENT_278	[p20l1042t2027r1141b2062],
17	a	DT	O	a	det	20	SENT_278	[p20l1156t2027r1181b2062],
18	thrombolytic	JJ	O	thrombolytic	amod	20	SENT_278	[p20l1195t2012r1539b2076],
19	predictive	JJ	O	predictive	amod	20	SENT_278	[p20l1555t2012r1815b2074],
20	instrument	NN	O	instrument	dep	1	SENT_278	[p20l1831t2014r2131b2062],
21	.	.	O	.	_	0	SENT_278	[p20l1831t2014r2131b2062],

1	Ann	NNP	PERSON	Ann	_	0	SENT_279	[p20l128t2091r243b2138],
2	.	.	O	.	_	0	SENT_279	[p20l128t2091r243b2138],

1	Intern	NNP	O	Intern	_	0	SENT_280	[p20l258t2091r417b2138],
2	.	.	O	.	_	0	SENT_280	[p20l258t2091r417b2138],

1	Med	NNP	O	Med	_	0	SENT_281	[p20l431t2089r553b2138],
2	.	.	O	.	_	0	SENT_281	[p20l431t2089r553b2138],

1	127	CD	NUMBER	127	_	0	SENT_282	[p20l571t2092r683b2146],
2	,	,	O	,	_	0	SENT_282	[p20l571t2092r683b2146],
3	538-556	CD	NUMBER	538-556	number	4	SENT_282	[p20l698t2092r922b2138],
4	(	CD	NUMBER	(	appos	1	SENT_282	[p20l938t2090r1112b2145],
5	1997	CD	DATE	1997	num	6	SENT_282	[p20l938t2090r1112b2145],
6	)	NN	O	)	dep	4	SENT_282	[p20l938t2090r1112b2145],
7	.	.	O	.	_	0	SENT_282	[p20l938t2090r1112b2145],

1	Selker	NNP	PERSON	Selker	_	0	SENT_283	[p20l131t2167r297b2224],
2	,	,	O	,	_	0	SENT_283	[p20l131t2167r297b2224],
3	H.P.	NNP	O	H.P.	conj_and	1	SENT_283	[p20l314t2169r413b2224],
4	,	,	O	,	_	0	SENT_283	[p20l314t2169r413b2224],
5	Beshansky	NNP	PERSON	Beshansky	conj_and	1	SENT_283	[p20l430t2167r713b2231],
6	,	,	O	,	_	0	SENT_283	[p20l430t2167r713b2231],
7	J.R.	NNP	ORGANIZATION	J.R.	conj_and	1	SENT_283	[p20l726t2169r807b2217],
8	&	CC	ORGANIZATION	&	_	0	SENT_283	[p20l821t2169r857b2217],
9	Grifﬁth	NNP	ORGANIZATION	Grifﬁth	conj_and	1	SENT_283	[p20l870t2166r1065b2225],
10	,	,	O	,	_	0	SENT_283	[p20l870t2166r1065b2225],
11	J.L.	NNP	O	J.L.	appos	1	SENT_283	[p20l1077t2169r1253b2224],
12	;	:	O	;	_	0	SENT_283	[p20l1077t2169r1253b2224],
13	TP	NNP	O	TP	nn	15	SENT_283	[p20l1077t2169r1253b2224],
14	|	NNP	O	|	nn	15	SENT_283	[p20l1077t2169r1253b2224],
15	Trial	NNP	O	Trial	dep	1	SENT_283	[p20l1265t2167r1371b2217],
16	Investigators	NNS	O	investigator	dep	15	SENT_283	[p20l1390t2169r1737b2230],
17	.	.	O	.	_	0	SENT_283	[p20l1390t2169r1737b2230],

1	Use	NN	O	use	nsubj	8	SENT_284	[p20l1754t2169r1846b2217],
2	of	IN	O	of	_	0	SENT_284	[p20l1860t2166r1915b2217],
3	the	DT	O	the	prep_of	1	SENT_284	[p20l1923t2167r2009b2217],
4	e	SYM	O	e	dep	3	SENT_284	[p20l132t2245r812b2308],
5	|	SYM	O	|	dep	1	SENT_284	[p20l132t2245r812b2308],
6	ectrocardiograph	FW	O	ectrocardiograph	nn	7	SENT_284	[p20l132t2245r812b2308],
7	—	FW	O	—	amod	1	SENT_284	[p20l132t2245r812b2308],
8	based	VBN	O	base	_	0	SENT_284	[p20l132t2245r812b2308],
9	thrombolytic	JJ	O	thrombolytic	amod	11	SENT_284	[p20l827t2245r1170b2309],
10	predictive	JJ	O	predictive	amod	11	SENT_284	[p20l1186t2245r1446b2307],
11	instrument	NN	O	instrument	dobj	8	SENT_284	[p20l1462t2247r1751b2295],
12	to	TO	O	to	aux	13	SENT_284	[p20l1763t2253r1816b2295],
13	assist	VB	O	assist	infmod	11	SENT_284	[p20l1831t2247r1970b2295],
14	thrombolytic	JJ	O	thrombolytic	amod	17	SENT_284	[p20l130t2323r473b2387],
15	and	CC	O	and	_	0	SENT_284	[p20l487t2323r583b2373],
16	reperfusion	NN	O	reperfusion	conj_and	14	SENT_284	[p20l602t2322r900b2385],
17	therapy	NN	O	therapy	dobj	13	SENT_284	[p20l916t2323r1120b2387],
18	for	IN	O	for	_	0	SENT_284	[p20l1131t2322r1204b2373],
19	acute	JJ	O	acute	amod	21	SENT_284	[p20l1216t2331r1359b2373],
20	myocardial	JJ	O	myocardial	amod	21	SENT_284	[p20l1376t2323r1660b2387],
21	infarction	NN	O	infarction	prep_for	13	SENT_284	[p20l1679t2322r1941b2373],
22	.	.	O	.	_	0	SENT_284	[p20l1679t2322r1941b2373],

1	A	DT	O	a	det	2	SENT_285	[p20l1955t2325r1991b2372],
2	multicenter	NN	O	multicenter	_	0	SENT_285	[p20l134t2400r445b2457],
3	,	,	O	,	_	0	SENT_285	[p20l134t2400r445b2457],
4	randomized	VBN	O	randomize	dep	2	SENT_285	[p20l461t2400r788b2457],
5	,	,	O	,	_	0	SENT_285	[p20l461t2400r788b2457],
6	controlled	VBN	O	control	dep	4	SENT_285	[p20l802t2400r1082b2457],
7	,	,	O	,	_	0	SENT_285	[p20l802t2400r1082b2457],
8	clinical	JJ	O	clinical	amod	11	SENT_285	[p20l1097t2400r1273b2449],
9	effectiveness	NN	O	effectiveness	nn	11	SENT_285	[p20l1290t2399r1630b2449],
10	tria	NN	O	trium	nn	11	SENT_285	[p20l1644t2400r1882b2449],
11	|	NN	O	|	dobj	4	SENT_285	[p20l1644t2400r1882b2449],
12	.	.	O	.	_	0	SENT_285	[p20l1644t2400r1882b2449],

1	Ann	NNP	PERSON	Ann	_	0	SENT_286	[p20l1644t2400r1882b2449],
2	.	.	O	.	_	0	SENT_286	[p20l1644t2400r1882b2449],

1	Intern	NNP	O	Intern	_	0	SENT_287	[p20l1897t2402r2056b2449],
2	.	.	O	.	_	0	SENT_287	[p20l1897t2402r2056b2449],

1	Med	NNP	O	Med	_	0	SENT_288	[p20l130t2477r253b2526],
2	.	.	O	.	_	0	SENT_288	[p20l130t2477r253b2526],

1	137	CD	NUMBER	137	_	0	SENT_289	[p20l270t2480r382b2533],
2	,	,	O	,	_	0	SENT_289	[p20l270t2480r382b2533],
3	87-95	CD	NUMBER	87-95	number	4	SENT_289	[p20l397t2480r554b2526],
4	(	CD	NUMBER	(	appos	1	SENT_289	[p20l572t2478r746b2533],
5	2002	CD	DATE	2002	num	6	SENT_289	[p20l572t2478r746b2533],
6	)	NN	O	)	dep	4	SENT_289	[p20l572t2478r746b2533],
7	.	.	O	.	_	0	SENT_289	[p20l572t2478r746b2533],

1	Kent	NNP	PERSON	Kent	_	0	SENT_290	[p20l132t2556r261b2611],
2	,	,	O	,	_	0	SENT_290	[p20l132t2556r261b2611],
3	D.M.	NNP	PERSON	D.M.	conj_and	1	SENT_290	[p20l279t2556r403b2611],
4	,	,	O	,	_	0	SENT_290	[p20l279t2556r403b2611],
5	Selker	NNP	PERSON	Selker	conj_and	1	SENT_290	[p20l418t2554r584b2610],
6	,	,	O	,	_	0	SENT_290	[p20l418t2554r584b2610],
7	H.P.	NNP	O	H.P.	conj_and	1	SENT_290	[p20l601t2556r700b2610],
8	,	,	O	,	_	0	SENT_290	[p20l601t2556r700b2610],
9	Ruthazer	NNP	PERSON	Ruthazer	conj_and	1	SENT_290	[p20l717t2554r956b2610],
10	,	,	O	,	_	0	SENT_290	[p20l717t2554r956b2610],
11	R.	NNP	O	R.	conj_and	1	SENT_290	[p20l973t2556r1027b2610],
12	,	,	O	,	_	0	SENT_290	[p20l973t2556r1027b2610],
13	Bluhmki	NNP	PERSON	Bluhmki	conj_and	1	SENT_290	[p20l1044t2554r1270b2610],
14	,	,	O	,	_	0	SENT_290	[p20l1044t2554r1270b2610],
15	E.	NNP	ORGANIZATION	E.	conj_and	1	SENT_290	[p20l1286t2556r1324b2603],
16	&	CC	ORGANIZATION	&	_	0	SENT_290	[p20l1338t2556r1375b2603],
17	Hacke	NNP	ORGANIZATION	Hacke	conj_and	1	SENT_290	[p20l1390t2554r1559b2611],
18	,	,	O	,	_	0	SENT_290	[p20l1390t2554r1559b2611],
19	W.	NNP	O	W.	nn	20	SENT_290	[p20l1570t2556r1631b2603],
20	The	NNP	O	The	appos	1	SENT_290	[p20l1640t2554r1737b2603],
21	strokethrombolytic	JJ	O	strokethrombolytic	amod	23	SENT_290	[p20l1752t2554r1932b2603, p20l130t2632r473b2696],
22	predictive	JJ	O	predictive	amod	23	SENT_290	[p20l489t2632r749b2694],
23	instrument	NN	O	instrument	dep	20	SENT_290	[p20l765t2634r1066b2682],
24	:	:	O	:	_	0	SENT_290	[p20l765t2634r1066b2682],
25	a	DT	O	a	det	27	SENT_290	[p20l1081t2647r1106b2682],
26	predictive	JJ	O	predictive	amod	27	SENT_290	[p20l1124t2632r1384b2695],
27	instrument	NN	O	instrument	dep	1	SENT_290	[p20l1400t2634r1689b2682],
28	for	IN	O	for	_	0	SENT_290	[p20l1701t2631r1773b2682],
29	intravenous	JJ	O	intravenous	amod	30	SENT_290	[p20l1788t2634r2096b2682],
30	thrombolysis	NN	O	thrombolysis	prep_for	27	SENT_290	[p20l130t2710r473b2774],
31	in	IN	O	in	_	0	SENT_290	[p20l489t2712r532b2759],
32	acute	JJ	O	acute	amod	34	SENT_290	[p20l548t2718r692b2760],
33	ischemic	JJ	O	ischemic	amod	34	SENT_290	[p20l707t2710r934b2760],
34	stroke	NN	O	stroke	prep_in	30	SENT_290	[p20l949t2710r1120b2760],
35	.	.	O	.	_	0	SENT_290	[p20l949t2710r1120b2760],

1	Stroke	NN	O	stroke	_	0	SENT_291	[p20l1133t2710r1292b2760],
2	37	CD	NUMBER	37	num	1	SENT_291	[p20l1304t2713r1384b2767],
3	,	,	O	,	_	0	SENT_291	[p20l1304t2713r1384b2767],
4	2957-2962	CD	DATE	2957-2962	number	5	SENT_291	[p20l1399t2713r1687b2760],
5	(	CD	NUMBER	(	appos	1	SENT_291	[p20l1704t2711r1878b2767],
6	2006	CD	DATE	2006	num	7	SENT_291	[p20l1704t2711r1878b2767],
7	)	NN	O	)	dep	5	SENT_291	[p20l1704t2711r1878b2767],
8	.	.	O	.	_	0	SENT_291	[p20l1704t2711r1878b2767],

1	Savvides	NNP	O	Savvides	_	0	SENT_292	[p20l131t2788r370b2845],
2	,	,	O	,	_	0	SENT_292	[p20l131t2788r370b2845],
3	P.S.	NNP	O	P.S.	conj_and	1	SENT_292	[p20l387t2790r648b2845],
4	,	,	O	,	_	0	SENT_292	[p20l387t2790r648b2845],
5	Terrin	NNP	LOCATION	Terrin	conj_and	1	SENT_292	[p20l387t2790r648b2845],
6	,	,	O	,	_	0	SENT_292	[p20l387t2790r648b2845],
7	N.C.	NNP	LOCATION	N.C.	conj_and	1	SENT_292	[p20l665t2790r777b2845],
8	,	,	O	,	_	0	SENT_292	[p20l665t2790r777b2845],
9	Erban	NNP	PERSON	Erban	conj_and	1	SENT_292	[p20l793t2788r955b2845],
10	,	,	O	,	_	0	SENT_292	[p20l793t2788r955b2845],
11	J.	NNP	ORGANIZATION	J.	conj_and	1	SENT_292	[p20l967t2790r1001b2838],
12	&	CC	ORGANIZATION	&	_	0	SENT_292	[p20l1015t2790r1052b2838],
13	Selker	NNP	ORGANIZATION	Selker	conj_and	1	SENT_292	[p20l1065t2788r1231b2845],
14	,	,	O	,	_	0	SENT_292	[p20l1065t2788r1231b2845],
15	H.P.	NNP	O	H.P.	nn	16	SENT_292	[p20l1248t2790r1334b2838],
16	Development	NNP	O	Development	conj_and	1	SENT_292	[p20l1352t2788r1710b2850],
17	and	CC	O	and	_	0	SENT_292	[p20l1724t2788r1820b2838],
18	validation	NN	O	validation	conj_and	1	SENT_292	[p20l1835t2788r2094b2838],
19	of	IN	O	of	_	0	SENT_292	[p20l132t2865r186b2916],
20	a	DT	O	a	det	23	SENT_292	[p20l195t2881r221b2916],
21	patient	NN	O	patient	nn	23	SENT_292	[p20l239t2865r641b2928],
22	—	CD	NUMBER	—	num	23	SENT_292	[p20l239t2865r641b2928],
23	speciﬁc	NN	O	speciﬁc	prep_of	18	SENT_292	[p20l239t2865r641b2928],
24	predictive	JJ	O	predictive	amod	27	SENT_292	[p20l657t2866r918b2928],
25	instrument	NN	O	instrument	nn	27	SENT_292	[p20l934t2868r1222b2916],
26	forthe	NN	O	forthe	nn	27	SENT_292	[p20l1234t2865r1404b2916],
27	need	NN	O	need	dep	23	SENT_292	[p20l1421t2866r1548b2916],
28	for	IN	O	for	_	0	SENT_292	[p20l1563t2865r1635b2916],
29	dose	NN	O	dose	nn	30	SENT_292	[p20l1649t2866r1773b2916],
30	reduction	NN	O	reduction	prep_for	27	SENT_292	[p20l1789t2866r2040b2916],
31	in	IN	O	in	_	0	SENT_292	[p20l133t2946r176b2993],
32	chemotherapy	NN	O	chemotherapy	prep_in	30	SENT_292	[p20l192t2944r579b3008],
33	for	IN	O	for	_	0	SENT_292	[p20l590t2943r663b2994],
34	breast	NN	O	breast	nn	35	SENT_292	[p20l678t2944r838b2994],
35	cancer	NN	O	cancer	prep_for	32	SENT_292	[p20l852t2959r1037b2994],
36	:	:	O	:	_	0	SENT_292	[p20l852t2959r1037b2994],
37	a	DT	O	a	det	40	SENT_292	[p20l1051t2959r1076b2994],
38	potential	JJ	O	potential	amod	40	SENT_292	[p20l1094t2944r1326b3006],
39	decision	NN	O	decision	nn	40	SENT_292	[p20l1343t2944r1558b2994],
40	aid	NN	O	aid	dep	1	SENT_292	[p20l1575t2944r1651b2994],
41	for	IN	O	for	_	0	SENT_292	[p20l1665t2943r1738b2994],
42	the	DT	O	the	det	43	SENT_292	[p20l1750t2944r1835b2994],
43	use	NN	O	use	prep_for	40	SENT_292	[p20l1852t2959r1938b2994],
44	of	IN	O	of	_	0	SENT_292	[p20l1953t2943r2007b2994],
45	myeloid	JJ	O	myeloid	amod	47	SENT_292	[p20l133t3022r340b3086],
46	growth	NN	O	growth	nn	47	SENT_292	[p20l357t3022r544b3085],
47	factors	NNS	O	factor	prep_of	43	SENT_292	[p20l559t3021r749b3072],
48	.	.	O	.	_	0	SENT_292	[p20l559t3021r749b3072],

1	Support	NN	O	support	nn	3	SENT_293	[p20l762t3024r968b3084],
2	Care	NNP	O	Care	nn	3	SENT_293	[p20l978t3024r1092b3072],
3	Cancer	NNP	O	Cancer	_	0	SENT_293	[p20l1104t3024r1280b3072],
4	1	CD	NUMBER	1	number	5	SENT_293	[p20l1294t3026r1314b3071],
5	1	CD	NUMBER	1	dep	3	SENT_293	[p20l1330t3026r1371b3079],
6	,	,	O	,	_	0	SENT_293	[p20l1330t3026r1371b3079],
7	313-320	CD	NUMBER	313-320	number	8	SENT_293	[p20l1386t3025r1609b3072],
8	(	CD	NUMBER	(	appos	3	SENT_293	[p20l1626t3023r1799b3079],
9	2003	CD	DATE	2003	num	10	SENT_293	[p20l1626t3023r1799b3079],
10	)	NN	O	)	dep	8	SENT_293	[p20l1626t3023r1799b3079],
11	.	.	O	.	_	0	SENT_293	[p20l1626t3023r1799b3079],

1	Selker	NNP	PERSON	Selker	_	0	SENT_294	[p20l131t3099r297b3155],
2	,	,	O	,	_	0	SENT_294	[p20l131t3099r297b3155],
3	H.P.	NNP	O	H.P.	conj_and	1	SENT_294	[p20l314t3101r413b3156],
4	,	,	O	,	_	0	SENT_294	[p20l314t3101r413b3156],
5	Ruthazer	NNP	PERSON	Ruthazer	conj_and	1	SENT_294	[p20l430t3099r669b3156],
6	,	,	O	,	_	0	SENT_294	[p20l430t3099r669b3156],
7	R.	NNP	O	R.	conj_and	1	SENT_294	[p20l686t3101r911b3156],
8	,	,	O	,	_	0	SENT_294	[p20l686t3101r911b3156],
9	Terrin	NNP	LOCATION	Terrin	conj_and	1	SENT_294	[p20l686t3101r911b3156],
10	,	,	O	,	_	0	SENT_294	[p20l686t3101r911b3156],
11	N.	NNP	O	N.	conj_and	1	SENT_294	[p20l929t3101r990b3156],
12	,	,	O	,	_	0	SENT_294	[p20l929t3101r990b3156],
13	Grifﬁth	NNP	LOCATION	Grifﬁth	conj_and	1	SENT_294	[p20l1005t3098r1199b3155],
14	,	,	O	,	_	0	SENT_294	[p20l1005t3098r1199b3155],
15	J.L.	NNP	PERSON	J.L.	conj_and	1	SENT_294	[p20l1212t3101r1302b3156],
16	,	,	O	,	_	0	SENT_294	[p20l1212t3101r1302b3156],
17	Concannon	NNP	PERSON	Concannon	conj_and	1	SENT_294	[p20l1316t3101r1681b3156],
18	,	,	O	,	_	0	SENT_294	[p20l1316t3101r1681b3156],
19	T.	NNP	ORGANIZATION	T.	conj_and	1	SENT_294	[p20l1316t3101r1681b3156],
20	&	CC	ORGANIZATION	&	_	0	SENT_294	[p20l1695t3101r1732b3148],
21	Kent	NNP	ORGANIZATION	Kent	conj_and	1	SENT_294	[p20l1747t3101r1876b3155],
22	,	,	O	,	_	0	SENT_294	[p20l1747t3101r1876b3155],
23	D.M.	NNP	PERSON	D.M.	nn	26	SENT_294	[p20l134t3179r246b3227],
24	Random	NNP	PERSON	Random	nn	26	SENT_294	[p20l262t3177r479b3227],
25	treatment	NN	O	treatment	nn	26	SENT_294	[p20l494t3185r758b3227],
26	assignment	NN	O	assignment	appos	1	SENT_294	[p20l772t3179r1077b3240],
27	using	VBG	O	use	partmod	26	SENT_294	[p20l1092t3179r1230b3240],
28	mathematical	JJ	O	mathematical	amod	29	SENT_294	[p20l1249t3177r1606b3227],
29	equipoise	NN	O	equipoise	dobj	27	SENT_294	[p20l1623t3179r1880b3240],
30	for	IN	O	for	_	0	SENT_294	[p20l1893t3176r1965b3227],
31	comparative	JJ	O	comparative	amod	33	SENT_294	[p20l132t3257r459b3318],
32	effectiveness	NN	O	effectiveness	nn	33	SENT_294	[p20l474t3254r814b3305],
33	trials	NNS	O	trial	prep_for	27	SENT_294	[p20l828t3255r965b3305],
34	.	.	O	.	_	0	SENT_294	[p20l828t3255r965b3305],

1	Clin	NNP	O	Clin	_	0	SENT_295	[p20l980t3255r1085b3305],
2	.	.	O	.	_	0	SENT_295	[p20l980t3255r1085b3305],

1	Transl	NN	O	transl	_	0	SENT_296	[p20l1102t3255r1257b3305],
2	.	.	O	.	_	0	SENT_296	[p20l1102t3255r1257b3305],

1	Sci	NNP	O	Sci	_	0	SENT_297	[p20l1271t3257r1353b3305],
2	.	.	O	.	_	0	SENT_297	[p20l1271t3257r1353b3305],

1	4	CD	NUMBER	4	_	0	SENT_298	[p20l1367t3259r1412b3312],
2	,	,	O	,	_	0	SENT_298	[p20l1367t3259r1412b3312],
3	10-16	CD	NUMBER	10-16	num	4	SENT_298	[p20l1431t3258r1586b3305],
4	(	NN	O	(	appos	1	SENT_298	[p20l1602t3256r1702b3312],
5	201	CD	NUMBER	201	number	6	SENT_298	[p20l1602t3256r1702b3312],
6	1	CD	NUMBER	1	num	7	SENT_298	[p20l1720t3256r1776b3312],
7	)	NN	O	)	dep	4	SENT_298	[p20l1720t3256r1776b3312],
8	.	.	O	.	_	0	SENT_298	[p20l1720t3256r1776b3312],

1	Kent	NNP	PERSON	Kent	_	0	SENT_299	[p20l132t3336r261b3391],
2	,	,	O	,	_	0	SENT_299	[p20l132t3336r261b3391],
3	D.M.	NNP	O	D.M.	nn	4	SENT_299	[p20l278t3335r390b3383],
4	etal	NNP	O	etal	appos	1	SENT_299	[p20l404t3333r519b3383],
5	.	.	O	.	_	0	SENT_299	[p20l404t3333r519b3383],

1	Comparison	NN	O	comparison	_	0	SENT_300	[p20l533t3335r850b3396],
2	of	IN	O	of	_	0	SENT_300	[p20l867t3333r921b3383],
3	mortality	NN	O	mortality	nn	4	SENT_300	[p20l933t3333r1172b3397],
4	beneﬁt	NN	O	beneﬁt	prep_of	1	SENT_300	[p20l1187t3333r1371b3383],
5	of	IN	O	of	_	0	SENT_300	[p20l1385t3333r1440b3383],
6	immediate	JJ	O	immediate	amod	8	SENT_300	[p20l1451t3333r1732b3383],
7	thrombolytic	JJ	O	thrombolytic	amod	8	SENT_300	[p20l1745t3333r2088b3397],
8	therapy	NN	O	therapy	prep_of	1	SENT_300	[p20l130t3411r334b3475],
9	versus	CC	O	versus	prep	1	SENT_300	[p20l346t3426r511b3461],
10	delayed	VBN	O	delay	amod	12	SENT_300	[p20l526t3411r730b3475],
11	primary	JJ	O	primary	amod	12	SENT_300	[p20l749t3414r953b3475],
12	angioplasty	NN	O	angioplasty	dep	9	SENT_300	[p20l965t3411r1273b3475],
13	for	IN	O	for	_	0	SENT_300	[p20l1284t3411r1356b3461],
14	acute	JJ	O	acute	amod	16	SENT_300	[p20l1369t3419r1512b3461],
15	myocardial	JJ	O	myocardial	amod	16	SENT_300	[p20l1529t3411r1813b3475],
16	infarction	NN	O	infarction	prep_for	12	SENT_300	[p20l1832t3411r2094b3461],
17	.	.	O	.	_	0	SENT_300	[p20l1832t3411r2094b3461],

1	Am	NNP	O	Am	_	0	SENT_301	[p20l128t3491r227b3537],
2	.	.	O	.	_	0	SENT_301	[p20l128t3491r227b3537],

1	J.	NNP	PERSON	J.	nn	2	SENT_302	[p20l238t3491r272b3537],
2	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_302	[p20l288t3488r480b3537],
3	.	.	O	.	_	0	SENT_302	[p20l288t3488r480b3537],

1	99	CD	NUMBER	99	_	0	SENT_303	[p20l494t3491r574b3545],
2	,	,	O	,	_	0	SENT_303	[p20l494t3491r574b3545],
3	1	CD	NUMBER	1	number	4	SENT_303	[p20l593t3492r607b3537],
4	384-1388	CD	NUMBER	384-1388	appos	1	SENT_303	[p20l622t3491r878b3537],
5	(	CD	NUMBER	(	num	7	SENT_303	[p20l894t3489r1068b3545],
6	2007	CD	DATE	2007	num	7	SENT_303	[p20l894t3489r1068b3545],
7	)	NN	O	)	dep	4	SENT_303	[p20l894t3489r1068b3545],
8	.	.	O	.	_	0	SENT_303	[p20l894t3489r1068b3545],

1	17	CD	NUMBER	17	_	0	SENT_304	[p21l13t21r83b67],
2	.	.	O	.	_	0	SENT_304	[p21l13t21r83b67],

1	Eichler	NNP	PERSON	Eichler	_	0	SENT_305	[p21l132t17r313b75],
2	,	,	O	,	_	0	SENT_305	[p21l132t17r313b75],
3	H.G.	NNP	PERSON	H.G.	nn	4	SENT_305	[p21l330t19r432b67],
4	etal	NNP	O	etal	appos	1	SENT_305	[p21l447t17r561b67],
5	.	.	O	.	_	0	SENT_305	[p21l447t17r561b67],

1	Adaptive	JJ	O	adaptive	amod	2	SENT_306	[p21l576t17r811b80],
2	licensing	NN	O	licensing	_	0	SENT_306	[p21l828t17r1071b80],
3	:	:	O	:	_	0	SENT_306	[p21l828t17r1071b80],
4	taking	VBG	O	take	dep	2	SENT_306	[p21l1084t17r1247b80],
5	the	DT	O	the	det	7	SENT_306	[p21l1262t17r1348b67],
6	next	JJ	O	next	amod	7	SENT_306	[p21l1365t25r1478b67],
7	step	NN	O	step	dobj	4	SENT_306	[p21l1492t25r1602b80],
8	in	IN	O	in	_	0	SENT_306	[p21l1618t20r1660b66],
9	the	DT	O	the	det	10	SENT_306	[p21l1676t17r1761b67],
10	evolution	NN	O	evolution	prep_in	4	SENT_306	[p21l1776t17r2023b67],
11	of	IN	O	of	_	0	SENT_306	[p21l2039t17r2094b67],
12	drug	NN	O	drug	nn	13	SENT_306	[p21l132t95r253b158],
13	approval	NN	O	approval	prep_of	10	SENT_306	[p21l269t95r512b158],
14	.	.	O	.	_	0	SENT_306	[p21l269t95r512b158],

1	Clin	NNP	O	Clin	_	0	SENT_307	[p21l527t95r631b145],
2	.	.	O	.	_	0	SENT_307	[p21l527t95r631b145],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_308	[p21l646t95r931b145],
2	.	.	O	.	_	0	SENT_308	[p21l646t95r931b145],

1	Ther	NNP	O	Ther	_	0	SENT_309	[p21l948t95r1068b145],
2	.	.	O	.	_	0	SENT_309	[p21l948t95r1068b145],

1	91	CD	NUMBER	91	_	0	SENT_310	[p21l1082t99r1163b153],
2	,	,	O	,	_	0	SENT_310	[p21l1082t99r1163b153],
3	426-437	CD	NUMBER	426-437	number	4	SENT_310	[p21l1176t98r1401b145],
4	(	CD	NUMBER	(	appos	1	SENT_310	[p21l1417t96r1592b153],
5	2012	CD	DATE	2012	num	6	SENT_310	[p21l1417t96r1592b153],
6	)	NN	O	)	dep	4	SENT_310	[p21l1417t96r1592b153],
7	.	.	O	.	_	0	SENT_310	[p21l1417t96r1592b153],

1	18	CD	NUMBER	18	_	0	SENT_311	[p21l13t176r83b223],
2	.	.	O	.	_	0	SENT_311	[p21l13t176r83b223],

1	Mollerup	NNP	O	Mollerup	_	0	SENT_312	[p21l131t173r378b236],
2	,	,	O	,	_	0	SENT_312	[p21l131t173r378b236],
3	J.	NNP	O	J.	conj_and	1	SENT_312	[p21l390t176r437b231],
4	,	,	O	,	_	0	SENT_312	[p21l390t176r437b231],
5	Henriksen	NNP	PERSON	Henriksen	conj_and	1	SENT_312	[p21l454t173r728b231],
6	,	,	O	,	_	0	SENT_312	[p21l454t173r728b231],
7	U.	NNP	O	U.	conj_and	1	SENT_312	[p21l745t176r804b231],
8	,	,	O	,	_	0	SENT_312	[p21l745t176r804b231],
9	Muller	NNP	PERSON	Muller	conj_and	1	SENT_312	[p21l820t173r993b231],
10	,	,	O	,	_	0	SENT_312	[p21l820t173r993b231],
11	S.	NNP	ORGANIZATION	S.	conj_and	1	SENT_312	[p21l1008t175r1048b223],
12	&	CC	ORGANIZATION	&	_	0	SENT_312	[p21l1062t175r1099b223],
13	Schonau	NNP	ORGANIZATION	Schonau	conj_and	1	SENT_312	[p21l1112t173r1353b231],
14	,	,	O	,	_	0	SENT_312	[p21l1112t173r1353b231],
15	A.	NNP	O	A.	nn	17	SENT_312	[p21l1366t176r1415b223],
16	Dual	JJ	O	dual	amod	17	SENT_312	[p21l1432t173r1547b223],
17	color	NN	O	color	appos	1	SENT_312	[p21l1564t173r1695b223],
18	chromogenic	JJ	O	chromogenic	dep	20	SENT_312	[p21l1708t173r2058b236],
19	in	FW	O	in	nn	20	SENT_312	[p21l133t254r176b300],
20	situ	FW	O	situ	rcmod	17	SENT_312	[p21l192t254r282b301],
21	hybridization	NN	O	hybridization	dep	17	SENT_312	[p21l301t251r644b315],
22	for	IN	O	for	_	0	SENT_312	[p21l659t251r731b301],
23	determination	NN	O	determination	prep_for	21	SENT_312	[p21l744t251r1120b301],
24	of	IN	O	of	_	0	SENT_312	[p21l1136t251r1191b301],
25	HER2	NN	O	her2	nn	26	SENT_312	[p21l1203t253r1335b300],
26	status	NN	O	status	prep_of	23	SENT_312	[p21l1351t259r1504b301],
27	in	IN	O	in	_	0	SENT_312	[p21l1521t254r1563b300],
28	breast	NN	O	breast	nn	29	SENT_312	[p21l1582t251r1742b301],
29	cancer	NN	O	cancer	prep_in	26	SENT_312	[p21l1756t266r1941b301],
30	:	:	O	:	_	0	SENT_312	[p21l1756t266r1941b301],
31	a	DT	O	a	det	34	SENT_312	[p21l131t344r156b379],
32	large	JJ	O	large	amod	34	SENT_312	[p21l175t329r302b392],
33	comparative	JJ	O	comparative	amod	34	SENT_312	[p21l317t332r645b392],
34	study	NN	O	study	dep	1	SENT_312	[p21l659t329r804b393],
35	to	TO	O	to	_	0	SENT_312	[p21l815t337r869b379],
36	current	JJ	DATE	current	amod	37	SENT_312	[p21l883t337r1073b379],
37	state	NN	O	state	prep_to	34	SENT_312	[p21l1086t337r1211b379],
38	of	IN	O	of	_	0	SENT_312	[p21l1226t329r1280b379],
39	the	DT	O	the	det	44	SENT_312	[p21l1289t329r1374b379],
40	art	NN	O	art	nn	41	SENT_312	[p21l1389t337r1460b379],
41	ﬂuorescence	NN	O	ﬂuorescence	dep	44	SENT_312	[p21l1472t329r1806b379],
42	in	FW	O	in	nn	43	SENT_312	[p21l1822t332r1864b378],
43	situ	FW	O	situ	dep	41	SENT_312	[p21l1881t332r1971b379],
44	hybridization	NN	O	hybridization	prep_of	37	SENT_312	[p21l134t407r492b471],
45	.	.	O	.	_	0	SENT_312	[p21l134t407r492b471],

1	BMC	NNP	O	BMC	nn	2	SENT_313	[p21l506t409r625b457],
2	Clin	NNP	O	Clin	_	0	SENT_313	[p21l634t407r738b457],
3	.	.	O	.	_	0	SENT_313	[p21l634t407r738b457],

1	Pathol	NN	PERSON	pathol	_	0	SENT_314	[p21l753t407r928b457],
2	.	.	O	.	_	0	SENT_314	[p21l753t407r928b457],

1	12	CD	NUMBER	12	_	0	SENT_315	[p21l946t410r1023b465],
2	,	,	O	,	_	0	SENT_315	[p21l946t410r1023b465],
3	3	CD	NUMBER	3	number	4	SENT_315	[p21l1038t411r1064b457],
4	(	CD	NUMBER	(	appos	1	SENT_315	[p21l1082t408r1256b465],
5	2012	CD	DATE	2012	num	6	SENT_315	[p21l1082t408r1256b465],
6	)	NN	O	)	dep	4	SENT_315	[p21l1082t408r1256b465],
7	.	.	O	.	_	0	SENT_315	[p21l1082t408r1256b465],

1	19	CD	NUMBER	19	_	0	SENT_316	[p21l13t488r83b535],
2	.	.	O	.	_	0	SENT_316	[p21l13t488r83b535],

1	Paik	NNP	PERSON	Paik	nn	7	SENT_317	[p21l132t485r248b543],
2	,	,	O	,	_	0	SENT_317	[p21l132t485r248b543],
3	S.	NNP	O	S.	appos	7	SENT_317	[p21l262t487r315b543],
4	,	,	O	,	_	0	SENT_317	[p21l262t487r315b543],
5	Kim	NNP	PERSON	Kim	appos	7	SENT_317	[p21l332t488r442b543],
6	,	,	O	,	_	0	SENT_317	[p21l332t488r442b543],
7	C.	NNP	O	C.	_	0	SENT_317	[p21l457t487r503b535],
8	&	CC	O	&	nsubj	10	SENT_317	[p21l517t485r811b543],
9	Wo	MD	O	will	aux	10	SENT_317	[p21l517t485r811b543],
10	|	VB	O	|	rcmod	7	SENT_317	[p21l517t485r811b543],
11	mark	NN	O	mark	dobj	10	SENT_317	[p21l517t485r811b543],
12	,	,	O	,	_	0	SENT_317	[p21l517t485r811b543],
13	N.	NNP	O	N.	nn	15	SENT_317	[p21l828t488r876b535],
14	HER2	NN	O	her2	nn	15	SENT_317	[p21l893t487r1026b534],
15	status	NN	O	status	conj_and	11	SENT_317	[p21l1042t493r1195b535],
16	and	CC	O	and	_	0	SENT_317	[p21l1210t485r1306b535],
17	beneﬁt	NN	O	beneﬁt	conj_and	11	SENT_317	[p21l1325t485r1509b535],
18	from	IN	O	from	_	0	SENT_317	[p21l1521t485r1644b535],
19	adjuvant	JJ	O	adjuvant	amod	20	SENT_317	[p21l1660t485r1892b549],
20	trastuzumab	NN	O	trastuzumab	prep_from	10	SENT_317	[p21l130t563r463b613],
21	in	IN	O	in	_	0	SENT_317	[p21l480t566r522b612],
22	breast	NN	O	breast	nn	23	SENT_317	[p21l540t563r701b613],
23	cancer	NN	O	cancer	prep_in	20	SENT_317	[p21l714t578r896b613],
24	.	.	O	.	_	0	SENT_317	[p21l714t578r896b613],

1	N.	NNP	O	N.	nn	2	SENT_318	[p21l910t566r957b613],
2	Engl	NNP	O	Engl	_	0	SENT_318	[p21l972t563r1136b626],
3	.	.	O	.	_	0	SENT_318	[p21l972t563r1136b626],

1	J.	NNP	O	J.	nn	2	SENT_319	[p21l972t563r1136b626],
2	Med	NNP	O	Med	_	0	SENT_319	[p21l1150t563r1272b613],
3	.	.	O	.	_	0	SENT_319	[p21l1150t563r1272b613],

1	358	CD	NUMBER	358	_	0	SENT_320	[p21l1287t566r1402b621],
2	,	,	O	,	_	0	SENT_320	[p21l1287t566r1402b621],
3	1409-141	CD	NUMBER	1409-141	number	4	SENT_320	[p21l1420t566r1663b613],
4	1	CD	NUMBER	1	appos	1	SENT_320	[p21l1681t567r1696b612],
5	(	CD	NUMBER	(	num	7	SENT_320	[p21l1722t564r1896b621],
6	2008	CD	DATE	2008	num	7	SENT_320	[p21l1722t564r1896b621],
7	)	NN	O	)	dep	4	SENT_320	[p21l1722t564r1896b621],
8	.	.	O	.	_	0	SENT_320	[p21l1722t564r1896b621],

1	20	CD	NUMBER	20	_	0	SENT_321	[p21l9t644r83b691],
2	.	.	O	.	_	0	SENT_321	[p21l9t644r83b691],

1	Dowsett	NNP	PERSON	Dowsett	nn	3	SENT_322	[p21l132t643r361b699],
2	,	,	O	,	_	0	SENT_322	[p21l132t643r361b699],
3	M.	NNP	O	M.	_	0	SENT_322	[p21l378t644r436b691],
4	et	FW	O	et	nn	5	SENT_322	[p21l451t649r500b691],
5	al.	FW	O	al.	dep	3	SENT_322	[p21l509t641r566b691],
6	.	.	O	.	_	0	SENT_322	[p21l509t641r566b691],

1	Disease	NN	O	disease	_	0	SENT_323	[p21l583t641r902b691],
2	—	CD	NUMBER	—	num	4	SENT_323	[p21l583t641r902b691],
3	free	JJ	O	free	amod	4	SENT_323	[p21l583t641r902b691],
4	survival	NN	O	survival	dep	1	SENT_323	[p21l917t641r1114b691],
5	according	VBG	O	accord	_	0	SENT_323	[p21l1131t641r1389b704],
6	to	TO	O	to	prepc_according_to	1	SENT_323	[p21l1404t649r1457b691],
7	degree	NN	O	degree	pobj	1	SENT_323	[p21l1471t641r1654b704],
8	of	IN	O	of	_	0	SENT_323	[p21l1669t641r1723b691],
9	HER2	NN	O	her2	prep_of	7	SENT_323	[p21l1735t643r1868b690],

1	ampliﬁcation	NN	O	ampliﬁcation	nsubj	4	SENT_324	[p21l131t719r474b782],
2	for	IN	O	for	_	0	SENT_324	[p21l489t719r561b769],
3	patients	NNS	O	patient	prep_for	1	SENT_324	[p21l576t722r785b782],
4	treated	VBN	O	treat	conj_or	4	SENT_324	[p21l799t719r986b769],
5	with	IN	O	with	_	0	SENT_324	[p21l1002t719r1115b769],
6	adjuvant	JJ	O	adjuvant	amod	7	SENT_324	[p21l1131t719r1362b782],
7	chemotherapy	NN	O	chemotherapy	prep_with	4	SENT_324	[p21l1376t719r1763b783],
8	with	IN	O	with	_	0	SENT_324	[p21l1775t719r1888b769],
9	or	CC	O	or	_	0	SENT_324	[p21l1905t734r1958b769],
10	without	IN	O	without	_	0	SENT_324	[p21l130t797r337b847],
11	1	CD	DURATION	1	num	12	SENT_324	[p21l356t801r370b846],
12	year	NN	NUMBER	year	prep_with	4	SENT_324	[p21l393t812r505b861],
13	of	IN	O	of	_	0	SENT_324	[p21l518t797r572b847],
14	trastuzumab	NN	O	trastuzumab	prep_of	12	SENT_324	[p21l580t797r927b847],
15	:	:	O	:	_	0	SENT_324	[p21l580t797r927b847],
16	the	DT	O	the	det	19	SENT_324	[p21l940t797r1026b847],
17	HERA	NNP	ORGANIZATION	HERA	nn	19	SENT_324	[p21l1042t799r1183b846],
18	Tria	NNP	ORGANIZATION	Tria	nn	19	SENT_324	[p21l1192t797r1358b847],
19	|	NN	O	|	dep	12	SENT_324	[p21l1192t797r1358b847],
20	.	.	O	.	_	0	SENT_324	[p21l1192t797r1358b847],

1	J.	NNP	PERSON	J.	nn	2	SENT_325	[p21l1192t797r1358b847],
2	Clin	NNP	PERSON	Clin	_	0	SENT_325	[p21l1374t797r1478b847],
3	.	.	O	.	_	0	SENT_325	[p21l1374t797r1478b847],

1	Oncol	NN	O	oncol	_	0	SENT_326	[p21l1494t797r1654b847],
2	.	.	O	.	_	0	SENT_326	[p21l1494t797r1654b847],

1	27	CD	NUMBER	27	_	0	SENT_327	[p21l1668t800r1748b855],
2	,	,	O	,	_	0	SENT_327	[p21l1668t800r1748b855],
3	2962-2969	CD	DATE	2962-2969	number	4	SENT_327	[p21l1763t800r2052b847],
4	(	CD	NUMBER	(	appos	1	SENT_327	[p21l133t875r307b931],
5	2009	CD	DATE	2009	num	6	SENT_327	[p21l133t875r307b931],
6	)	NN	O	)	dep	4	SENT_327	[p21l133t875r307b931],
7	.	.	O	.	_	0	SENT_327	[p21l133t875r307b931],

1	21	CD	NUMBER	21	_	0	SENT_328	[p21l9t956r83b1002],
2	.	.	O	.	_	0	SENT_328	[p21l9t956r83b1002],

1	Wolff	NNP	PERSON	Wolff	_	0	SENT_329	[p21l129t952r276b1010],
2	,	,	O	,	_	0	SENT_329	[p21l129t952r276b1010],
3	A.C.	NNP	PERSON	A.C.	nn	4	SENT_329	[p21l290t954r388b1002],
4	etal.	NNP	PERSON	etal.	appos	1	SENT_329	[p21l403t952r531b1010],
5	;	:	O	;	_	0	SENT_329	[p21l403t952r531b1010],
6	American	NNP	ORGANIZATION	American	nn	7	SENT_329	[p21l544t955r793b1002],
7	Society	NNP	ORGANIZATION	Society	dep	1	SENT_329	[p21l810t954r1001b1016],
8	of	IN	ORGANIZATION	of	_	0	SENT_329	[p21l1014t952r1068b1002],
9	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_329	[p21l1078t952r1262b1002],
10	Oncology	NN	ORGANIZATION	oncology	prep_of	7	SENT_329	[p21l1279t952r1548b1016],
11	;	:	O	;	_	0	SENT_329	[p21l1279t952r1548b1016],
12	College	NNP	O	College	dep	7	SENT_329	[p21l1562t952r1759b1015],
13	of	IN	O	of	_	0	SENT_329	[p21l1774t952r1828b1002],
14	American	NNP	LOCATION	American	prep_of	12	SENT_329	[p21l1837t955r2086b1002],

1	Pathologists	NNS	O	pathologist	_	0	SENT_330	[p21l134t1030r465b1093],
2	.	.	O	.	_	0	SENT_330	[p21l134t1030r465b1093],

1	American	NNP	ORGANIZATION	American	nn	2	SENT_331	[p21l479t1033r728b1080],
2	Society	NNP	ORGANIZATION	Society	_	0	SENT_331	[p21l745t1032r935b1094],
3	of	IN	ORGANIZATION	of	_	0	SENT_331	[p21l948t1030r1002b1080],
4	Clinical	JJ	ORGANIZATION	clinical	amod	5	SENT_331	[p21l1012t1030r1197b1080],
5	Oncology/College	NN	ORGANIZATION	oncology/college	prep_of	2	SENT_331	[p21l1213t1030r1690b1094],
6	of	IN	ORGANIZATION	of	_	0	SENT_331	[p21l1705t1030r1759b1080],
7	American	NNP	ORGANIZATION	American	nn	10	SENT_331	[p21l1768t1033r2017b1080],
8	Pathologists	NNP	ORGANIZATION	Pathologists	nn	10	SENT_331	[p21l134t1108r452b1171],
9	guideline	NN	O	guideline	nn	10	SENT_331	[p21l467t1108r713b1171],
10	recommendations	NNS	O	recommendation	prep_of	2	SENT_331	[p21l730t1108r1210b1158],
11	for	IN	O	for	_	0	SENT_331	[p21l1224t1108r1296b1158],
12	human	JJ	O	human	amod	18	SENT_331	[p21l1311t1108r1493b1158],
13	epidermal	JJ	O	epidermal	dep	14	SENT_331	[p21l1509t1108r1774b1171],
14	growth	NN	O	growth	amod	18	SENT_331	[p21l1791t1108r1978b1171],
15	factor	NN	O	factor	nn	18	SENT_331	[p21l1993t1108r2147b1158],
16	receptor	NN	O	receptor	nn	18	SENT_331	[p21l133t1194r353b1249],
17	2	CD	NUMBER	2	num	18	SENT_331	[p21l367t1189r394b1235],
18	testing	NN	O	testing	prep_for	2	SENT_331	[p21l408t1189r588b1249],
19	in	IN	O	in	_	0	SENT_331	[p21l606t1189r649b1235],
20	breast	NN	O	breast	nn	21	SENT_331	[p21l667t1186r827b1236],
21	cancer	NN	O	cancer	prep_in	18	SENT_331	[p21l841t1201r1022b1236],
22	.	.	O	.	_	0	SENT_331	[p21l841t1201r1022b1236],

1	J.	NNP	PERSON	J.	nn	2	SENT_332	[p21l1032t1189r1067b1236],
2	Clin	NNP	PERSON	Clin	_	0	SENT_332	[p21l1083t1186r1187b1236],
3	.	.	O	.	_	0	SENT_332	[p21l1083t1186r1187b1236],

1	Oncol	NN	O	oncol	_	0	SENT_333	[p21l1203t1186r1363b1236],
2	.	.	O	.	_	0	SENT_333	[p21l1203t1186r1363b1236],

1	25	CD	NUMBER	25	_	0	SENT_334	[p21l1377t1190r1457b1244],
2	,	,	O	,	_	0	SENT_334	[p21l1377t1190r1457b1244],
3	1	CD	NUMBER	1	number	4	SENT_334	[p21l1476t1190r1490b1235],
4	18-145	CD	NUMBER	18-145	appos	1	SENT_334	[p21l1508t1189r1694b1236],
5	(	CD	NUMBER	(	num	7	SENT_334	[p21l1711t1187r1885b1244],
6	2007	CD	DATE	2007	num	7	SENT_334	[p21l1711t1187r1885b1244],
7	)	NN	O	)	dep	4	SENT_334	[p21l1711t1187r1885b1244],
8	.	.	O	.	_	0	SENT_334	[p21l1711t1187r1885b1244],

1	22	CD	NUMBER	22	_	0	SENT_335	[p21l9t1267r83b1314],
2	.	.	O	.	_	0	SENT_335	[p21l9t1267r83b1314],

1	Thorpe	NNP	PERSON	Thorpe	_	0	SENT_336	[p21l127t1264r329b1327],
2	,	,	O	,	_	0	SENT_336	[p21l127t1264r329b1327],
3	K.E.	NNP	PERSON	K.E.	nn	4	SENT_336	[p21l346t1267r432b1314],
4	etal	NNP	O	etal	appos	1	SENT_336	[p21l446t1264r561b1314],
5	.	.	O	.	_	0	SENT_336	[p21l446t1264r561b1314],

1	A	DT	O	a	det	5	SENT_337	[p21l575t1267r611b1313],
2	pragmatic	JJ	O	pragmatic	amod	5	SENT_337	[p21l627t1264r1231b1328],
3	—	NN	O	—	nn	5	SENT_337	[p21l627t1264r1231b1328],
4	exp	NN	O	exp	nn	5	SENT_337	[p21l627t1264r1231b1328],
5	|	NN	O	|	_	0	SENT_337	[p21l627t1264r1231b1328],
6	anatory	JJ	O	anatory	amod	12	SENT_337	[p21l627t1264r1231b1328],
7	continuum	NN	O	continuum	nn	12	SENT_337	[p21l1244t1267r1531b1314],
8	indicator	NN	O	indicator	nn	12	SENT_337	[p21l1549t1264r1781b1314],
9	summary	NN	O	summary	nn	12	SENT_337	[p21l1794t1279r2042b1328],
10	(	CD	NUMBER	(	num	12	SENT_337	[p21l133t1343r359b1400],
11	PRECIS	NN	O	precis	nn	12	SENT_337	[p21l133t1343r359b1400],
12	)	NN	O	)	dep	5	SENT_337	[p21l133t1343r359b1400],
13	:	:	O	:	_	0	SENT_337	[p21l133t1343r359b1400],
14	a	DT	O	a	det	15	SENT_337	[p21l373t1357r399b1392],
15	tool	NN	O	tool	dep	5	SENT_337	[p21l414t1342r514b1392],
16	to	TO	O	to	aux	17	SENT_337	[p21l530t1350r582b1392],
17	help	VB	O	help	infmod	15	SENT_337	[p21l599t1342r712b1405],
18	trial	NN	O	trial	nn	19	SENT_337	[p21l725t1342r822b1392],
19	designers	NNS	O	designer	dobj	17	SENT_337	[p21l839t1342r1104b1406],
20	.	.	O	.	_	0	SENT_337	[p21l839t1342r1104b1406],

1	J.	NNP	PERSON	J.	nn	2	SENT_338	[p21l1114t1345r1148b1392],
2	Clin	NNP	PERSON	Clin	_	0	SENT_338	[p21l1164t1342r1269b1392],
3	.	.	O	.	_	0	SENT_338	[p21l1164t1342r1269b1392],

1	Epidemiol	NNP	PERSON	Epidemiol	_	0	SENT_339	[p21l1284t1342r1547b1405],
2	.	.	O	.	_	0	SENT_339	[p21l1284t1342r1547b1405],

1	62	CD	NUMBER	62	_	0	SENT_340	[p21l1561t1346r1641b1400],
2	,	,	O	,	_	0	SENT_340	[p21l1561t1346r1641b1400],
3	464-475	CD	NUMBER	464-475	number	4	SENT_340	[p21l1654t1346r1878b1392],
4	(	CD	NUMBER	(	appos	1	SENT_340	[p21l1896t1343r2070b1400],
5	2009	CD	DATE	2009	num	6	SENT_340	[p21l1896t1343r2070b1400],
6	)	NN	O	)	dep	4	SENT_340	[p21l1896t1343r2070b1400],
7	.	.	O	.	_	0	SENT_340	[p21l1896t1343r2070b1400],

1	23	CD	NUMBER	23	_	0	SENT_341	[p21l9t1424r83b1470],
2	.	.	O	.	_	0	SENT_341	[p21l9t1424r83b1470],

1	Oye	NNP	O	Oye	_	0	SENT_342	[p21l130t1422r244b1484],
2	,	,	O	,	_	0	SENT_342	[p21l130t1422r244b1484],
3	K.	NNP	O	K.	nn	4	SENT_342	[p21l261t1423r303b1470],
4	etal	NN	O	etal	appos	1	SENT_342	[p21l317t1420r432b1470],
5	.	.	O	.	_	0	SENT_342	[p21l317t1420r432b1470],

1	Legal	JJ	O	legal	amod	2	SENT_343	[p21l449t1420r583b1484],
2	foundations	NNS	O	foundation	_	0	SENT_343	[p21l598t1420r916b1470],
3	of	IN	O	of	_	0	SENT_343	[p21l931t1420r985b1470],
4	adaptive	JJ	O	adaptive	amod	5	SENT_343	[p21l995t1420r1223b1483],
5	licensing	NN	O	licensing	prep_of	2	SENT_343	[p21l1239t1420r1481b1484],
6	.	.	O	.	_	0	SENT_343	[p21l1239t1420r1481b1484],

1	Clin	NNP	O	Clin	_	0	SENT_344	[p21l1496t1420r1601b1470],
2	.	.	O	.	_	0	SENT_344	[p21l1496t1420r1601b1470],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_345	[p21l1615t1420r1900b1470],
2	.	.	O	.	_	0	SENT_345	[p21l1615t1420r1900b1470],

1	Ther	NNP	O	Ther	_	0	SENT_346	[p21l1917t1420r2038b1470],
2	.	.	O	.	_	0	SENT_346	[p21l1917t1420r2038b1470],

1	94	CD	NUMBER	94	_	0	SENT_347	[p21l2052t1424r2132b1478],
2	,	,	O	,	_	0	SENT_347	[p21l2052t1424r2132b1478],

1	This	DT	O	this	det	2	SENT_348	[p21l430t1642r589b1706],
2	work	NN	O	work	nsubjpass	4	SENT_348	[p21l652t1642r850b1706],
3	is	VBZ	O	be	auxpass	4	SENT_348	[p21l913t1644r967b1706],
4	licensed	VBN	O	license	_	0	SENT_348	[p21l1034t1642r1356b1706],
5	under	IN	O	under	_	0	SENT_348	[p21l1426t1642r1658b1706],
6	a	DT	O	a	det	7	SENT_348	[p21l1721t1661r1757b1706],
7	Creative	JJ	MISC	creative	prep_under	4	SENT_348	[p21l1824t1644r2152b1706],

1	Commons	NNP	O	Commons	_	0	SENT_349	[p21l432t1749r828b1810],
2	Attribution-NonCommercial-No	NN	O	attribution-noncommercial-no	dep	1	SENT_349	[p21l875t1747r2152b1810],

1	Derivative	JJ	O	derivative	amod	2	SENT_350	[p21l13t1853r389b1914],
2	Works	NNP	O	Works	_	0	SENT_350	[p21l404t1851r633b1914],
3	3.0	CD	NUMBER	3.0	num	4	SENT_350	[p21l653t1856r761b1914],
4	License	NNP	O	License	dep	2	SENT_350	[p21l784t1853r1073b1914],
5	.	.	O	.	_	0	SENT_350	[p21l784t1853r1073b1914],

1	To	TO	O	to	aux	2	SENT_351	[p21l1087t1854r1172b1914],
2	view	VB	O	view	_	0	SENT_351	[p21l1190t1853r1364b1914],
3	a	DT	O	a	det	4	SENT_351	[p21l1382t1870r1419b1914],
4	copy	NN	O	copy	dobj	2	SENT_351	[p21l1440t1870r1618b1932],
5	of	IN	O	of	dep	13	SENT_351	[p21l1636t1851r1712b1914],
6	this	DT	O	this	det	7	SENT_351	[p21l1725t1851r1860b1914],
7	license	NN	O	license	pobj	5	SENT_351	[p21l1882t1851r2152b1924],
8	,	,	O	,	_	0	SENT_351	[p21l1882t1851r2152b1924],
9	visit	NN	O	visit	nn	10	SENT_351	[p21l8t1948r160b2009],
10	http://creativecommons.org/	NN	O	http://creativecommons.org/	appos	7	SENT_351	[p21l186t1946r2098b2027],
11	|	CD	NUMBER	|	num	12	SENT_351	[p21l186t1946r2098b2027],
12	icenses/by-nc-nd/3	NN	O	icenses/by-nc-nd/3	dep	10	SENT_351	[p21l186t1946r2098b2027],
13	.0	CD	NUMBER	.0	dep	2	SENT_351	[p21l186t1946r2098b2027],
14	/	:	O	/	punct	13	SENT_351	[p21l186t1946r2098b2027],

